hgnc_symbol,hgnc_id,go_name,go_id,go_domain,ncon_gene,ncon_go,mean_padj,cilow_padj,ciupp_padj,mean_pval,cilow_pval,ciupp_pval,mean_sim,sem_sim
LAP3,18449,extracellular exosome,GO:0070062,cellular component,10.0,33.0,4.460e-02,3.446e-02,5.771e-02,2.006e-02,1.466e-02,2.747e-02,8.777e-01,6.384e-03
LAP3,18449,focal adhesion,GO:0005925,cellular component,10.0,11.0,4.460e-02,3.446e-02,5.771e-02,2.059e-02,8.147e-03,5.203e-02,8.719e-01,1.779e-02
LAP3,18449,midbody,GO:0030496,cellular component,10.0,26.0,4.509e-02,3.364e-02,6.043e-02,3.473e-02,2.650e-02,4.550e-02,8.256e-01,6.610e-03
LAP3,18449,cytosol,GO:0005829,cellular component,10.0,78.0,4.509e-02,3.364e-02,6.043e-02,4.066e-02,3.080e-02,5.368e-02,8.091e-01,7.410e-03
LAP3,18449,nucleus,GO:0005634,cellular component,10.0,151.0,4.509e-02,3.364e-02,6.043e-02,4.267e-02,2.921e-02,6.232e-02,8.038e-01,1.027e-02
LAP3,18449,nucleoplasm,GO:0005654,cellular component,10.0,74.0,4.509e-02,3.364e-02,6.043e-02,4.439e-02,3.424e-02,5.756e-02,7.995e-01,7.029e-03
CREBBP,2348,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,50.0,41.0,4.781e-02,2.640e-02,8.659e-02,9.023e-03,5.176e-03,1.573e-02,9.292e-01,6.462e-03
CREBBP,2348,protein destabilization,GO:0031648,biological process,50.0,2.0,5.044e-02,2.786e-02,9.134e-02,1.684e-02,5.477e-03,5.179e-02,8.864e-01,1.978e-02
CREBBP,2348,cellular response to UV,GO:0034644,biological process,50.0,12.0,5.299e-02,3.304e-02,8.500e-02,2.747e-02,2.081e-02,3.625e-02,8.489e-01,6.596e-03
CREBBP,2348,"regulation of transcription, DNA-templated",GO:0006355,biological process,50.0,36.0,5.299e-02,3.304e-02,8.500e-02,2.913e-02,1.346e-02,6.308e-02,8.421e-01,1.896e-02
CREBBP,2348,positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030511,biological process,50.0,4.0,6.302e-02,3.437e-02,1.155e-01,4.882e-02,2.939e-02,8.109e-02,7.884e-01,1.376e-02
CREBBP,2348,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,50.0,54.0,7.312e-02,2.946e-02,1.815e-01,5.638e-02,1.807e-02,1.759e-01,7.688e-01,3.145e-02
CREBBP,2348,N-terminal peptidyl-lysine acetylation,GO:0018076,biological process,50.0,4.0,7.839e-02,2.605e-02,2.359e-01,6.997e-02,2.259e-02,2.168e-01,7.425e-01,3.505e-02
CREBBP,2348,protein acetylation,GO:0006473,biological process,50.0,10.0,8.661e-02,2.462e-02,3.047e-01,7.174e-02,1.494e-02,3.445e-01,7.353e-01,5.067e-02
CREBBP,2348,histone acetylation,GO:0016573,biological process,50.0,8.0,8.813e-02,2.744e-02,2.830e-01,7.183e-02,1.701e-02,3.033e-01,7.370e-01,4.114e-02
CREBBP,2348,nuclear chromatin,GO:0000790,cellular component,50.0,14.0,4.833e-02,2.574e-02,9.074e-02,8.624e-03,2.215e-03,3.358e-02,9.274e-01,1.832e-02
CREBBP,2348,nucleus,GO:0005634,cellular component,50.0,151.0,5.299e-02,3.304e-02,8.500e-02,2.389e-02,1.204e-02,4.741e-02,8.610e-01,1.508e-02
CREBBP,2348,nucleoplasm,GO:0005654,cellular component,50.0,74.0,5.299e-02,3.304e-02,8.500e-02,3.186e-02,1.901e-02,5.337e-02,8.337e-01,1.257e-02
CREBBP,2348,cytoplasm,GO:0005737,cellular component,50.0,69.0,5.299e-02,3.304e-02,8.500e-02,3.457e-02,1.647e-02,7.259e-02,8.250e-01,1.814e-02
CREBBP,2348,nuclear body,GO:0016604,cellular component,50.0,30.0,6.801e-02,2.753e-02,1.680e-01,5.623e-02,2.179e-02,1.451e-01,7.703e-01,2.781e-02
CREBBP,2348,RNA polymerase II transcription factor binding,GO:0001085,molecular function,50.0,6.0,4.781e-02,2.640e-02,8.659e-02,2.818e-03,1.006e-03,7.893e-03,9.738e-01,5.598e-03
CREBBP,2348,p53 binding,GO:0002039,molecular function,50.0,5.0,4.781e-02,2.640e-02,8.659e-02,5.018e-03,3.766e-03,6.685e-03,9.558e-01,3.002e-03
CREBBP,2348,transcription factor binding,GO:0008134,molecular function,50.0,19.0,4.990e-02,2.850e-02,8.737e-02,8.954e-03,8.048e-03,9.961e-03,9.295e-01,1.302e-03
CREBBP,2348,transcription corepressor activity,GO:0003714,molecular function,50.0,6.0,5.044e-02,2.786e-02,9.134e-02,1.387e-02,9.302e-03,2.069e-02,9.052e-01,6.439e-03
CREBBP,2348,proximal promoter sequence-specific DNA binding,GO:0000987,molecular function,50.0,5.0,5.044e-02,2.786e-02,9.134e-02,1.756e-02,6.303e-03,4.894e-02,8.841e-01,1.737e-02
CREBBP,2348,transcription coactivator activity,GO:0003713,molecular function,50.0,8.0,5.169e-02,3.042e-02,8.785e-02,2.109e-02,1.505e-02,2.955e-02,8.734e-01,6.988e-03
CREBBP,2348,protein binding,GO:0005515,molecular function,50.0,332.0,5.299e-02,3.304e-02,8.500e-02,3.435e-02,2.247e-02,5.251e-02,8.268e-01,1.032e-02
CREBBP,2348,chromatin binding,GO:0003682,molecular function,50.0,17.0,5.299e-02,3.304e-02,8.500e-02,3.519e-02,2.056e-02,6.022e-02,8.232e-01,1.354e-02
CREBBP,2348,damaged DNA binding,GO:0003684,molecular function,50.0,6.0,5.545e-02,2.936e-02,1.047e-01,2.807e-02,6.916e-03,1.139e-01,8.409e-01,2.947e-02
CREBBP,2348,MRF binding,GO:0043426,molecular function,50.0,2.0,6.391e-02,3.030e-02,1.348e-01,4.082e-02,8.721e-03,1.910e-01,8.025e-01,3.732e-02
CREBBP,2348,histone acetyltransferase activity,GO:0004402,molecular function,50.0,6.0,9.934e-02,2.472e-02,3.993e-01,8.606e-02,1.606e-02,4.611e-01,7.110e-01,5.065e-02
CREBBP,2348,acetyltransferase activity,GO:0016407,molecular function,50.0,12.0,1.282e-01,1.631e-02,1.008e+00,1.190e-01,1.371e-02,1.033e+00,6.524e-01,8.183e-02
ZNF263,13056,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,5.0,41.0,3.743e-02,1.983e-02,7.065e-02,1.426e-02,3.767e-03,5.398e-02,8.977e-01,1.931e-02
ZNF263,13056,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,5.0,54.0,6.420e-02,4.830e-02,8.535e-02,5.833e-02,3.475e-02,9.792e-02,7.677e-01,1.463e-02
ZNF263,13056,sequence-specific DNA binding,GO:0043565,molecular function,5.0,12.0,4.388e-02,3.688e-02,5.221e-02,2.162e-02,1.625e-02,2.876e-02,8.712e-01,6.019e-03
ZNF263,13056,protein binding,GO:0005515,molecular function,5.0,332.0,5.330e-02,3.539e-02,8.027e-02,4.754e-02,2.341e-02,9.655e-02,7.905e-01,1.855e-02
KDM7A,22224,,,,nan,nan,,,,,,,,
DBF4,17364,positive regulation of nuclear cell cycle DNA replication,GO:0010571,biological process,12.0,8.0,3.723e-02,2.471e-02,5.609e-02,1.396e-02,3.361e-03,5.801e-02,8.971e-01,2.525e-02
DBF4,17364,regulation of cell cycle phase transition,GO:1901987,biological process,12.0,9.0,3.756e-02,2.479e-02,5.690e-02,2.423e-02,1.112e-02,5.280e-02,8.594e-01,1.731e-02
DBF4,17364,Dbf4-dependent protein kinase complex,GO:0031431,cellular component,12.0,2.0,4.072e-02,1.177e-02,1.408e-01,1.402e-02,6.070e-04,3.238e-01,8.741e-01,6.235e-02
DBF4,17364,nuclear body,GO:0016604,cellular component,12.0,30.0,5.613e-02,2.721e-02,1.158e-01,4.016e-02,1.124e-02,1.435e-01,8.065e-01,3.396e-02
DBF4,17364,nucleus,GO:0005634,cellular component,12.0,151.0,5.836e-02,2.940e-02,1.158e-01,3.590e-02,8.469e-03,1.522e-01,8.166e-01,3.418e-02
DBF4,17364,protein serine/threonine kinase activator activity,GO:0043539,molecular function,12.0,4.0,3.756e-02,2.479e-02,5.690e-02,2.373e-02,1.047e-02,5.381e-02,8.609e-01,1.774e-02
DBF4,17364,protein binding,GO:0005515,molecular function,12.0,332.0,6.561e-02,3.195e-02,1.347e-01,5.624e-02,1.629e-02,1.942e-01,7.688e-01,3.341e-02
GTF2IRD1,4661,nucleoplasm,GO:0005654,cellular component,6.0,74.0,2.820e-02,1.977e-02,4.021e-02,2.206e-02,1.358e-02,3.582e-02,8.688e-01,9.997e-03
GTF2IRD1,4661,cytosol,GO:0005829,cellular component,6.0,78.0,2.820e-02,1.977e-02,4.021e-02,2.264e-02,2.082e-02,2.462e-02,8.674e-01,1.881e-03
GTF2IRD1,4661,protein binding,GO:0005515,molecular function,6.0,332.0,2.923e-02,1.816e-02,4.705e-02,2.681e-02,1.441e-02,4.991e-02,8.508e-01,1.468e-02
SS18L2,15593,,,,nan,nan,,,,,,,,
ANLN,14082,positive regulation of bleb assembly,GO:1904172,biological process,21.0,3.0,5.064e-02,3.277e-02,7.826e-02,1.488e-02,4.551e-03,4.862e-02,8.946e-01,2.179e-02
ANLN,14082,septin ring organization,GO:0031106,biological process,21.0,5.0,5.064e-02,3.277e-02,7.826e-02,2.051e-02,1.231e-02,3.415e-02,8.749e-01,1.008e-02
ANLN,14082,cortical cytoskeleton organization,GO:0030865,biological process,21.0,5.0,5.110e-02,3.261e-02,8.007e-02,1.837e-02,5.751e-03,5.867e-02,8.801e-01,2.395e-02
ANLN,14082,protein localization to mitotic actomyosin contractile ring,GO:1904498,biological process,21.0,2.0,5.269e-02,3.121e-02,8.897e-02,2.601e-02,9.965e-03,6.789e-02,8.520e-01,2.275e-02
ANLN,14082,actomyosin contractile ring assembly,GO:0000915,biological process,21.0,5.0,5.431e-02,3.091e-02,9.541e-02,4.061e-02,2.245e-02,7.348e-02,8.081e-01,1.514e-02
ANLN,14082,mitotic cytokinesis,GO:0000281,biological process,21.0,12.0,6.380e-02,2.589e-02,1.572e-01,5.417e-02,2.137e-02,1.373e-01,7.748e-01,2.517e-02
ANLN,14082,glomerular visceral epithelial cell migration,GO:0090521,biological process,21.0,2.0,7.649e-02,1.803e-02,3.244e-01,4.597e-02,2.832e-03,7.462e-01,7.721e-01,7.126e-02
ANLN,14082,bleb,GO:0032059,cellular component,21.0,2.0,5.064e-02,3.277e-02,7.826e-02,1.780e-02,1.169e-02,2.710e-02,8.872e-01,7.737e-03
ANLN,14082,actomyosin contractile ring,GO:0005826,cellular component,21.0,5.0,5.064e-02,3.277e-02,7.826e-02,1.997e-02,1.212e-02,3.293e-02,8.775e-01,1.037e-02
ANLN,14082,cell cortex region,GO:0099738,cellular component,21.0,17.0,5.105e-02,3.251e-02,8.016e-02,2.745e-02,1.681e-02,4.484e-02,8.486e-01,1.139e-02
ANLN,14082,actin cytoskeleton,GO:0015629,cellular component,21.0,6.0,6.050e-02,2.504e-02,1.462e-01,2.264e-02,1.991e-03,2.575e-01,8.479e-01,4.837e-02
ANLN,14082,midbody,GO:0030496,cellular component,21.0,26.0,6.752e-02,2.332e-02,1.955e-01,5.605e-02,1.524e-02,2.062e-01,7.686e-01,3.595e-02
ANLN,14082,nucleoplasm,GO:0005654,cellular component,21.0,74.0,8.405e-02,2.642e-02,2.674e-01,8.227e-02,2.730e-02,2.479e-01,7.220e-01,3.370e-02
ANLN,14082,GTP-Rho binding,GO:0017049,molecular function,21.0,2.0,5.064e-02,3.277e-02,7.826e-02,2.369e-02,1.110e-02,5.055e-02,8.606e-01,1.586e-02
ANLN,14082,cadherin binding,GO:0045296,molecular function,21.0,9.0,5.079e-02,3.320e-02,7.771e-02,2.529e-02,1.398e-02,4.575e-02,8.564e-01,1.373e-02
ANLN,14082,actin binding,GO:0003779,molecular function,21.0,7.0,5.186e-02,3.244e-02,8.289e-02,3.582e-02,2.907e-02,4.413e-02,8.226e-01,4.966e-03
WIZ,30917,,,,nan,nan,,,,,,,,
TACC3,11524,microtubule cytoskeleton organization,GO:0000226,biological process,20.0,25.0,5.276e-02,3.565e-02,7.808e-02,1.466e-02,8.862e-03,2.426e-02,9.009e-01,7.849e-03
TACC3,11524,microtubule cytoskeleton organization involved in mitosis,GO:1902850,biological process,20.0,7.0,5.276e-02,3.565e-02,7.808e-02,2.108e-02,1.286e-02,3.455e-02,8.730e-01,1.020e-02
TACC3,11524,regulation of mitotic spindle organization,GO:0060236,biological process,20.0,9.0,5.438e-02,3.759e-02,7.867e-02,4.431e-02,2.569e-02,7.642e-02,7.993e-01,1.483e-02
TACC3,11524,cell population proliferation,GO:0008283,biological process,20.0,35.0,6.675e-02,2.877e-02,1.549e-01,4.580e-02,1.310e-02,1.601e-01,7.921e-01,3.480e-02
TACC3,11524,cerebral cortex development,GO:0021987,biological process,20.0,2.0,7.738e-02,4.693e-02,1.276e-01,6.801e-02,3.194e-02,1.448e-01,7.481e-01,2.288e-02
TACC3,11524,metaphase/anaphase transition of mitotic cell cycle,GO:0007091,biological process,20.0,4.0,8.219e-02,5.637e-02,1.198e-01,7.687e-02,4.324e-02,1.367e-01,7.338e-01,1.750e-02
TACC3,11524,microtubule organizing center,GO:0005815,cellular component,20.0,16.0,5.276e-02,3.565e-02,7.808e-02,1.038e-02,4.077e-03,2.642e-02,9.197e-01,1.312e-02
TACC3,11524,mitotic spindle,GO:0072686,cellular component,20.0,17.0,5.276e-02,3.565e-02,7.808e-02,1.844e-02,8.533e-03,3.985e-02,8.825e-01,1.414e-02
TACC3,11524,cytoplasm,GO:0005737,cellular component,20.0,69.0,5.276e-02,3.565e-02,7.808e-02,3.152e-02,1.346e-02,7.381e-02,8.337e-01,2.084e-02
TACC3,11524,cytosol,GO:0005829,cellular component,20.0,78.0,5.276e-02,3.565e-02,7.808e-02,3.487e-02,1.689e-02,7.199e-02,8.236e-01,1.850e-02
TACC3,11524,protein binding,GO:0005515,molecular function,20.0,332.0,5.387e-02,3.840e-02,7.558e-02,4.010e-02,2.550e-02,6.306e-02,8.102e-01,1.205e-02
PHLDB1,23697,regulation of gastrulation,GO:0010470,biological process,7.0,13.0,2.039e-02,1.313e-02,3.166e-02,1.032e-02,6.874e-03,1.551e-02,9.226e-01,4.977e-03
PHLDB1,23697,regulation of microtubule cytoskeleton organization,GO:0070507,biological process,7.0,11.0,2.093e-02,1.472e-02,2.977e-02,1.443e-02,1.039e-02,2.004e-02,9.027e-01,5.414e-03
PHLDB1,23697,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,GO:1904261,biological process,7.0,4.0,2.182e-02,1.240e-02,3.838e-02,1.214e-02,2.034e-03,7.246e-02,9.052e-01,2.375e-02
PHLDB1,23697,regulation of epithelial to mesenchymal transition,GO:0010717,biological process,7.0,7.0,2.191e-02,1.233e-02,3.892e-02,1.698e-02,5.850e-03,4.929e-02,8.863e-01,1.863e-02
PHLDB1,23697,basal cortex,GO:0045180,cellular component,7.0,2.0,2.249e-02,1.718e-02,2.943e-02,1.897e-02,9.946e-03,3.617e-02,8.809e-01,1.253e-02
NCAPH2,25071,chromosome organization,GO:0051276,biological process,16.0,21.0,5.201e-02,3.098e-02,8.731e-02,1.981e-02,1.081e-02,3.631e-02,8.774e-01,1.278e-02
NCAPH2,25071,meiotic chromosome condensation,GO:0010032,biological process,16.0,3.0,5.201e-02,3.098e-02,8.731e-02,2.122e-02,1.061e-02,4.245e-02,8.710e-01,1.435e-02
NCAPH2,25071,mitotic sister chromatid separation,GO:0051306,biological process,16.0,3.0,5.627e-02,2.658e-02,1.191e-01,2.609e-02,8.919e-03,7.630e-02,8.505e-01,2.261e-02
NCAPH2,25071,condensed chromosome,GO:0000793,cellular component,16.0,6.0,5.201e-02,3.098e-02,8.731e-02,1.546e-02,6.671e-03,3.581e-02,8.951e-01,1.361e-02
NCAPH2,25071,condensin complex,GO:0000796,cellular component,16.0,6.0,5.201e-02,3.098e-02,8.731e-02,1.667e-02,7.132e-03,3.895e-02,8.897e-01,1.389e-02
NCAPH2,25071,intercellular bridge,GO:0045171,cellular component,16.0,25.0,6.349e-02,2.801e-02,1.439e-01,4.850e-02,2.233e-02,1.053e-01,7.882e-01,2.031e-02
NCAPH2,25071,membrane,GO:0016020,cellular component,16.0,53.0,6.349e-02,2.801e-02,1.439e-01,4.868e-02,1.512e-02,1.567e-01,7.859e-01,3.062e-02
NCAPH2,25071,nucleus,GO:0005634,cellular component,16.0,151.0,6.349e-02,2.801e-02,1.439e-01,5.435e-02,1.859e-02,1.589e-01,7.736e-01,2.860e-02
NCAPH2,25071,nucleoplasm,GO:0005654,cellular component,16.0,74.0,6.349e-02,2.801e-02,1.439e-01,5.936e-02,2.845e-02,1.238e-01,7.651e-01,2.075e-02
NCAPH2,25071,cell junction,GO:0030054,cellular component,16.0,9.0,6.349e-02,2.801e-02,1.439e-01,6.091e-02,2.626e-02,1.412e-01,7.617e-01,2.364e-02
NCAPH2,25071,chromatin binding,GO:0003682,molecular function,16.0,17.0,6.349e-02,2.801e-02,1.439e-01,4.540e-02,1.601e-02,1.287e-01,7.945e-01,2.670e-02
NCAPH2,25071,protein binding,GO:0005515,molecular function,16.0,332.0,6.349e-02,2.801e-02,1.439e-01,5.778e-02,2.507e-02,1.332e-01,7.679e-01,2.307e-02
ZFYVE16,20756,,,,nan,nan,,,,,,,,
CAPG,1474,centriole,GO:0005814,cellular component,14.0,5.0,4.811e-02,3.786e-02,6.115e-02,1.519e-02,1.021e-02,2.259e-02,8.988e-01,6.626e-03
CAPG,1474,mitotic spindle,GO:0072686,cellular component,14.0,17.0,4.811e-02,3.786e-02,6.115e-02,2.517e-02,2.177e-02,2.909e-02,8.575e-01,3.272e-03
CAPG,1474,extracellular exosome,GO:0070062,cellular component,14.0,33.0,4.811e-02,3.786e-02,6.115e-02,3.024e-02,1.853e-02,4.935e-02,8.391e-01,1.168e-02
CAPG,1474,nucleolus,GO:0005730,cellular component,14.0,41.0,4.894e-02,3.933e-02,6.089e-02,3.375e-02,2.298e-02,4.955e-02,8.282e-01,9.301e-03
CAPG,1474,nucleus,GO:0005634,cellular component,14.0,151.0,4.894e-02,3.933e-02,6.089e-02,3.912e-02,2.815e-02,5.436e-02,8.132e-01,8.673e-03
CAPG,1474,nucleoplasm,GO:0005654,cellular component,14.0,74.0,4.894e-02,3.933e-02,6.089e-02,4.296e-02,3.458e-02,5.337e-02,8.033e-01,5.882e-03
CAPG,1474,cytoplasm,GO:0005737,cellular component,14.0,69.0,4.894e-02,3.933e-02,6.089e-02,4.531e-02,3.637e-02,5.644e-02,7.972e-01,5.914e-03
CAPG,1474,Flemming body,GO:0090543,cellular component,14.0,4.0,5.622e-02,3.819e-02,8.276e-02,4.697e-02,1.744e-02,1.265e-01,7.909e-01,2.572e-02
CAPG,1474,cadherin binding,GO:0045296,molecular function,14.0,9.0,4.811e-02,3.786e-02,6.115e-02,2.016e-02,1.841e-02,2.209e-02,8.779e-01,1.859e-03
CAPG,1474,protein domain specific binding,GO:0019904,molecular function,14.0,82.0,4.811e-02,3.786e-02,6.115e-02,2.127e-02,1.677e-02,2.698e-02,8.730e-01,5.145e-03
CAPG,1474,protein-containing complex binding,GO:0044877,molecular function,14.0,79.0,4.811e-02,3.786e-02,6.115e-02,2.639e-02,1.141e-02,6.106e-02,8.508e-01,1.841e-02
CAPG,1474,protein binding,GO:0005515,molecular function,14.0,332.0,4.894e-02,3.933e-02,6.089e-02,4.031e-02,3.361e-02,4.834e-02,8.103e-01,4.732e-03
DTNBP1,17328,neuron projection development,GO:0031175,biological process,16.0,12.0,3.249e-02,1.659e-02,6.365e-02,1.271e-02,9.853e-03,1.640e-02,9.110e-01,3.573e-03
DTNBP1,17328,microtubule cytoskeleton,GO:0015630,cellular component,16.0,17.0,3.249e-02,1.659e-02,6.365e-02,1.539e-02,6.091e-03,3.888e-02,8.951e-01,1.412e-02
DTNBP1,17328,midbody,GO:0030496,cellular component,16.0,26.0,3.249e-02,1.659e-02,6.365e-02,1.929e-02,6.718e-03,5.541e-02,8.763e-01,1.960e-02
DTNBP1,17328,neuron projection,GO:0043005,cellular component,16.0,21.0,3.341e-02,1.873e-02,5.960e-02,2.304e-02,1.085e-02,4.892e-02,8.636e-01,1.564e-02
DTNBP1,17328,BLOC-1 complex,GO:0031083,cellular component,16.0,2.0,3.341e-02,1.873e-02,5.960e-02,2.789e-02,1.995e-02,3.900e-02,8.475e-01,7.834e-03
DTNBP1,17328,synaptic vesicle membrane,GO:0030672,cellular component,16.0,2.0,3.341e-02,1.873e-02,5.960e-02,3.060e-02,1.971e-02,4.751e-02,8.383e-01,1.032e-02
DTNBP1,17328,postsynaptic density,GO:0014069,cellular component,16.0,4.0,4.001e-02,1.167e-02,1.371e-01,2.961e-02,4.011e-03,2.186e-01,8.294e-01,4.455e-02
DTNBP1,17328,protein binding,GO:0005515,molecular function,16.0,332.0,3.341e-02,1.873e-02,5.960e-02,3.028e-02,1.798e-02,5.101e-02,8.390e-01,1.227e-02
CELF2,2550,,,,nan,nan,,,,,,,,
PIK3CB,8976,phosphatidylinositol phosphorylation,GO:0046854,biological process,25.0,5.0,1.201e-01,6.503e-02,2.217e-01,3.491e-02,2.806e-03,4.344e-01,8.058e-01,5.373e-02
PIK3CB,8976,phosphatidylinositol 3-kinase signaling,GO:0014065,biological process,25.0,3.0,1.237e-01,7.419e-02,2.063e-01,1.499e-02,1.067e-02,2.107e-02,9.002e-01,5.888e-03
PIK3CB,8976,phosphorylation,GO:0016310,biological process,25.0,12.0,1.239e-01,6.347e-02,2.419e-01,5.260e-02,2.324e-03,1.191e+00,7.511e-01,7.434e-02
PIK3CB,8976,phosphatidylinositol-mediated signaling,GO:0048015,biological process,25.0,4.0,1.286e-01,8.798e-02,1.881e-01,2.274e-02,1.397e-02,3.702e-02,8.660e-01,1.069e-02
PIK3CB,8976,positive regulation of neutrophil apoptotic process,GO:0033031,biological process,25.0,6.0,1.286e-01,8.798e-02,1.881e-01,3.562e-02,2.716e-02,4.671e-02,8.230e-01,6.500e-03
PIK3CB,8976,phosphatidylinositol-3-phosphate biosynthetic process,GO:0036092,biological process,25.0,3.0,1.286e-01,8.798e-02,1.881e-01,3.868e-02,2.464e-02,6.073e-02,8.139e-01,1.149e-02
PIK3CB,8976,positive regulation of gene expression,GO:0010628,biological process,25.0,20.0,1.359e-01,1.118e-01,1.652e-01,2.800e-02,6.428e-03,1.220e-01,8.403e-01,3.083e-02
PIK3CB,8976,cell migration,GO:0016477,biological process,25.0,38.0,1.359e-01,1.118e-01,1.652e-01,6.058e-02,3.233e-02,1.135e-01,7.627e-01,1.839e-02
PIK3CB,8976,regulation of cell-matrix adhesion,GO:0001952,biological process,25.0,7.0,1.702e-01,1.274e-01,2.273e-01,1.587e-01,1.266e-01,1.987e-01,6.311e-01,8.722e-03
PIK3CB,8976,plasma membrane,GO:0005886,cellular component,25.0,24.0,1.599e-01,1.113e-01,2.297e-01,1.027e-01,8.050e-02,1.310e-01,6.958e-01,8.134e-03
PIK3CB,8976,midbody,GO:0030496,cellular component,25.0,26.0,1.608e-01,1.099e-01,2.352e-01,9.793e-02,5.754e-02,1.667e-01,7.017e-01,1.720e-02
PIK3CB,8976,nucleus,GO:0005634,cellular component,25.0,151.0,1.608e-01,1.099e-01,2.352e-01,1.105e-01,5.446e-02,2.242e-01,6.840e-01,2.480e-02
PIK3CB,8976,cytoplasm,GO:0005737,cellular component,25.0,69.0,1.608e-01,1.099e-01,2.352e-01,1.161e-01,8.821e-02,1.527e-01,6.785e-01,9.628e-03
PIK3CB,8976,nucleolus,GO:0005730,cellular component,25.0,41.0,1.608e-01,1.099e-01,2.352e-01,1.277e-01,7.150e-02,2.280e-01,6.634e-01,2.132e-02
PIK3CB,8976,membrane,GO:0016020,cellular component,25.0,53.0,1.725e-01,1.208e-01,2.463e-01,1.471e-01,9.624e-02,2.249e-01,6.426e-01,1.555e-02
PIK3CB,8976,phosphatidylinositol 3-kinase complex,GO:0005942,cellular component,25.0,8.0,2.111e-01,1.124e-01,3.964e-01,2.102e-01,1.104e-01,3.999e-01,5.804e-01,2.817e-02
PIK3CB,8976,1-phosphatidylinositol-3-kinase activity,GO:0016303,molecular function,25.0,4.0,1.608e-01,1.099e-01,2.352e-01,9.354e-02,3.600e-02,2.430e-01,7.056e-01,3.222e-02
PIK3CB,8976,1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0035005,molecular function,25.0,4.0,1.608e-01,1.099e-01,2.352e-01,9.801e-02,3.841e-02,2.501e-01,6.994e-01,3.214e-02
PIK3CB,8976,protein binding,GO:0005515,molecular function,25.0,332.0,1.642e-01,1.149e-01,2.346e-01,1.286e-01,8.091e-02,2.045e-01,6.628e-01,1.667e-02
PIK3CB,8976,kinase activity,GO:0016301,molecular function,25.0,138.0,1.812e-01,8.254e-02,3.979e-01,1.548e-01,5.380e-02,4.457e-01,6.282e-01,4.382e-02
SYNE2,17084,centriole-centriole cohesion,GO:0010457,biological process,29.0,4.0,1.360e-01,5.846e-02,3.165e-01,5.233e-02,1.611e-02,1.700e-01,7.774e-01,3.432e-02
SYNE2,17084,centrosome localization,GO:0051642,biological process,29.0,5.0,1.406e-01,6.177e-02,3.202e-01,1.141e-01,6.085e-02,2.140e-01,6.798e-01,2.174e-02
SYNE2,17084,cytoskeletal anchoring at nuclear membrane,GO:0090286,biological process,29.0,3.0,1.495e-01,5.410e-02,4.129e-01,1.150e-01,3.924e-02,3.371e-01,6.755e-01,3.773e-02
SYNE2,17084,nuclear migration,GO:0007097,biological process,29.0,14.0,1.508e-01,4.610e-02,4.930e-01,1.109e-01,2.057e-02,5.982e-01,6.714e-01,6.487e-02
SYNE2,17084,extracellular exosome,GO:0070062,cellular component,29.0,33.0,1.360e-01,5.846e-02,3.165e-01,3.584e-02,1.046e-02,1.228e-01,8.187e-01,2.969e-02
SYNE2,17084,centrosome,GO:0005813,cellular component,29.0,31.0,1.360e-01,5.846e-02,3.165e-01,4.136e-02,1.892e-02,9.040e-02,8.057e-01,1.982e-02
SYNE2,17084,aggresome,GO:0016235,cellular component,29.0,2.0,1.360e-01,5.846e-02,3.165e-01,4.399e-02,3.950e-03,4.899e-01,7.836e-01,5.697e-02
SYNE2,17084,focal adhesion,GO:0005925,cellular component,29.0,11.0,1.360e-01,5.846e-02,3.165e-01,5.406e-02,2.660e-02,1.099e-01,7.761e-01,1.948e-02
SYNE2,17084,nucleus,GO:0005634,cellular component,29.0,151.0,1.360e-01,5.846e-02,3.165e-01,6.866e-02,2.686e-02,1.755e-01,7.460e-01,2.892e-02
SYNE2,17084,nuclear envelope,GO:0005635,cellular component,29.0,4.0,1.360e-01,5.846e-02,3.165e-01,7.339e-02,4.701e-02,1.146e-01,7.401e-01,1.319e-02
SYNE2,17084,cytoplasm,GO:0005737,cellular component,29.0,69.0,1.360e-01,5.846e-02,3.165e-01,7.642e-02,2.602e-02,2.245e-01,7.314e-01,3.457e-02
SYNE2,17084,filopodium membrane,GO:0031527,cellular component,29.0,2.0,1.360e-01,5.846e-02,3.165e-01,8.451e-02,3.372e-02,2.118e-01,7.194e-01,3.022e-02
SYNE2,17084,lamellipodium membrane,GO:0031258,cellular component,29.0,4.0,1.360e-01,5.846e-02,3.165e-01,9.311e-02,3.908e-02,2.219e-01,7.068e-01,2.868e-02
SYNE2,17084,mitochondrion,GO:0005739,cellular component,29.0,19.0,1.387e-01,6.050e-02,3.181e-01,5.636e-02,1.402e-02,2.266e-01,7.676e-01,3.728e-02
SYNE2,17084,sarcoplasmic reticulum,GO:0016529,cellular component,29.0,2.0,1.406e-01,6.177e-02,3.202e-01,6.255e-02,1.095e-02,3.574e-01,7.518e-01,4.776e-02
SYNE2,17084,intermediate filament cytoskeleton,GO:0045111,cellular component,29.0,8.0,1.406e-01,6.177e-02,3.202e-01,7.145e-02,1.523e-02,3.351e-01,7.366e-01,4.400e-02
SYNE2,17084,Z disc,GO:0030018,cellular component,29.0,4.0,1.508e-01,4.610e-02,4.930e-01,1.143e-01,2.371e-02,5.512e-01,6.693e-01,5.910e-02
SYNE2,17084,nuclear membrane,GO:0031965,cellular component,29.0,9.0,1.528e-01,5.149e-02,4.533e-01,1.287e-01,4.267e-02,3.879e-01,6.584e-01,4.031e-02
SYNE2,17084,meiotic nuclear membrane microtubule tethering complex,GO:0034993,cellular component,29.0,3.0,1.543e-01,5.214e-02,4.564e-01,1.440e-01,5.676e-02,3.655e-01,6.420e-01,3.638e-02
SYNE2,17084,nuclear lumen,GO:0031981,cellular component,29.0,2.0,2.650e-01,4.004e-02,1.754e+00,2.557e-01,3.618e-02,1.807e+00,5.060e-01,1.023e-01
SYNE2,17084,protein binding,GO:0005515,molecular function,29.0,332.0,1.360e-01,5.846e-02,3.165e-01,7.289e-02,2.242e-02,2.370e-01,7.371e-01,3.660e-02
HPF1,26051,regulation of protein ADP-ribosylation,GO:0010835,biological process,9.0,3.0,6.890e-02,1.248e-02,3.803e-01,2.482e-02,1.224e-03,5.031e-01,8.309e-01,5.447e-02
HPF1,26051,peptidyl-serine ADP-ribosylation,GO:0018312,biological process,9.0,3.0,1.091e-01,7.924e-02,1.502e-01,5.615e-02,3.511e-02,8.980e-02,7.725e-01,1.310e-02
HPF1,26051,cellular response to DNA damage stimulus,GO:0006974,biological process,9.0,20.0,1.273e-01,9.358e-02,1.732e-01,1.273e-01,9.358e-02,1.732e-01,6.648e-01,1.109e-02
HPF1,26051,nucleus,GO:0005634,cellular component,9.0,151.0,1.091e-01,7.924e-02,1.502e-01,8.592e-02,6.592e-02,1.120e-01,7.201e-01,8.465e-03
HPF1,26051,histone binding,GO:0042393,molecular function,9.0,9.0,6.890e-02,1.248e-02,3.803e-01,1.877e-02,3.787e-03,9.302e-02,8.741e-01,2.959e-02
HPF1,26051,poly-ADP-D-ribose binding,GO:0072572,molecular function,9.0,2.0,6.890e-02,1.248e-02,3.803e-01,2.688e-02,3.648e-03,1.981e-01,8.384e-01,4.403e-02
HPF1,26051,zinc ion binding,GO:0008270,molecular function,9.0,6.0,1.091e-01,7.924e-02,1.502e-01,7.254e-02,3.156e-02,1.667e-01,7.397e-01,2.566e-02
HPF1,26051,protein binding,GO:0005515,molecular function,9.0,332.0,1.091e-01,7.924e-02,1.502e-01,9.100e-02,7.753e-02,1.068e-01,7.127e-01,5.231e-03
CDK17,8750,protein phosphorylation,GO:0006468,biological process,6.0,33.0,4.318e-02,2.131e-02,8.752e-02,1.057e-02,3.752e-03,2.979e-02,9.191e-01,1.293e-02
CDK17,8750,cytoplasm,GO:0005737,cellular component,6.0,69.0,5.541e-02,4.338e-02,7.077e-02,4.415e-02,3.110e-02,6.269e-02,7.999e-01,9.302e-03
CDK17,8750,nucleus,GO:0005634,cellular component,6.0,151.0,5.541e-02,4.338e-02,7.077e-02,4.954e-02,2.662e-02,9.221e-02,7.865e-01,1.662e-02
CDK17,8750,protein serine/threonine kinase activity,GO:0004674,molecular function,6.0,34.0,4.372e-02,2.247e-02,8.508e-02,2.776e-02,6.529e-03,1.180e-01,8.415e-01,3.064e-02
CDK17,8750,protein binding,GO:0005515,molecular function,6.0,332.0,5.541e-02,4.338e-02,7.077e-02,5.201e-02,4.337e-02,6.237e-02,7.816e-01,4.961e-03
COL11A1,2186,endodermal cell differentiation,GO:0035987,biological process,11.0,2.0,1.557e-01,5.068e-02,4.784e-01,8.316e-02,4.390e-02,1.575e-01,7.232e-01,1.957e-02
COL11A1,2186,extracellular matrix organization,GO:0030198,biological process,11.0,11.0,1.557e-01,5.068e-02,4.784e-01,9.247e-02,2.054e-02,4.163e-01,7.028e-01,4.783e-02
COL11A1,2186,sensory perception of sound,GO:0007605,biological process,11.0,4.0,1.574e-01,4.940e-02,5.013e-01,8.814e-02,1.759e-02,4.415e-01,7.073e-01,5.471e-02
COL11A1,2186,detection of mechanical stimulus involved in sensory perception of sound,GO:0050910,biological process,11.0,3.0,1.826e-01,4.957e-02,6.727e-01,9.897e-02,7.094e-03,1.381e+00,6.724e-01,9.143e-02
COL11A1,2186,visual perception,GO:0007601,biological process,11.0,3.0,1.826e-01,4.957e-02,6.727e-01,1.466e-01,2.803e-02,7.672e-01,6.267e-01,6.986e-02
COL11A1,2186,collagen-containing extracellular matrix,GO:0062023,cellular component,11.0,13.0,1.557e-01,5.068e-02,4.784e-01,3.213e-02,2.567e-02,4.023e-02,8.335e-01,5.228e-03
COL11A1,2186,extracellular matrix,GO:0031012,cellular component,11.0,10.0,1.557e-01,5.068e-02,4.784e-01,7.826e-02,4.025e-02,1.522e-01,7.308e-01,2.058e-02
COL11A1,2186,extracellular space,GO:0005615,cellular component,11.0,6.0,1.680e-01,6.004e-02,4.701e-01,1.197e-01,5.922e-02,2.420e-01,6.723e-01,2.529e-02
COL11A1,2186,collagen type XI trimer,GO:0005592,cellular component,11.0,2.0,1.732e-01,6.321e-02,4.744e-01,8.015e-02,1.239e-02,5.184e-01,7.188e-01,5.488e-02
COL11A1,2186,extracellular matrix structural constituent,GO:0005201,molecular function,11.0,7.0,1.865e-01,5.164e-02,6.732e-01,1.457e-01,2.256e-02,9.405e-01,6.246e-01,7.592e-02
MCM10,18043,cellular response to DNA damage stimulus,GO:0006974,biological process,16.0,20.0,4.685e-02,2.176e-02,1.008e-01,4.378e-02,2.435e-02,7.872e-02,8.000e-01,1.513e-02
MCM10,18043,DNA replication initiation,GO:0006270,biological process,16.0,4.0,4.701e-02,1.623e-02,1.362e-01,2.942e-02,3.144e-03,2.754e-01,8.267e-01,4.871e-02
MCM10,18043,replication fork protection complex,GO:0031298,cellular component,16.0,3.0,2.301e-02,5.573e-03,9.501e-02,3.852e-03,3.950e-04,3.758e-02,9.554e-01,1.470e-02
MCM10,18043,nucleus,GO:0005634,cellular component,16.0,151.0,4.329e-02,1.821e-02,1.029e-01,2.688e-02,8.653e-03,8.353e-02,8.469e-01,2.519e-02
MCM10,18043,nucleolus,GO:0005730,cellular component,16.0,41.0,4.475e-02,2.062e-02,9.714e-02,3.271e-02,1.151e-02,9.299e-02,8.293e-01,2.661e-02
MCM10,18043,single-stranded DNA binding,GO:0003697,molecular function,16.0,7.0,4.259e-02,1.883e-02,9.634e-02,1.612e-02,7.180e-03,3.621e-02,8.923e-01,1.391e-02
MCM10,18043,identical protein binding,GO:0042802,molecular function,16.0,20.0,4.259e-02,1.883e-02,9.634e-02,1.735e-02,4.007e-03,7.509e-02,8.811e-01,2.393e-02
MCM10,18043,DNA replication origin binding,GO:0003688,molecular function,16.0,4.0,4.403e-02,2.135e-02,9.078e-02,2.203e-02,1.120e-02,4.333e-02,8.678e-01,1.389e-02
MCM10,18043,double-stranded DNA binding,GO:0003690,molecular function,16.0,13.0,4.475e-02,2.062e-02,9.714e-02,3.295e-02,1.083e-02,1.003e-01,8.280e-01,2.804e-02
MCM10,18043,protein binding,GO:0005515,molecular function,16.0,332.0,4.532e-02,1.901e-02,1.080e-01,3.511e-02,1.001e-02,1.232e-01,8.205e-01,2.970e-02
TRMT11,21080,,,,nan,nan,,,,,,,,
METTL22,28368,,,,nan,nan,,,,,,,,
PRR11,25619,cell cycle arrest,GO:0007050,biological process,11.0,8.0,3.882e-02,2.311e-02,6.522e-02,3.604e-02,1.667e-02,7.793e-02,8.203e-01,1.885e-02
PRR11,25619,regulation of cell cycle,GO:0051726,biological process,11.0,14.0,4.066e-02,2.556e-02,6.466e-02,2.850e-02,1.025e-02,7.925e-02,8.429e-01,2.457e-02
PRR11,25619,membrane,GO:0016020,cellular component,11.0,53.0,3.059e-02,1.723e-02,5.433e-02,1.771e-02,6.259e-03,5.014e-02,8.836e-01,2.082e-02
PRR11,25619,nucleus,GO:0005634,cellular component,11.0,151.0,3.059e-02,1.723e-02,5.433e-02,1.931e-02,5.595e-03,6.664e-02,8.750e-01,2.283e-02
PRR11,25619,cytoplasm,GO:0005737,cellular component,11.0,69.0,3.059e-02,1.723e-02,5.433e-02,2.139e-02,9.893e-03,4.623e-02,8.702e-01,1.606e-02
KIF2A,6318,mitotic spindle assembly,GO:0090307,biological process,44.0,6.0,4.074e-02,3.312e-02,5.012e-02,1.099e-02,6.299e-03,1.916e-02,9.186e-01,7.369e-03
KIF2A,6318,mitotic spindle organization,GO:0007052,biological process,44.0,12.0,4.074e-02,3.312e-02,5.012e-02,1.285e-02,1.093e-02,1.510e-02,9.104e-01,2.338e-03
KIF2A,6318,microtubule-based movement,GO:0007018,biological process,44.0,21.0,4.584e-02,3.611e-02,5.819e-02,3.327e-02,2.420e-02,4.572e-02,8.301e-01,7.492e-03
KIF2A,6318,microtubule cytoskeleton organization,GO:0000226,biological process,44.0,25.0,4.848e-02,3.162e-02,7.435e-02,3.762e-02,2.864e-02,4.941e-02,8.174e-01,6.944e-03
KIF2A,6318,regulation of cell migration,GO:0030334,biological process,44.0,30.0,3.142e-01,1.251e-01,7.891e-01,3.142e-01,1.251e-01,7.891e-01,4.913e-01,5.211e-02
KIF2A,6318,centriolar subdistal appendage,GO:0120103,cellular component,44.0,4.0,4.040e-02,3.191e-02,5.114e-02,4.711e-03,1.777e-03,1.249e-02,9.571e-01,9.255e-03
KIF2A,6318,centriole,GO:0005814,cellular component,44.0,5.0,4.040e-02,3.191e-02,5.114e-02,5.672e-03,3.476e-03,9.256e-03,9.504e-01,5.029e-03
KIF2A,6318,spindle microtubule,GO:0005876,cellular component,44.0,11.0,4.040e-02,3.191e-02,5.114e-02,7.357e-03,2.899e-03,1.867e-02,9.383e-01,1.017e-02
KIF2A,6318,microtubule,GO:0005874,cellular component,44.0,22.0,4.339e-02,3.000e-02,6.275e-02,1.838e-02,8.930e-03,3.781e-02,8.829e-01,1.293e-02
KIF2A,6318,centrosome,GO:0005813,cellular component,44.0,31.0,4.361e-02,3.061e-02,6.214e-02,1.901e-02,1.231e-02,2.936e-02,8.819e-01,8.132e-03
KIF2A,6318,kinesin complex,GO:0005871,cellular component,44.0,16.0,4.361e-02,3.061e-02,6.214e-02,2.067e-02,1.629e-02,2.623e-02,8.753e-01,4.828e-03
KIF2A,6318,spindle pole,GO:0000922,cellular component,44.0,15.0,4.443e-02,2.856e-02,6.913e-02,2.439e-02,1.100e-02,5.409e-02,8.582e-01,1.689e-02
KIF2A,6318,nuclear body,GO:0016604,cellular component,44.0,30.0,4.775e-02,2.508e-02,9.091e-02,2.595e-02,6.766e-03,9.954e-02,8.497e-01,3.206e-02
KIF2A,6318,membrane,GO:0016020,cellular component,44.0,53.0,4.829e-02,3.131e-02,7.449e-02,3.659e-02,2.448e-02,5.471e-02,8.197e-01,9.898e-03
KIF2A,6318,nucleolus,GO:0005730,cellular component,44.0,41.0,4.871e-02,3.067e-02,7.736e-02,3.675e-02,2.266e-02,5.961e-02,8.191e-01,1.238e-02
KIF2A,6318,nucleus,GO:0005634,cellular component,44.0,151.0,5.015e-02,2.917e-02,8.623e-02,4.377e-02,2.628e-02,7.290e-02,8.007e-01,1.380e-02
KIF2A,6318,cytoplasm,GO:0005737,cellular component,44.0,69.0,5.271e-02,2.988e-02,9.298e-02,4.843e-02,2.773e-02,8.459e-02,7.891e-01,1.533e-02
KIF2A,6318,microtubule motor activity,GO:0003777,molecular function,44.0,13.0,4.074e-02,3.312e-02,5.012e-02,1.296e-02,6.285e-03,2.674e-02,9.078e-01,1.102e-02
KIF2A,6318,microtubule binding,GO:0008017,molecular function,44.0,22.0,4.339e-02,3.000e-02,6.275e-02,2.064e-02,1.193e-02,3.569e-02,8.743e-01,1.078e-02
KIF2A,6318,ATPase activity,GO:0016887,molecular function,44.0,14.0,4.672e-02,3.387e-02,6.446e-02,2.916e-02,2.140e-02,3.975e-02,8.433e-01,7.353e-03
KIF2A,6318,protein binding,GO:0005515,molecular function,44.0,332.0,5.625e-02,3.560e-02,8.888e-02,5.267e-02,3.202e-02,8.663e-02,7.798e-01,1.392e-02
PITX1,9004,anatomical structure morphogenesis,GO:0009653,biological process,10.0,90.0,2.060e-01,7.835e-02,5.414e-01,2.060e-01,7.835e-02,5.414e-01,5.795e-01,4.443e-02
PITX1,9004,nucleus,GO:0005634,cellular component,10.0,151.0,7.448e-02,3.092e-02,1.794e-01,3.813e-02,1.603e-02,9.071e-02,8.141e-01,2.160e-02
PITX1,9004,nucleolus,GO:0005730,cellular component,10.0,41.0,7.677e-02,3.533e-02,1.668e-01,5.473e-02,2.284e-02,1.311e-01,7.741e-01,2.448e-02
PITX1,9004,RNA polymerase II transcription factor binding,GO:0001085,molecular function,10.0,6.0,6.424e-02,3.075e-02,1.342e-01,1.603e-02,5.740e-03,4.479e-02,8.910e-01,1.711e-02
PITX1,9004,protein binding,GO:0005515,molecular function,10.0,332.0,7.448e-02,3.092e-02,1.794e-01,3.754e-02,1.151e-02,1.225e-01,8.143e-01,2.936e-02
PITX1,9004,sequence-specific DNA binding,GO:0043565,molecular function,10.0,12.0,7.448e-02,3.092e-02,1.794e-01,4.712e-02,1.322e-02,1.680e-01,7.891e-01,3.274e-02
PITX1,9004,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,10.0,25.0,9.745e-02,9.191e-02,1.033e-01,7.911e-02,6.677e-02,9.374e-02,7.311e-01,5.195e-03
NUCKS1,29923,double-strand break repair via homologous recombination,GO:0000724,biological process,20.0,8.0,9.087e-02,3.075e-02,2.685e-01,1.758e-02,1.382e-02,2.236e-02,8.886e-01,4.237e-03
NUCKS1,29923,modulation by host of RNA binding by virus,GO:1990968,biological process,20.0,3.0,9.087e-02,3.075e-02,2.685e-01,1.820e-02,8.752e-03,3.785e-02,8.838e-01,1.404e-02
NUCKS1,29923,regulation of DNA replication,GO:0006275,biological process,20.0,8.0,9.087e-02,3.075e-02,2.685e-01,2.668e-02,6.978e-03,1.020e-01,8.474e-01,3.258e-02
NUCKS1,29923,replication fork processing,GO:0031297,biological process,20.0,4.0,9.087e-02,3.075e-02,2.685e-01,3.807e-02,1.710e-02,8.476e-02,8.144e-01,2.080e-02
NUCKS1,29923,positive regulation by host of viral transcription,GO:0043923,biological process,20.0,4.0,9.087e-02,3.075e-02,2.685e-01,4.701e-02,2.761e-02,8.006e-02,7.925e-01,1.442e-02
NUCKS1,29923,interstrand cross-link repair,GO:0036297,biological process,20.0,5.0,9.087e-02,3.075e-02,2.685e-01,5.267e-02,1.783e-02,1.556e-01,7.769e-01,3.002e-02
NUCKS1,29923,cellular response to X-ray,GO:0071481,biological process,20.0,4.0,9.087e-02,3.075e-02,2.685e-01,5.530e-02,1.765e-02,1.733e-01,7.712e-01,3.075e-02
NUCKS1,29923,regulation of DNA strand elongation,GO:0060382,biological process,20.0,3.0,9.122e-02,3.058e-02,2.721e-01,4.688e-02,1.481e-02,1.485e-01,7.901e-01,3.166e-02
NUCKS1,29923,positive regulation by host of viral genome replication,GO:0044829,biological process,20.0,4.0,9.582e-02,2.828e-02,3.246e-01,7.556e-02,1.846e-02,3.093e-01,7.309e-01,4.143e-02
NUCKS1,29923,modulation by host of viral RNA-binding transcription factor activity,GO:1990969,biological process,20.0,4.0,1.046e-01,4.036e-02,2.709e-01,8.781e-02,3.515e-02,2.194e-01,7.144e-01,3.045e-02
NUCKS1,29923,release from viral latency,GO:0019046,biological process,20.0,3.0,1.309e-01,2.129e-02,8.055e-01,1.224e-01,1.741e-02,8.604e-01,6.509e-01,7.709e-02
NUCKS1,29923,nuclear chromatin,GO:0000790,cellular component,20.0,14.0,9.087e-02,3.075e-02,2.685e-01,3.092e-02,1.005e-02,9.513e-02,8.341e-01,2.590e-02
NUCKS1,29923,nucleus,GO:0005634,cellular component,20.0,151.0,9.954e-02,3.562e-02,2.782e-01,7.585e-02,3.053e-02,1.885e-01,7.337e-01,2.715e-02
NUCKS1,29923,nucleolus,GO:0005730,cellular component,20.0,41.0,9.979e-02,2.870e-02,3.470e-01,8.482e-02,1.928e-02,3.731e-01,7.150e-01,4.461e-02
NUCKS1,29923,cytoplasm,GO:0005737,cellular component,20.0,69.0,1.046e-01,4.036e-02,2.709e-01,9.763e-02,4.201e-02,2.269e-01,7.005e-01,2.797e-02
NUCKS1,29923,transcription factor binding,GO:0008134,molecular function,20.0,19.0,9.087e-02,3.075e-02,2.685e-01,3.107e-02,1.068e-02,9.037e-02,8.344e-01,2.684e-02
NUCKS1,29923,double-stranded DNA binding,GO:0003690,molecular function,20.0,13.0,9.122e-02,3.058e-02,2.721e-01,4.736e-02,9.466e-03,2.369e-01,7.858e-01,4.166e-02
NUCKS1,29923,chromatin binding,GO:0003682,molecular function,20.0,17.0,9.678e-02,3.924e-02,2.387e-01,6.791e-02,4.059e-02,1.136e-01,7.493e-01,1.521e-02
NUCKS1,29923,RNA binding,GO:0003723,molecular function,20.0,63.0,1.017e-01,2.546e-02,4.060e-01,7.463e-02,8.349e-03,6.670e-01,7.239e-01,6.459e-02
BCL3,998,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,33.0,41.0,1.449e-01,1.213e-01,1.732e-01,2.283e-02,1.507e-02,3.458e-02,8.659e-01,8.883e-03
BCL3,998,negative regulation of apoptotic process,GO:0043066,biological process,33.0,31.0,1.449e-01,1.213e-01,1.732e-01,4.279e-02,1.744e-02,1.050e-01,8.015e-01,2.418e-02
BCL3,998,I-kappaB kinase/NF-kappaB signaling,GO:0007249,biological process,33.0,2.0,1.449e-01,1.213e-01,1.732e-01,4.665e-02,4.206e-02,5.174e-02,7.938e-01,2.764e-03
BCL3,998,response to UV-C,GO:0010225,biological process,33.0,3.0,1.449e-01,1.213e-01,1.732e-01,5.014e-02,2.685e-02,9.361e-02,7.851e-01,1.740e-02
BCL3,998,"DNA damage response, signal transduction by p53 class mediator",GO:0030330,biological process,33.0,5.0,1.449e-01,1.213e-01,1.732e-01,5.911e-02,1.590e-02,2.197e-01,7.619e-01,3.802e-02
BCL3,998,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,33.0,41.0,1.449e-01,1.213e-01,1.732e-01,6.464e-02,2.993e-02,1.396e-01,7.547e-01,2.232e-02
BCL3,998,positive regulation of translation,GO:0045727,biological process,33.0,20.0,1.471e-01,1.170e-01,1.850e-01,4.366e-02,4.408e-03,4.324e-01,7.862e-01,5.699e-02
BCL3,998,"transcription, DNA-templated",GO:0006351,biological process,33.0,16.0,1.471e-01,1.170e-01,1.850e-01,6.613e-02,2.410e-02,1.815e-01,7.503e-01,3.078e-02
BCL3,998,regulation of NIK/NF-kappaB signaling,GO:1901222,biological process,33.0,5.0,1.471e-01,1.170e-01,1.850e-01,1.073e-01,8.905e-02,1.292e-01,6.898e-01,6.342e-03
BCL3,998,cellular response to DNA damage stimulus,GO:0006974,biological process,33.0,20.0,1.489e-01,1.202e-01,1.844e-01,1.108e-01,1.005e-01,1.221e-01,6.854e-01,3.319e-03
BCL3,998,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,biological process,33.0,3.0,1.525e-01,1.227e-01,1.896e-01,1.184e-01,9.481e-02,1.480e-01,6.755e-01,7.673e-03
BCL3,998,response to virus,GO:0009615,biological process,33.0,7.0,1.680e-01,1.329e-01,2.123e-01,1.486e-01,1.292e-01,1.709e-01,6.416e-01,5.199e-03
BCL3,998,negative regulation of receptor signaling pathway via JAK-STAT,GO:0046426,biological process,33.0,4.0,1.684e-01,1.178e-01,2.409e-01,1.388e-01,8.440e-02,2.283e-01,6.512e-01,1.788e-02
BCL3,998,regulation of apoptotic process,GO:0042981,biological process,33.0,24.0,1.872e-01,1.375e-01,2.549e-01,1.669e-01,1.096e-01,2.542e-01,6.223e-01,1.657e-02
BCL3,998,regulation of DNA binding,GO:0051101,biological process,33.0,12.0,1.988e-01,1.002e-01,3.943e-01,1.826e-01,7.714e-02,4.325e-01,6.035e-01,3.513e-02
BCL3,998,negative regulation of interleukin-8 biosynthetic process,GO:0045415,biological process,33.0,4.0,1.999e-01,5.613e-02,7.123e-01,9.915e-02,8.201e-03,1.199e+00,6.695e-01,9.933e-02
BCL3,998,Bcl3-Bcl10 complex,GO:0032996,cellular component,33.0,2.0,1.022e-01,2.809e-02,3.719e-01,1.025e-02,2.736e-04,3.837e-01,8.877e-01,5.831e-02
BCL3,998,intracellular membrane-bounded organelle,GO:0043231,cellular component,33.0,40.0,1.449e-01,1.213e-01,1.732e-01,4.131e-02,2.099e-02,8.131e-02,8.062e-01,1.742e-02
BCL3,998,plasma membrane,GO:0005886,cellular component,33.0,24.0,1.449e-01,1.213e-01,1.732e-01,6.266e-02,4.338e-02,9.052e-02,7.594e-01,1.057e-02
BCL3,998,nucleus,GO:0005634,cellular component,33.0,151.0,1.449e-01,1.213e-01,1.732e-01,7.633e-02,5.827e-02,9.998e-02,7.353e-01,8.235e-03
BCL3,998,cytosol,GO:0005829,cellular component,33.0,78.0,1.449e-01,1.213e-01,1.732e-01,8.169e-02,7.050e-02,9.465e-02,7.268e-01,4.601e-03
BCL3,998,cytoplasm,GO:0005737,cellular component,33.0,69.0,1.449e-01,1.213e-01,1.732e-01,8.355e-02,6.834e-02,1.022e-01,7.238e-01,6.293e-03
BCL3,998,midbody,GO:0030496,cellular component,33.0,26.0,1.449e-01,1.213e-01,1.732e-01,9.102e-02,8.195e-02,1.011e-01,7.126e-01,3.412e-03
BCL3,998,nucleoplasm,GO:0005654,cellular component,33.0,74.0,1.449e-01,1.213e-01,1.732e-01,9.110e-02,8.583e-02,9.670e-02,7.125e-01,1.885e-03
BCL3,998,Bcl3/NF-kappaB2 complex,GO:0033257,cellular component,33.0,2.0,1.636e-01,1.100e-01,2.432e-01,1.351e-01,6.982e-02,2.614e-01,6.545e-01,2.382e-02
BCL3,998,protein-containing complex,GO:0032991,cellular component,33.0,481.0,2.799e-01,1.495e-01,5.238e-01,2.732e-01,1.404e-01,5.315e-01,5.278e-01,3.509e-02
BCL3,998,transcription factor binding,GO:0008134,molecular function,33.0,19.0,1.449e-01,1.213e-01,1.732e-01,4.503e-02,2.300e-02,8.814e-02,7.969e-01,1.805e-02
BCL3,998,protein binding,GO:0005515,molecular function,33.0,332.0,1.466e-01,1.244e-01,1.728e-01,8.928e-02,6.161e-02,1.294e-01,7.147e-01,1.213e-02
ZXDC,28160,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,7.0,41.0,4.071e-02,2.614e-02,6.340e-02,3.121e-02,1.660e-02,5.867e-02,8.360e-01,1.488e-02
ZXDC,28160,DNA-binding transcription factor activity,GO:0003700,molecular function,7.0,18.0,3.747e-02,2.363e-02,5.941e-02,1.401e-02,5.758e-03,3.411e-02,9.019e-01,1.313e-02
ZXDC,28160,C2H2 zinc finger domain binding,GO:0070742,molecular function,7.0,2.0,3.747e-02,2.363e-02,5.941e-02,1.904e-02,9.602e-03,3.774e-02,8.805e-01,1.359e-02
ZXDC,28160,LRR domain binding,GO:0030275,molecular function,7.0,3.0,3.754e-02,2.373e-02,5.939e-02,2.754e-02,1.396e-02,5.431e-02,8.481e-01,1.609e-02
ZXDC,28160,protein binding,GO:0005515,molecular function,7.0,332.0,4.908e-02,3.955e-02,6.090e-02,4.908e-02,3.955e-02,6.090e-02,7.881e-01,5.902e-03
ASNS,753,negative regulation of apoptotic process,GO:0043066,biological process,17.0,31.0,5.259e-02,2.423e-02,1.141e-01,3.092e-02,7.556e-03,1.265e-01,8.328e-01,3.583e-02
ASNS,753,cellular response to glucose starvation,GO:0042149,biological process,17.0,6.0,5.259e-02,2.423e-02,1.141e-01,3.698e-02,1.177e-02,1.162e-01,8.160e-01,2.971e-02
ASNS,753,positive regulation of mitotic cell cycle,GO:0045931,biological process,17.0,18.0,1.049e-01,1.510e-02,7.282e-01,5.815e-02,3.359e-03,1.007e+00,7.396e-01,9.623e-02
ASNS,753,asparagine biosynthetic process,GO:0006529,biological process,17.0,8.0,2.692e-01,1.100e-01,6.590e-01,2.557e-01,8.911e-02,7.339e-01,5.354e-01,5.091e-02
ASNS,753,cytosol,GO:0005829,cellular component,17.0,78.0,5.259e-02,2.423e-02,1.141e-01,2.220e-02,5.405e-03,9.116e-02,8.627e-01,3.216e-02
ASNS,753,protein binding,GO:0005515,molecular function,17.0,332.0,5.259e-02,2.423e-02,1.141e-01,2.712e-02,6.220e-03,1.183e-01,8.446e-01,3.568e-02
ASNS,753,asparagine synthase (glutamine-hydrolyzing) activity,GO:0004066,molecular function,17.0,2.0,9.039e-02,5.436e-02,1.503e-01,5.719e-02,2.258e-02,1.448e-01,7.687e-01,2.593e-02
CDC42,1736,positive regulation of cytokinesis,GO:0032467,biological process,84.0,16.0,9.308e-02,8.064e-02,1.074e-01,1.824e-02,9.061e-03,3.672e-02,8.837e-01,1.253e-02
CDC42,1736,regulation of attachment of spindle microtubules to kinetochore,GO:0051988,biological process,84.0,9.0,9.308e-02,8.064e-02,1.074e-01,1.733e-02,4.852e-03,6.189e-02,8.835e-01,2.531e-02
CDC42,1736,Cdc42 protein signal transduction,GO:0032488,biological process,84.0,2.0,9.324e-02,8.049e-02,1.080e-01,1.269e-02,3.264e-03,4.931e-02,9.051e-01,1.994e-02
CDC42,1736,Rho protein signal transduction,GO:0007266,biological process,84.0,3.0,9.324e-02,8.049e-02,1.080e-01,1.288e-02,2.027e-03,8.184e-02,8.994e-01,2.757e-02
CDC42,1736,actin cytoskeleton organization,GO:0030036,biological process,84.0,15.0,9.722e-02,9.460e-02,9.992e-02,3.363e-02,1.299e-02,8.709e-02,8.269e-01,2.430e-02
CDC42,1736,positive regulation of stress fiber assembly,GO:0051496,biological process,84.0,3.0,1.087e-01,5.809e-02,2.034e-01,3.503e-02,1.313e-02,9.344e-02,8.227e-01,2.444e-02
CDC42,1736,regulation of stress fiber assembly,GO:0051492,biological process,84.0,5.0,1.107e-01,5.570e-02,2.198e-01,3.646e-02,1.391e-02,9.558e-02,8.182e-01,2.495e-02
CDC42,1736,positive regulation of filopodium assembly,GO:0051491,biological process,84.0,3.0,1.130e-01,5.302e-02,2.409e-01,3.310e-02,6.101e-03,1.795e-01,8.236e-01,4.435e-02
CDC42,1736,positive regulation of actin cytoskeleton reorganization,GO:2000251,biological process,84.0,3.0,1.130e-01,5.302e-02,2.409e-01,3.480e-02,7.804e-03,1.552e-01,8.201e-01,3.894e-02
CDC42,1736,negative regulation of protein complex assembly,GO:0031333,biological process,84.0,36.0,1.130e-01,5.302e-02,2.409e-01,4.090e-02,7.131e-03,2.346e-01,8.001e-01,4.270e-02
CDC42,1736,regulation of actin cytoskeleton organization,GO:0032956,biological process,84.0,11.0,1.130e-01,5.302e-02,2.409e-01,4.752e-02,1.455e-02,1.552e-01,7.885e-01,3.130e-02
CDC42,1736,positive regulation of lamellipodium assembly,GO:0010592,biological process,84.0,4.0,1.160e-01,4.981e-02,2.703e-01,3.710e-02,5.715e-03,2.409e-01,8.094e-01,5.004e-02
CDC42,1736,regulation of cell shape,GO:0008360,biological process,84.0,9.0,1.216e-01,5.790e-02,2.554e-01,7.438e-02,4.211e-02,1.314e-01,7.378e-01,1.759e-02
CDC42,1736,regulation of filopodium assembly,GO:0051489,biological process,84.0,4.0,1.219e-01,4.432e-02,3.353e-01,4.694e-02,6.496e-03,3.392e-01,7.824e-01,5.748e-02
CDC42,1736,regulation of lamellipodium assembly,GO:0010591,biological process,84.0,5.0,1.237e-01,4.281e-02,3.573e-01,5.458e-02,8.116e-03,3.670e-01,7.658e-01,5.701e-02
CDC42,1736,positive regulation of pseudopodium assembly,GO:0031274,biological process,84.0,4.0,1.250e-01,4.415e-02,3.537e-01,7.240e-02,1.385e-02,3.785e-01,7.330e-01,5.415e-02
CDC42,1736,actin filament organization,GO:0007015,biological process,84.0,14.0,1.270e-01,4.617e-02,3.495e-01,8.361e-02,1.735e-02,4.030e-01,7.148e-01,5.298e-02
CDC42,1736,positive regulation of substrate adhesion-dependent cell spreading,GO:1900026,biological process,84.0,4.0,1.283e-01,4.759e-02,3.461e-01,8.010e-02,1.848e-02,3.472e-01,7.216e-01,4.893e-02
CDC42,1736,integrin-mediated signaling pathway,GO:0007229,biological process,84.0,3.0,1.296e-01,5.382e-02,3.121e-01,4.443e-02,1.766e-03,1.118e+00,7.680e-01,7.209e-02
CDC42,1736,establishment or maintenance of cell polarity,GO:0007163,biological process,84.0,14.0,1.298e-01,4.905e-02,3.434e-01,9.045e-02,2.563e-02,3.192e-01,7.075e-01,4.321e-02
CDC42,1736,neuropilin signaling pathway,GO:0038189,biological process,84.0,3.0,1.311e-01,4.840e-02,3.553e-01,6.239e-02,5.687e-03,6.845e-01,7.438e-01,6.616e-02
CDC42,1736,modification of synaptic structure,GO:0099563,biological process,84.0,4.0,1.369e-01,5.588e-02,3.355e-01,1.076e-01,3.287e-02,3.523e-01,6.838e-01,4.206e-02
CDC42,1736,positive regulation of cell growth,GO:0030307,biological process,84.0,16.0,1.394e-01,5.753e-02,3.378e-01,1.039e-01,2.554e-02,4.223e-01,6.871e-01,4.715e-02
CDC42,1736,cell projection assembly,GO:0030031,biological process,84.0,7.0,1.411e-01,7.161e-02,2.779e-01,1.039e-01,7.029e-02,1.536e-01,6.940e-01,1.311e-02
CDC42,1736,cell junction assembly,GO:0034329,biological process,84.0,6.0,1.441e-01,6.466e-02,3.209e-01,1.236e-01,5.032e-02,3.038e-01,6.660e-01,3.340e-02
CDC42,1736,substantia nigra development,GO:0021762,biological process,84.0,2.0,1.452e-01,9.202e-02,2.291e-01,1.069e-01,6.811e-02,1.678e-01,6.896e-01,1.559e-02
CDC42,1736,establishment of epithelial cell apical/basal polarity,GO:0045198,biological process,84.0,7.0,1.522e-01,6.587e-02,3.518e-01,1.286e-01,4.598e-02,3.595e-01,6.596e-01,3.602e-02
CDC42,1736,viral RNA genome replication,GO:0039694,biological process,84.0,7.0,1.599e-01,5.993e-02,4.268e-01,1.321e-01,3.174e-02,5.499e-01,6.507e-01,5.104e-02
CDC42,1736,"phagocytosis, engulfment",GO:0006911,biological process,84.0,3.0,1.676e-01,7.634e-02,3.681e-01,1.568e-01,6.572e-02,3.739e-01,6.287e-01,3.548e-02
CDC42,1736,endocytosis,GO:0006897,biological process,84.0,11.0,2.584e-01,1.133e-01,5.890e-01,2.553e-01,1.076e-01,6.060e-01,5.395e-01,3.983e-02
CDC42,1736,centrosome,GO:0005813,cellular component,84.0,31.0,9.308e-02,8.064e-02,1.074e-01,1.009e-02,2.325e-03,4.378e-02,9.185e-01,1.981e-02
CDC42,1736,cell cortex,GO:0005938,cellular component,84.0,5.0,9.308e-02,8.064e-02,1.074e-01,1.389e-02,1.219e-02,1.582e-02,9.057e-01,2.138e-03
CDC42,1736,mitotic spindle,GO:0072686,cellular component,84.0,17.0,9.308e-02,8.064e-02,1.074e-01,2.020e-02,5.897e-03,6.923e-02,8.719e-01,2.439e-02
CDC42,1736,spindle midzone,GO:0051233,cellular component,84.0,8.0,9.324e-02,8.049e-02,1.080e-01,3.173e-02,1.018e-02,9.895e-02,8.315e-01,2.643e-02
CDC42,1736,neuronal cell body,GO:0043025,cellular component,84.0,3.0,9.384e-02,7.979e-02,1.104e-01,2.523e-02,9.419e-03,6.758e-02,8.540e-01,2.080e-02
CDC42,1736,midbody,GO:0030496,cellular component,84.0,26.0,9.706e-02,9.491e-02,9.927e-02,3.334e-02,7.064e-03,1.573e-01,8.229e-01,3.533e-02
CDC42,1736,plasma membrane,GO:0005886,cellular component,84.0,24.0,9.735e-02,9.472e-02,1.000e-01,4.210e-02,1.252e-02,1.415e-01,8.018e-01,3.056e-02
CDC42,1736,cytoplasm,GO:0005737,cellular component,84.0,69.0,9.836e-02,9.742e-02,9.931e-02,4.475e-02,1.102e-02,1.818e-01,7.938e-01,3.543e-02
CDC42,1736,focal adhesion,GO:0005925,cellular component,84.0,11.0,9.964e-02,9.531e-02,1.042e-01,4.935e-02,1.368e-02,1.780e-01,7.838e-01,3.329e-02
CDC42,1736,membrane,GO:0016020,cellular component,84.0,53.0,1.006e-01,8.882e-02,1.140e-01,3.550e-02,5.093e-03,2.475e-01,8.126e-01,4.598e-02
CDC42,1736,extracellular exosome,GO:0070062,cellular component,84.0,33.0,1.010e-01,8.868e-02,1.150e-01,4.963e-02,1.466e-02,1.680e-01,7.832e-01,3.335e-02
CDC42,1736,neuron projection,GO:0043005,cellular component,84.0,21.0,1.079e-01,5.910e-02,1.970e-01,3.403e-02,1.552e-02,7.463e-02,8.259e-01,1.991e-02
CDC42,1736,filopodium,GO:0030175,cellular component,84.0,4.0,1.209e-01,4.774e-02,3.063e-01,6.036e-02,1.603e-02,2.273e-01,7.594e-01,4.053e-02
CDC42,1736,dendritic spine,GO:0043197,cellular component,84.0,4.0,1.290e-01,4.821e-02,3.450e-01,7.528e-02,1.437e-02,3.945e-01,7.281e-01,5.423e-02
CDC42,1736,cytoplasmic ribonucleoprotein granule,GO:0036464,cellular component,84.0,12.0,1.424e-01,8.744e-02,2.320e-01,9.814e-02,5.247e-02,1.836e-01,7.009e-01,2.129e-02
CDC42,1736,cell projection,GO:0042995,cellular component,84.0,8.0,1.426e-01,9.979e-02,2.038e-01,1.064e-01,7.760e-02,1.458e-01,6.907e-01,1.063e-02
CDC42,1736,Golgi transport complex,GO:0017119,cellular component,84.0,2.0,1.478e-01,6.944e-02,3.146e-01,1.247e-01,5.170e-02,3.010e-01,6.649e-01,3.243e-02
CDC42,1736,protein-containing complex,GO:0032991,cellular component,84.0,481.0,1.819e-01,9.408e-02,3.518e-01,1.735e-01,8.429e-02,3.572e-01,6.134e-01,2.971e-02
CDC42,1736,protein kinase binding,GO:0019901,molecular function,84.0,32.0,9.308e-02,8.064e-02,1.074e-01,2.484e-02,4.704e-03,1.312e-01,8.488e-01,3.330e-02
CDC42,1736,identical protein binding,GO:0042802,molecular function,84.0,20.0,9.675e-02,9.360e-02,1.000e-01,4.034e-02,2.285e-02,7.120e-02,8.089e-01,1.438e-02
CDC42,1736,protein binding,GO:0005515,molecular function,84.0,332.0,1.104e-01,9.279e-02,1.314e-01,6.393e-02,2.562e-02,1.595e-01,7.553e-01,2.658e-02
CDC42,1736,GTPase activity,GO:0003924,molecular function,84.0,7.0,1.198e-01,5.900e-02,2.433e-01,6.133e-02,2.286e-02,1.645e-01,7.600e-01,2.780e-02
CDC42,1736,thioesterase binding,GO:0031996,molecular function,84.0,2.0,1.230e-01,5.575e-02,2.715e-01,6.616e-02,1.787e-02,2.449e-01,7.483e-01,3.703e-02
CDC42,1736,ubiquitin protein ligase activity,GO:0061630,molecular function,84.0,4.0,1.237e-01,4.281e-02,3.573e-01,4.539e-02,4.032e-03,5.111e-01,7.803e-01,7.250e-02
CDC42,1736,GBD domain binding,GO:0032427,molecular function,84.0,2.0,1.265e-01,4.927e-02,3.247e-01,7.446e-02,2.394e-02,2.317e-01,7.342e-01,3.635e-02
CDC42,1736,apolipoprotein A-I receptor binding,GO:0034191,molecular function,84.0,2.0,1.308e-01,5.008e-02,3.417e-01,9.850e-02,2.723e-02,3.563e-01,6.953e-01,4.546e-02
CDC42,1736,GTP binding,GO:0005525,molecular function,84.0,7.0,2.031e-01,1.356e-01,3.043e-01,1.970e-01,1.409e-01,2.755e-01,5.947e-01,1.405e-02
FAM3A,13749,,,,nan,nan,,,,,,,,
PDCD2,8762,positive regulation of apoptotic process,GO:0043065,biological process,9.0,28.0,4.309e-02,3.312e-02,5.606e-02,1.159e-02,3.144e-03,4.274e-02,9.117e-01,1.678e-02
PDCD2,8762,activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,biological process,9.0,4.0,4.309e-02,3.312e-02,5.606e-02,1.570e-02,7.142e-03,3.451e-02,8.944e-01,1.378e-02
PDCD2,8762,regulation of hematopoietic progenitor cell differentiation,GO:1901532,biological process,9.0,8.0,6.960e-02,4.199e-02,1.153e-01,5.561e-02,2.591e-02,1.194e-01,7.727e-01,2.135e-02
PDCD2,8762,positive regulation of hematopoietic stem cell proliferation,GO:1902035,biological process,9.0,4.0,1.285e-01,1.845e-02,8.948e-01,9.201e-02,5.677e-03,1.491e+00,6.807e-01,9.404e-02
PDCD2,8762,extracellular exosome,GO:0070062,cellular component,9.0,33.0,5.075e-02,3.436e-02,7.495e-02,2.167e-02,8.497e-03,5.527e-02,8.685e-01,2.014e-02
PDCD2,8762,protein binding,GO:0005515,molecular function,9.0,332.0,5.397e-02,3.126e-02,9.316e-02,3.530e-02,1.294e-02,9.633e-02,8.217e-01,2.604e-02
PDCD2,8762,enzyme binding,GO:0019899,molecular function,9.0,33.0,1.147e-01,4.452e-02,2.955e-01,9.740e-02,2.845e-02,3.335e-01,6.981e-01,3.863e-02
HMMR,5012,centrosome,GO:0005813,cellular component,14.0,31.0,2.102e-02,9.221e-03,4.790e-02,4.598e-03,2.240e-03,9.439e-03,9.588e-01,6.979e-03
HMMR,5012,microtubule cytoskeleton,GO:0015630,cellular component,14.0,17.0,2.190e-02,9.024e-03,5.314e-02,1.023e-02,3.396e-03,3.082e-02,9.207e-01,1.330e-02
HMMR,5012,membrane,GO:0016020,cellular component,14.0,53.0,2.190e-02,9.024e-03,5.314e-02,1.768e-02,4.381e-03,7.136e-02,8.801e-01,2.329e-02
HMMR,5012,cytosol,GO:0005829,cellular component,14.0,78.0,2.308e-02,1.136e-02,4.688e-02,1.869e-02,8.968e-03,3.897e-02,8.815e-01,1.330e-02
HMMR,5012,protein binding,GO:0005515,molecular function,14.0,332.0,2.446e-02,1.466e-02,4.080e-02,2.293e-02,1.462e-02,3.596e-02,8.653e-01,9.918e-03
NUAK1,14311,regulation of myosin-light-chain-phosphatase activity,GO:0035507,biological process,13.0,4.0,6.844e-02,3.931e-02,1.191e-01,1.349e-02,4.386e-03,4.147e-02,9.018e-01,1.954e-02
NUAK1,14311,protein phosphorylation,GO:0006468,biological process,13.0,33.0,8.597e-02,4.874e-02,1.516e-01,2.078e-02,8.692e-03,4.966e-02,8.723e-01,1.860e-02
NUAK1,14311,intracellular signal transduction,GO:0035556,biological process,13.0,30.0,8.819e-02,4.940e-02,1.575e-01,3.789e-02,2.307e-02,6.222e-02,8.159e-01,1.277e-02
NUAK1,14311,regulation of cellular senescence,GO:2000772,biological process,13.0,5.0,8.823e-02,4.948e-02,1.573e-01,4.686e-02,3.765e-02,5.831e-02,7.934e-01,6.037e-03
NUAK1,14311,regulation of cell adhesion,GO:0030155,biological process,13.0,11.0,1.001e-01,3.901e-02,2.567e-01,6.263e-02,9.359e-03,4.192e-01,7.494e-01,5.637e-02
NUAK1,14311,microtubule cytoskeleton,GO:0015630,cellular component,13.0,17.0,8.819e-02,4.940e-02,1.575e-01,6.188e-02,2.600e-02,1.472e-01,7.596e-01,2.436e-02
NUAK1,14311,cytoplasm,GO:0005737,cellular component,13.0,69.0,8.823e-02,4.948e-02,1.573e-01,6.851e-02,3.944e-02,1.190e-01,7.483e-01,1.594e-02
NUAK1,14311,nucleus,GO:0005634,cellular component,13.0,151.0,8.823e-02,4.948e-02,1.573e-01,7.564e-02,4.881e-02,1.172e-01,7.363e-01,1.308e-02
NUAK1,14311,fibrillar center,GO:0001650,cellular component,13.0,9.0,1.145e-01,4.226e-02,3.103e-01,1.073e-01,3.650e-02,3.156e-01,6.858e-01,3.516e-02
NUAK1,14311,p53 binding,GO:0002039,molecular function,13.0,5.0,5.935e-02,4.474e-02,7.873e-02,4.985e-03,3.765e-03,6.602e-03,9.562e-01,2.813e-03
NUAK1,14311,protein serine/threonine kinase activity,GO:0004674,molecular function,13.0,34.0,8.819e-02,4.940e-02,1.575e-01,5.047e-02,2.566e-02,9.925e-02,7.842e-01,1.813e-02
NUAK1,14311,protein binding,GO:0005515,molecular function,13.0,332.0,9.400e-02,5.545e-02,1.593e-01,8.372e-02,5.868e-02,1.194e-01,7.234e-01,1.126e-02
TIPIN,30750,replication fork protection,GO:0048478,biological process,13.0,3.0,4.358e-02,2.837e-02,6.696e-02,1.211e-02,2.577e-03,5.689e-02,9.061e-01,2.386e-02
TIPIN,30750,replication fork arrest,GO:0043111,biological process,13.0,7.0,4.382e-02,2.833e-02,6.778e-02,1.662e-02,3.316e-03,8.333e-02,8.832e-01,2.949e-02
TIPIN,30750,cell cycle phase transition,GO:0044770,biological process,13.0,9.0,5.429e-02,3.492e-02,8.439e-02,3.090e-02,5.234e-03,1.824e-01,8.283e-01,4.023e-02
TIPIN,30750,intra-S DNA damage checkpoint,GO:0031573,biological process,13.0,2.0,6.219e-02,1.724e-02,2.243e-01,4.213e-02,5.265e-03,3.370e-01,7.931e-01,5.306e-02
TIPIN,30750,DNA replication checkpoint,GO:0000076,biological process,13.0,4.0,6.678e-02,1.863e-02,2.394e-01,4.881e-02,6.956e-03,3.424e-01,7.787e-01,5.012e-02
TIPIN,30750,positive regulation of cell population proliferation,GO:0008284,biological process,13.0,40.0,8.969e-02,1.878e-02,4.285e-01,7.635e-02,1.199e-02,4.864e-01,7.233e-01,6.209e-02
TIPIN,30750,replication fork protection complex,GO:0031298,cellular component,13.0,3.0,4.813e-02,4.306e-02,5.381e-02,1.887e-02,8.092e-03,4.401e-02,8.801e-01,1.553e-02
TIPIN,30750,nuclear chromatin,GO:0000790,cellular component,13.0,14.0,5.616e-02,1.892e-02,1.667e-01,1.897e-02,1.369e-03,2.629e-01,8.602e-01,5.302e-02
TIPIN,30750,intracellular membrane-bounded organelle,GO:0043231,cellular component,13.0,40.0,5.855e-02,3.279e-02,1.045e-01,2.744e-02,1.250e-02,6.020e-02,8.478e-01,1.735e-02
TIPIN,30750,nucleus,GO:0005634,cellular component,13.0,151.0,6.740e-02,3.828e-02,1.187e-01,3.868e-02,1.186e-02,1.262e-01,8.110e-01,2.900e-02
TIPIN,30750,DNA binding,GO:0003677,molecular function,13.0,26.0,5.408e-02,2.049e-02,1.428e-01,3.129e-02,9.173e-03,1.067e-01,8.324e-01,2.882e-02
TIPIN,30750,protein binding,GO:0005515,molecular function,13.0,332.0,7.699e-02,3.836e-02,1.545e-01,5.652e-02,1.783e-02,1.792e-01,7.684e-01,3.217e-02
GTSE1,13698,membrane,GO:0016020,cellular component,19.0,53.0,1.762e-02,7.333e-03,4.234e-02,8.334e-03,4.767e-03,1.457e-02,9.329e-01,6.379e-03
GTSE1,13698,cytoplasmic microtubule,GO:0005881,cellular component,19.0,8.0,1.990e-02,6.953e-03,5.696e-02,1.990e-02,6.953e-03,5.696e-02,8.745e-01,2.154e-02
GTSE1,13698,protein binding,GO:0005515,molecular function,19.0,332.0,1.763e-02,7.324e-03,4.244e-02,1.342e-02,7.070e-03,2.546e-02,9.061e-01,1.035e-02
FRYL,29127,neuron projection development,GO:0031175,biological process,5.0,12.0,1.720e-02,6.162e-03,4.803e-02,6.827e-03,2.090e-03,2.230e-02,9.404e-01,1.377e-02
FRYL,29127,cell morphogenesis,GO:0000902,biological process,5.0,5.0,4.660e-02,3.921e-02,5.538e-02,4.468e-02,4.328e-02,4.613e-02,7.986e-01,9.236e-04
FRYL,29127,cell cortex,GO:0005938,cellular component,5.0,5.0,1.736e-02,6.371e-03,4.731e-02,6.726e-03,2.996e-03,1.510e-02,9.427e-01,8.871e-03
FRYL,29127,protein binding,GO:0005515,molecular function,5.0,332.0,4.660e-02,3.921e-02,5.538e-02,4.368e-02,3.290e-02,5.798e-02,8.013e-01,7.738e-03
PIAS2,17311,negative regulation of androgen receptor signaling pathway,GO:0060766,biological process,19.0,4.0,1.300e-01,5.322e-02,3.178e-01,1.155e-01,4.327e-02,3.082e-01,6.756e-01,3.455e-02
PIAS2,17311,protein sumoylation,GO:0016925,biological process,19.0,4.0,1.498e-01,1.023e-01,2.193e-01,1.328e-01,7.604e-02,2.319e-01,6.577e-01,2.044e-02
PIAS2,17311,regulation of transcription by RNA polymerase II,GO:0006357,biological process,19.0,46.0,1.717e-01,8.985e-02,3.281e-01,1.668e-01,7.914e-02,3.515e-01,6.206e-01,2.823e-02
PIAS2,17311,PML body,GO:0016605,cellular component,19.0,3.0,4.537e-02,2.039e-02,1.010e-01,1.731e-02,1.897e-03,1.580e-01,8.730e-01,3.740e-02
PIAS2,17311,nucleoplasm,GO:0005654,cellular component,19.0,74.0,4.585e-02,4.180e-02,5.031e-02,2.130e-02,1.373e-02,3.305e-02,8.721e-01,9.109e-03
PIAS2,17311,nucleus,GO:0005634,cellular component,19.0,151.0,4.585e-02,4.180e-02,5.031e-02,2.265e-02,1.557e-02,3.294e-02,8.669e-01,8.437e-03
PIAS2,17311,transcription factor binding,GO:0008134,molecular function,19.0,19.0,4.044e-02,2.428e-02,6.737e-02,8.416e-03,1.028e-03,6.892e-02,9.231e-01,2.815e-02
PIAS2,17311,RNA polymerase II transcription factor binding,GO:0001085,molecular function,19.0,6.0,4.430e-02,3.613e-02,5.432e-02,1.469e-02,6.191e-03,3.488e-02,8.985e-01,1.482e-02
PIAS2,17311,transcription coregulator activity,GO:0003712,molecular function,19.0,5.0,4.585e-02,4.180e-02,5.031e-02,1.514e-02,6.424e-03,3.569e-02,8.968e-01,1.306e-02
PIAS2,17311,protein binding,GO:0005515,molecular function,19.0,332.0,5.223e-02,4.397e-02,6.203e-02,3.237e-02,1.965e-02,5.333e-02,8.322e-01,1.223e-02
PIAS2,17311,SUMO ligase activity,GO:0061665,molecular function,19.0,4.0,5.588e-02,2.921e-02,1.069e-01,3.366e-02,1.215e-02,9.328e-02,8.264e-01,2.612e-02
PIAS2,17311,SUMO transferase activity,GO:0019789,molecular function,19.0,4.0,6.061e-02,4.707e-02,7.806e-02,4.203e-02,2.870e-02,6.155e-02,8.053e-01,1.026e-02
GSK3B,4617,regulation of microtubule anchoring at centrosome,GO:0150101,biological process,80.0,2.0,5.925e-02,4.083e-02,8.599e-02,1.139e-02,3.498e-03,3.712e-02,9.124e-01,1.807e-02
GSK3B,4617,positive regulation of GTPase activity,GO:0043547,biological process,80.0,6.0,5.925e-02,4.083e-02,8.599e-02,1.673e-02,2.671e-03,1.049e-01,8.804e-01,2.959e-02
GSK3B,4617,negative regulation of protein binding,GO:0032091,biological process,80.0,14.0,5.925e-02,4.083e-02,8.599e-02,2.005e-02,8.642e-03,4.650e-02,8.749e-01,1.577e-02
GSK3B,4617,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436,biological process,80.0,10.0,6.035e-02,4.161e-02,8.752e-02,2.078e-02,1.508e-02,2.864e-02,8.747e-01,6.755e-03
GSK3B,4617,positive regulation of protein export from nucleus,GO:0046827,biological process,80.0,9.0,6.068e-02,3.880e-02,9.492e-02,2.127e-02,3.428e-03,1.319e-01,8.611e-01,3.714e-02
GSK3B,4617,positive regulation of mitochondrion organization,GO:0010822,biological process,80.0,11.0,6.068e-02,3.880e-02,9.492e-02,2.487e-02,4.041e-03,1.530e-01,8.475e-01,3.819e-02
GSK3B,4617,protein phosphorylation,GO:0006468,biological process,80.0,33.0,6.171e-02,4.200e-02,9.068e-02,1.499e-02,5.836e-03,3.849e-02,8.966e-01,1.740e-02
GSK3B,4617,ER overload response,GO:0006983,biological process,80.0,7.0,6.171e-02,4.200e-02,9.068e-02,2.630e-02,1.739e-02,3.978e-02,8.531e-01,9.672e-03
GSK3B,4617,positive regulation of protein localization to centrosome,GO:1904781,biological process,80.0,3.0,6.171e-02,4.200e-02,9.068e-02,2.858e-02,2.011e-02,4.063e-02,8.450e-01,8.208e-03
GSK3B,4617,negative regulation of dendrite development,GO:2000171,biological process,80.0,5.0,6.181e-02,3.976e-02,9.608e-02,3.030e-02,8.176e-03,1.123e-01,8.348e-01,3.165e-02
GSK3B,4617,intracellular signal transduction,GO:0035556,biological process,80.0,30.0,6.195e-02,4.201e-02,9.137e-02,2.088e-02,5.018e-03,8.691e-02,8.665e-01,2.673e-02
GSK3B,4617,peptidyl-threonine phosphorylation,GO:0018107,biological process,80.0,10.0,6.195e-02,4.201e-02,9.137e-02,2.383e-02,9.018e-03,6.297e-02,8.598e-01,2.143e-02
GSK3B,4617,extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,biological process,80.0,3.0,6.197e-02,4.176e-02,9.196e-02,3.182e-02,2.169e-02,4.669e-02,8.341e-01,9.150e-03
GSK3B,4617,regulation of microtubule cytoskeleton organization,GO:0070507,biological process,80.0,11.0,6.216e-02,4.218e-02,9.162e-02,2.829e-02,5.447e-03,1.469e-01,8.379e-01,3.670e-02
GSK3B,4617,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,80.0,14.0,6.320e-02,4.049e-02,9.866e-02,3.116e-02,1.033e-02,9.397e-02,8.340e-01,2.777e-02
GSK3B,4617,positive regulation of neuron death,GO:1901216,biological process,80.0,5.0,6.322e-02,4.654e-02,8.587e-02,3.232e-02,2.737e-02,3.818e-02,8.328e-01,3.724e-03
GSK3B,4617,regulation of microtubule-based process,GO:0032886,biological process,80.0,4.0,6.332e-02,4.356e-02,9.203e-02,3.293e-02,9.563e-03,1.134e-01,8.273e-01,2.987e-02
GSK3B,4617,negative regulation of apoptotic process,GO:0043066,biological process,80.0,31.0,6.381e-02,4.661e-02,8.735e-02,2.749e-02,6.953e-03,1.087e-01,8.431e-01,2.950e-02
GSK3B,4617,peptidyl-serine phosphorylation,GO:0018105,biological process,80.0,13.0,6.407e-02,4.141e-02,9.914e-02,3.456e-02,1.301e-02,9.179e-02,8.240e-01,2.472e-02
GSK3B,4617,positive regulation of cell-matrix adhesion,GO:0001954,biological process,80.0,6.0,6.410e-02,4.553e-02,9.025e-02,3.481e-02,1.128e-02,1.074e-01,8.223e-01,2.701e-02
GSK3B,4617,protein autophosphorylation,GO:0046777,biological process,80.0,12.0,6.418e-02,4.886e-02,8.431e-02,3.016e-02,1.024e-02,8.885e-02,8.369e-01,2.420e-02
GSK3B,4617,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901030,biological process,80.0,6.0,6.435e-02,4.940e-02,8.382e-02,4.053e-02,3.221e-02,5.100e-02,8.094e-01,5.937e-03
GSK3B,4617,positive regulation of protein complex assembly,GO:0031334,biological process,80.0,35.0,6.547e-02,4.674e-02,9.172e-02,4.148e-02,1.925e-02,8.938e-02,8.055e-01,2.001e-02
GSK3B,4617,insulin receptor signaling pathway,GO:0008286,biological process,80.0,6.0,6.575e-02,4.340e-02,9.961e-02,4.103e-02,1.436e-02,1.172e-01,8.055e-01,2.803e-02
GSK3B,4617,signal transduction,GO:0007165,biological process,80.0,47.0,6.777e-02,5.320e-02,8.634e-02,4.470e-02,2.271e-02,8.797e-02,7.974e-01,1.737e-02
GSK3B,4617,negative regulation of neuron death,GO:1901215,biological process,80.0,5.0,6.867e-02,4.953e-02,9.522e-02,5.024e-02,3.827e-02,6.594e-02,7.854e-01,7.422e-03
GSK3B,4617,negative regulation of calcineurin-NFAT signaling cascade,GO:0070885,biological process,80.0,3.0,7.194e-02,5.756e-02,8.991e-02,6.052e-02,5.383e-02,6.805e-02,7.641e-01,3.342e-03
GSK3B,4617,superior temporal gyrus development,GO:0071109,biological process,80.0,2.0,7.256e-02,4.788e-02,1.100e-01,6.278e-02,3.674e-02,1.073e-01,7.588e-01,1.514e-02
GSK3B,4617,hippocampus development,GO:0021766,biological process,80.0,2.0,7.316e-02,4.965e-02,1.078e-01,6.375e-02,4.081e-02,9.959e-02,7.573e-01,1.269e-02
GSK3B,4617,regulation of synaptic vesicle exocytosis,GO:2000300,biological process,80.0,10.0,7.520e-02,5.453e-02,1.037e-01,6.722e-02,4.604e-02,9.816e-02,7.510e-01,1.097e-02
GSK3B,4617,negative regulation of protein complex assembly,GO:0031333,biological process,80.0,36.0,7.675e-02,3.543e-02,1.662e-01,6.172e-02,2.051e-02,1.857e-01,7.581e-01,3.341e-02
GSK3B,4617,establishment of cell polarity,GO:0030010,biological process,80.0,11.0,8.396e-02,6.731e-02,1.047e-01,7.927e-02,6.646e-02,9.454e-02,7.307e-01,5.403e-03
GSK3B,4617,neuron projection development,GO:0031175,biological process,80.0,12.0,8.580e-02,4.563e-02,1.613e-01,7.711e-02,3.754e-02,1.584e-01,7.325e-01,2.274e-02
GSK3B,4617,epithelial to mesenchymal transition,GO:0001837,biological process,80.0,8.0,1.078e-01,5.525e-02,2.104e-01,1.046e-01,5.266e-02,2.078e-01,6.918e-01,2.292e-02
GSK3B,4617,glycogen metabolic process,GO:0005977,biological process,80.0,5.0,1.141e-01,4.863e-02,2.679e-01,1.084e-01,4.201e-02,2.798e-01,6.850e-01,3.348e-02
GSK3B,4617,centrosome,GO:0005813,cellular component,80.0,31.0,6.171e-02,4.200e-02,9.068e-02,2.553e-02,1.733e-02,3.761e-02,8.558e-01,8.949e-03
GSK3B,4617,cytoplasm,GO:0005737,cellular component,80.0,69.0,6.195e-02,4.201e-02,9.137e-02,3.318e-02,2.252e-02,4.888e-02,8.304e-01,9.402e-03
GSK3B,4617,cytosol,GO:0005829,cellular component,80.0,78.0,6.229e-02,4.199e-02,9.240e-02,3.269e-02,1.662e-02,6.428e-02,8.307e-01,1.661e-02
GSK3B,4617,nucleus,GO:0005634,cellular component,80.0,151.0,6.373e-02,4.630e-02,8.771e-02,3.881e-02,2.955e-02,5.096e-02,8.142e-01,6.994e-03
GSK3B,4617,glutamatergic synapse,GO:0098978,cellular component,80.0,4.0,6.387e-02,4.066e-02,1.003e-01,3.123e-02,7.166e-03,1.361e-01,8.300e-01,3.256e-02
GSK3B,4617,beta-catenin destruction complex,GO:0030877,cellular component,80.0,3.0,6.478e-02,3.965e-02,1.058e-01,4.193e-02,1.195e-02,1.471e-01,8.020e-01,3.211e-02
GSK3B,4617,plasma membrane,GO:0005886,cellular component,80.0,24.0,6.577e-02,4.032e-02,1.073e-01,2.942e-02,7.302e-03,1.185e-01,8.377e-01,3.497e-02
GSK3B,4617,axon,GO:0030424,cellular component,80.0,11.0,7.370e-02,4.353e-02,1.248e-01,5.880e-02,2.826e-02,1.224e-01,7.662e-01,2.098e-02
GSK3B,4617,p53 binding,GO:0002039,molecular function,80.0,5.0,5.925e-02,4.083e-02,8.599e-02,3.700e-03,2.559e-03,5.350e-03,9.682e-01,3.261e-03
GSK3B,4617,beta-catenin binding,GO:0008013,molecular function,80.0,6.0,5.925e-02,4.083e-02,8.599e-02,6.841e-03,1.150e-03,4.070e-02,9.378e-01,1.810e-02
GSK3B,4617,ubiquitin protein ligase binding,GO:0031625,molecular function,80.0,4.0,5.925e-02,4.083e-02,8.599e-02,8.598e-03,3.150e-03,2.347e-02,9.301e-01,1.164e-02
GSK3B,4617,RNA polymerase II transcription factor binding,GO:0001085,molecular function,80.0,6.0,5.925e-02,4.083e-02,8.599e-02,1.434e-02,4.924e-03,4.179e-02,8.993e-01,1.572e-02
GSK3B,4617,protein kinase binding,GO:0019901,molecular function,80.0,32.0,5.925e-02,4.083e-02,8.599e-02,1.879e-02,8.651e-03,4.082e-02,8.807e-01,1.408e-02
GSK3B,4617,NF-kappaB binding,GO:0051059,molecular function,80.0,2.0,6.019e-02,3.949e-02,9.172e-02,1.461e-02,1.567e-03,1.362e-01,8.864e-01,3.712e-02
GSK3B,4617,tau-protein kinase activity,GO:0050321,molecular function,80.0,2.0,6.035e-02,4.161e-02,8.752e-02,1.358e-02,4.547e-03,4.055e-02,9.028e-01,1.544e-02
GSK3B,4617,protein kinase A catalytic subunit binding,GO:0034236,molecular function,80.0,3.0,6.171e-02,4.200e-02,9.068e-02,1.673e-02,8.573e-03,3.265e-02,8.905e-01,1.254e-02
GSK3B,4617,dynactin binding,GO:0034452,molecular function,80.0,2.0,6.171e-02,4.200e-02,9.068e-02,2.808e-02,1.383e-02,5.702e-02,8.459e-01,1.598e-02
GSK3B,4617,protease binding,GO:0002020,molecular function,80.0,7.0,6.195e-02,4.201e-02,9.137e-02,1.570e-02,3.119e-03,7.906e-02,8.869e-01,3.141e-02
GSK3B,4617,protein binding,GO:0005515,molecular function,80.0,332.0,6.369e-02,4.155e-02,9.761e-02,3.653e-02,1.606e-02,8.307e-02,8.190e-01,2.068e-02
GSK3B,4617,protein serine/threonine kinase activity,GO:0004674,molecular function,80.0,34.0,6.397e-02,4.688e-02,8.730e-02,2.908e-02,7.288e-03,1.161e-01,8.379e-01,3.043e-02
GSK3B,4617,protein kinase activity,GO:0004672,molecular function,80.0,38.0,7.247e-02,6.090e-02,8.624e-02,5.234e-02,2.269e-02,1.207e-01,7.792e-01,2.244e-02
GSK3B,4617,kinase activity,GO:0016301,molecular function,80.0,138.0,1.505e-01,4.153e-02,5.456e-01,1.496e-01,4.053e-02,5.525e-01,6.320e-01,4.945e-02
NUFIP1,8057,box C/D snoRNP assembly,GO:0000492,biological process,19.0,2.0,8.590e-02,6.992e-02,1.055e-01,2.460e-02,8.253e-03,7.332e-02,8.560e-01,2.490e-02
NUFIP1,8057,protein complex oligomerization,GO:0051259,biological process,19.0,8.0,9.960e-02,7.052e-02,1.407e-01,4.367e-02,8.166e-03,2.336e-01,7.941e-01,4.647e-02
NUFIP1,8057,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,19.0,62.0,1.380e-01,8.064e-02,2.361e-01,1.264e-01,6.923e-02,2.306e-01,6.649e-01,2.196e-02
NUFIP1,8057,transcription elongation factor complex,GO:0008023,cellular component,19.0,11.0,8.590e-02,6.992e-02,1.055e-01,1.668e-02,8.423e-03,3.302e-02,8.908e-01,1.320e-02
NUFIP1,8057,nucleolus,GO:0005730,cellular component,19.0,41.0,8.791e-02,6.660e-02,1.160e-01,4.000e-02,2.464e-02,6.493e-02,8.100e-01,1.213e-02
NUFIP1,8057,cytosolic ribosome,GO:0022626,cellular component,19.0,2.0,8.791e-02,6.660e-02,1.160e-01,4.272e-02,2.027e-02,9.003e-02,8.023e-01,1.939e-02
NUFIP1,8057,nucleus,GO:0005634,cellular component,19.0,151.0,9.205e-02,7.643e-02,1.109e-01,4.779e-02,3.265e-02,6.996e-02,7.912e-01,1.040e-02
NUFIP1,8057,fibrillar center,GO:0001650,cellular component,19.0,9.0,9.956e-02,7.449e-02,1.331e-01,5.748e-02,2.967e-02,1.113e-01,7.690e-01,1.897e-02
NUFIP1,8057,nuclear matrix,GO:0016363,cellular component,19.0,6.0,1.061e-01,9.037e-02,1.247e-01,8.199e-02,5.264e-02,1.277e-01,7.258e-01,1.375e-02
NUFIP1,8057,perichromatin fibrils,GO:0005726,cellular component,19.0,2.0,1.134e-01,9.511e-02,1.351e-01,9.978e-02,5.988e-02,1.663e-01,6.991e-01,1.657e-02
NUFIP1,8057,pre-snoRNP complex,GO:0070761,cellular component,19.0,2.0,1.260e-01,7.205e-02,2.204e-01,9.570e-02,4.103e-02,2.232e-01,7.033e-01,2.847e-02
NUFIP1,8057,protein-containing complex,GO:0032991,cellular component,19.0,481.0,1.700e-01,5.675e-02,5.093e-01,1.692e-01,5.591e-02,5.117e-01,6.124e-01,4.809e-02
NUFIP1,8057,identical protein binding,GO:0042802,molecular function,19.0,20.0,8.590e-02,6.992e-02,1.055e-01,3.100e-02,2.920e-02,3.290e-02,8.367e-01,1.387e-03
NUFIP1,8057,snoRNA binding,GO:0030515,molecular function,19.0,6.0,8.791e-02,6.660e-02,1.160e-01,3.408e-02,1.673e-02,6.941e-02,8.261e-01,1.801e-02
NUFIP1,8057,RNA binding,GO:0003723,molecular function,19.0,63.0,9.135e-02,6.109e-02,1.366e-01,4.290e-02,1.075e-02,1.712e-01,7.985e-01,3.794e-02
NUFIP1,8057,protein binding,GO:0005515,molecular function,19.0,332.0,9.712e-02,8.383e-02,1.125e-01,5.759e-02,4.381e-02,7.571e-02,7.696e-01,7.706e-03
NUFIP1,8057,ATPase binding,GO:0051117,molecular function,19.0,2.0,1.044e-01,8.358e-02,1.304e-01,5.573e-02,1.932e-02,1.607e-01,7.707e-01,2.942e-02
NUFIP1,8057,"protein binding, bridging",GO:0030674,molecular function,19.0,12.0,1.051e-01,8.231e-02,1.341e-01,5.777e-02,1.470e-02,2.270e-01,7.647e-01,3.752e-02
CYLD,2584,protein linear deubiquitination,GO:1990108,biological process,47.0,2.0,3.883e-02,2.176e-02,6.930e-02,8.767e-03,4.844e-03,1.587e-02,9.304e-01,7.358e-03
CYLD,2584,regulation of microtubule cytoskeleton organization,GO:0070507,biological process,47.0,11.0,3.883e-02,2.176e-02,6.930e-02,1.306e-02,9.690e-03,1.761e-02,9.091e-01,4.633e-03
CYLD,2584,protein K63-linked deubiquitination,GO:0070536,biological process,47.0,3.0,3.883e-02,2.176e-02,6.930e-02,1.308e-02,8.311e-03,2.059e-02,9.085e-01,7.068e-03
CYLD,2584,regulation of mitotic cell cycle,GO:0007346,biological process,47.0,19.0,3.883e-02,2.176e-02,6.930e-02,1.318e-02,6.749e-03,2.575e-02,9.071e-01,9.650e-03
CYLD,2584,negative regulation of p38MAPK cascade,GO:1903753,biological process,47.0,3.0,3.883e-02,2.176e-02,6.930e-02,1.537e-02,4.147e-03,5.699e-02,8.916e-01,2.310e-02
CYLD,2584,regulation of tumor necrosis factor-mediated signaling pathway,GO:0010803,biological process,47.0,4.0,3.883e-02,2.176e-02,6.930e-02,1.634e-02,5.885e-03,4.534e-02,8.896e-01,1.852e-02
CYLD,2584,negative regulation of JNK cascade,GO:0046329,biological process,47.0,4.0,3.883e-02,2.176e-02,6.930e-02,1.659e-02,6.432e-03,4.278e-02,8.892e-01,1.720e-02
CYLD,2584,negative regulation of NIK/NF-kappaB signaling,GO:1901223,biological process,47.0,3.0,3.883e-02,2.176e-02,6.930e-02,1.787e-02,5.771e-03,5.536e-02,8.825e-01,2.301e-02
CYLD,2584,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,47.0,14.0,3.883e-02,2.176e-02,6.930e-02,1.952e-02,1.430e-02,2.663e-02,8.801e-01,5.958e-03
CYLD,2584,regulation of necroptotic process,GO:0060544,biological process,47.0,5.0,3.883e-02,2.176e-02,6.930e-02,2.140e-02,1.171e-02,3.910e-02,8.709e-01,1.283e-02
CYLD,2584,necroptotic process,GO:0070266,biological process,47.0,2.0,4.094e-02,2.164e-02,7.745e-02,2.952e-02,1.123e-02,7.757e-02,8.397e-01,2.329e-02
CYLD,2584,protein deubiquitination,GO:0016579,biological process,47.0,13.0,4.177e-02,2.446e-02,7.131e-02,2.760e-02,1.149e-02,6.632e-02,8.466e-01,2.025e-02
CYLD,2584,positive regulation of extrinsic apoptotic signaling pathway,GO:2001238,biological process,47.0,5.0,4.443e-02,2.214e-02,8.914e-02,3.478e-02,1.372e-02,8.815e-02,8.233e-01,2.373e-02
CYLD,2584,negative regulation of NF-kappaB transcription factor activity,GO:0032088,biological process,47.0,3.0,4.474e-02,2.472e-02,8.095e-02,3.203e-02,1.471e-02,6.974e-02,8.329e-01,1.830e-02
CYLD,2584,regulation of intrinsic apoptotic signaling pathway,GO:2001242,biological process,47.0,12.0,6.302e-02,1.382e-02,2.874e-01,3.855e-02,3.572e-03,4.159e-01,7.983e-01,6.450e-02
CYLD,2584,innate immune response,GO:0045087,biological process,47.0,17.0,1.096e-01,2.433e-02,4.936e-01,1.071e-01,2.297e-02,4.990e-01,6.809e-01,5.327e-02
CYLD,2584,regulation of inflammatory response,GO:0050727,biological process,47.0,14.0,1.146e-01,9.153e-03,1.434e+00,1.000e-01,6.283e-03,1.593e+00,6.573e-01,1.163e-01
CYLD,2584,centrosome,GO:0005813,cellular component,47.0,31.0,3.883e-02,2.176e-02,6.930e-02,1.403e-02,5.637e-03,3.494e-02,9.013e-01,1.481e-02
CYLD,2584,spindle,GO:0005819,cellular component,47.0,15.0,3.883e-02,2.176e-02,6.930e-02,2.071e-02,8.556e-03,5.013e-02,8.721e-01,1.771e-02
CYLD,2584,extrinsic component of cytoplasmic side of plasma membrane,GO:0031234,cellular component,47.0,3.0,3.883e-02,2.176e-02,6.930e-02,2.078e-02,5.759e-03,7.498e-02,8.692e-01,2.761e-02
CYLD,2584,cytosol,GO:0005829,cellular component,47.0,78.0,3.973e-02,2.326e-02,6.788e-02,2.614e-02,1.438e-02,4.752e-02,8.528e-01,1.342e-02
CYLD,2584,midbody,GO:0030496,cellular component,47.0,26.0,4.065e-02,2.372e-02,6.967e-02,2.303e-02,1.011e-02,5.244e-02,8.635e-01,1.738e-02
CYLD,2584,cytoplasmic microtubule,GO:0005881,cellular component,47.0,8.0,4.922e-02,2.166e-02,1.119e-01,4.052e-02,1.394e-02,1.178e-01,8.068e-01,2.730e-02
CYLD,2584,protein kinase binding,GO:0019901,molecular function,47.0,32.0,3.883e-02,2.176e-02,6.930e-02,9.554e-03,3.348e-03,2.726e-02,9.247e-01,1.229e-02
CYLD,2584,proline-rich region binding,GO:0070064,molecular function,47.0,3.0,4.330e-02,2.488e-02,7.537e-02,2.285e-02,1.174e-02,4.450e-02,8.650e-01,1.459e-02
CYLD,2584,thiol-dependent ubiquitin-specific protease activity,GO:0004843,molecular function,47.0,2.0,4.474e-02,2.472e-02,8.095e-02,2.321e-02,6.933e-03,7.772e-02,8.599e-01,2.441e-02
CYLD,2584,protein binding,GO:0005515,molecular function,47.0,332.0,4.895e-02,3.667e-02,6.535e-02,4.092e-02,3.665e-02,4.570e-02,8.087e-01,2.900e-03
CYLD,2584,Lys63-specific deubiquitinase activity,GO:0061578,molecular function,47.0,2.0,4.905e-02,2.936e-02,8.197e-02,4.388e-02,2.656e-02,7.251e-02,8.000e-01,1.300e-02
CYLD,2584,zinc ion binding,GO:0008270,molecular function,47.0,6.0,5.595e-02,2.026e-02,1.545e-01,4.997e-02,1.492e-02,1.673e-01,7.826e-01,3.319e-02
AGBL5,26147,mitotic spindle,GO:0072686,cellular component,8.0,17.0,6.149e-02,4.146e-02,9.120e-02,3.015e-02,2.430e-02,3.742e-02,8.398e-01,5.295e-03
AGBL5,26147,microtubule cytoskeleton,GO:0015630,cellular component,8.0,17.0,6.149e-02,4.146e-02,9.120e-02,4.031e-02,2.629e-02,6.178e-02,8.093e-01,1.078e-02
AGBL5,26147,midbody,GO:0030496,cellular component,8.0,26.0,6.149e-02,4.146e-02,9.120e-02,4.351e-02,3.527e-02,5.367e-02,8.018e-01,5.692e-03
AGBL5,26147,cytosol,GO:0005829,cellular component,8.0,78.0,6.149e-02,4.146e-02,9.120e-02,5.697e-02,4.351e-02,7.459e-02,7.710e-01,7.492e-03
AGBL5,26147,intercellular bridge,GO:0045171,cellular component,8.0,25.0,6.149e-02,4.146e-02,9.120e-02,5.796e-02,3.793e-02,8.856e-02,7.687e-01,1.190e-02
AGBL5,26147,nucleus,GO:0005634,cellular component,8.0,151.0,6.149e-02,4.146e-02,9.120e-02,5.955e-02,3.833e-02,9.251e-02,7.654e-01,1.226e-02
AGBL5,26147,cytoplasm,GO:0005737,cellular component,8.0,69.0,6.149e-02,4.146e-02,9.120e-02,5.980e-02,4.044e-02,8.843e-02,7.651e-01,1.096e-02
CHMP5,26942,nucleus organization,GO:0006997,biological process,15.0,16.0,6.090e-02,2.698e-02,1.375e-01,1.756e-02,2.703e-03,1.140e-01,8.762e-01,3.177e-02
CHMP5,26942,mitotic metaphase plate congression,GO:0007080,biological process,15.0,9.0,6.358e-02,2.496e-02,1.620e-01,2.439e-02,2.374e-03,2.507e-01,8.436e-01,5.548e-02
CHMP5,26942,midbody abscission,GO:0061952,biological process,15.0,6.0,7.254e-02,2.545e-02,2.067e-01,3.953e-02,9.417e-03,1.659e-01,8.069e-01,3.869e-02
CHMP5,26942,regulation of mitotic spindle assembly,GO:1901673,biological process,15.0,8.0,7.324e-02,2.475e-02,2.168e-01,4.250e-02,2.126e-02,8.498e-02,8.031e-01,1.825e-02
CHMP5,26942,viral budding,GO:0046755,biological process,15.0,7.0,7.324e-02,2.475e-02,2.168e-01,5.202e-02,1.976e-02,1.370e-01,7.793e-01,2.718e-02
CHMP5,26942,regulation of centrosome duplication,GO:0010824,biological process,15.0,7.0,7.646e-02,2.448e-02,2.388e-01,5.736e-02,2.025e-02,1.625e-01,7.675e-01,2.823e-02
CHMP5,26942,multivesicular body sorting pathway,GO:0071985,biological process,15.0,4.0,7.693e-02,2.441e-02,2.425e-01,4.585e-02,8.668e-03,2.425e-01,7.887e-01,4.432e-02
CHMP5,26942,cellular response to lipopolysaccharide,GO:0071222,biological process,15.0,5.0,8.510e-02,4.692e-02,1.544e-01,4.261e-02,1.077e-02,1.686e-01,7.994e-01,3.440e-02
CHMP5,26942,cellular response to muramyl dipeptide,GO:0071225,biological process,15.0,4.0,1.190e-01,4.239e-02,3.343e-01,8.970e-02,1.623e-02,4.959e-01,7.042e-01,5.672e-02
CHMP5,26942,extracellular exosome,GO:0070062,cellular component,15.0,33.0,7.324e-02,2.475e-02,2.168e-01,2.174e-02,3.969e-03,1.191e-01,8.609e-01,3.623e-02
CHMP5,26942,cytosol,GO:0005829,cellular component,15.0,78.0,7.324e-02,2.475e-02,2.168e-01,4.850e-02,1.397e-02,1.684e-01,7.857e-01,3.452e-02
CHMP5,26942,cadherin binding,GO:0045296,molecular function,15.0,9.0,7.324e-02,2.475e-02,2.168e-01,3.510e-02,2.621e-03,4.701e-01,8.040e-01,5.552e-02
CHMP5,26942,protein binding,GO:0005515,molecular function,15.0,332.0,7.369e-02,2.455e-02,2.212e-01,5.155e-02,1.248e-02,2.130e-01,7.774e-01,3.928e-02
TPX2,1249,mitotic spindle assembly,GO:0090307,biological process,22.0,6.0,4.456e-02,2.792e-02,7.112e-02,1.679e-02,8.275e-03,3.407e-02,8.903e-01,1.203e-02
TPX2,1249,activation of protein kinase activity,GO:0032147,biological process,22.0,13.0,6.766e-02,2.573e-02,1.779e-01,6.052e-02,1.901e-02,1.927e-01,7.600e-01,3.497e-02
TPX2,1249,mitotic spindle,GO:0072686,cellular component,22.0,17.0,4.456e-02,2.792e-02,7.112e-02,1.510e-02,2.315e-03,9.852e-02,8.877e-01,3.059e-02
TPX2,1249,microtubule cytoskeleton,GO:0015630,cellular component,22.0,17.0,4.456e-02,2.792e-02,7.112e-02,2.355e-02,1.467e-02,3.782e-02,8.629e-01,1.023e-02
TPX2,1249,microtubule organizing center,GO:0005815,cellular component,22.0,16.0,4.456e-02,2.792e-02,7.112e-02,2.820e-02,1.693e-02,4.698e-02,8.460e-01,1.189e-02
TPX2,1249,spindle pole,GO:0000922,cellular component,22.0,15.0,4.456e-02,2.792e-02,7.112e-02,2.859e-02,5.212e-03,1.568e-01,8.359e-01,3.534e-02
TPX2,1249,intercellular bridge,GO:0045171,cellular component,22.0,25.0,4.630e-02,3.291e-02,6.516e-02,3.622e-02,3.084e-02,4.252e-02,8.215e-01,3.888e-03
TPX2,1249,nucleoplasm,GO:0005654,cellular component,22.0,74.0,4.630e-02,3.291e-02,6.516e-02,3.894e-02,2.322e-02,6.528e-02,8.129e-01,1.286e-02
TPX2,1249,importin-alpha family protein binding,GO:0061676,molecular function,22.0,2.0,1.725e-02,2.715e-03,1.096e-01,2.707e-03,9.633e-05,7.604e-02,9.571e-01,2.498e-02
TPX2,1249,protein kinase binding,GO:0019901,molecular function,22.0,32.0,4.456e-02,2.792e-02,7.112e-02,2.854e-02,1.682e-02,4.843e-02,8.449e-01,1.223e-02
TPX2,1249,protein binding,GO:0005515,molecular function,22.0,332.0,4.630e-02,3.291e-02,6.516e-02,4.373e-02,2.848e-02,6.715e-02,8.007e-01,1.146e-02
TGDS,20324,,,,nan,nan,,,,,,,,
RPL6,10362,cytoplasmic translation,GO:0002181,biological process,22.0,3.0,4.667e-02,2.163e-02,1.007e-01,2.258e-02,1.360e-02,3.751e-02,8.669e-01,1.151e-02
RPL6,10362,ribosomal large subunit assembly,GO:0000027,biological process,22.0,3.0,7.154e-02,1.904e-02,2.688e-01,6.754e-02,1.904e-02,2.396e-01,7.457e-01,3.973e-02
RPL6,10362,polysomal ribosome,GO:0042788,cellular component,22.0,2.0,4.257e-02,1.547e-02,1.171e-01,8.114e-03,5.634e-04,1.169e-01,9.169e-01,4.197e-02
RPL6,10362,focal adhesion,GO:0005925,cellular component,22.0,11.0,4.568e-02,2.009e-02,1.039e-01,1.774e-02,9.309e-03,3.382e-02,8.861e-01,1.286e-02
RPL6,10362,membrane,GO:0016020,cellular component,22.0,53.0,4.568e-02,2.009e-02,1.039e-01,1.801e-02,9.883e-03,3.283e-02,8.854e-01,1.198e-02
RPL6,10362,nucleus,GO:0005634,cellular component,22.0,151.0,4.938e-02,2.439e-02,9.995e-02,3.918e-02,2.348e-02,6.540e-02,8.122e-01,1.274e-02
RPL6,10362,cytosolic large ribosomal subunit,GO:0022625,cellular component,22.0,2.0,5.185e-02,1.503e-02,1.789e-01,2.957e-02,5.041e-03,1.735e-01,8.330e-01,4.243e-02
RPL6,10362,cytoplasmic ribonucleoprotein granule,GO:0036464,cellular component,22.0,12.0,5.453e-02,1.620e-02,1.835e-01,3.875e-02,9.128e-03,1.645e-01,8.090e-01,3.922e-02
RPL6,10362,RNA binding,GO:0003723,molecular function,22.0,63.0,4.257e-02,1.547e-02,1.171e-01,1.586e-02,1.910e-03,1.317e-01,8.814e-01,3.329e-02
RPL6,10362,cadherin binding,GO:0045296,molecular function,22.0,9.0,4.787e-02,2.316e-02,9.895e-02,3.520e-02,2.091e-02,5.927e-02,8.237e-01,1.310e-02
RPL6,10362,structural constituent of ribosome,GO:0003735,molecular function,22.0,3.0,7.142e-02,9.443e-03,5.402e-01,6.222e-02,6.510e-03,5.947e-01,7.437e-01,7.365e-02
MAPKAPK5,6889,positive regulation of telomere maintenance via telomerase,GO:0032212,biological process,22.0,6.0,4.755e-02,2.735e-02,8.264e-02,1.098e-02,3.633e-03,3.320e-02,9.153e-01,1.654e-02
MAPKAPK5,6889,Ras protein signal transduction,GO:0007265,biological process,22.0,12.0,4.764e-02,2.751e-02,8.253e-02,1.449e-02,6.799e-03,3.086e-02,9.003e-01,1.118e-02
MAPKAPK5,6889,positive regulation of telomere capping,GO:1904355,biological process,22.0,5.0,4.764e-02,2.751e-02,8.253e-02,1.621e-02,7.857e-03,3.345e-02,8.925e-01,1.355e-02
MAPKAPK5,6889,positive regulation of telomerase activity,GO:0051973,biological process,22.0,7.0,4.839e-02,2.861e-02,8.183e-02,1.368e-02,5.246e-03,3.568e-02,9.030e-01,1.457e-02
MAPKAPK5,6889,protein autophosphorylation,GO:0046777,biological process,22.0,12.0,5.603e-02,3.254e-02,9.646e-02,3.050e-02,1.821e-02,5.110e-02,8.382e-01,1.240e-02
MAPKAPK5,6889,peptidyl-serine phosphorylation,GO:0018105,biological process,22.0,13.0,5.603e-02,3.254e-02,9.646e-02,3.477e-02,1.412e-02,8.562e-02,8.234e-01,2.293e-02
MAPKAPK5,6889,intracellular signal transduction,GO:0035556,biological process,22.0,30.0,5.688e-02,3.215e-02,1.006e-01,2.946e-02,1.929e-02,4.499e-02,8.419e-01,9.971e-03
MAPKAPK5,6889,stress-induced premature senescence,GO:0090400,biological process,22.0,3.0,6.656e-02,6.211e-02,7.134e-02,4.722e-02,4.425e-02,5.039e-02,7.925e-01,1.706e-03
MAPKAPK5,6889,regulation of translation,GO:0006417,biological process,22.0,25.0,1.106e-01,2.717e-02,4.500e-01,1.086e-01,2.568e-02,4.594e-01,6.791e-01,5.316e-02
MAPKAPK5,6889,cytoplasm,GO:0005737,cellular component,22.0,69.0,7.086e-02,5.356e-02,9.374e-02,5.657e-02,4.684e-02,6.832e-02,7.718e-01,5.248e-03
MAPKAPK5,6889,nucleus,GO:0005634,cellular component,22.0,151.0,7.145e-02,5.251e-02,9.721e-02,5.954e-02,4.388e-02,8.080e-02,7.658e-01,8.635e-03
MAPKAPK5,6889,nucleoplasm,GO:0005654,cellular component,22.0,74.0,7.264e-02,5.204e-02,1.014e-01,6.650e-02,4.408e-02,1.003e-01,7.523e-01,1.218e-02
MAPKAPK5,6889,cytosol,GO:0005829,cellular component,22.0,78.0,7.353e-02,5.628e-02,9.607e-02,6.511e-02,5.005e-02,8.470e-02,7.551e-01,7.791e-03
MAPKAPK5,6889,calmodulin binding,GO:0005516,molecular function,22.0,2.0,4.015e-02,3.933e-02,4.099e-02,4.005e-03,1.594e-03,1.006e-02,9.636e-01,8.187e-03
MAPKAPK5,6889,p53 binding,GO:0002039,molecular function,22.0,5.0,4.024e-02,3.923e-02,4.127e-02,6.255e-03,1.626e-03,2.407e-02,9.446e-01,1.448e-02
MAPKAPK5,6889,mitogen-activated protein kinase binding,GO:0051019,molecular function,22.0,4.0,4.755e-02,2.735e-02,8.264e-02,8.251e-03,2.939e-03,2.316e-02,9.326e-01,1.142e-02
MAPKAPK5,6889,calmodulin-dependent protein kinase activity,GO:0004683,molecular function,22.0,5.0,5.688e-02,3.215e-02,1.006e-01,3.170e-02,1.850e-02,5.431e-02,8.346e-01,1.265e-02
MAPKAPK5,6889,calcium-dependent protein serine/threonine kinase activity,GO:0009931,molecular function,22.0,4.0,5.703e-02,3.207e-02,1.014e-01,3.663e-02,1.580e-02,8.496e-02,8.185e-01,2.063e-02
MAPKAPK5,6889,protein serine/threonine kinase activity,GO:0004674,molecular function,22.0,34.0,5.949e-02,3.859e-02,9.171e-02,3.883e-02,2.418e-02,6.236e-02,8.134e-01,1.189e-02
MAPKAPK5,6889,protein binding,GO:0005515,molecular function,22.0,332.0,7.546e-02,6.086e-02,9.356e-02,7.162e-02,6.246e-02,8.213e-02,7.435e-01,4.098e-03
ZNF302,13848,,,,nan,nan,,,,,,,,
BIRC5,593,mitotic spindle assembly,GO:0090307,biological process,45.0,6.0,3.942e-02,3.836e-02,4.051e-02,1.411e-02,5.426e-03,3.671e-02,9.007e-01,1.492e-02
BIRC5,593,negative regulation of apoptotic process,GO:0043066,biological process,45.0,31.0,4.415e-02,3.085e-02,6.320e-02,2.653e-02,1.093e-02,6.437e-02,8.506e-01,2.100e-02
BIRC5,593,sensory perception of sound,GO:0007605,biological process,45.0,4.0,4.415e-02,3.085e-02,6.320e-02,2.741e-02,1.582e-02,4.749e-02,8.488e-01,1.302e-02
BIRC5,593,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,biological process,45.0,7.0,4.514e-02,2.926e-02,6.962e-02,2.017e-02,3.589e-03,1.133e-01,8.670e-01,3.757e-02
BIRC5,593,protein-containing complex localization,GO:0031503,biological process,45.0,15.0,4.514e-02,2.926e-02,6.962e-02,3.098e-02,1.125e-02,8.535e-02,8.349e-01,2.534e-02
BIRC5,593,protein phosphorylation,GO:0006468,biological process,45.0,33.0,4.699e-02,3.530e-02,6.255e-02,3.751e-02,2.204e-02,6.385e-02,8.169e-01,1.320e-02
BIRC5,593,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,45.0,41.0,5.220e-02,4.725e-02,5.766e-02,4.421e-02,3.205e-02,6.100e-02,7.998e-01,8.575e-03
BIRC5,593,midbody,GO:0030496,cellular component,45.0,26.0,4.234e-02,3.258e-02,5.501e-02,1.905e-02,5.462e-03,6.647e-02,8.764e-01,2.538e-02
BIRC5,593,chromosome passenger complex,GO:0032133,cellular component,45.0,4.0,4.266e-02,3.350e-02,5.432e-02,2.321e-02,1.373e-02,3.924e-02,8.643e-01,1.202e-02
BIRC5,593,spindle microtubule,GO:0005876,cellular component,45.0,11.0,4.403e-02,3.106e-02,6.241e-02,2.365e-02,2.201e-02,2.541e-02,8.634e-01,1.603e-03
BIRC5,593,condensed chromosome kinetochore,GO:0000777,cellular component,45.0,6.0,4.415e-02,3.085e-02,6.320e-02,1.855e-02,8.669e-03,3.967e-02,8.818e-01,1.576e-02
BIRC5,593,"chromosome, centromeric region",GO:0000775,cellular component,45.0,8.0,4.415e-02,3.085e-02,6.320e-02,2.601e-02,1.030e-02,6.571e-02,8.515e-01,1.977e-02
BIRC5,593,cytoplasm,GO:0005737,cellular component,45.0,69.0,4.492e-02,2.829e-02,7.131e-02,2.539e-02,7.462e-03,8.640e-02,8.522e-01,2.775e-02
BIRC5,593,cytosol,GO:0005829,cellular component,45.0,78.0,4.492e-02,2.829e-02,7.132e-02,2.724e-02,7.293e-03,1.017e-01,8.448e-01,3.014e-02
BIRC5,593,nucleus,GO:0005634,cellular component,45.0,151.0,4.503e-02,2.812e-02,7.210e-02,2.859e-02,7.040e-03,1.161e-01,8.393e-01,3.211e-02
BIRC5,593,nuclear chromosome,GO:0000228,cellular component,45.0,7.0,5.031e-02,3.327e-02,7.608e-02,3.959e-02,2.389e-02,6.562e-02,8.113e-01,1.287e-02
BIRC5,593,chaperone binding,GO:0051087,molecular function,45.0,3.0,3.942e-02,3.836e-02,4.051e-02,8.035e-03,3.347e-03,1.929e-02,9.341e-01,9.563e-03
BIRC5,593,identical protein binding,GO:0042802,molecular function,45.0,20.0,3.942e-02,3.836e-02,4.051e-02,1.306e-02,6.558e-03,2.601e-02,9.076e-01,1.022e-02
BIRC5,593,protein binding,GO:0005515,molecular function,45.0,332.0,4.503e-02,2.812e-02,7.210e-02,2.863e-02,5.996e-03,1.367e-01,8.376e-01,3.472e-02
BIRC5,593,Ran GTPase binding,GO:0008536,molecular function,45.0,3.0,4.704e-02,3.454e-02,6.405e-02,2.899e-02,1.122e-02,7.492e-02,8.414e-01,2.156e-02
BIRC5,593,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043027,molecular function,45.0,3.0,4.724e-02,2.623e-02,8.508e-02,2.211e-02,3.246e-03,1.506e-01,8.574e-01,4.339e-02
BIRC5,593,enzyme binding,GO:0019899,molecular function,45.0,33.0,5.779e-02,2.735e-02,1.221e-01,4.759e-02,1.536e-02,1.475e-01,7.884e-01,3.079e-02
MAEA,13731,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,18.0,17.0,9.222e-02,3.416e-02,2.490e-01,3.689e-02,4.966e-03,2.741e-01,8.086e-01,5.447e-02
MAEA,13731,negative regulation of apoptotic process,GO:0043066,biological process,18.0,31.0,9.371e-02,3.330e-02,2.637e-01,4.366e-02,5.664e-03,3.365e-01,7.897e-01,5.821e-02
MAEA,13731,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,18.0,9.0,1.183e-01,8.493e-02,1.648e-01,5.173e-02,2.033e-02,1.317e-01,7.800e-01,2.465e-02
MAEA,13731,negative regulation of myeloid cell apoptotic process,GO:0033033,biological process,18.0,7.0,1.323e-01,9.950e-02,1.758e-01,1.050e-01,6.696e-02,1.646e-01,6.923e-01,1.543e-02
MAEA,13731,cell adhesion,GO:0007155,biological process,18.0,11.0,2.185e-01,1.224e-01,3.900e-01,2.185e-01,1.224e-01,3.900e-01,5.737e-01,2.637e-02
MAEA,13731,ubiquitin ligase complex,GO:0000151,cellular component,18.0,13.0,8.604e-02,3.748e-02,1.975e-01,2.152e-02,1.399e-02,3.311e-02,8.712e-01,8.930e-03
MAEA,13731,actomyosin contractile ring,GO:0005826,cellular component,18.0,5.0,8.604e-02,3.748e-02,1.975e-01,2.267e-02,1.338e-02,3.843e-02,8.660e-01,1.136e-02
MAEA,13731,cytoskeleton,GO:0005856,cellular component,18.0,12.0,8.646e-02,3.742e-02,1.998e-01,2.389e-02,8.616e-03,6.622e-02,8.589e-01,2.116e-02
MAEA,13731,GID complex,GO:0034657,cellular component,18.0,2.0,9.388e-02,3.518e-02,2.506e-01,2.204e-02,2.827e-03,1.718e-01,8.559e-01,4.650e-02
MAEA,13731,integral component of plasma membrane,GO:0005887,cellular component,18.0,10.0,1.031e-01,3.330e-02,3.192e-01,5.707e-02,1.268e-02,2.568e-01,7.650e-01,4.158e-02
MAEA,13731,spindle,GO:0005819,cellular component,18.0,15.0,1.094e-01,5.253e-02,2.278e-01,4.401e-02,3.156e-02,6.138e-02,8.003e-01,8.974e-03
MAEA,13731,cytoplasm,GO:0005737,cellular component,18.0,69.0,1.323e-01,9.950e-02,1.758e-01,1.128e-01,8.755e-02,1.453e-01,6.826e-01,8.804e-03
MAEA,13731,nucleoplasm,GO:0005654,cellular component,18.0,74.0,1.323e-01,9.950e-02,1.758e-01,1.129e-01,8.062e-02,1.580e-01,6.823e-01,1.163e-02
MAEA,13731,nucleus,GO:0005634,cellular component,18.0,151.0,1.323e-01,9.950e-02,1.758e-01,1.151e-01,8.706e-02,1.522e-01,6.797e-01,9.842e-03
MAEA,13731,nuclear matrix,GO:0016363,cellular component,18.0,6.0,1.344e-01,9.820e-02,1.840e-01,1.186e-01,8.497e-02,1.656e-01,6.751e-01,1.160e-02
MAEA,13731,ubiquitin-protein transferase activity,GO:0004842,molecular function,18.0,11.0,1.006e-01,3.381e-02,2.995e-01,4.893e-02,1.204e-02,1.989e-01,7.839e-01,3.624e-02
MAEA,13731,actin binding,GO:0003779,molecular function,18.0,7.0,1.291e-01,1.005e-01,1.659e-01,9.833e-02,6.628e-02,1.459e-01,7.016e-01,1.294e-02
RAB11FIP3,17224,endocytic recycling,GO:0032456,biological process,22.0,4.0,4.373e-02,2.082e-02,9.187e-02,1.389e-02,3.849e-03,5.015e-02,8.985e-01,2.298e-02
RAB11FIP3,17224,negative regulation of adiponectin secretion,GO:0070164,biological process,22.0,6.0,4.805e-02,2.551e-02,9.048e-02,2.585e-02,6.805e-03,9.820e-02,8.489e-01,2.868e-02
RAB11FIP3,17224,regulation of cytokinesis,GO:0032465,biological process,22.0,12.0,4.911e-02,2.762e-02,8.730e-02,2.211e-02,1.534e-02,3.188e-02,8.690e-01,7.704e-03
RAB11FIP3,17224,endocytic vesicle,GO:0030139,cellular component,22.0,6.0,2.966e-02,1.695e-02,5.190e-02,4.328e-03,1.306e-03,1.434e-02,9.602e-01,1.183e-02
RAB11FIP3,17224,recycling endosome membrane,GO:0055038,cellular component,22.0,2.0,2.966e-02,1.695e-02,5.190e-02,7.576e-03,2.480e-03,2.315e-02,9.362e-01,1.306e-02
RAB11FIP3,17224,endosome,GO:0005768,cellular component,22.0,14.0,3.122e-02,2.123e-02,4.591e-02,7.772e-03,4.453e-03,1.356e-02,9.363e-01,6.469e-03
RAB11FIP3,17224,recycling endosome,GO:0055037,cellular component,22.0,8.0,3.390e-02,1.432e-02,8.022e-02,9.362e-03,2.555e-03,3.431e-02,9.247e-01,1.568e-02
RAB11FIP3,17224,microtubule organizing center,GO:0005815,cellular component,22.0,16.0,4.911e-02,2.762e-02,8.730e-02,2.459e-02,1.493e-02,4.051e-02,8.590e-01,1.145e-02
RAB11FIP3,17224,intracellular membrane-bounded organelle,GO:0043231,cellular component,22.0,40.0,5.029e-02,2.998e-02,8.437e-02,3.121e-02,1.358e-02,7.176e-02,8.348e-01,2.056e-02
RAB11FIP3,17224,centrosome,GO:0005813,cellular component,22.0,31.0,5.114e-02,2.907e-02,8.996e-02,3.044e-02,1.683e-02,5.505e-02,8.386e-01,1.383e-02
RAB11FIP3,17224,cleavage furrow,GO:0032154,cellular component,22.0,5.0,5.411e-02,3.213e-02,9.112e-02,3.859e-02,1.845e-02,8.071e-02,8.133e-01,1.913e-02
RAB11FIP3,17224,midbody,GO:0030496,cellular component,22.0,26.0,6.464e-02,5.953e-02,7.019e-02,4.788e-02,4.161e-02,5.510e-02,7.910e-01,3.781e-03
RAB11FIP3,17224,intercellular bridge,GO:0045171,cellular component,22.0,25.0,8.572e-02,6.607e-02,1.112e-01,7.695e-02,5.275e-02,1.123e-01,7.341e-01,1.144e-02
RAB11FIP3,17224,nucleoplasm,GO:0005654,cellular component,22.0,74.0,9.159e-02,6.349e-02,1.321e-01,8.668e-02,5.590e-02,1.344e-01,7.184e-01,1.377e-02
RAB11FIP3,17224,dynein light intermediate chain binding,GO:0051959,molecular function,22.0,3.0,2.966e-02,1.695e-02,5.190e-02,7.424e-03,2.169e-03,2.542e-02,9.362e-01,1.502e-02
RAB11FIP3,17224,ADP-ribosylation factor binding,GO:0030306,molecular function,22.0,2.0,4.447e-02,3.251e-02,6.081e-02,1.969e-02,1.167e-02,3.322e-02,8.786e-01,1.085e-02
RAB11FIP3,17224,Rab GTPase binding,GO:0017137,molecular function,22.0,6.0,5.003e-02,2.661e-02,9.409e-02,2.399e-02,4.314e-03,1.334e-01,8.515e-01,3.240e-02
RAB11FIP3,17224,protein homodimerization activity,GO:0042803,molecular function,22.0,15.0,8.245e-02,6.828e-02,9.956e-02,7.283e-02,6.163e-02,8.607e-02,7.414e-01,4.972e-03
RAB11FIP3,17224,protein binding,GO:0005515,molecular function,22.0,332.0,1.063e-01,8.477e-02,1.333e-01,1.043e-01,7.805e-02,1.394e-01,6.936e-01,9.668e-03
KIF4A,13339,mitotic spindle organization,GO:0007052,biological process,21.0,12.0,5.010e-02,2.847e-02,8.815e-02,1.388e-02,1.120e-02,1.720e-02,9.056e-01,3.485e-03
KIF4A,13339,mitotic cytokinesis,GO:0000281,biological process,21.0,12.0,5.024e-02,2.855e-02,8.842e-02,2.534e-02,8.641e-03,7.433e-02,8.530e-01,2.260e-02
KIF4A,13339,mitotic spindle midzone assembly,GO:0051256,biological process,21.0,6.0,5.024e-02,2.855e-02,8.842e-02,2.652e-02,1.684e-02,4.179e-02,8.522e-01,1.049e-02
KIF4A,13339,microtubule-based movement,GO:0007018,biological process,21.0,21.0,5.262e-02,2.912e-02,9.508e-02,3.801e-02,1.791e-02,8.066e-02,8.149e-01,1.943e-02
KIF4A,13339,microtubule,GO:0005874,cellular component,21.0,22.0,5.010e-02,2.847e-02,8.815e-02,2.014e-02,8.219e-03,4.935e-02,8.748e-01,1.903e-02
KIF4A,13339,kinesin complex,GO:0005871,cellular component,21.0,16.0,5.024e-02,2.855e-02,8.842e-02,2.375e-02,1.401e-02,4.028e-02,8.621e-01,1.189e-02
KIF4A,13339,midbody,GO:0030496,cellular component,21.0,26.0,5.322e-02,2.542e-02,1.114e-01,2.883e-02,7.858e-03,1.058e-01,8.400e-01,3.157e-02
KIF4A,13339,membrane,GO:0016020,cellular component,21.0,53.0,5.322e-02,2.542e-02,1.114e-01,4.001e-02,1.577e-02,1.015e-01,8.089e-01,2.464e-02
KIF4A,13339,intercellular bridge,GO:0045171,cellular component,21.0,25.0,5.322e-02,2.542e-02,1.114e-01,4.273e-02,2.034e-02,8.980e-02,8.024e-01,1.969e-02
KIF4A,13339,nucleoplasm,GO:0005654,cellular component,21.0,74.0,5.807e-02,2.470e-02,1.365e-01,5.241e-02,1.758e-02,1.562e-01,7.777e-01,2.947e-02
KIF4A,13339,microtubule motor activity,GO:0003777,molecular function,21.0,13.0,5.010e-02,2.847e-02,8.815e-02,1.471e-02,8.516e-03,2.540e-02,9.006e-01,9.370e-03
KIF4A,13339,microtubule binding,GO:0008017,molecular function,21.0,22.0,5.010e-02,2.847e-02,8.815e-02,1.939e-02,7.197e-03,5.226e-02,8.770e-01,2.011e-02
KIF4A,13339,ATPase activity,GO:0016887,molecular function,21.0,14.0,5.114e-02,2.758e-02,9.483e-02,3.750e-02,2.416e-02,5.822e-02,8.171e-01,1.086e-02
KIF4A,13339,protein binding,GO:0005515,molecular function,21.0,332.0,6.356e-02,3.465e-02,1.166e-01,6.188e-02,3.281e-02,1.167e-01,7.601e-01,1.872e-02
ORC6,17151,negative regulation of cell division,GO:0051782,biological process,16.0,9.0,6.081e-02,3.078e-02,1.201e-01,2.835e-02,8.034e-03,1.000e-01,8.424e-01,3.114e-02
ORC6,17151,DNA replication initiation,GO:0006270,biological process,16.0,4.0,6.995e-02,3.434e-02,1.425e-01,5.338e-02,1.050e-02,2.715e-01,7.721e-01,4.277e-02
ORC6,17151,nuclear origin of replication recognition complex,GO:0005664,cellular component,16.0,2.0,3.284e-02,1.828e-02,5.899e-02,6.579e-03,5.139e-03,8.422e-03,9.444e-01,2.686e-03
ORC6,17151,origin recognition complex,GO:0000808,cellular component,16.0,4.0,3.284e-02,1.828e-02,5.899e-02,6.755e-03,1.881e-03,2.426e-02,9.406e-01,1.513e-02
ORC6,17151,membrane,GO:0016020,cellular component,16.0,53.0,6.871e-02,3.700e-02,1.276e-01,4.918e-02,1.980e-02,1.222e-01,7.858e-01,2.477e-02
ORC6,17151,nucleus,GO:0005634,cellular component,16.0,151.0,6.871e-02,3.700e-02,1.276e-01,5.110e-02,2.962e-02,8.815e-02,7.830e-01,1.492e-02
ORC6,17151,fibrillar center,GO:0001650,cellular component,16.0,9.0,6.871e-02,3.700e-02,1.276e-01,5.391e-02,2.169e-02,1.340e-01,7.755e-01,2.500e-02
ORC6,17151,DNA replication origin binding,GO:0003688,molecular function,16.0,4.0,5.336e-02,4.488e-02,6.344e-02,2.750e-02,1.166e-02,6.488e-02,8.471e-01,2.055e-02
ORC6,17151,protein binding,GO:0005515,molecular function,16.0,332.0,7.113e-02,3.694e-02,1.369e-01,6.721e-02,3.848e-02,1.174e-01,7.505e-01,1.606e-02
MFSD11,25458,,,,nan,nan,,,,,,,,
CDC6,1744,mitotic cell cycle,GO:0000278,biological process,23.0,13.0,4.418e-02,2.408e-02,8.108e-02,1.856e-02,4.254e-03,8.102e-02,8.764e-01,3.112e-02
CDC6,1744,positive regulation of chromosome segregation,GO:0051984,biological process,23.0,8.0,4.507e-02,2.626e-02,7.735e-02,2.578e-02,1.567e-02,4.240e-02,8.546e-01,1.134e-02
CDC6,1744,regulation of mitotic metaphase/anaphase transition,GO:0030071,biological process,23.0,7.0,4.507e-02,2.626e-02,7.735e-02,2.828e-02,2.533e-02,3.157e-02,8.460e-01,2.698e-03
CDC6,1744,mitotic DNA replication checkpoint,GO:0033314,biological process,23.0,4.0,4.507e-02,2.626e-02,7.735e-02,2.939e-02,1.993e-02,4.335e-02,8.423e-01,9.178e-03
CDC6,1744,positive regulation of cytokinesis,GO:0032467,biological process,23.0,16.0,4.880e-02,2.186e-02,1.090e-01,2.132e-02,4.792e-03,9.486e-02,8.643e-01,2.942e-02
CDC6,1744,spindle pole,GO:0000922,cellular component,23.0,15.0,5.268e-02,1.926e-02,1.441e-01,3.058e-02,5.199e-03,1.799e-01,8.291e-01,3.852e-02
CDC6,1744,spindle midzone,GO:0051233,cellular component,23.0,8.0,5.278e-02,1.919e-02,1.451e-01,3.123e-02,3.446e-03,2.831e-01,8.210e-01,4.700e-02
CDC6,1744,nucleus,GO:0005634,cellular component,23.0,151.0,5.809e-02,2.152e-02,1.568e-01,4.577e-02,1.052e-02,1.991e-01,7.909e-01,3.738e-02
CDC6,1744,kinase binding,GO:0019900,molecular function,23.0,7.0,4.489e-02,2.579e-02,7.811e-02,1.413e-02,1.281e-02,1.558e-02,9.046e-01,1.612e-03
CDC6,1744,DNA replication origin binding,GO:0003688,molecular function,23.0,4.0,4.507e-02,2.626e-02,7.735e-02,2.576e-02,2.209e-02,3.005e-02,8.552e-01,3.611e-03
CDC6,1744,protein binding,GO:0005515,molecular function,23.0,332.0,6.652e-02,1.991e-02,2.222e-01,6.634e-02,1.967e-02,2.237e-01,7.488e-01,3.430e-02
CDC7,1745,peptidyl-serine phosphorylation,GO:0018105,biological process,22.0,13.0,6.545e-02,5.626e-02,7.614e-02,2.379e-02,8.836e-03,6.403e-02,8.595e-01,2.093e-02
CDC7,1745,positive regulation of nuclear cell cycle DNA replication,GO:0010571,biological process,22.0,8.0,6.545e-02,5.626e-02,7.614e-02,2.350e-02,6.645e-03,8.314e-02,8.590e-01,2.899e-02
CDC7,1745,peptidyl-threonine phosphorylation,GO:0018107,biological process,22.0,10.0,6.545e-02,5.626e-02,7.614e-02,2.586e-02,7.655e-03,8.738e-02,8.507e-01,2.856e-02
CDC7,1745,double-strand break repair via break-induced replication,GO:0000727,biological process,22.0,2.0,6.582e-02,5.723e-02,7.569e-02,2.133e-02,1.331e-02,3.416e-02,8.718e-01,1.034e-02
CDC7,1745,cell cycle phase transition,GO:0044770,biological process,22.0,9.0,7.527e-02,4.032e-02,1.405e-01,2.173e-02,1.290e-03,3.661e-01,8.456e-01,6.422e-02
CDC7,1745,positive regulation of G2/M transition of mitotic cell cycle,GO:0010971,biological process,22.0,9.0,8.036e-02,4.882e-02,1.323e-01,4.186e-02,9.576e-03,1.830e-01,8.005e-01,3.631e-02
CDC7,1745,positive regulation of cell population proliferation,GO:0008284,biological process,22.0,40.0,9.694e-02,5.468e-02,1.719e-01,9.050e-02,4.516e-02,1.814e-01,7.116e-01,2.251e-02
CDC7,1745,mitotic spindle,GO:0072686,cellular component,22.0,17.0,7.872e-02,4.574e-02,1.355e-01,4.405e-02,2.400e-02,8.086e-02,7.994e-01,1.601e-02
CDC7,1745,cytoplasm,GO:0005737,cellular component,22.0,69.0,7.872e-02,4.574e-02,1.355e-01,4.732e-02,1.748e-02,1.281e-01,7.897e-01,2.697e-02
CDC7,1745,nucleus,GO:0005634,cellular component,22.0,151.0,7.872e-02,4.574e-02,1.355e-01,4.914e-02,2.338e-02,1.033e-01,7.868e-01,2.066e-02
CDC7,1745,intercellular bridge,GO:0045171,cellular component,22.0,25.0,7.933e-02,4.643e-02,1.355e-01,5.495e-02,2.255e-02,1.339e-01,7.734e-01,2.552e-02
CDC7,1745,nucleoplasm,GO:0005654,cellular component,22.0,74.0,7.933e-02,4.643e-02,1.355e-01,5.820e-02,2.138e-02,1.584e-01,7.662e-01,2.832e-02
CDC7,1745,protein serine/threonine kinase activity,GO:0004674,molecular function,22.0,34.0,6.947e-02,5.936e-02,8.130e-02,2.929e-02,1.907e-02,4.499e-02,8.425e-01,9.972e-03
CDC7,1745,protein kinase activity,GO:0004672,molecular function,22.0,38.0,6.947e-02,5.936e-02,8.130e-02,3.083e-02,1.265e-02,7.516e-02,8.357e-01,2.132e-02
CDC7,1745,protein binding,GO:0005515,molecular function,22.0,332.0,7.933e-02,4.643e-02,1.355e-01,5.970e-02,2.713e-02,1.314e-01,7.642e-01,2.272e-02
CDC7,1745,kinase activity,GO:0016301,molecular function,22.0,138.0,1.161e-01,9.442e-02,1.427e-01,1.161e-01,9.442e-02,1.427e-01,6.785e-01,7.178e-03
KLHL22,25888,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,24.0,17.0,1.431e-01,1.254e-01,1.633e-01,3.601e-02,6.715e-03,1.931e-01,8.144e-01,4.292e-02
KLHL22,25888,protein monoubiquitination,GO:0006513,biological process,24.0,4.0,1.431e-01,1.254e-01,1.633e-01,7.717e-02,3.456e-02,1.723e-01,7.320e-01,2.527e-02
KLHL22,25888,positive regulation of TORC1 signaling,GO:1904263,biological process,24.0,3.0,1.506e-01,1.171e-01,1.936e-01,1.048e-01,8.588e-02,1.278e-01,6.932e-01,6.740e-03
KLHL22,25888,mitotic sister chromatid segregation,GO:0000070,biological process,24.0,9.0,1.651e-01,9.574e-02,2.846e-01,1.104e-01,4.264e-02,2.857e-01,6.824e-01,3.375e-02
KLHL22,25888,positive regulation of cell growth,GO:0030307,biological process,24.0,16.0,1.789e-01,1.322e-01,2.421e-01,1.371e-01,7.875e-02,2.388e-01,6.527e-01,2.027e-02
KLHL22,25888,negative regulation of autophagy,GO:0010507,biological process,24.0,9.0,1.838e-01,8.938e-02,3.780e-01,1.141e-01,1.924e-02,6.771e-01,6.672e-01,6.376e-02
KLHL22,25888,mitotic spindle assembly checkpoint,GO:0007094,biological process,24.0,5.0,1.857e-01,7.264e-02,4.749e-01,1.072e-01,1.641e-02,7.009e-01,6.738e-01,6.974e-02
KLHL22,25888,cell division,GO:0051301,biological process,24.0,20.0,2.096e-01,9.466e-02,4.642e-01,1.678e-01,4.524e-02,6.224e-01,6.134e-01,4.914e-02
KLHL22,25888,cellular response to leucine,GO:0071233,biological process,24.0,3.0,3.084e-01,1.444e-01,6.588e-01,3.029e-01,1.376e-01,6.669e-01,5.024e-01,4.621e-02
KLHL22,25888,centrosome,GO:0005813,cellular component,24.0,31.0,1.431e-01,1.254e-01,1.633e-01,3.459e-02,2.260e-02,5.292e-02,8.253e-01,1.053e-02
KLHL22,25888,mitotic spindle,GO:0072686,cellular component,24.0,17.0,1.431e-01,1.254e-01,1.633e-01,6.468e-02,5.224e-02,8.008e-02,7.560e-01,6.201e-03
KLHL22,25888,polar microtubule,GO:0005827,cellular component,24.0,3.0,1.431e-01,1.254e-01,1.633e-01,7.490e-02,3.837e-02,1.462e-01,7.364e-01,2.030e-02
KLHL22,25888,cytoplasm,GO:0005737,cellular component,24.0,69.0,1.431e-01,1.254e-01,1.633e-01,7.733e-02,4.989e-02,1.199e-01,7.333e-01,1.370e-02
KLHL22,25888,cytosol,GO:0005829,cellular component,24.0,78.0,1.431e-01,1.254e-01,1.633e-01,8.582e-02,6.222e-02,1.184e-01,7.200e-01,1.034e-02
KLHL22,25888,nucleus,GO:0005634,cellular component,24.0,151.0,1.431e-01,1.254e-01,1.633e-01,1.024e-01,6.371e-02,1.645e-01,6.958e-01,1.619e-02
KLHL22,25888,lysosome,GO:0005764,cellular component,24.0,9.0,1.562e-01,1.318e-01,1.850e-01,1.028e-01,5.625e-02,1.878e-01,6.947e-01,2.068e-02
KLHL22,25888,Cul3-RING ubiquitin ligase complex,GO:0031463,cellular component,24.0,2.0,1.598e-01,1.031e-01,2.478e-01,7.633e-02,1.989e-02,2.930e-01,7.297e-01,4.300e-02
KLHL22,25888,14-3-3 protein binding,GO:0071889,molecular function,24.0,2.0,1.431e-01,1.254e-01,1.633e-01,1.531e-02,1.094e-02,2.143e-02,8.986e-01,5.758e-03
KLHL22,25888,protein binding,GO:0005515,molecular function,24.0,332.0,1.431e-01,1.254e-01,1.633e-01,9.725e-02,5.941e-02,1.592e-01,7.028e-01,1.653e-02
GCAT,4188,nuclear speck,GO:0016607,cellular component,6.0,6.0,1.686e-02,3.612e-03,7.870e-02,7.486e-03,1.079e-03,5.194e-02,9.328e-01,1.965e-02
GCAT,4188,mitochondrion,GO:0005739,cellular component,6.0,19.0,2.429e-02,1.385e-02,4.260e-02,1.619e-02,9.235e-03,2.840e-02,8.937e-01,1.050e-02
GCAT,4188,nucleoplasm,GO:0005654,cellular component,6.0,74.0,3.022e-02,2.312e-02,3.949e-02,3.022e-02,2.312e-02,3.949e-02,8.396e-01,6.331e-03
ANKRD54,25185,,,,nan,nan,,,,,,,,
DESI1,24577,,,,nan,nan,,,,,,,,
ATP6V1D,13527,protein localization to cilium,GO:0061512,biological process,12.0,6.0,8.141e-02,6.282e-02,1.055e-01,2.785e-02,9.192e-03,8.436e-02,8.443e-01,2.567e-02
ATP6V1D,13527,cilium assembly,GO:0060271,biological process,12.0,12.0,9.119e-02,5.144e-02,1.617e-01,4.122e-02,8.915e-03,1.906e-01,8.015e-01,3.717e-02
ATP6V1D,13527,proton-transporting V-type ATPase complex,GO:0033176,cellular component,12.0,4.0,7.309e-02,3.786e-02,1.411e-01,1.764e-02,3.683e-03,8.450e-02,8.789e-01,3.215e-02
ATP6V1D,13527,cilium,GO:0005929,cellular component,12.0,6.0,8.537e-02,5.897e-02,1.236e-01,3.890e-02,3.288e-02,4.604e-02,8.141e-01,4.252e-03
ATP6V1D,13527,lysosomal membrane,GO:0005765,cellular component,12.0,8.0,8.948e-02,4.724e-02,1.695e-01,4.652e-02,1.029e-02,2.103e-01,7.887e-01,3.906e-02
ATP6V1D,13527,centrosome,GO:0005813,cellular component,12.0,31.0,9.145e-02,5.116e-02,1.635e-01,5.987e-02,3.583e-02,1.000e-01,7.645e-01,1.460e-02
ATP6V1D,13527,extracellular exosome,GO:0070062,cellular component,12.0,33.0,9.290e-02,5.115e-02,1.687e-01,6.647e-02,3.020e-02,1.463e-01,7.508e-01,2.383e-02
ATP6V1D,13527,membrane,GO:0016020,cellular component,12.0,53.0,1.004e-01,4.040e-02,2.495e-01,6.630e-02,1.235e-02,3.560e-01,7.447e-01,4.965e-02
ATP6V1D,13527,"proton-transporting ATPase activity, rotational mechanism",GO:0046961,molecular function,12.0,4.0,8.319e-02,3.280e-02,2.110e-01,2.780e-02,2.034e-03,3.799e-01,8.269e-01,6.174e-02
ATP6V1D,13527,protein binding,GO:0005515,molecular function,12.0,332.0,1.391e-01,6.777e-02,2.854e-01,1.391e-01,6.777e-02,2.854e-01,6.496e-01,2.663e-02
GMPR2,4377,GMP metabolic process,GO:0046037,biological process,5.0,6.0,7.255e-02,1.110e-02,4.740e-01,3.792e-02,6.817e-03,2.109e-01,8.084e-01,3.995e-02
GMPR2,4377,purine ribonucleotide interconversion,GO:0015951,biological process,5.0,3.0,7.255e-02,1.110e-02,4.740e-01,5.077e-02,1.231e-02,2.094e-01,7.792e-01,3.937e-02
GMPR2,4377,GMP reductase activity,GO:0003920,molecular function,5.0,2.0,9.412e-02,8.882e-03,9.973e-01,9.290e-02,8.406e-03,1.027e+00,6.894e-01,7.623e-02
PCIF1,16200,positive regulation of translation,GO:0045727,biological process,11.0,20.0,2.575e-01,1.219e-01,5.439e-01,9.044e-02,3.659e-02,2.236e-01,7.105e-01,2.892e-02
PCIF1,16200,mRNA methylation,GO:0080009,biological process,11.0,4.0,3.111e-01,1.025e-01,9.443e-01,2.011e-01,3.448e-02,1.173e+00,5.712e-01,7.078e-02
PCIF1,16200,negative regulation of phosphatase activity,GO:0010923,biological process,11.0,10.0,3.800e-01,9.171e-02,1.575e+00,3.698e-01,9.437e-02,1.449e+00,4.376e-01,7.704e-02
PCIF1,16200,nucleus,GO:0005634,cellular component,11.0,151.0,2.575e-01,1.219e-01,5.439e-01,1.404e-01,8.086e-02,2.436e-01,6.495e-01,1.994e-02
PCIF1,16200,nucleoplasm,GO:0005654,cellular component,11.0,74.0,2.575e-01,1.219e-01,5.439e-01,1.536e-01,8.641e-02,2.730e-01,6.348e-01,2.263e-02
PCIF1,16200,intercellular bridge,GO:0045171,cellular component,11.0,25.0,2.575e-01,1.219e-01,5.439e-01,1.570e-01,6.480e-02,3.804e-01,6.286e-01,3.505e-02
PCIF1,16200,microtubule cytoskeleton,GO:0015630,cellular component,11.0,17.0,2.575e-01,1.219e-01,5.439e-01,1.648e-01,8.918e-02,3.046e-01,6.230e-01,2.494e-02
PCIF1,16200,RNA polymerase II C-terminal domain binding,GO:0099122,molecular function,11.0,3.0,3.017e-01,1.014e-01,8.972e-01,1.715e-01,2.558e-02,1.149e+00,5.988e-01,7.203e-02
PCIF1,16200,S-adenosyl-L-methionine binding,GO:1904047,molecular function,11.0,4.0,3.280e-01,8.721e-02,1.234e+00,1.576e-01,1.077e-02,2.307e+00,5.846e-01,1.175e-01
PCIF1,16200,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,GO:0016422,molecular function,11.0,2.0,3.280e-01,8.721e-02,1.234e+00,2.258e-01,3.794e-02,1.344e+00,5.340e-01,1.009e-01
NINL,29163,microtubule anchoring at centrosome,GO:0034454,biological process,23.0,3.0,1.735e-02,7.130e-03,4.222e-02,7.574e-03,3.032e-03,1.892e-02,9.364e-01,1.051e-02
NINL,29163,centrosome,GO:0005813,cellular component,23.0,31.0,1.339e-02,7.355e-03,2.436e-02,3.101e-03,1.827e-03,5.262e-03,9.736e-01,3.520e-03
NINL,29163,intercellular bridge,GO:0045171,cellular component,23.0,25.0,1.886e-02,7.422e-03,4.791e-02,1.337e-02,3.572e-03,5.002e-02,9.017e-01,2.057e-02
NINL,29163,cytosol,GO:0005829,cellular component,23.0,78.0,2.110e-02,1.198e-02,3.717e-02,1.797e-02,9.037e-03,3.574e-02,8.850e-01,1.267e-02
NINL,29163,protein binding,GO:0005515,molecular function,23.0,332.0,2.163e-02,1.328e-02,3.524e-02,2.163e-02,1.328e-02,3.524e-02,8.706e-01,1.024e-02
MYBL2,7548,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,16.0,41.0,4.266e-02,2.867e-02,6.348e-02,1.880e-02,5.818e-03,6.075e-02,8.781e-01,2.311e-02
MYBL2,7548,mitotic cell cycle,GO:0000278,biological process,16.0,13.0,4.352e-02,2.988e-02,6.337e-02,3.345e-02,2.650e-02,4.224e-02,8.295e-01,5.362e-03
MYBL2,7548,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,16.0,62.0,4.694e-02,3.032e-02,7.267e-02,4.694e-02,3.032e-02,7.267e-02,7.931e-01,1.178e-02
MYBL2,7548,nucleoplasm,GO:0005654,cellular component,16.0,74.0,4.266e-02,2.867e-02,6.348e-02,2.551e-02,9.164e-03,7.103e-02,8.529e-01,2.223e-02
MYBL2,7548,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,16.0,7.0,4.266e-02,2.867e-02,6.348e-02,1.661e-02,1.104e-02,2.500e-02,8.923e-01,7.536e-03
MYBL2,7548,protein binding,GO:0005515,molecular function,16.0,332.0,4.266e-02,2.867e-02,6.348e-02,2.956e-02,1.374e-02,6.358e-02,8.406e-01,1.885e-02
MYBL2,7548,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,16.0,25.0,4.569e-02,3.148e-02,6.632e-02,3.482e-02,2.374e-02,5.107e-02,8.252e-01,9.216e-03
CDC25B,1726,positive regulation of mitotic cell cycle,GO:0045931,biological process,19.0,18.0,4.137e-02,1.897e-02,9.024e-02,1.515e-02,6.498e-03,3.534e-02,8.964e-01,1.403e-02
CDC25B,1726,protein phosphorylation,GO:0006468,biological process,19.0,33.0,4.192e-02,1.850e-02,9.500e-02,1.929e-02,5.434e-03,6.848e-02,8.748e-01,2.333e-02
CDC25B,1726,positive regulation of G2/MI transition of meiotic cell cycle,GO:0110032,biological process,19.0,4.0,4.249e-02,1.932e-02,9.343e-02,1.409e-02,6.756e-03,2.938e-02,9.022e-01,1.124e-02
CDC25B,1726,positive regulation of cytokinesis,GO:0032467,biological process,19.0,16.0,4.249e-02,1.932e-02,9.343e-02,2.084e-02,1.623e-02,2.675e-02,8.747e-01,5.266e-03
CDC25B,1726,G2/M transition of mitotic cell cycle,GO:0000086,biological process,19.0,4.0,4.504e-02,1.598e-02,1.269e-01,1.631e-02,1.436e-03,1.852e-01,8.748e-01,4.561e-02
CDC25B,1726,positive regulation of G2/M transition of mitotic cell cycle,GO:0010971,biological process,19.0,9.0,4.738e-02,1.892e-02,1.187e-01,1.704e-02,2.587e-03,1.122e-01,8.783e-01,3.702e-02
CDC25B,1726,centrosome,GO:0005813,cellular component,19.0,31.0,4.249e-02,1.932e-02,9.343e-02,1.836e-02,7.948e-03,4.242e-02,8.822e-01,1.623e-02
CDC25B,1726,spindle pole,GO:0000922,cellular component,19.0,15.0,5.107e-02,1.766e-02,1.477e-01,3.331e-02,1.383e-02,8.025e-02,8.283e-01,2.101e-02
CDC25B,1726,cytoplasm,GO:0005737,cellular component,19.0,69.0,5.158e-02,1.744e-02,1.525e-01,4.228e-02,1.472e-02,1.215e-01,8.021e-01,2.698e-02
CDC25B,1726,nucleus,GO:0005634,cellular component,19.0,151.0,5.224e-02,1.741e-02,1.567e-01,4.394e-02,1.460e-02,1.323e-01,7.978e-01,2.794e-02
CDC25B,1726,protein kinase binding,GO:0019901,molecular function,19.0,32.0,4.249e-02,1.932e-02,9.343e-02,2.151e-02,1.237e-02,3.740e-02,8.706e-01,1.115e-02
CDC25B,1726,protein binding,GO:0005515,molecular function,19.0,332.0,5.548e-02,2.098e-02,1.467e-01,5.402e-02,1.869e-02,1.561e-01,7.743e-01,2.841e-02
CDC25B,1726,protein tyrosine phosphatase activity,GO:0004725,molecular function,19.0,10.0,5.845e-02,2.663e-02,1.283e-01,5.587e-02,2.718e-02,1.149e-01,7.723e-01,2.009e-02
SNPH,15931,cytoplasm,GO:0005737,cellular component,5.0,69.0,3.245e-02,2.502e-02,4.207e-02,2.056e-02,1.063e-02,3.974e-02,8.742e-01,1.437e-02
SNPH,15931,cytoplasmic microtubule,GO:0005881,cellular component,5.0,8.0,3.968e-02,1.845e-02,8.533e-02,3.968e-02,1.845e-02,8.533e-02,8.102e-01,1.992e-02
FAM83D,16122,epithelial to mesenchymal transition,GO:0001837,biological process,21.0,8.0,1.124e-01,7.957e-02,1.587e-01,2.244e-02,3.126e-03,1.611e-01,8.550e-01,4.088e-02
FAM83D,16122,metaphase plate congression,GO:0051310,biological process,21.0,6.0,1.124e-01,7.957e-02,1.587e-01,4.733e-02,1.026e-02,2.182e-01,7.864e-01,4.380e-02
FAM83D,16122,cell population proliferation,GO:0008283,biological process,21.0,35.0,1.199e-01,9.342e-02,1.539e-01,6.711e-02,2.551e-02,1.766e-01,7.485e-01,2.983e-02
FAM83D,16122,regulation of ERK1 and ERK2 cascade,GO:0070372,biological process,21.0,4.0,1.339e-01,7.358e-02,2.436e-01,6.990e-02,1.727e-02,2.830e-01,7.408e-01,4.098e-02
FAM83D,16122,cell migration,GO:0016477,biological process,21.0,38.0,1.387e-01,8.107e-02,2.374e-01,7.717e-02,1.280e-02,4.654e-01,7.241e-01,5.379e-02
FAM83D,16122,positive regulation of cell cycle G1/S phase transition,GO:1902808,biological process,21.0,4.0,1.394e-01,6.811e-02,2.852e-01,4.574e-02,1.712e-03,1.222e+00,7.629e-01,7.988e-02
FAM83D,16122,regulation of protein catabolic process,GO:0042176,biological process,21.0,11.0,1.433e-01,1.297e-01,1.582e-01,5.345e-02,1.000e-02,2.856e-01,7.716e-01,4.396e-02
FAM83D,16122,protein localization to mitotic spindle,GO:1902480,biological process,21.0,3.0,1.703e-01,1.384e-01,2.094e-01,1.406e-01,8.777e-02,2.251e-01,6.495e-01,1.701e-02
FAM83D,16122,regulation of TOR signaling,GO:0032006,biological process,21.0,6.0,1.924e-01,9.642e-02,3.839e-01,1.594e-01,4.457e-02,5.699e-01,6.221e-01,4.848e-02
FAM83D,16122,mitotic spindle pole,GO:0097431,cellular component,21.0,5.0,1.124e-01,7.957e-02,1.587e-01,3.478e-02,3.085e-02,3.920e-02,8.257e-01,2.779e-03
FAM83D,16122,cytoplasm,GO:0005737,cellular component,21.0,69.0,1.337e-01,8.696e-02,2.056e-01,8.681e-02,2.819e-02,2.673e-01,7.147e-01,3.430e-02
FAM83D,16122,protein kinase binding,GO:0019901,molecular function,21.0,32.0,1.199e-01,9.342e-02,1.539e-01,4.994e-02,3.936e-02,6.335e-02,7.861e-01,6.511e-03
FAM83D,16122,microtubule binding,GO:0008017,molecular function,21.0,22.0,1.337e-01,8.696e-02,2.056e-01,8.786e-02,3.886e-02,1.986e-01,7.150e-01,2.583e-02
FAM83D,16122,protein binding,GO:0005515,molecular function,21.0,332.0,1.549e-01,1.160e-01,2.070e-01,1.219e-01,6.391e-02,2.323e-01,6.702e-01,2.230e-02
FAM83D,16122,kinesin binding,GO:0019894,molecular function,21.0,7.0,1.628e-01,1.170e-01,2.265e-01,8.958e-02,1.663e-02,4.825e-01,7.057e-01,5.121e-02
KCND1,6237,potassium ion transmembrane transport,GO:0071805,biological process,5.0,6.0,6.672e-02,3.395e-02,1.311e-01,3.336e-02,9.237e-03,1.205e-01,8.259e-01,3.322e-02
KCND1,6237,integral component of membrane,GO:0016021,cellular component,5.0,8.0,9.490e-02,2.597e-02,3.468e-01,6.094e-02,2.560e-02,1.451e-01,7.610e-01,2.574e-02
KCND1,6237,voltage-gated potassium channel complex,GO:0008076,cellular component,5.0,16.0,2.124e-01,2.634e-02,1.713e+00,1.997e-01,2.051e-02,1.944e+00,5.516e-01,1.064e-01
KCND1,6237,voltage-gated potassium channel activity,GO:0005249,molecular function,5.0,9.0,9.086e-02,1.781e-02,4.634e-01,5.834e-02,6.860e-03,4.962e-01,7.552e-01,6.210e-02
PIN4,8992,nucleolus,GO:0005730,cellular component,8.0,41.0,2.582e-02,1.319e-02,5.055e-02,1.813e-02,8.501e-03,3.866e-02,8.838e-01,1.405e-02
PIN4,8992,nucleus,GO:0005634,cellular component,8.0,151.0,2.582e-02,1.319e-02,5.055e-02,2.143e-02,9.801e-03,4.684e-02,8.704e-01,1.712e-02
PIN4,8992,protein binding,GO:0005515,molecular function,8.0,332.0,2.582e-02,1.319e-02,5.055e-02,2.346e-02,1.153e-02,4.773e-02,8.628e-01,1.608e-02
PIN4,8992,RNA binding,GO:0003723,molecular function,8.0,63.0,2.876e-02,1.288e-02,6.423e-02,2.212e-02,8.875e-03,5.511e-02,8.669e-01,2.011e-02
MAGED2,16353,renal sodium ion absorption,GO:0070294,biological process,11.0,4.0,1.566e-01,1.089e-01,2.253e-01,7.705e-02,4.871e-02,1.219e-01,7.337e-01,1.427e-02
MAGED2,16353,female pregnancy,GO:0007565,biological process,11.0,3.0,1.566e-01,1.089e-01,2.253e-01,1.276e-01,4.740e-02,3.437e-01,6.609e-01,3.449e-02
MAGED2,16353,nucleus,GO:0005634,cellular component,11.0,151.0,1.566e-01,1.089e-01,2.253e-01,1.063e-01,7.780e-02,1.454e-01,6.909e-01,1.058e-02
MAGED2,16353,cytosol,GO:0005829,cellular component,11.0,78.0,1.566e-01,1.089e-01,2.253e-01,1.089e-01,9.138e-02,1.299e-01,6.876e-01,6.040e-03
MAGED2,16353,nucleolus,GO:0005730,cellular component,11.0,41.0,1.566e-01,1.089e-01,2.253e-01,1.320e-01,1.072e-01,1.626e-01,6.596e-01,7.538e-03
MAGED2,16353,membrane,GO:0016020,cellular component,11.0,53.0,1.566e-01,1.089e-01,2.253e-01,1.457e-01,1.160e-01,1.829e-01,6.446e-01,8.556e-03
MAGED2,16353,protein binding,GO:0005515,molecular function,11.0,332.0,1.566e-01,1.089e-01,2.253e-01,1.118e-01,8.863e-02,1.411e-01,6.839e-01,8.048e-03
SYTL4,15588,multivesicular body sorting pathway,GO:0071985,biological process,13.0,4.0,2.314e-01,1.474e-01,3.634e-01,1.117e-01,2.353e-02,5.303e-01,6.733e-01,5.689e-02
SYTL4,15588,lysosome localization,GO:0032418,biological process,13.0,3.0,2.315e-01,1.522e-01,3.522e-01,9.768e-02,5.538e-02,1.723e-01,7.018e-01,1.903e-02
SYTL4,15588,positive regulation of exocytosis,GO:0045921,biological process,13.0,7.0,2.315e-01,1.522e-01,3.522e-01,1.171e-01,3.563e-02,3.851e-01,6.716e-01,4.228e-02
SYTL4,15588,regulation of plasma membrane repair,GO:1905684,biological process,13.0,5.0,2.442e-01,1.467e-01,4.067e-01,1.139e-01,1.946e-02,6.667e-01,6.671e-01,6.538e-02
SYTL4,15588,positive regulation of protein secretion,GO:0050714,biological process,13.0,17.0,2.548e-01,2.043e-01,3.177e-01,2.006e-01,1.452e-01,2.771e-01,5.915e-01,1.353e-02
SYTL4,15588,plasma membrane repair,GO:0001778,biological process,13.0,2.0,2.808e-01,1.824e-01,4.321e-01,2.181e-01,7.158e-02,6.648e-01,5.669e-01,4.929e-02
SYTL4,15588,endosome,GO:0005768,cellular component,13.0,14.0,2.273e-01,1.519e-01,3.402e-01,3.592e-02,1.457e-02,8.854e-02,8.202e-01,2.304e-02
SYTL4,15588,exocytic vesicle,GO:0070382,cellular component,13.0,6.0,2.273e-01,1.519e-01,3.402e-01,7.525e-02,3.685e-02,1.536e-01,7.356e-01,2.154e-02
SYTL4,15588,microtubule organizing center,GO:0005815,cellular component,13.0,16.0,2.357e-01,1.485e-01,3.740e-01,1.418e-01,4.641e-02,4.332e-01,6.435e-01,4.056e-02
SYTL4,15588,cytosol,GO:0005829,cellular component,13.0,78.0,2.474e-01,1.818e-01,3.365e-01,1.914e-01,1.337e-01,2.740e-01,5.995e-01,1.509e-02
SYTL4,15588,nucleoplasm,GO:0005654,cellular component,13.0,74.0,2.474e-01,1.818e-01,3.365e-01,2.050e-01,1.391e-01,3.021e-01,5.870e-01,1.721e-02
SYTL4,15588,protein binding,GO:0005515,molecular function,13.0,332.0,2.474e-01,1.818e-01,3.365e-01,2.003e-01,1.442e-01,2.782e-01,5.918e-01,1.382e-02
LYRM1,25074,,,,nan,nan,,,,,,,,
NFAT5,7774,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,19.0,62.0,1.210e-01,6.590e-02,2.223e-01,5.314e-02,1.178e-02,2.397e-01,7.734e-01,4.036e-02
NFAT5,7774,positive regulation of NIK/NF-kappaB signaling,GO:1901224,biological process,19.0,4.0,1.295e-01,8.458e-02,1.983e-01,9.462e-02,5.918e-02,1.513e-01,7.067e-01,1.507e-02
NFAT5,7774,cellular response to cytokine stimulus,GO:0071345,biological process,19.0,31.0,1.295e-01,8.458e-02,1.983e-01,1.005e-01,5.535e-02,1.826e-01,6.978e-01,1.958e-02
NFAT5,7774,calcineurin-NFAT signaling cascade,GO:0033173,biological process,19.0,3.0,1.808e-01,6.280e-02,5.204e-01,1.521e-01,4.598e-02,5.029e-01,6.304e-01,4.665e-02
NFAT5,7774,cytokine production,GO:0001816,biological process,19.0,54.0,3.051e-01,3.879e-02,2.400e+00,2.987e-01,3.776e-02,2.364e+00,4.379e-01,1.449e-01
NFAT5,7774,positive regulation of leukocyte adhesion to vascular endothelial cell,GO:1904996,biological process,19.0,5.0,3.653e-01,3.632e-02,3.675e+00,2.785e-01,1.219e-02,6.361e+00,4.261e-01,1.571e-01
NFAT5,7774,transcription factor complex,GO:0005667,cellular component,19.0,9.0,1.210e-01,6.590e-02,2.223e-01,2.712e-02,7.915e-03,9.295e-02,8.455e-01,2.709e-02
NFAT5,7774,nuclear transcription factor complex,GO:0044798,cellular component,19.0,9.0,1.210e-01,6.590e-02,2.223e-01,5.319e-02,2.530e-02,1.118e-01,7.778e-01,2.080e-02
NFAT5,7774,nucleus,GO:0005634,cellular component,19.0,151.0,1.289e-01,8.335e-02,1.995e-01,7.757e-02,5.341e-02,1.127e-01,7.331e-01,1.146e-02
NFAT5,7774,nucleoplasm,GO:0005654,cellular component,19.0,74.0,1.289e-01,8.335e-02,1.995e-01,9.593e-02,4.941e-02,1.863e-01,7.040e-01,2.195e-02
NFAT5,7774,cytosol,GO:0005829,cellular component,19.0,78.0,1.294e-01,8.432e-02,1.985e-01,1.010e-01,7.731e-02,1.319e-01,6.981e-01,8.942e-03
NFAT5,7774,transcription factor binding,GO:0008134,molecular function,19.0,19.0,1.210e-01,6.590e-02,2.223e-01,2.433e-02,1.447e-02,4.090e-02,8.599e-01,1.154e-02
NFAT5,7774,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,19.0,7.0,1.210e-01,6.590e-02,2.223e-01,2.757e-02,1.300e-02,5.849e-02,8.472e-01,1.696e-02
NFAT5,7774,DNA-binding transcription factor activity,GO:0003700,molecular function,19.0,18.0,1.210e-01,6.590e-02,2.223e-01,3.316e-02,1.744e-02,6.305e-02,8.295e-01,1.551e-02
NFAT5,7774,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,19.0,25.0,1.210e-01,6.590e-02,2.223e-01,5.077e-02,2.011e-02,1.282e-01,7.822e-01,2.553e-02
NFAT5,7774,protein binding,GO:0005515,molecular function,19.0,332.0,1.289e-01,8.335e-02,1.995e-01,9.195e-02,5.775e-02,1.464e-01,7.105e-01,1.533e-02
NFAT5,7774,chromatin binding,GO:0003682,molecular function,19.0,17.0,1.289e-01,8.335e-02,1.995e-01,9.406e-02,5.983e-02,1.479e-01,7.074e-01,1.456e-02
CCDC113,25002,cilium assembly,GO:0060271,biological process,7.0,12.0,1.549e-01,1.309e-01,1.833e-01,8.286e-02,5.995e-02,1.145e-01,7.248e-01,1.002e-02
CCDC113,25002,nucleoplasm,GO:0005654,cellular component,7.0,74.0,1.549e-01,1.309e-01,1.833e-01,8.720e-02,6.737e-02,1.129e-01,7.181e-01,8.242e-03
CCDC113,25002,cytosol,GO:0005829,cellular component,7.0,78.0,1.549e-01,1.309e-01,1.833e-01,9.308e-02,6.652e-02,1.302e-01,7.092e-01,1.077e-02
CCDC113,25002,centriolar satellite,GO:0034451,cellular component,7.0,4.0,1.735e-01,1.490e-01,2.020e-01,1.615e-01,1.202e-01,2.170e-01,6.281e-01,1.143e-02
CCDC113,25002,protein-containing complex,GO:0032991,cellular component,7.0,481.0,2.010e-01,1.253e-01,3.223e-01,1.992e-01,1.233e-01,3.218e-01,5.915e-01,2.113e-02
CCDC113,25002,protein binding,GO:0005515,molecular function,7.0,332.0,1.549e-01,1.309e-01,1.833e-01,1.001e-01,5.438e-02,1.844e-01,6.983e-01,2.017e-02
RHBDL1,10007,,,,nan,nan,,,,,,,,
RBL2,9894,negative regulation of G1/S transition of mitotic cell cycle,GO:2000134,biological process,34.0,8.0,4.373e-02,4.210e-02,4.543e-02,2.502e-02,8.810e-03,7.108e-02,8.543e-01,2.172e-02
RBL2,9894,regulation of mitotic cell cycle,GO:0007346,biological process,34.0,19.0,4.819e-02,1.790e-02,1.298e-01,3.469e-02,7.155e-03,1.681e-01,8.190e-01,3.744e-02
RBL2,9894,negative regulation of gene expression,GO:0010629,biological process,34.0,21.0,5.596e-02,2.496e-02,1.254e-01,4.209e-02,1.400e-02,1.266e-01,8.025e-01,2.960e-02
RBL2,9894,regulation of lipid kinase activity,GO:0043550,biological process,34.0,8.0,6.390e-02,1.816e-02,2.248e-01,4.722e-02,7.309e-03,3.050e-01,7.835e-01,5.319e-02
RBL2,9894,cell differentiation,GO:0030154,biological process,34.0,83.0,2.510e-01,7.938e-02,7.938e-01,2.453e-01,7.175e-02,8.387e-01,5.414e-01,5.466e-02
RBL2,9894,chromatin,GO:0000785,cellular component,34.0,15.0,3.775e-02,2.276e-02,6.263e-02,1.449e-02,6.105e-03,3.438e-02,8.996e-01,1.550e-02
RBL2,9894,nucleus,GO:0005634,cellular component,34.0,151.0,3.824e-02,2.258e-02,6.474e-02,1.490e-02,4.811e-03,4.612e-02,8.962e-01,1.688e-02
RBL2,9894,cytosol,GO:0005829,cellular component,34.0,78.0,3.898e-02,2.222e-02,6.836e-02,2.171e-02,6.365e-03,7.407e-02,8.654e-01,2.396e-02
RBL2,9894,nucleolus,GO:0005730,cellular component,34.0,41.0,3.975e-02,2.174e-02,7.267e-02,1.997e-02,2.695e-03,1.480e-01,8.640e-01,3.423e-02
RBL2,9894,extracellular exosome,GO:0070062,cellular component,34.0,33.0,4.105e-02,2.738e-02,6.157e-02,2.694e-02,1.499e-02,4.841e-02,8.501e-01,1.334e-02
RBL2,9894,transcription factor complex,GO:0005667,cellular component,34.0,9.0,4.781e-02,3.544e-02,6.449e-02,2.700e-02,4.950e-03,1.473e-01,8.413e-01,3.500e-02
RBL2,9894,promoter-specific chromatin binding,GO:1990841,molecular function,34.0,2.0,3.652e-02,2.323e-02,5.742e-02,8.818e-03,2.965e-03,2.623e-02,9.281e-01,1.427e-02
RBL2,9894,RNA polymerase II regulatory region DNA binding,GO:0001012,molecular function,34.0,3.0,3.652e-02,2.323e-02,5.742e-02,1.072e-02,4.118e-03,2.788e-02,9.183e-01,1.287e-02
RBL2,9894,protein binding,GO:0005515,molecular function,34.0,332.0,4.032e-02,2.135e-02,7.612e-02,2.812e-02,9.512e-03,8.315e-02,8.435e-01,2.365e-02
RBL2,9894,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,34.0,5.0,4.047e-02,3.603e-02,4.546e-02,1.182e-02,3.217e-03,4.342e-02,9.089e-01,2.136e-02
FAH,3579,,,,nan,nan,,,,,,,,
SFRP1,10776,positive regulation of non-canonical Wnt signaling pathway,GO:2000052,biological process,69.0,6.0,7.732e-02,5.669e-02,1.055e-01,1.067e-02,4.040e-03,2.817e-02,9.186e-01,1.283e-02
SFRP1,10776,negative regulation of apoptotic process,GO:0043066,biological process,69.0,31.0,7.732e-02,5.669e-02,1.055e-01,1.101e-02,6.177e-03,1.963e-02,9.185e-01,7.532e-03
SFRP1,10776,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,GO:2000080,biological process,69.0,4.0,7.732e-02,5.669e-02,1.055e-01,1.300e-02,6.685e-03,2.530e-02,9.079e-01,9.308e-03
SFRP1,10776,negative regulation of ossification,GO:0030279,biological process,69.0,5.0,7.732e-02,5.669e-02,1.055e-01,1.377e-02,4.865e-03,3.900e-02,9.021e-01,1.497e-02
SFRP1,10776,cellular response to interleukin-1,GO:0071347,biological process,69.0,3.0,7.732e-02,5.669e-02,1.055e-01,1.355e-02,3.422e-03,5.369e-02,9.009e-01,1.946e-02
SFRP1,10776,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,GO:2000054,biological process,69.0,5.0,7.732e-02,5.669e-02,1.055e-01,1.543e-02,9.094e-03,2.619e-02,8.973e-01,8.819e-03
SFRP1,10776,positive regulation of fibroblast apoptotic process,GO:2000271,biological process,69.0,3.0,7.732e-02,5.669e-02,1.055e-01,1.586e-02,9.756e-03,2.579e-02,8.955e-01,8.618e-03
SFRP1,10776,negative regulation of fibroblast apoptotic process,GO:2000270,biological process,69.0,3.0,7.732e-02,5.669e-02,1.055e-01,1.591e-02,7.688e-03,3.293e-02,8.938e-01,1.304e-02
SFRP1,10776,cellular response to tumor necrosis factor,GO:0071356,biological process,69.0,3.0,7.732e-02,5.669e-02,1.055e-01,1.579e-02,3.554e-03,7.017e-02,8.882e-01,2.301e-02
SFRP1,10776,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,69.0,14.0,7.732e-02,5.669e-02,1.055e-01,1.943e-02,4.530e-03,8.336e-02,8.727e-01,2.987e-02
SFRP1,10776,positive regulation of apoptotic process,GO:0043065,biological process,69.0,28.0,7.732e-02,5.669e-02,1.055e-01,2.015e-02,5.020e-03,8.087e-02,8.707e-01,2.960e-02
SFRP1,10776,cellular response to growth factor stimulus,GO:0071363,biological process,69.0,12.0,7.732e-02,5.669e-02,1.055e-01,2.366e-02,1.706e-02,3.283e-02,8.629e-01,7.264e-03
SFRP1,10776,negative regulation of osteoblast proliferation,GO:0033689,biological process,69.0,3.0,7.763e-02,5.737e-02,1.050e-01,2.569e-02,2.210e-02,2.986e-02,8.554e-01,3.550e-03
SFRP1,10776,positive regulation of canonical Wnt signaling pathway,GO:0090263,biological process,69.0,7.0,7.799e-02,5.799e-02,1.049e-01,2.409e-02,1.695e-02,3.424e-02,8.612e-01,8.283e-03
SFRP1,10776,negative regulation of Wnt signaling pathway,GO:0030178,biological process,69.0,10.0,7.825e-02,5.809e-02,1.054e-01,2.384e-02,1.271e-02,4.472e-02,8.619e-01,1.437e-02
SFRP1,10776,hematopoietic stem cell differentiation,GO:0060218,biological process,69.0,3.0,7.856e-02,5.887e-02,1.048e-01,3.237e-02,2.332e-02,4.492e-02,8.330e-01,7.859e-03
SFRP1,10776,cellular response to heparin,GO:0071504,biological process,69.0,5.0,7.902e-02,5.904e-02,1.058e-01,3.592e-02,1.264e-02,1.021e-01,8.195e-01,2.513e-02
SFRP1,10776,cellular response to vitamin D,GO:0071305,biological process,69.0,6.0,8.016e-02,6.007e-02,1.070e-01,4.213e-02,1.976e-02,8.982e-02,8.037e-01,1.935e-02
SFRP1,10776,negative regulation of fibroblast proliferation,GO:0048147,biological process,69.0,5.0,8.100e-02,6.443e-02,1.018e-01,3.800e-02,3.717e-02,3.885e-02,8.166e-01,5.855e-04
SFRP1,10776,cellular response to estrogen stimulus,GO:0071391,biological process,69.0,3.0,8.111e-02,6.463e-02,1.018e-01,4.325e-02,3.292e-02,5.682e-02,8.022e-01,7.291e-03
SFRP1,10776,cellular response to estradiol stimulus,GO:0071392,biological process,69.0,6.0,8.140e-02,5.654e-02,1.172e-01,4.348e-02,1.897e-02,9.964e-02,8.001e-01,2.140e-02
SFRP1,10776,cellular response to transforming growth factor beta stimulus,GO:0071560,biological process,69.0,4.0,8.180e-02,6.620e-02,1.011e-01,3.802e-02,2.684e-02,5.385e-02,8.160e-01,9.038e-03
SFRP1,10776,cellular response to BMP stimulus,GO:0071773,biological process,69.0,4.0,8.180e-02,6.620e-02,1.011e-01,4.004e-02,2.961e-02,5.414e-02,8.107e-01,7.967e-03
SFRP1,10776,hematopoietic progenitor cell differentiation,GO:0002244,biological process,69.0,5.0,8.190e-02,6.644e-02,1.010e-01,4.266e-02,3.567e-02,5.101e-02,8.040e-01,4.806e-03
SFRP1,10776,cellular response to hypoxia,GO:0071456,biological process,69.0,5.0,8.196e-02,6.588e-02,1.020e-01,4.465e-02,3.331e-02,5.985e-02,7.987e-01,7.796e-03
SFRP1,10776,response to drug,GO:0042493,biological process,69.0,78.0,8.203e-02,4.928e-02,1.365e-01,3.320e-02,7.633e-03,1.444e-01,8.248e-01,3.735e-02
SFRP1,10776,cellular response to fibroblast growth factor stimulus,GO:0044344,biological process,69.0,5.0,8.218e-02,6.590e-02,1.025e-01,4.863e-02,4.060e-02,5.824e-02,7.892e-01,4.935e-03
SFRP1,10776,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902043,biological process,69.0,4.0,8.342e-02,5.384e-02,1.293e-01,4.125e-02,1.091e-02,1.560e-01,8.032e-01,3.323e-02
SFRP1,10776,positive regulation of Wnt signaling pathway,GO:0030177,biological process,69.0,10.0,8.473e-02,7.188e-02,9.989e-02,4.119e-02,1.638e-02,1.036e-01,8.056e-01,2.327e-02
SFRP1,10776,negative regulation of epithelial cell proliferation,GO:0050680,biological process,69.0,16.0,8.555e-02,6.625e-02,1.105e-01,3.866e-02,1.357e-02,1.101e-01,8.117e-01,2.774e-02
SFRP1,10776,negative regulation of epithelial to mesenchymal transition,GO:0010719,biological process,69.0,6.0,8.691e-02,7.101e-02,1.064e-01,4.315e-02,1.760e-02,1.058e-01,8.008e-01,2.355e-02
SFRP1,10776,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,69.0,41.0,8.819e-02,4.969e-02,1.565e-01,4.392e-02,1.111e-02,1.737e-01,7.960e-01,3.651e-02
SFRP1,10776,negative regulation of androgen receptor signaling pathway,GO:0060766,biological process,69.0,4.0,8.915e-02,4.041e-02,1.967e-01,3.564e-02,4.703e-03,2.701e-01,8.120e-01,5.428e-02
SFRP1,10776,positive regulation of smoothened signaling pathway,GO:0045880,biological process,69.0,4.0,8.929e-02,7.118e-02,1.120e-01,5.322e-02,2.531e-02,1.119e-01,7.778e-01,2.090e-02
SFRP1,10776,negative regulation of peptidyl-tyrosine phosphorylation,GO:0050732,biological process,69.0,7.0,9.001e-02,4.030e-02,2.010e-01,3.992e-02,5.897e-03,2.703e-01,8.014e-01,5.362e-02
SFRP1,10776,cellular response to prostaglandin E stimulus,GO:0071380,biological process,69.0,5.0,9.299e-02,5.589e-02,1.547e-01,6.124e-02,2.625e-02,1.429e-01,7.608e-01,2.487e-02
SFRP1,10776,cellular response to starvation,GO:0009267,biological process,69.0,28.0,9.345e-02,6.559e-02,1.332e-01,6.003e-02,2.711e-02,1.329e-01,7.634e-01,2.221e-02
SFRP1,10776,positive regulation of epithelial cell proliferation,GO:0050679,biological process,69.0,18.0,9.666e-02,6.940e-02,1.346e-01,6.163e-02,2.332e-02,1.629e-01,7.593e-01,2.841e-02
SFRP1,10776,negative regulation of cell population proliferation,GO:0008285,biological process,69.0,34.0,9.723e-02,8.747e-02,1.081e-01,7.070e-02,6.003e-02,8.325e-02,7.451e-01,4.890e-03
SFRP1,10776,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,69.0,41.0,9.847e-02,4.942e-02,1.962e-01,5.271e-02,8.845e-03,3.142e-01,7.717e-01,4.860e-02
SFRP1,10776,negative regulation of insulin secretion,GO:0046676,biological process,69.0,5.0,1.036e-01,7.859e-02,1.365e-01,7.670e-02,4.322e-02,1.361e-01,7.339e-01,1.791e-02
SFRP1,10776,negative regulation of cell growth,GO:0030308,biological process,69.0,15.0,1.047e-01,8.338e-02,1.316e-01,7.219e-02,3.105e-02,1.678e-01,7.405e-01,2.469e-02
SFRP1,10776,positive regulation of fat cell differentiation,GO:0045600,biological process,69.0,4.0,1.068e-01,7.580e-02,1.504e-01,7.170e-02,2.279e-02,2.256e-01,7.397e-01,3.381e-02
SFRP1,10776,positive regulation of cell growth,GO:0030307,biological process,69.0,16.0,1.085e-01,8.297e-02,1.418e-01,7.534e-02,2.651e-02,2.141e-01,7.340e-01,3.071e-02
SFRP1,10776,negative regulation of B cell differentiation,GO:0045578,biological process,69.0,8.0,1.123e-01,7.251e-02,1.741e-01,8.264e-02,2.765e-02,2.469e-01,7.213e-01,3.401e-02
SFRP1,10776,negative regulation of bone remodeling,GO:0046851,biological process,69.0,4.0,1.142e-01,7.984e-02,1.633e-01,8.575e-02,2.935e-02,2.506e-01,7.167e-01,3.258e-02
SFRP1,10776,osteoblast differentiation,GO:0001649,biological process,69.0,4.0,1.182e-01,4.464e-02,3.128e-01,8.610e-02,1.809e-02,4.098e-01,7.120e-01,4.953e-02
SFRP1,10776,non-canonical Wnt signaling pathway,GO:0035567,biological process,69.0,9.0,1.182e-01,9.925e-02,1.407e-01,9.951e-02,7.758e-02,1.276e-01,7.002e-01,8.311e-03
SFRP1,10776,negative regulation of gene expression,GO:0010629,biological process,69.0,21.0,1.239e-01,4.502e-02,3.407e-01,6.319e-02,3.158e-03,1.264e+00,7.315e-01,7.833e-02
SFRP1,10776,canonical Wnt signaling pathway,GO:0060070,biological process,69.0,22.0,1.263e-01,1.071e-01,1.491e-01,1.075e-01,7.381e-02,1.566e-01,6.892e-01,1.297e-02
SFRP1,10776,positive regulation of cell population proliferation,GO:0008284,biological process,69.0,40.0,1.345e-01,1.013e-01,1.785e-01,1.175e-01,6.851e-02,2.015e-01,6.759e-01,1.888e-02
SFRP1,10776,negative regulation of cell migration,GO:0030336,biological process,69.0,28.0,1.372e-01,1.248e-01,1.508e-01,1.235e-01,1.049e-01,1.453e-01,6.697e-01,5.711e-03
SFRP1,10776,dorsal/ventral axis specification,GO:0009950,biological process,69.0,5.0,1.451e-01,6.661e-02,3.160e-01,1.276e-01,4.803e-02,3.389e-01,6.613e-01,3.357e-02
SFRP1,10776,response to organic cyclic compound,GO:0014070,biological process,69.0,129.0,1.932e-01,9.019e-02,4.137e-01,1.890e-01,8.266e-02,4.323e-01,5.977e-01,3.448e-02
SFRP1,10776,regulation of cell cycle process,GO:0010564,biological process,69.0,28.0,2.061e-01,1.007e-01,4.219e-01,1.993e-01,9.237e-02,4.299e-01,5.889e-01,3.289e-02
SFRP1,10776,collagen-containing extracellular matrix,GO:0062023,cellular component,69.0,13.0,8.053e-02,5.424e-02,1.196e-01,2.818e-02,4.937e-03,1.609e-01,8.370e-01,3.808e-02
SFRP1,10776,extracellular exosome,GO:0070062,cellular component,69.0,33.0,8.717e-02,5.077e-02,1.497e-01,3.862e-02,9.496e-03,1.571e-01,8.100e-01,3.701e-02
SFRP1,10776,extracellular space,GO:0005615,cellular component,69.0,6.0,1.039e-01,3.006e-02,3.591e-01,5.416e-02,5.724e-03,5.125e-01,7.615e-01,7.009e-02
SFRP1,10776,cytosol,GO:0005829,cellular component,69.0,78.0,1.066e-01,4.155e-02,2.735e-01,6.638e-02,1.166e-02,3.779e-01,7.441e-01,5.179e-02
SFRP1,10776,cell surface,GO:0009986,cellular component,69.0,5.0,1.102e-01,3.262e-02,3.725e-01,7.445e-02,1.188e-02,4.664e-01,7.269e-01,6.147e-02
SFRP1,10776,Wnt-protein binding,GO:0017147,molecular function,69.0,2.0,7.732e-02,5.669e-02,1.055e-01,5.592e-03,4.819e-03,6.489e-03,9.513e-01,1.308e-03
SFRP1,10776,identical protein binding,GO:0042802,molecular function,69.0,20.0,8.069e-02,6.125e-02,1.063e-01,3.473e-02,1.025e-02,1.177e-01,8.217e-01,2.882e-02
SFRP1,10776,heparin binding,GO:0008201,molecular function,69.0,4.0,8.070e-02,6.299e-02,1.034e-01,2.832e-02,9.887e-03,8.112e-02,8.433e-01,2.535e-02
SFRP1,10776,frizzled binding,GO:0005109,molecular function,69.0,3.0,8.556e-02,5.916e-02,1.237e-01,1.427e-02,7.642e-04,2.663e-01,8.759e-01,5.832e-02
SFRP1,10776,cysteine-type endopeptidase activity,GO:0004197,molecular function,69.0,7.0,1.021e-01,5.526e-02,1.887e-01,7.584e-02,3.258e-02,1.765e-01,7.339e-01,2.632e-02
SFRP1,10776,protein binding,GO:0005515,molecular function,69.0,332.0,1.075e-01,4.073e-02,2.839e-01,6.993e-02,1.211e-02,4.039e-01,7.370e-01,5.288e-02
SFRP1,10776,drug binding,GO:0008144,molecular function,69.0,53.0,1.280e-01,3.836e-02,4.273e-01,1.033e-01,2.205e-02,4.838e-01,6.848e-01,5.691e-02
R3HCC1,27329,,,,nan,nan,,,,,,,,
C19orf53,24991,nucleolus,GO:0005730,cellular component,4.0,41.0,2.946e-02,2.317e-02,3.745e-02,2.301e-02,1.880e-02,2.817e-02,8.659e-01,4.602e-03
C19orf53,24991,nucleus,GO:0005634,cellular component,4.0,151.0,2.946e-02,2.317e-02,3.745e-02,2.946e-02,2.317e-02,3.745e-02,8.420e-01,5.754e-03
PPP6R1,29195,regulation of phosphoprotein phosphatase activity,GO:0043666,biological process,8.0,9.0,9.229e-02,7.491e-02,1.137e-01,5.817e-02,3.199e-02,1.058e-01,7.680e-01,1.680e-02
PPP6R1,29195,cytosol,GO:0005829,cellular component,8.0,78.0,9.229e-02,7.491e-02,1.137e-01,8.366e-02,7.697e-02,9.094e-02,7.239e-01,2.650e-03
PPP6R1,29195,protein phosphatase binding,GO:0019903,molecular function,8.0,7.0,9.229e-02,7.491e-02,1.137e-01,4.672e-02,2.069e-02,1.055e-01,7.925e-01,2.258e-02
PPP6R1,29195,Rho GTPase binding,GO:0017048,molecular function,8.0,5.0,9.229e-02,7.491e-02,1.137e-01,4.596e-02,1.430e-02,1.477e-01,7.924e-01,2.987e-02
PPP6R1,29195,protein binding,GO:0005515,molecular function,8.0,332.0,9.647e-02,6.738e-02,1.381e-01,9.396e-02,6.247e-02,1.413e-01,7.078e-01,1.359e-02
CCNE1,1589,G1/S transition of mitotic cell cycle,GO:0000082,biological process,30.0,3.0,3.684e-02,2.116e-02,6.414e-02,7.986e-03,2.294e-03,2.780e-02,9.335e-01,1.378e-02
CCNE1,1589,protein phosphorylation,GO:0006468,biological process,30.0,33.0,3.877e-02,2.491e-02,6.033e-02,1.628e-02,8.641e-03,3.068e-02,8.931e-01,1.051e-02
CCNE1,1589,mitotic cell cycle phase transition,GO:0044772,biological process,30.0,11.0,3.877e-02,2.491e-02,6.033e-02,1.635e-02,6.155e-03,4.344e-02,8.901e-01,1.572e-02
CCNE1,1589,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,30.0,10.0,3.877e-02,2.491e-02,6.033e-02,2.035e-02,6.673e-03,6.206e-02,8.714e-01,2.092e-02
CCNE1,1589,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,30.0,7.0,3.879e-02,2.495e-02,6.031e-02,1.380e-02,5.325e-03,3.576e-02,9.025e-01,1.491e-02
CCNE1,1589,cyclin E1-CDK2 complex,GO:0097134,cellular component,30.0,2.0,3.684e-02,2.116e-02,6.414e-02,5.471e-03,2.435e-03,1.229e-02,9.516e-01,8.579e-03
CCNE1,1589,centrosome,GO:0005813,cellular component,30.0,31.0,3.879e-02,2.495e-02,6.031e-02,2.061e-02,1.182e-02,3.595e-02,8.744e-01,1.101e-02
CCNE1,1589,cytoplasm,GO:0005737,cellular component,30.0,69.0,4.094e-02,2.807e-02,5.972e-02,3.159e-02,1.738e-02,5.739e-02,8.345e-01,1.441e-02
CCNE1,1589,nucleus,GO:0005634,cellular component,30.0,151.0,4.145e-02,2.851e-02,6.026e-02,3.191e-02,1.601e-02,6.360e-02,8.336e-01,1.636e-02
CCNE1,1589,nucleoplasm,GO:0005654,cellular component,30.0,74.0,4.198e-02,2.994e-02,5.886e-02,3.762e-02,2.614e-02,5.414e-02,8.169e-01,9.148e-03
CCNE1,1589,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,30.0,27.0,4.938e-02,2.388e-02,1.021e-01,3.579e-02,9.865e-03,1.298e-01,8.187e-01,3.266e-02
CCNE1,1589,protein kinase binding,GO:0019901,molecular function,30.0,32.0,3.879e-02,2.495e-02,6.031e-02,2.559e-02,8.633e-03,7.583e-02,8.526e-01,2.515e-02
CCNE1,1589,cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,molecular function,30.0,8.0,4.206e-02,3.084e-02,5.736e-02,2.637e-02,1.232e-02,5.644e-02,8.513e-01,1.665e-02
CCNE1,1589,protein binding,GO:0005515,molecular function,30.0,332.0,4.283e-02,3.053e-02,6.010e-02,3.830e-02,2.426e-02,6.047e-02,8.146e-01,1.125e-02
CCNE1,1589,protein kinase activity,GO:0004672,molecular function,30.0,38.0,4.425e-02,1.820e-02,1.076e-01,3.207e-02,7.634e-03,1.347e-01,8.290e-01,3.705e-02
DYRK1B,3092,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,13.0,41.0,6.250e-02,5.066e-02,7.710e-02,1.981e-02,7.418e-03,5.290e-02,8.750e-01,1.879e-02
DYRK1B,3092,protein phosphorylation,GO:0006468,biological process,13.0,33.0,6.250e-02,5.066e-02,7.710e-02,2.032e-02,7.971e-03,5.180e-02,8.737e-01,2.006e-02
DYRK1B,3092,peptidyl-serine phosphorylation,GO:0018105,biological process,13.0,13.0,6.250e-02,5.066e-02,7.710e-02,3.343e-02,2.255e-02,4.955e-02,8.296e-01,9.522e-03
DYRK1B,3092,peptidyl-threonine phosphorylation,GO:0018107,biological process,13.0,10.0,6.250e-02,5.066e-02,7.710e-02,3.687e-02,2.995e-02,4.540e-02,8.197e-01,5.229e-03
DYRK1B,3092,adipose tissue development,GO:0060612,biological process,13.0,5.0,9.848e-02,5.359e-02,1.810e-01,9.848e-02,5.359e-02,1.810e-01,7.006e-01,1.969e-02
DYRK1B,3092,nucleus,GO:0005634,cellular component,13.0,151.0,6.472e-02,5.496e-02,7.620e-02,5.185e-02,4.466e-02,6.020e-02,7.820e-01,4.074e-03
DYRK1B,3092,transcription coactivator activity,GO:0003713,molecular function,13.0,8.0,6.250e-02,5.066e-02,7.710e-02,4.143e-02,2.612e-02,6.572e-02,8.065e-01,1.201e-02
DYRK1B,3092,protein serine/threonine kinase activity,GO:0004674,molecular function,13.0,34.0,6.299e-02,4.988e-02,7.956e-02,3.190e-02,1.129e-02,9.011e-02,8.317e-01,2.580e-02
DYRK1B,3092,protein kinase activity,GO:0004672,molecular function,13.0,38.0,6.417e-02,5.588e-02,7.368e-02,4.493e-02,3.331e-02,6.060e-02,7.981e-01,8.224e-03
DYRK1B,3092,protein binding,GO:0005515,molecular function,13.0,332.0,6.630e-02,5.715e-02,7.692e-02,5.883e-02,4.897e-02,7.067e-02,7.672e-01,5.181e-03
RPS19,10402,maturation of SSU-rRNA,GO:0030490,biological process,37.0,6.0,1.293e-01,1.215e-01,1.376e-01,9.534e-03,3.452e-03,2.633e-02,9.247e-01,1.232e-02
RPS19,10402,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000462,biological process,37.0,3.0,1.293e-01,1.215e-01,1.376e-01,2.909e-02,1.408e-02,6.008e-02,8.425e-01,1.655e-02
RPS19,10402,nucleolus organization,GO:0007000,biological process,37.0,4.0,1.320e-01,1.168e-01,1.493e-01,3.540e-02,2.896e-03,4.326e-01,8.044e-01,5.548e-02
RPS19,10402,protein tetramerization,GO:0051262,biological process,37.0,4.0,1.320e-01,1.168e-01,1.493e-01,5.734e-02,1.888e-02,1.742e-01,7.669e-01,3.214e-02
RPS19,10402,erythrocyte differentiation,GO:0030218,biological process,37.0,6.0,1.320e-01,1.168e-01,1.493e-01,6.643e-02,3.202e-02,1.378e-01,7.515e-01,2.090e-02
RPS19,10402,monocyte chemotaxis,GO:0002548,biological process,37.0,4.0,1.320e-01,1.168e-01,1.493e-01,6.957e-02,3.160e-02,1.531e-01,7.454e-01,2.278e-02
RPS19,10402,antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,biological process,37.0,2.0,1.321e-01,1.298e-01,1.344e-01,5.959e-02,3.684e-02,9.640e-02,7.651e-01,1.393e-02
RPS19,10402,rRNA processing,GO:0006364,biological process,37.0,15.0,1.409e-01,1.118e-01,1.775e-01,8.127e-02,2.481e-02,2.662e-01,7.232e-01,3.569e-02
RPS19,10402,ribosomal small subunit assembly,GO:0000028,biological process,37.0,2.0,1.453e-01,1.188e-01,1.778e-01,1.047e-01,4.225e-02,2.593e-01,6.905e-01,2.956e-02
RPS19,10402,negative regulation of respiratory burst involved in inflammatory response,GO:0060266,biological process,37.0,8.0,1.486e-01,8.869e-02,2.488e-01,5.818e-02,7.961e-03,4.252e-01,7.564e-01,6.229e-02
RPS19,10402,defense response to Gram-negative bacterium,GO:0050829,biological process,37.0,2.0,1.605e-01,1.092e-01,2.358e-01,1.368e-01,7.443e-02,2.514e-01,6.530e-01,2.173e-02
RPS19,10402,positive regulation of respiratory burst involved in inflammatory response,GO:0060265,biological process,37.0,7.0,1.608e-01,8.024e-02,3.221e-01,1.011e-01,2.293e-02,4.453e-01,6.890e-01,5.378e-02
RPS19,10402,ribosomal small subunit biogenesis,GO:0042274,biological process,37.0,3.0,1.730e-01,6.978e-02,4.288e-01,1.026e-01,1.160e-02,9.072e-01,6.769e-01,7.469e-02
RPS19,10402,killing of cells of other organism,GO:0031640,biological process,37.0,5.0,2.037e-01,1.250e-01,3.320e-01,1.925e-01,1.023e-01,3.625e-01,5.969e-01,2.544e-02
RPS19,10402,postsynaptic density,GO:0014069,cellular component,37.0,4.0,1.293e-01,1.215e-01,1.376e-01,3.995e-02,2.537e-02,6.290e-02,8.106e-01,1.207e-02
RPS19,10402,ribosome,GO:0005840,cellular component,37.0,5.0,1.293e-01,1.215e-01,1.376e-01,4.263e-02,2.516e-02,7.223e-02,8.030e-01,1.366e-02
RPS19,10402,focal adhesion,GO:0005925,cellular component,37.0,11.0,1.293e-01,1.215e-01,1.376e-01,4.926e-02,1.739e-02,1.395e-01,7.853e-01,2.970e-02
RPS19,10402,cytosolic small ribosomal subunit,GO:0022627,cellular component,37.0,2.0,1.293e-01,1.215e-01,1.376e-01,5.556e-02,1.824e-02,1.693e-01,7.709e-01,3.294e-02
RPS19,10402,extracellular exosome,GO:0070062,cellular component,37.0,33.0,1.294e-01,1.213e-01,1.382e-01,6.473e-02,3.176e-02,1.319e-01,7.544e-01,2.097e-02
RPS19,10402,membrane,GO:0016020,cellular component,37.0,53.0,1.379e-01,1.177e-01,1.615e-01,6.396e-02,2.289e-02,1.787e-01,7.546e-01,2.914e-02
RPS19,10402,nucleolus,GO:0005730,cellular component,37.0,41.0,1.409e-01,1.118e-01,1.775e-01,8.057e-02,2.700e-02,2.405e-01,7.250e-01,3.285e-02
RPS19,10402,cytosol,GO:0005829,cellular component,37.0,78.0,1.439e-01,1.168e-01,1.773e-01,9.510e-02,5.176e-02,1.747e-01,7.054e-01,2.019e-02
RPS19,10402,cytoplasm,GO:0005737,cellular component,37.0,69.0,1.439e-01,1.168e-01,1.773e-01,1.051e-01,6.293e-02,1.757e-01,6.919e-01,1.761e-02
RPS19,10402,nucleoplasm,GO:0005654,cellular component,37.0,74.0,1.439e-01,1.168e-01,1.773e-01,1.122e-01,7.999e-02,1.574e-01,6.832e-01,1.181e-02
RPS19,10402,RNA binding,GO:0003723,molecular function,37.0,63.0,1.321e-01,1.298e-01,1.344e-01,5.412e-02,8.579e-03,3.415e-01,7.682e-01,4.866e-02
RPS19,10402,structural constituent of ribosome,GO:0003735,molecular function,37.0,3.0,1.321e-01,1.298e-01,1.344e-01,6.892e-02,3.890e-02,1.221e-01,7.475e-01,1.651e-02
RPS19,10402,protein homodimerization activity,GO:0042803,molecular function,37.0,15.0,1.409e-01,1.118e-01,1.775e-01,9.048e-02,4.159e-02,1.968e-01,7.113e-01,2.431e-02
RPS19,10402,protein kinase binding,GO:0019901,molecular function,37.0,32.0,1.439e-01,1.168e-01,1.773e-01,9.916e-02,4.436e-02,2.217e-01,6.987e-01,2.585e-02
RPS19,10402,protein binding,GO:0005515,molecular function,37.0,332.0,1.550e-01,1.322e-01,1.816e-01,1.282e-01,6.988e-02,2.350e-01,6.629e-01,2.109e-02
RPS19,10402,fibroblast growth factor binding,GO:0017134,molecular function,37.0,2.0,1.706e-01,1.103e-01,2.640e-01,1.567e-01,8.814e-02,2.787e-01,6.317e-01,2.219e-02
CNFN,30183,cornified envelope,GO:0001533,cellular component,2.0,2.0,1.435e-01,6.342e-02,3.248e-01,1.435e-01,6.342e-02,3.248e-01,6.441e-01,2.987e-02
PLEKHA4,14339,,,,nan,nan,,,,,,,,
TNPO2,19998,protein import into nucleus,GO:0006606,biological process,9.0,10.0,5.859e-02,2.553e-02,1.345e-01,1.492e-02,1.098e-02,2.029e-02,9.004e-01,4.934e-03
TNPO2,19998,nucleus,GO:0005634,cellular component,9.0,151.0,6.446e-02,2.035e-02,2.042e-01,4.907e-02,2.629e-02,9.162e-02,7.877e-01,1.743e-02
TNPO2,19998,cytoplasm,GO:0005737,cellular component,9.0,69.0,6.464e-02,2.021e-02,2.068e-01,5.163e-02,1.487e-02,1.793e-01,7.785e-01,3.602e-02
TNPO2,19998,protein binding,GO:0005515,molecular function,9.0,332.0,6.446e-02,2.035e-02,2.042e-01,5.079e-02,2.085e-02,1.237e-01,7.825e-01,2.510e-02
TNPO2,19998,nuclear localization sequence binding,GO:0008139,molecular function,9.0,3.0,6.607e-02,2.156e-02,2.025e-01,4.966e-02,1.954e-02,1.262e-01,7.845e-01,2.515e-02
TNPO2,19998,nuclear import signal receptor activity,GO:0061608,molecular function,9.0,2.0,7.134e-02,1.597e-02,3.186e-01,4.860e-02,4.943e-03,4.779e-01,7.745e-01,6.613e-02
IQCE,29171,,,,nan,nan,,,,,,,,
ANKRD7,18588,,,,nan,nan,,,,,,,,
ZKSCAN1,13101,,,,nan,nan,,,,,,,,
SETX,445,negative regulation of apoptotic process,GO:0043066,biological process,34.0,31.0,1.333e-01,7.315e-02,2.430e-01,2.551e-02,6.137e-03,1.061e-01,8.507e-01,3.412e-02
SETX,445,cellular response to retinoic acid,GO:0071300,biological process,34.0,5.0,1.333e-01,7.315e-02,2.430e-01,5.182e-02,2.510e-02,1.070e-01,7.810e-01,1.975e-02
SETX,445,termination of RNA polymerase II transcription,GO:0006369,biological process,34.0,4.0,1.333e-01,7.315e-02,2.430e-01,5.119e-02,1.725e-02,1.519e-01,7.806e-01,3.133e-02
SETX,445,cellular response to DNA damage stimulus,GO:0006974,biological process,34.0,20.0,1.333e-01,7.315e-02,2.430e-01,6.207e-02,2.236e-02,1.723e-01,7.579e-01,3.081e-02
SETX,445,positive regulation of RNA splicing,GO:0033120,biological process,34.0,5.0,1.333e-01,7.315e-02,2.430e-01,7.476e-02,1.858e-02,3.009e-01,7.324e-01,4.163e-02
SETX,445,cellular response to hydrogen peroxide,GO:0070301,biological process,34.0,7.0,1.334e-01,7.333e-02,2.428e-01,4.826e-02,4.330e-02,5.378e-02,7.900e-01,2.938e-03
SETX,445,double-strand break repair,GO:0006302,biological process,34.0,10.0,1.334e-01,7.333e-02,2.428e-01,5.420e-02,1.833e-02,1.603e-01,7.737e-01,3.085e-02
SETX,445,protein kinase B signaling,GO:0043491,biological process,34.0,2.0,1.345e-01,7.531e-02,2.400e-01,6.157e-02,3.574e-02,1.061e-01,7.612e-01,1.563e-02
SETX,445,"DNA-templated transcription, termination",GO:0006353,biological process,34.0,7.0,1.346e-01,7.514e-02,2.411e-01,7.116e-02,1.929e-02,2.626e-01,7.390e-01,4.090e-02
SETX,445,"positive regulation of DNA-templated transcription, initiation",GO:2000144,biological process,34.0,5.0,1.376e-01,8.135e-02,2.329e-01,6.319e-02,3.055e-02,1.307e-01,7.577e-01,2.068e-02
SETX,445,cellular response to fibroblast growth factor stimulus,GO:0044344,biological process,34.0,5.0,1.409e-01,8.719e-02,2.276e-01,8.964e-02,8.194e-02,9.806e-02,7.147e-01,2.928e-03
SETX,445,cellular response to oxidative stress,GO:0034599,biological process,34.0,7.0,1.409e-01,8.719e-02,2.276e-01,8.942e-02,4.601e-02,1.738e-01,7.135e-01,2.118e-02
SETX,445,"positive regulation of DNA-templated transcription, termination",GO:0060566,biological process,34.0,6.0,1.533e-01,1.021e-01,2.303e-01,1.028e-01,5.829e-02,1.813e-01,6.948e-01,1.854e-02
SETX,445,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,34.0,62.0,1.534e-01,1.021e-01,2.304e-01,9.296e-02,3.490e-02,2.476e-01,7.064e-01,3.056e-02
SETX,445,MAPK cascade,GO:0000165,biological process,34.0,11.0,1.541e-01,1.024e-01,2.319e-01,1.133e-01,5.796e-02,2.213e-01,6.806e-01,2.246e-02
SETX,445,positive regulation of neuron projection development,GO:0010976,biological process,34.0,10.0,2.043e-01,9.145e-02,4.564e-01,1.749e-01,6.469e-02,4.730e-01,6.098e-01,3.896e-02
SETX,445,mRNA splice site selection,GO:0006376,biological process,34.0,4.0,2.210e-01,8.818e-02,5.538e-01,1.984e-01,6.128e-02,6.426e-01,5.847e-01,4.760e-02
SETX,445,"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled",GO:2000806,biological process,34.0,3.0,2.248e-01,1.329e-01,3.801e-01,2.052e-01,1.097e-01,3.838e-01,5.850e-01,2.699e-02
SETX,445,fibroblast growth factor receptor signaling pathway,GO:0008543,biological process,34.0,20.0,2.804e-01,1.599e-01,4.920e-01,2.723e-01,1.471e-01,5.043e-01,5.292e-01,3.129e-02
SETX,445,nucleus,GO:0005634,cellular component,34.0,151.0,1.333e-01,7.315e-02,2.430e-01,4.356e-02,1.407e-02,1.348e-01,7.987e-01,2.858e-02
SETX,445,cytoplasm,GO:0005737,cellular component,34.0,69.0,1.333e-01,7.315e-02,2.430e-01,5.156e-02,2.011e-02,1.322e-01,7.803e-01,2.475e-02
SETX,445,nucleoplasm,GO:0005654,cellular component,34.0,74.0,1.333e-01,7.315e-02,2.430e-01,5.536e-02,3.170e-02,9.671e-02,7.739e-01,1.543e-02
SETX,445,intercellular bridge,GO:0045171,cellular component,34.0,25.0,1.333e-01,7.315e-02,2.430e-01,5.585e-02,2.058e-02,1.516e-01,7.708e-01,2.696e-02
SETX,445,nuclear chromosome,GO:0000228,cellular component,34.0,7.0,1.380e-01,7.679e-02,2.480e-01,6.446e-02,1.691e-02,2.458e-01,7.513e-01,3.764e-02
SETX,445,nuclear body,GO:0016604,cellular component,34.0,30.0,1.552e-01,8.243e-02,2.921e-01,1.199e-01,4.286e-02,3.357e-01,6.701e-01,3.457e-02
SETX,445,growth cone,GO:0030426,cellular component,34.0,4.0,1.680e-01,9.544e-02,2.957e-01,1.428e-01,6.272e-02,3.252e-01,6.450e-01,3.000e-02
SETX,445,axon,GO:0030424,cellular component,34.0,11.0,1.748e-01,7.310e-02,4.178e-01,1.357e-01,2.894e-02,6.366e-01,6.458e-01,5.314e-02
SETX,445,identical protein binding,GO:0042802,molecular function,34.0,20.0,1.333e-01,7.315e-02,2.430e-01,2.135e-02,1.444e-02,3.156e-02,8.724e-01,8.418e-03
SETX,445,protein binding,GO:0005515,molecular function,34.0,332.0,1.333e-01,7.315e-02,2.430e-01,4.732e-02,2.742e-02,8.164e-02,7.918e-01,1.452e-02
SETX,445,transcription termination site sequence-specific DNA binding,GO:0001147,molecular function,34.0,5.0,1.409e-01,8.719e-02,2.276e-01,8.813e-02,7.560e-02,1.027e-01,7.169e-01,4.983e-03
SETX,445,RNA binding,GO:0003723,molecular function,34.0,63.0,1.479e-01,7.902e-02,2.769e-01,5.578e-02,2.740e-03,1.136e+00,7.461e-01,7.385e-02
SH3GL2,10831,identical protein binding,GO:0042802,molecular function,13.0,20.0,4.601e-03,2.138e-03,9.899e-03,3.208e-03,1.160e-03,8.871e-03,9.702e-01,7.338e-03
SH3GL2,10831,protein binding,GO:0005515,molecular function,13.0,332.0,4.601e-03,2.138e-03,9.899e-03,4.601e-03,2.138e-03,9.899e-03,9.591e-01,7.752e-03
DNMBP,30373,regulation of cell shape,GO:0008360,biological process,12.0,9.0,5.619e-02,1.500e-02,2.104e-01,4.220e-02,4.586e-03,3.883e-01,7.909e-01,5.422e-02
DNMBP,30373,cell-cell junction,GO:0005911,cellular component,12.0,12.0,4.325e-02,2.113e-02,8.852e-02,2.231e-02,1.192e-02,4.176e-02,8.669e-01,1.304e-02
DNMBP,30373,Rho guanyl-nucleotide exchange factor activity,GO:0005089,molecular function,12.0,4.0,4.325e-02,2.113e-02,8.852e-02,2.494e-02,7.698e-03,8.078e-02,8.544e-01,2.707e-02
DNMBP,30373,protein binding,GO:0005515,molecular function,12.0,332.0,5.661e-02,5.519e-02,5.808e-02,4.430e-02,2.793e-02,7.025e-02,7.995e-01,1.240e-02
EIF3A,3271,formation of cytoplasmic translation initiation complex,GO:0001732,biological process,24.0,2.0,5.206e-02,2.235e-02,1.212e-01,2.227e-02,2.021e-03,2.453e-01,8.493e-01,4.216e-02
EIF3A,3271,viral translational termination-reinitiation,GO:0075525,biological process,24.0,2.0,5.640e-02,1.652e-02,1.925e-01,3.080e-02,3.417e-03,2.777e-01,8.243e-01,5.625e-02
EIF3A,3271,IRES-dependent viral translational initiation,GO:0075522,biological process,24.0,2.0,5.640e-02,1.652e-02,1.925e-01,3.194e-02,3.782e-03,2.698e-01,8.218e-01,5.571e-02
EIF3A,3271,translation reinitiation,GO:0002188,biological process,24.0,2.0,7.974e-02,2.117e-02,3.003e-01,6.329e-02,7.681e-03,5.215e-01,7.463e-01,5.706e-02
EIF3A,3271,"eukaryotic translation initiation factor 3 complex, eIF3m",GO:0071541,cellular component,24.0,2.0,4.245e-02,2.604e-02,6.921e-02,9.432e-03,4.971e-03,1.790e-02,9.264e-01,7.786e-03
EIF3A,3271,"eukaryotic translation initiation factor 3 complex, eIF3e",GO:0071540,cellular component,24.0,2.0,4.245e-02,2.604e-02,6.921e-02,9.669e-03,4.609e-03,2.029e-02,9.248e-01,9.282e-03
EIF3A,3271,eukaryotic translation initiation factor 3 complex,GO:0005852,cellular component,24.0,4.0,4.245e-02,2.604e-02,6.921e-02,9.957e-03,6.059e-03,1.636e-02,9.239e-01,6.344e-03
EIF3A,3271,multi-eIF complex,GO:0043614,cellular component,24.0,2.0,5.281e-02,3.671e-02,7.597e-02,2.280e-02,1.684e-02,3.087e-02,8.665e-01,6.592e-03
EIF3A,3271,membrane,GO:0016020,cellular component,24.0,53.0,6.631e-02,3.972e-02,1.107e-01,3.726e-02,1.656e-02,8.379e-02,8.171e-01,2.057e-02
EIF3A,3271,nucleolus,GO:0005730,cellular component,24.0,41.0,7.137e-02,4.668e-02,1.091e-01,4.819e-02,2.599e-02,8.936e-02,7.898e-01,1.715e-02
EIF3A,3271,cytosol,GO:0005829,cellular component,24.0,78.0,7.815e-02,6.170e-02,9.898e-02,6.298e-02,4.238e-02,9.359e-02,7.588e-01,1.155e-02
EIF3A,3271,nucleus,GO:0005634,cellular component,24.0,151.0,8.476e-02,7.758e-02,9.261e-02,7.479e-02,5.548e-02,1.008e-01,7.379e-01,9.035e-03
EIF3A,3271,mRNA binding,GO:0003729,molecular function,24.0,12.0,4.408e-02,2.613e-02,7.437e-02,1.531e-02,6.080e-03,3.855e-02,8.952e-01,1.707e-02
EIF3A,3271,translation initiation factor activity,GO:0003743,molecular function,24.0,2.0,6.110e-02,4.244e-02,8.794e-02,3.109e-02,1.688e-02,5.727e-02,8.359e-01,1.498e-02
EIF3A,3271,RNA binding,GO:0003723,molecular function,24.0,63.0,7.033e-02,4.404e-02,1.123e-01,4.442e-02,1.831e-02,1.077e-01,7.978e-01,2.440e-02
EIF3A,3271,protein binding,GO:0005515,molecular function,24.0,332.0,8.618e-02,5.799e-02,1.281e-01,7.691e-02,5.157e-02,1.147e-01,7.341e-01,1.201e-02
PSMD3,9560,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,23.0,9.0,2.728e-02,2.351e-02,3.165e-02,1.556e-02,5.769e-03,4.198e-02,8.937e-01,1.548e-02
PSMD3,9560,"proteasome regulatory particle, lid subcomplex",GO:0008541,cellular component,23.0,4.0,2.728e-02,2.351e-02,3.165e-02,1.244e-02,4.928e-03,3.141e-02,9.091e-01,1.447e-02
PSMD3,9560,proteasome complex,GO:0000502,cellular component,23.0,7.0,2.767e-02,2.300e-02,3.329e-02,1.893e-02,7.660e-03,4.676e-02,8.793e-01,1.785e-02
PSMD3,9560,extracellular exosome,GO:0070062,cellular component,23.0,33.0,2.939e-02,2.113e-02,4.087e-02,1.545e-02,8.965e-03,2.663e-02,8.972e-01,9.074e-03
PSMD3,9560,nucleus,GO:0005634,cellular component,23.0,151.0,3.426e-02,1.493e-02,7.862e-02,2.756e-02,8.365e-03,9.082e-02,8.454e-01,2.916e-02
PSMD3,9560,membrane,GO:0016020,cellular component,23.0,53.0,3.426e-02,1.493e-02,7.862e-02,2.988e-02,1.614e-02,5.534e-02,8.401e-01,1.501e-02
PSMD3,9560,protein binding,GO:0005515,molecular function,23.0,332.0,3.426e-02,1.493e-02,7.862e-02,2.638e-02,9.205e-03,7.558e-02,8.503e-01,2.531e-02
RAPGEFL1,17428,,,,nan,nan,,,,,,,,
MED31,24260,regulation of transcription by RNA polymerase II,GO:0006357,biological process,8.0,46.0,9.042e-02,3.274e-02,2.498e-01,9.042e-02,3.274e-02,2.498e-01,7.097e-01,3.429e-02
MED31,24260,core mediator complex,GO:0070847,cellular component,8.0,2.0,3.470e-02,2.418e-02,4.979e-02,1.964e-02,7.516e-03,5.132e-02,8.761e-01,1.942e-02
MED31,24260,mediator complex,GO:0016592,cellular component,8.0,3.0,3.915e-02,2.728e-02,5.619e-02,2.175e-02,9.287e-03,5.093e-02,8.686e-01,1.852e-02
MED31,24260,transcription coactivator activity,GO:0003713,molecular function,8.0,8.0,3.470e-02,2.418e-02,4.979e-02,1.921e-02,6.731e-03,5.480e-02,8.775e-01,2.130e-02
MED31,24260,protein binding,GO:0005515,molecular function,8.0,332.0,5.614e-02,2.367e-02,1.331e-01,3.941e-02,1.284e-02,1.210e-01,8.094e-01,2.979e-02
AKAP10,368,,,,nan,nan,,,,,,,,
ALDH3A1,405,oxidation-reduction process,GO:0055114,biological process,15.0,36.0,3.069e-01,2.689e-02,3.504e+00,2.590e-01,1.764e-02,3.804e+00,4.808e-01,1.223e-01
ALDH3A1,405,cellular aldehyde metabolic process,GO:0006081,biological process,15.0,21.0,8.962e-01,7.600e-01,1.057e+00,8.962e-01,7.600e-01,1.057e+00,6.555e-02,5.380e-02
ALDH3A1,405,endoplasmic reticulum,GO:0005783,cellular component,15.0,9.0,5.538e-02,3.326e-02,9.221e-02,1.816e-02,6.522e-03,5.057e-02,8.816e-01,1.877e-02
ALDH3A1,405,plasma membrane,GO:0005886,cellular component,15.0,24.0,5.605e-02,3.424e-02,9.176e-02,2.344e-02,1.717e-02,3.201e-02,8.639e-01,6.791e-03
ALDH3A1,405,extracellular space,GO:0005615,cellular component,15.0,6.0,6.556e-02,4.291e-02,1.002e-01,4.302e-02,2.005e-02,9.229e-02,8.016e-01,2.060e-02
ALDH3A1,405,cytosol,GO:0005829,cellular component,15.0,78.0,6.648e-02,4.610e-02,9.586e-02,4.782e-02,3.380e-02,6.766e-02,7.909e-01,9.419e-03
ALDH3A1,405,alcohol dehydrogenase (NADP+) activity,GO:0008106,molecular function,15.0,6.0,5.538e-02,3.326e-02,9.221e-02,1.631e-02,5.455e-03,4.878e-02,8.888e-01,2.036e-02
ALDH3A1,405,benzaldehyde dehydrogenase (NAD+) activity,GO:0018479,molecular function,15.0,3.0,5.538e-02,3.326e-02,9.221e-02,1.807e-02,2.635e-03,1.240e-01,8.732e-01,3.997e-02
ALDH3A1,405,aldehyde dehydrogenase (NAD+) activity,GO:0004029,molecular function,15.0,21.0,5.605e-02,3.424e-02,9.176e-02,2.119e-02,1.118e-02,4.016e-02,8.715e-01,1.263e-02
ALDH3A1,405,protein binding,GO:0005515,molecular function,15.0,332.0,6.772e-02,4.946e-02,9.273e-02,5.461e-02,3.788e-02,7.874e-02,7.756e-01,1.019e-02
ALDH3A1,405,3-chloroallyl aldehyde dehydrogenase activity,GO:0004028,molecular function,15.0,2.0,8.931e-02,1.126e-02,7.084e-01,5.296e-02,3.835e-03,7.313e-01,7.576e-01,8.373e-02
RANGRF,17679,,,,nan,nan,,,,,,,,
UGDH,12525,,,,nan,nan,,,,,,,,
ITFG2,30879,negative regulation of TORC1 signaling,GO:1904262,biological process,6.0,4.0,1.499e-02,6.826e-03,3.293e-02,6.458e-03,6.643e-04,6.278e-02,9.347e-01,2.949e-02
ITFG2,30879,cellular response to glucose starvation,GO:0042149,biological process,6.0,6.0,1.781e-02,8.030e-03,3.950e-02,1.087e-02,2.408e-03,4.911e-02,9.146e-01,1.888e-02
ITFG2,30879,cellular response to amino acid starvation,GO:0034198,biological process,6.0,7.0,2.302e-02,1.420e-02,3.733e-02,1.615e-02,5.614e-03,4.645e-02,8.904e-01,1.673e-02
ITFG2,30879,lysosomal membrane,GO:0005765,cellular component,6.0,8.0,1.822e-02,1.115e-02,2.978e-02,1.082e-02,6.836e-03,1.712e-02,9.197e-01,5.946e-03
ITFG2,30879,KICSTOR complex,GO:0140007,cellular component,6.0,3.0,4.680e-02,1.287e-02,1.702e-01,4.253e-02,8.688e-03,2.082e-01,7.977e-01,4.055e-02
RAD51AP1,16956,double-strand break repair via homologous recombination,GO:0000724,biological process,12.0,8.0,1.003e-01,3.923e-02,2.564e-01,2.442e-02,1.582e-02,3.768e-02,8.596e-01,9.828e-03
RAD51AP1,16956,cellular response to ionizing radiation,GO:0071479,biological process,12.0,6.0,1.006e-01,3.969e-02,2.548e-01,5.182e-02,1.443e-02,1.861e-01,7.777e-01,3.715e-02
RAD51AP1,16956,interstrand cross-link repair,GO:0036297,biological process,12.0,5.0,1.190e-01,5.531e-02,2.562e-01,7.334e-02,2.251e-02,2.390e-01,7.358e-01,3.776e-02
RAD51AP1,16956,regulation of double-strand break repair via homologous recombination,GO:0010569,biological process,12.0,6.0,2.100e-01,5.609e-02,7.865e-01,1.659e-01,3.232e-02,8.514e-01,6.044e-01,7.464e-02
RAD51AP1,16956,nuclear chromatin,GO:0000790,cellular component,12.0,14.0,1.003e-01,3.923e-02,2.564e-01,4.852e-02,1.610e-02,1.462e-01,7.866e-01,2.973e-02
RAD51AP1,16956,nucleus,GO:0005634,cellular component,12.0,151.0,1.300e-01,7.136e-02,2.369e-01,8.824e-02,4.424e-02,1.760e-01,7.150e-01,2.261e-02
RAD51AP1,16956,protein-containing complex,GO:0032991,cellular component,12.0,481.0,2.286e-01,7.178e-02,7.281e-01,2.061e-01,5.211e-02,8.153e-01,5.702e-01,6.723e-02
RAD51AP1,16956,single-stranded DNA binding,GO:0003697,molecular function,12.0,7.0,1.003e-01,3.923e-02,2.564e-01,2.948e-02,3.463e-03,2.510e-01,8.273e-01,4.393e-02
RAD51AP1,16956,double-stranded DNA binding,GO:0003690,molecular function,12.0,13.0,1.124e-01,3.765e-02,3.355e-01,5.071e-02,9.945e-03,2.586e-01,7.779e-01,4.377e-02
RAD51AP1,16956,RNA binding,GO:0003723,molecular function,12.0,63.0,1.211e-01,3.469e-02,4.225e-01,6.968e-02,7.855e-03,6.181e-01,7.324e-01,6.561e-02
RAD51AP1,16956,protein binding,GO:0005515,molecular function,12.0,332.0,1.517e-01,1.059e-01,2.175e-01,1.194e-01,6.765e-02,2.107e-01,6.733e-01,2.040e-02
KRR1,5176,small-subunit processome,GO:0032040,cellular component,12.0,2.0,5.448e-02,4.227e-02,7.020e-02,1.968e-02,1.080e-02,3.587e-02,8.782e-01,1.189e-02
KRR1,5176,nucleolus,GO:0005730,cellular component,12.0,41.0,5.448e-02,4.227e-02,7.020e-02,2.944e-02,2.218e-02,3.907e-02,8.425e-01,6.702e-03
KRR1,5176,membrane,GO:0016020,cellular component,12.0,53.0,5.448e-02,4.227e-02,7.020e-02,3.690e-02,2.874e-02,4.736e-02,8.194e-01,6.055e-03
KRR1,5176,nucleus,GO:0005634,cellular component,12.0,151.0,5.605e-02,4.209e-02,7.464e-02,4.459e-02,3.183e-02,6.244e-02,7.988e-01,9.134e-03
KRR1,5176,intercellular bridge,GO:0045171,cellular component,12.0,25.0,6.102e-02,3.717e-02,1.002e-01,5.690e-02,2.866e-02,1.130e-01,7.702e-01,1.932e-02
KRR1,5176,RNA binding,GO:0003723,molecular function,12.0,63.0,5.448e-02,4.227e-02,7.020e-02,1.645e-02,1.383e-02,1.956e-02,8.937e-01,3.024e-03
KRR1,5176,protein binding,GO:0005515,molecular function,12.0,332.0,6.328e-02,5.395e-02,7.422e-02,6.011e-02,5.845e-02,6.182e-02,7.649e-01,8.330e-04
ING4,19423,positive regulation of apoptotic process,GO:0043065,biological process,22.0,28.0,1.393e-01,1.096e-01,1.770e-01,1.130e-02,5.852e-03,2.183e-02,9.167e-01,8.594e-03
ING4,19423,histone H3 acetylation,GO:0043966,biological process,22.0,13.0,1.409e-01,1.077e-01,1.842e-01,5.524e-02,2.395e-02,1.274e-01,7.730e-01,2.405e-02
ING4,19423,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,22.0,41.0,1.409e-01,1.077e-01,1.842e-01,6.502e-02,2.832e-02,1.493e-01,7.536e-01,2.385e-02
ING4,19423,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",GO:0006978,biological process,22.0,3.0,1.475e-01,1.287e-01,1.692e-01,4.626e-02,2.055e-02,1.041e-01,7.931e-01,2.099e-02
ING4,19423,protein acetylation,GO:0006473,biological process,22.0,10.0,1.544e-01,1.369e-01,1.740e-01,7.383e-02,3.191e-02,1.708e-01,7.373e-01,2.628e-02
ING4,19423,histone H4-K5 acetylation,GO:0043981,biological process,22.0,2.0,1.544e-01,1.369e-01,1.740e-01,8.596e-02,5.090e-02,1.452e-01,7.193e-01,1.628e-02
ING4,19423,histone H4-K12 acetylation,GO:0043983,biological process,22.0,2.0,1.544e-01,1.369e-01,1.740e-01,8.752e-02,5.019e-02,1.526e-01,7.169e-01,1.730e-02
ING4,19423,histone H4-K8 acetylation,GO:0043982,biological process,22.0,2.0,1.544e-01,1.369e-01,1.740e-01,9.161e-02,5.373e-02,1.562e-01,7.106e-01,1.689e-02
ING4,19423,cell cycle arrest,GO:0007050,biological process,22.0,8.0,1.593e-01,1.307e-01,1.940e-01,9.927e-02,4.919e-02,2.003e-01,6.990e-01,2.387e-02
ING4,19423,negative regulation of cell population proliferation,GO:0008285,biological process,22.0,34.0,2.055e-01,1.269e-01,3.327e-01,1.575e-01,6.460e-02,3.841e-01,6.289e-01,3.320e-02
ING4,19423,DNA replication,GO:0006260,biological process,22.0,4.0,2.125e-01,9.770e-02,4.623e-01,1.753e-01,6.282e-02,4.893e-01,6.074e-01,4.467e-02
ING4,19423,negative regulation of growth,GO:0045926,biological process,22.0,8.0,2.153e-01,1.521e-01,3.048e-01,1.794e-01,1.317e-01,2.442e-01,6.109e-01,1.215e-02
ING4,19423,apoptotic process,GO:0006915,biological process,22.0,20.0,4.091e-01,9.895e-02,1.692e+00,4.022e-01,9.280e-02,1.743e+00,3.871e-01,1.189e-01
ING4,19423,intermediate filament cytoskeleton,GO:0045111,cellular component,22.0,8.0,1.409e-01,1.077e-01,1.842e-01,6.848e-02,3.130e-02,1.498e-01,7.474e-01,2.268e-02
ING4,19423,cytosol,GO:0005829,cellular component,22.0,78.0,1.409e-01,1.077e-01,1.842e-01,7.405e-02,2.937e-02,1.867e-01,7.370e-01,2.711e-02
ING4,19423,nucleus,GO:0005634,cellular component,22.0,151.0,1.409e-01,1.077e-01,1.842e-01,8.153e-02,3.140e-02,2.117e-01,7.241e-01,2.872e-02
ING4,19423,histone acetyltransferase complex,GO:0000123,cellular component,22.0,5.0,2.888e-01,2.200e-01,3.791e-01,2.770e-01,2.260e-01,3.396e-01,5.290e-01,1.053e-02
ING4,19423,protein binding,GO:0005515,molecular function,22.0,332.0,1.464e-01,1.000e-01,2.143e-01,8.573e-02,2.687e-02,2.735e-01,7.161e-01,3.575e-02
ING4,19423,transcription coactivator activity,GO:0003713,molecular function,22.0,8.0,1.544e-01,1.369e-01,1.740e-01,9.817e-02,7.651e-02,1.260e-01,7.021e-01,8.231e-03
ING4,19423,methylated histone binding,GO:0035064,molecular function,22.0,8.0,1.632e-01,7.851e-02,3.394e-01,8.140e-02,1.407e-02,4.711e-01,7.162e-01,5.950e-02
SRSF9,10791,"mRNA cis splicing, via spliceosome",GO:0045292,biological process,15.0,2.0,3.463e-02,2.196e-02,5.461e-02,1.557e-02,3.653e-03,6.633e-02,8.896e-01,2.306e-02
SRSF9,10791,"regulation of alternative mRNA splicing, via spliceosome",GO:0000381,biological process,15.0,2.0,3.463e-02,2.196e-02,5.461e-02,2.012e-02,1.076e-02,3.763e-02,8.760e-01,1.301e-02
SRSF9,10791,"negative regulation of mRNA splicing, via spliceosome",GO:0048025,biological process,15.0,5.0,3.463e-02,2.196e-02,5.461e-02,2.259e-02,1.137e-02,4.492e-02,8.655e-01,1.410e-02
SRSF9,10791,nuclear speck,GO:0016607,cellular component,15.0,6.0,3.254e-02,2.233e-02,4.741e-02,4.476e-03,1.811e-03,1.106e-02,9.599e-01,8.773e-03
SRSF9,10791,nucleolus,GO:0005730,cellular component,15.0,41.0,3.726e-02,2.647e-02,5.244e-02,2.019e-02,1.241e-02,3.286e-02,8.764e-01,9.712e-03
SRSF9,10791,nucleus,GO:0005634,cellular component,15.0,151.0,4.012e-02,2.720e-02,5.918e-02,3.190e-02,2.376e-02,4.284e-02,8.344e-01,7.120e-03
SRSF9,10791,nucleoplasm,GO:0005654,cellular component,15.0,74.0,4.127e-02,2.647e-02,6.435e-02,3.602e-02,1.790e-02,7.248e-02,8.209e-01,1.726e-02
SRSF9,10791,RNA binding,GO:0003723,molecular function,15.0,63.0,3.346e-02,2.375e-02,4.713e-02,9.769e-03,5.658e-03,1.687e-02,9.249e-01,7.009e-03
SRSF9,10791,protein domain specific binding,GO:0019904,molecular function,15.0,82.0,3.823e-02,1.740e-02,8.397e-02,2.677e-02,6.691e-03,1.071e-01,8.467e-01,3.376e-02
SRSF9,10791,protein binding,GO:0005515,molecular function,15.0,332.0,4.234e-02,3.227e-02,5.557e-02,3.947e-02,3.382e-02,4.606e-02,8.126e-01,3.942e-03
GMNN,17493,positive regulation of chromatin binding,GO:0035563,biological process,20.0,4.0,4.425e-02,1.990e-02,9.838e-02,1.007e-02,3.829e-03,2.647e-02,9.219e-01,1.244e-02
GMNN,17493,negative regulation of DNA replication,GO:0008156,biological process,20.0,5.0,4.425e-02,1.990e-02,9.838e-02,1.239e-02,1.855e-03,8.274e-02,9.016e-01,2.844e-02
GMNN,17493,negative regulation of DNA-dependent DNA replication,GO:2000104,biological process,20.0,11.0,4.425e-02,1.990e-02,9.838e-02,2.161e-02,9.251e-03,5.047e-02,8.686e-01,1.701e-02
GMNN,17493,regulation of DNA replication,GO:0006275,biological process,20.0,8.0,4.425e-02,1.990e-02,9.838e-02,2.291e-02,1.007e-02,5.211e-02,8.633e-01,1.695e-02
GMNN,17493,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,20.0,41.0,4.425e-02,1.990e-02,9.838e-02,2.467e-02,1.033e-02,5.893e-02,8.567e-01,1.843e-02
GMNN,17493,negative regulation of cell cycle,GO:0045786,biological process,20.0,9.0,5.133e-02,3.769e-02,6.991e-02,3.634e-02,1.732e-02,7.623e-02,8.198e-01,1.831e-02
GMNN,17493,DNA replication preinitiation complex assembly,GO:0071163,biological process,20.0,6.0,6.012e-02,4.567e-02,7.916e-02,2.448e-02,3.512e-03,1.706e-01,8.481e-01,4.312e-02
GMNN,17493,cytoplasm,GO:0005737,cellular component,20.0,69.0,4.428e-02,1.996e-02,9.823e-02,3.065e-02,1.135e-02,8.282e-02,8.359e-01,2.257e-02
GMNN,17493,cytosol,GO:0005829,cellular component,20.0,78.0,4.449e-02,2.038e-02,9.712e-02,3.511e-02,1.245e-02,9.904e-02,8.220e-01,2.516e-02
GMNN,17493,nucleus,GO:0005634,cellular component,20.0,151.0,4.630e-02,1.944e-02,1.102e-01,3.344e-02,8.111e-03,1.379e-01,8.238e-01,3.214e-02
GMNN,17493,histone deacetylase binding,GO:0042826,molecular function,20.0,4.0,4.425e-02,1.990e-02,9.838e-02,2.643e-02,9.507e-03,7.347e-02,8.498e-01,2.168e-02
GMNN,17493,protein binding,GO:0005515,molecular function,20.0,332.0,4.818e-02,1.970e-02,1.178e-01,4.327e-02,1.359e-02,1.378e-01,7.993e-01,2.923e-02
GMNN,17493,chromatin binding,GO:0003682,molecular function,20.0,17.0,5.009e-02,2.561e-02,9.797e-02,4.295e-02,1.983e-02,9.302e-02,8.014e-01,1.999e-02
ZBTB24,21143,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,10.0,62.0,3.558e-02,2.235e-02,5.665e-02,2.617e-02,1.518e-02,4.513e-02,8.528e-01,1.239e-02
ZBTB24,21143,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,10.0,54.0,3.632e-02,2.256e-02,5.849e-02,3.632e-02,2.256e-02,5.849e-02,8.204e-01,1.181e-02
ZBTB24,21143,nucleoplasm,GO:0005654,cellular component,10.0,74.0,3.399e-02,2.157e-02,5.357e-02,1.980e-02,1.635e-02,2.397e-02,8.792e-01,3.929e-03
ZBTB24,21143,DNA-binding transcription factor activity,GO:0003700,molecular function,10.0,18.0,3.399e-02,2.157e-02,5.357e-02,1.420e-02,9.981e-03,2.019e-02,9.037e-01,5.730e-03
ZBTB24,21143,transcription regulatory region DNA binding,GO:0044212,molecular function,10.0,24.0,3.399e-02,2.157e-02,5.357e-02,2.183e-02,1.245e-02,3.830e-02,8.693e-01,1.204e-02
ZBTB24,21143,protein binding,GO:0005515,molecular function,10.0,332.0,3.445e-02,2.096e-02,5.664e-02,2.508e-02,1.002e-02,6.274e-02,8.556e-01,2.090e-02
KIF20A,9787,regulation of cytokinesis,GO:0032465,biological process,25.0,12.0,6.667e-02,4.564e-02,9.740e-02,1.817e-02,1.191e-02,2.774e-02,8.854e-01,8.463e-03
KIF20A,9787,microtubule bundle formation,GO:0001578,biological process,25.0,6.0,6.667e-02,4.564e-02,9.740e-02,3.417e-02,1.101e-02,1.061e-01,8.243e-01,2.922e-02
KIF20A,9787,mitotic cytokinesis,GO:0000281,biological process,25.0,12.0,6.879e-02,4.870e-02,9.718e-02,3.004e-02,1.556e-02,5.802e-02,8.394e-01,1.612e-02
KIF20A,9787,midbody abscission,GO:0061952,biological process,25.0,6.0,7.076e-02,5.028e-02,9.957e-02,3.283e-02,8.682e-03,1.242e-01,8.263e-01,3.038e-02
KIF20A,9787,microtubule-based movement,GO:0007018,biological process,25.0,21.0,7.076e-02,5.028e-02,9.957e-02,4.438e-02,1.270e-02,1.550e-01,7.959e-01,3.191e-02
KIF20A,9787,spindle,GO:0005819,cellular component,25.0,15.0,6.667e-02,4.564e-02,9.740e-02,1.404e-02,6.300e-03,3.128e-02,9.021e-01,1.338e-02
KIF20A,9787,microtubule,GO:0005874,cellular component,25.0,22.0,6.667e-02,4.564e-02,9.740e-02,2.683e-02,1.507e-02,4.777e-02,8.505e-01,1.318e-02
KIF20A,9787,kinesin complex,GO:0005871,cellular component,25.0,16.0,6.667e-02,4.564e-02,9.740e-02,3.389e-02,1.950e-02,5.891e-02,8.276e-01,1.351e-02
KIF20A,9787,cleavage furrow,GO:0032154,cellular component,25.0,5.0,6.667e-02,4.564e-02,9.740e-02,3.805e-02,1.807e-02,8.013e-02,8.151e-01,1.924e-02
KIF20A,9787,midbody,GO:0030496,cellular component,25.0,26.0,7.431e-02,5.350e-02,1.032e-01,4.375e-02,2.673e-02,7.162e-02,8.007e-01,1.323e-02
KIF20A,9787,intercellular bridge,GO:0045171,cellular component,25.0,25.0,8.619e-02,6.423e-02,1.157e-01,7.339e-02,5.498e-02,9.796e-02,7.403e-01,8.700e-03
KIF20A,9787,nucleoplasm,GO:0005654,cellular component,25.0,74.0,9.302e-02,5.827e-02,1.485e-01,8.219e-02,4.810e-02,1.405e-01,7.250e-01,1.700e-02
KIF20A,9787,nucleus,GO:0005634,cellular component,25.0,151.0,9.316e-02,5.847e-02,1.484e-01,8.743e-02,5.415e-02,1.412e-01,7.171e-01,1.558e-02
KIF20A,9787,microtubule motor activity,GO:0003777,molecular function,25.0,13.0,6.667e-02,4.564e-02,9.740e-02,2.160e-02,1.735e-02,2.689e-02,8.716e-01,4.780e-03
KIF20A,9787,microtubule binding,GO:0008017,molecular function,25.0,22.0,6.667e-02,4.564e-02,9.740e-02,2.734e-02,1.393e-02,5.365e-02,8.485e-01,1.507e-02
KIF20A,9787,ATPase activity,GO:0016887,molecular function,25.0,14.0,7.376e-02,5.361e-02,1.015e-01,5.021e-02,2.934e-02,8.594e-02,7.851e-01,1.468e-02
KIF20A,9787,protein kinase binding,GO:0019901,molecular function,25.0,32.0,7.881e-02,4.953e-02,1.254e-01,5.525e-02,2.003e-02,1.524e-01,7.720e-01,2.730e-02
KIF20A,9787,protein binding,GO:0005515,molecular function,25.0,332.0,1.032e-01,6.213e-02,1.713e-01,1.013e-01,5.773e-02,1.778e-01,6.968e-01,1.858e-02
TFDP2,11751,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,32.0,62.0,1.923e-02,1.517e-02,2.438e-02,1.236e-02,9.119e-03,1.676e-02,9.126e-01,4.571e-03
TFDP2,11751,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,32.0,41.0,2.865e-02,1.987e-02,4.132e-02,2.384e-02,1.447e-02,3.928e-02,8.622e-01,1.163e-02
TFDP2,11751,nucleus,GO:0005634,cellular component,32.0,151.0,1.645e-02,9.656e-03,2.803e-02,7.473e-03,2.883e-03,1.937e-02,9.375e-01,1.063e-02
TFDP2,11751,RNA polymerase II transcription factor complex,GO:0090575,cellular component,32.0,43.0,4.931e-02,2.641e-02,9.205e-02,4.931e-02,2.641e-02,9.205e-02,7.871e-01,1.748e-02
TFDP2,11751,transcription factor binding,GO:0008134,molecular function,32.0,19.0,1.321e-02,5.130e-03,3.404e-02,2.370e-03,2.530e-04,2.219e-02,9.700e-01,1.426e-02
TFDP2,11751,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,32.0,7.0,1.538e-02,8.482e-03,2.789e-02,3.825e-03,1.969e-03,7.433e-03,9.659e-01,5.814e-03
TFDP2,11751,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,32.0,10.0,1.645e-02,9.656e-03,2.803e-02,7.237e-03,1.771e-03,2.957e-02,9.369e-01,1.675e-02
TFDP2,11751,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,32.0,10.0,1.819e-02,1.327e-02,2.494e-02,1.088e-02,6.373e-03,1.856e-02,9.194e-01,6.790e-03
TFDP2,11751,protein binding,GO:0005515,molecular function,32.0,332.0,2.024e-02,1.527e-02,2.681e-02,1.411e-02,1.071e-02,1.858e-02,9.041e-01,4.282e-03
TFDP2,11751,protein domain specific binding,GO:0019904,molecular function,32.0,82.0,3.929e-02,1.691e-02,9.129e-02,3.400e-02,1.322e-02,8.747e-02,8.257e-01,2.371e-02
CISH,1984,phosphatidylinositol phosphorylation,GO:0046854,biological process,7.0,5.0,1.749e-01,4.656e-02,6.573e-01,7.011e-02,5.378e-03,9.139e-01,7.211e-01,8.840e-02
CISH,1984,negative regulation of insulin receptor signaling pathway,GO:0046627,biological process,7.0,6.0,2.743e-01,1.063e-01,7.077e-01,1.899e-01,5.279e-02,6.828e-01,5.905e-01,5.375e-02
CISH,1984,phosphatidylinositol 3-kinase complex,GO:0005942,cellular component,7.0,8.0,2.465e-01,1.150e-01,5.284e-01,1.748e-01,3.643e-02,8.389e-01,6.012e-01,6.201e-02
CISH,1984,1-phosphatidylinositol-3-kinase regulator activity,GO:0046935,molecular function,7.0,2.0,2.361e-01,5.511e-02,1.012e+00,1.356e-01,5.280e-03,3.482e+00,6.089e-01,1.103e-01
CISH,1984,protein binding,GO:0005515,molecular function,7.0,332.0,2.480e-01,1.134e-01,5.426e-01,1.542e-01,1.077e-01,2.207e-01,6.352e-01,1.385e-02
APC2,24036,activation of GTPase activity,GO:0090630,biological process,27.0,3.0,2.020e-01,1.473e-01,2.772e-01,5.238e-02,1.157e-02,2.371e-01,7.745e-01,4.456e-02
APC2,24036,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,27.0,14.0,2.020e-01,1.473e-01,2.772e-01,6.795e-02,2.903e-02,1.591e-01,7.477e-01,2.598e-02
APC2,24036,negative regulation of microtubule depolymerization,GO:0007026,biological process,27.0,8.0,2.020e-01,1.473e-01,2.772e-01,7.803e-02,3.875e-02,1.571e-01,7.311e-01,2.091e-02
APC2,24036,positive regulation of protein catabolic process,GO:0045732,biological process,27.0,9.0,2.439e-01,1.477e-01,4.028e-01,1.502e-01,4.830e-02,4.669e-01,6.340e-01,4.205e-02
APC2,24036,microtubule cytoskeleton organization,GO:0000226,biological process,27.0,25.0,2.549e-01,2.011e-01,3.231e-01,2.038e-01,1.729e-01,2.401e-01,5.893e-01,6.944e-03
APC2,24036,regulation of cell differentiation,GO:0045595,biological process,27.0,44.0,2.720e-01,1.252e-01,5.909e-01,1.851e-01,4.550e-02,7.527e-01,5.914e-01,6.265e-02
APC2,24036,cell migration,GO:0016477,biological process,27.0,38.0,2.861e-01,1.560e-01,5.248e-01,2.112e-01,7.673e-02,5.815e-01,5.738e-01,4.754e-02
APC2,24036,cell fate specification,GO:0001708,biological process,27.0,23.0,4.629e-01,3.231e-01,6.630e-01,4.444e-01,3.102e-01,6.365e-01,4.110e-01,2.459e-02
APC2,24036,pattern specification process,GO:0007389,biological process,27.0,18.0,4.975e-01,2.132e-01,1.161e+00,4.767e-01,1.824e-01,1.246e+00,3.660e-01,8.059e-02
APC2,24036,filamentous actin,GO:0031941,cellular component,27.0,3.0,2.020e-01,1.473e-01,2.772e-01,4.727e-02,7.948e-03,2.811e-01,7.843e-01,5.011e-02
APC2,24036,cytoplasmic microtubule,GO:0005881,cellular component,27.0,8.0,2.020e-01,1.473e-01,2.772e-01,6.938e-02,3.105e-02,1.550e-01,7.454e-01,2.477e-02
APC2,24036,beta-catenin destruction complex,GO:0030877,cellular component,27.0,3.0,2.042e-01,1.473e-01,2.831e-01,9.770e-02,3.551e-02,2.688e-01,6.992e-01,3.203e-02
APC2,24036,Golgi apparatus,GO:0005794,cellular component,27.0,15.0,2.081e-01,1.668e-01,2.596e-01,6.939e-02,4.024e-02,1.197e-01,7.467e-01,1.581e-02
APC2,24036,lamellipodium membrane,GO:0031258,cellular component,27.0,4.0,2.119e-01,1.533e-01,2.928e-01,1.106e-01,4.196e-02,2.916e-01,6.823e-01,3.202e-02
APC2,24036,midbody,GO:0030496,cellular component,27.0,26.0,2.212e-01,2.029e-01,2.412e-01,8.705e-02,4.376e-02,1.732e-01,7.169e-01,2.196e-02
APC2,24036,cytosol,GO:0005829,cellular component,27.0,78.0,2.212e-01,2.029e-01,2.412e-01,1.100e-01,5.008e-02,2.415e-01,6.842e-01,2.634e-02
APC2,24036,microtubule cytoskeleton,GO:0015630,cellular component,27.0,17.0,2.212e-01,2.029e-01,2.412e-01,1.285e-01,9.401e-02,1.757e-01,6.634e-01,1.121e-02
APC2,24036,cytoplasm,GO:0005737,cellular component,27.0,69.0,2.212e-01,2.029e-01,2.412e-01,1.335e-01,7.590e-02,2.348e-01,6.569e-01,2.064e-02
APC2,24036,intercellular bridge,GO:0045171,cellular component,27.0,25.0,2.243e-01,1.973e-01,2.548e-01,1.439e-01,1.121e-01,1.846e-01,6.465e-01,9.064e-03
APC2,24036,actin filament,GO:0005884,cellular component,27.0,5.0,2.851e-01,1.861e-01,4.367e-01,2.373e-01,1.385e-01,4.067e-01,5.583e-01,2.430e-02
APC2,24036,perinuclear region of cytoplasm,GO:0048471,cellular component,27.0,5.0,2.940e-01,2.061e-01,4.194e-01,2.332e-01,1.349e-01,4.033e-01,5.615e-01,2.627e-02
APC2,24036,catenin complex,GO:0016342,cellular component,27.0,2.0,4.152e-01,2.301e-01,7.494e-01,3.817e-01,1.800e-01,8.094e-01,4.451e-01,5.006e-02
APC2,24036,gamma-catenin binding,GO:0045295,molecular function,27.0,3.0,2.020e-01,1.473e-01,2.772e-01,3.771e-02,2.516e-02,5.651e-02,8.167e-01,1.029e-02
APC2,24036,beta-catenin binding,GO:0008013,molecular function,27.0,6.0,2.020e-01,1.473e-01,2.772e-01,4.801e-02,2.957e-02,7.794e-02,7.904e-01,1.312e-02
APC2,24036,protein binding,GO:0005515,molecular function,27.0,332.0,2.212e-01,2.029e-01,2.412e-01,1.385e-01,1.031e-01,1.862e-01,6.522e-01,1.079e-02
BIRC6,13516,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,19.0,9.0,7.182e-02,3.557e-02,1.450e-01,2.518e-02,7.443e-03,8.520e-02,8.525e-01,2.482e-02
BIRC6,13516,negative regulation of extrinsic apoptotic signaling pathway,GO:2001237,biological process,19.0,6.0,8.061e-02,2.624e-02,2.477e-01,3.817e-02,4.754e-03,3.064e-01,8.038e-01,5.657e-02
BIRC6,13516,negative regulation of apoptotic process,GO:0043066,biological process,19.0,31.0,8.336e-02,2.333e-02,2.978e-01,2.538e-02,6.496e-04,9.913e-01,8.162e-01,8.199e-02
BIRC6,13516,regulation of cytokinesis,GO:0032465,biological process,19.0,12.0,8.452e-02,4.177e-02,1.710e-01,3.122e-02,1.122e-02,8.690e-02,8.336e-01,2.500e-02
BIRC6,13516,trans-Golgi network,GO:0005802,cellular component,19.0,4.0,8.065e-02,2.621e-02,2.482e-01,3.761e-02,4.044e-03,3.498e-01,8.036e-01,6.110e-02
BIRC6,13516,endosome,GO:0005768,cellular component,19.0,14.0,8.452e-02,4.177e-02,1.710e-01,2.410e-02,5.632e-03,1.032e-01,8.542e-01,3.015e-02
BIRC6,13516,microtubule organizing center,GO:0005815,cellular component,19.0,16.0,8.452e-02,4.177e-02,1.710e-01,4.420e-02,1.508e-02,1.296e-01,7.970e-01,2.939e-02
BIRC6,13516,midbody,GO:0030496,cellular component,19.0,26.0,8.831e-02,3.985e-02,1.957e-01,5.534e-02,2.327e-02,1.316e-01,7.728e-01,2.379e-02
BIRC6,13516,spindle pole,GO:0000922,cellular component,19.0,15.0,9.555e-02,5.555e-02,1.644e-01,5.325e-02,4.650e-02,6.098e-02,7.789e-01,3.733e-03
BIRC6,13516,membrane,GO:0016020,cellular component,19.0,53.0,1.015e-01,6.043e-02,1.706e-01,8.324e-02,5.814e-02,1.192e-01,7.241e-01,1.122e-02
BIRC6,13516,nucleus,GO:0005634,cellular component,19.0,151.0,1.072e-01,6.383e-02,1.799e-01,9.504e-02,6.636e-02,1.361e-01,7.063e-01,1.187e-02
BIRC6,13516,ubiquitin conjugating enzyme activity,GO:0061631,molecular function,19.0,5.0,8.452e-02,4.177e-02,1.710e-01,3.454e-02,9.173e-03,1.301e-01,8.218e-01,3.381e-02
BIRC6,13516,ubiquitin-protein transferase activity,GO:0004842,molecular function,19.0,11.0,8.819e-02,3.962e-02,1.963e-01,3.996e-02,7.674e-03,2.081e-01,8.035e-01,3.922e-02
BIRC6,13516,protein binding,GO:0005515,molecular function,19.0,332.0,1.071e-01,6.382e-02,1.797e-01,9.096e-02,6.490e-02,1.275e-01,7.123e-01,1.087e-02
BIRC6,13516,cysteine-type endopeptidase inhibitor activity,GO:0004869,molecular function,19.0,4.0,1.075e-01,2.987e-02,3.869e-01,8.572e-02,1.693e-02,4.339e-01,7.111e-01,5.483e-02
RMDN2,26567,mitotic spindle,GO:0072686,cellular component,6.0,17.0,4.552e-02,1.580e-02,1.311e-01,2.625e-02,2.225e-02,3.096e-02,8.533e-01,4.000e-03
RMDN2,26567,Golgi apparatus,GO:0005794,cellular component,6.0,15.0,4.552e-02,1.580e-02,1.311e-01,2.806e-02,4.513e-03,1.745e-01,8.380e-01,4.471e-02
RMDN2,26567,cytosol,GO:0005829,cellular component,6.0,78.0,4.552e-02,1.580e-02,1.311e-01,3.571e-02,1.800e-02,7.083e-02,8.218e-01,1.699e-02
RMDN2,26567,protein binding,GO:0005515,molecular function,6.0,332.0,4.552e-02,1.580e-02,1.311e-01,4.201e-02,1.846e-02,9.560e-02,8.040e-01,2.132e-02
KIF21B,29442,microtubule-based movement,GO:0007018,biological process,7.0,21.0,3.874e-02,2.865e-02,5.239e-02,3.711e-02,2.495e-02,5.520e-02,8.183e-01,1.009e-02
KIF21B,29442,microtubule,GO:0005874,cellular component,7.0,22.0,3.449e-02,2.350e-02,5.061e-02,2.081e-02,1.593e-02,2.719e-02,8.748e-01,5.439e-03
KIF21B,29442,kinesin complex,GO:0005871,cellular component,7.0,16.0,3.449e-02,2.350e-02,5.061e-02,2.173e-02,1.628e-02,2.902e-02,8.708e-01,6.076e-03
KIF21B,29442,microtubule motor activity,GO:0003777,molecular function,7.0,13.0,3.449e-02,2.350e-02,5.061e-02,1.234e-02,4.958e-03,3.071e-02,9.099e-01,1.378e-02
KIF21B,29442,microtubule binding,GO:0008017,molecular function,7.0,22.0,3.449e-02,2.350e-02,5.061e-02,2.387e-02,1.694e-02,3.365e-02,8.620e-01,7.616e-03
KIF21B,29442,ATPase activity,GO:0016887,molecular function,7.0,14.0,3.514e-02,2.271e-02,5.439e-02,2.936e-02,1.479e-02,5.826e-02,8.417e-01,1.568e-02
RAB29,9789,"retrograde transport, endosome to Golgi",GO:0042147,biological process,34.0,8.0,1.964e-01,1.305e-01,2.955e-01,1.925e-02,3.426e-03,1.081e-01,8.705e-01,3.475e-02
RAB29,9789,intracellular protein transport,GO:0006886,biological process,34.0,22.0,1.964e-01,1.305e-01,2.955e-01,3.617e-02,1.113e-02,1.176e-01,8.182e-01,2.964e-02
RAB29,9789,protein localization to membrane,GO:0072657,biological process,34.0,23.0,2.044e-01,1.208e-01,3.457e-01,6.982e-02,1.812e-02,2.690e-01,7.413e-01,3.838e-02
RAB29,9789,Golgi organization,GO:0007030,biological process,34.0,8.0,2.083e-01,1.161e-01,3.736e-01,7.638e-02,2.029e-02,2.875e-01,7.301e-01,3.965e-02
RAB29,9789,mitochondrion organization,GO:0007005,biological process,34.0,13.0,2.160e-01,1.472e-01,3.171e-01,7.522e-02,3.876e-02,1.460e-01,7.359e-01,1.969e-02
RAB29,9789,positive regulation of T cell receptor signaling pathway,GO:0050862,biological process,34.0,3.0,2.285e-01,1.695e-01,3.079e-01,9.875e-02,5.687e-02,1.715e-01,7.005e-01,1.824e-02
RAB29,9789,T cell activation,GO:0042110,biological process,34.0,8.0,2.322e-01,1.756e-01,3.071e-01,1.084e-01,5.658e-02,2.076e-01,6.870e-01,2.236e-02
RAB29,9789,positive regulation of intracellular protein transport,GO:0090316,biological process,34.0,17.0,2.329e-01,1.625e-01,3.337e-01,9.516e-02,3.781e-02,2.395e-01,7.036e-01,3.107e-02
RAB29,9789,Rab protein signal transduction,GO:0032482,biological process,34.0,2.0,2.520e-01,1.687e-01,3.762e-01,1.404e-01,7.495e-02,2.632e-01,6.487e-01,2.363e-02
RAB29,9789,multi-organism toxin transport,GO:1990967,biological process,34.0,3.0,2.535e-01,1.687e-01,3.811e-01,1.357e-01,6.943e-02,2.654e-01,6.536e-01,2.528e-02
RAB29,9789,positive regulation of receptor recycling,GO:0001921,biological process,34.0,5.0,2.734e-01,1.989e-01,3.758e-01,1.710e-01,5.747e-02,5.086e-01,6.117e-01,4.525e-02
RAB29,9789,negative regulation of neuron projection development,GO:0010977,biological process,34.0,9.0,2.832e-01,1.265e-01,6.341e-01,1.599e-01,2.906e-02,8.792e-01,6.102e-01,7.525e-02
RAB29,9789,viral RNA genome replication,GO:0039694,biological process,34.0,7.0,2.867e-01,1.460e-01,5.630e-01,1.946e-01,6.286e-02,6.025e-01,5.883e-01,4.803e-02
RAB29,9789,response to bacterium,GO:0009617,biological process,34.0,5.0,3.327e-01,2.306e-01,4.800e-01,2.856e-01,2.105e-01,3.875e-01,5.220e-01,1.609e-02
RAB29,9789,synapse assembly,GO:0007416,biological process,34.0,7.0,3.345e-01,2.143e-01,5.223e-01,2.854e-01,1.567e-01,5.200e-01,5.193e-01,3.199e-02
RAB29,9789,recycling endosome,GO:0055037,cellular component,34.0,8.0,1.964e-01,1.305e-01,2.955e-01,2.455e-02,2.315e-02,2.603e-02,8.599e-01,1.304e-03
RAB29,9789,intracellular vesicle,GO:0097708,cellular component,34.0,7.0,1.964e-01,1.305e-01,2.955e-01,2.833e-02,6.706e-03,1.197e-01,8.397e-01,3.103e-02
RAB29,9789,early endosome,GO:0005769,cellular component,34.0,4.0,1.964e-01,1.305e-01,2.955e-01,3.031e-02,2.035e-02,4.515e-02,8.393e-01,9.642e-03
RAB29,9789,cis-Golgi network,GO:0005801,cellular component,34.0,3.0,1.964e-01,1.305e-01,2.955e-01,3.582e-02,2.387e-02,5.374e-02,8.220e-01,1.001e-02
RAB29,9789,trans-Golgi network,GO:0005802,cellular component,34.0,4.0,2.195e-01,1.842e-01,2.617e-01,5.496e-02,1.899e-02,1.590e-01,7.723e-01,2.841e-02
RAB29,9789,melanosome,GO:0042470,cellular component,34.0,2.0,2.285e-01,1.695e-01,3.079e-01,7.668e-02,6.147e-02,9.564e-02,7.349e-01,6.784e-03
RAB29,9789,extracellular exosome,GO:0070062,cellular component,34.0,33.0,2.512e-01,1.705e-01,3.701e-01,1.484e-01,1.070e-01,2.058e-01,6.414e-01,1.218e-02
RAB29,9789,mitochondrion,GO:0005739,cellular component,34.0,19.0,2.666e-01,1.630e-01,4.361e-01,1.812e-01,1.214e-01,2.704e-01,6.087e-01,1.591e-02
RAB29,9789,Golgi apparatus,GO:0005794,cellular component,34.0,15.0,2.679e-01,1.430e-01,5.019e-01,1.618e-01,6.717e-02,3.899e-01,6.233e-01,3.648e-02
RAB29,9789,cytoplasm,GO:0005737,cellular component,34.0,69.0,3.152e-01,1.990e-01,4.995e-01,2.609e-01,1.729e-01,3.938e-01,5.403e-01,1.981e-02
RAB29,9789,symbiont-containing vacuole,GO:0020003,cellular component,34.0,3.0,3.189e-01,2.389e-01,4.257e-01,2.378e-01,9.649e-02,5.858e-01,5.531e-01,4.306e-02
RAB29,9789,dynein complex binding,GO:0070840,molecular function,34.0,3.0,2.575e-01,1.676e-01,3.956e-01,1.717e-01,1.072e-01,2.749e-01,6.174e-01,1.914e-02
RAB29,9789,Rab GTPase binding,GO:0017137,molecular function,34.0,6.0,2.650e-01,1.640e-01,4.283e-01,1.207e-01,2.269e-02,6.418e-01,6.627e-01,5.511e-02
RAB29,9789,GDP binding,GO:0019003,molecular function,34.0,4.0,2.960e-01,1.514e-01,5.789e-01,2.072e-01,6.102e-02,7.036e-01,5.758e-01,5.020e-02
RAB29,9789,kinesin binding,GO:0019894,molecular function,34.0,7.0,3.027e-01,1.483e-01,6.179e-01,2.526e-01,9.366e-02,6.814e-01,5.396e-01,4.510e-02
RAB29,9789,protein binding,GO:0005515,molecular function,34.0,332.0,3.245e-01,2.208e-01,4.770e-01,2.793e-01,1.967e-01,3.965e-01,5.266e-01,1.773e-02
RAB29,9789,GTP binding,GO:0005525,molecular function,34.0,7.0,3.376e-01,1.463e-01,7.793e-01,3.055e-01,1.061e-01,8.796e-01,4.955e-01,5.556e-02
RAB29,9789,GTPase activity,GO:0003924,molecular function,34.0,7.0,3.616e-01,1.634e-01,8.005e-01,3.382e-01,1.243e-01,9.206e-01,4.717e-01,5.719e-02
ERI3,17276,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000467,biological process,5.0,3.0,5.180e-02,1.062e-02,2.527e-01,2.007e-02,2.868e-03,1.404e-01,8.643e-01,3.325e-02
ERI3,17276,"DNA catabolic process, exonucleolytic",GO:0000738,biological process,5.0,3.0,6.691e-02,7.044e-03,6.356e-01,5.494e-02,5.362e-03,5.629e-01,7.593e-01,7.147e-02
ERI3,17276,3'-5'-exoribonuclease activity,GO:0000175,molecular function,5.0,6.0,5.180e-02,1.062e-02,2.527e-01,3.879e-02,1.308e-02,1.150e-01,8.114e-01,2.697e-02
ERI3,17276,RNA binding,GO:0003723,molecular function,5.0,63.0,6.005e-02,8.543e-03,4.221e-01,4.706e-02,5.249e-03,4.219e-01,7.797e-01,5.460e-02
CENPF,1857,mitotic cell cycle,GO:0000278,biological process,43.0,13.0,6.342e-02,4.823e-02,8.339e-02,2.074e-02,9.489e-03,4.534e-02,8.725e-01,1.571e-02
CENPF,1857,metaphase plate congression,GO:0051310,biological process,43.0,6.0,6.342e-02,4.823e-02,8.339e-02,3.411e-02,1.146e-02,1.015e-01,8.244e-01,2.571e-02
CENPF,1857,chromosome segregation,GO:0007059,biological process,43.0,7.0,6.342e-02,4.823e-02,8.339e-02,3.633e-02,2.004e-02,6.586e-02,8.202e-01,1.505e-02
CENPF,1857,ventricular system development,GO:0021591,biological process,43.0,2.0,6.785e-02,4.126e-02,1.116e-01,3.383e-02,6.788e-03,1.686e-01,8.223e-01,4.227e-02
CENPF,1857,kidney development,GO:0001822,biological process,43.0,5.0,7.840e-02,3.868e-02,1.589e-01,4.956e-02,9.969e-03,2.464e-01,7.803e-01,4.471e-02
CENPF,1857,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,43.0,41.0,9.480e-02,4.707e-02,1.910e-01,7.978e-02,2.970e-02,2.143e-01,7.267e-01,3.073e-02
CENPF,1857,protein transport,GO:0015031,biological process,43.0,23.0,9.515e-02,2.888e-02,3.134e-01,6.365e-02,9.009e-03,4.496e-01,7.460e-01,6.100e-02
CENPF,1857,regulation of G2/M transition of mitotic cell cycle,GO:0010389,biological process,43.0,7.0,9.783e-02,3.810e-02,2.512e-01,7.097e-02,1.708e-02,2.948e-01,7.380e-01,4.564e-02
CENPF,1857,"chromosome, centromeric region",GO:0000775,cellular component,43.0,8.0,6.342e-02,4.823e-02,8.339e-02,1.194e-02,3.795e-03,3.757e-02,9.095e-01,1.849e-02
CENPF,1857,ciliary transition fiber,GO:0097539,cellular component,43.0,2.0,6.342e-02,4.823e-02,8.339e-02,1.410e-02,3.975e-03,4.999e-02,8.987e-01,1.882e-02
CENPF,1857,kinetochore,GO:0000776,cellular component,43.0,13.0,6.342e-02,4.823e-02,8.339e-02,2.207e-02,1.502e-02,3.241e-02,8.693e-01,8.453e-03
CENPF,1857,condensed chromosome outer kinetochore,GO:0000940,cellular component,43.0,5.0,6.342e-02,4.823e-02,8.339e-02,2.344e-02,1.104e-02,4.975e-02,8.627e-01,1.702e-02
CENPF,1857,spindle,GO:0005819,cellular component,43.0,15.0,6.342e-02,4.823e-02,8.339e-02,2.486e-02,1.650e-02,3.746e-02,8.584e-01,9.605e-03
CENPF,1857,nucleoplasm,GO:0005654,cellular component,43.0,74.0,6.911e-02,4.871e-02,9.806e-02,4.920e-02,2.982e-02,8.117e-02,7.875e-01,1.356e-02
CENPF,1857,nucleus,GO:0005634,cellular component,43.0,151.0,6.911e-02,4.871e-02,9.806e-02,4.925e-02,2.880e-02,8.423e-02,7.873e-01,1.458e-02
CENPF,1857,nuclear matrix,GO:0016363,cellular component,43.0,6.0,6.939e-02,5.551e-02,8.674e-02,4.522e-02,3.626e-02,5.640e-02,7.974e-01,6.004e-03
CENPF,1857,midbody,GO:0030496,cellular component,43.0,26.0,7.023e-02,4.837e-02,1.020e-01,5.250e-02,3.543e-02,7.779e-02,7.805e-01,1.079e-02
CENPF,1857,spindle pole,GO:0000922,cellular component,43.0,15.0,7.060e-02,4.819e-02,1.034e-01,5.764e-02,3.791e-02,8.765e-02,7.693e-01,1.162e-02
CENPF,1857,cytoplasm,GO:0005737,cellular component,43.0,69.0,7.344e-02,4.607e-02,1.171e-01,6.287e-02,3.524e-02,1.121e-01,7.586e-01,1.639e-02
CENPF,1857,nuclear envelope,GO:0005635,cellular component,43.0,4.0,8.650e-02,5.612e-02,1.333e-01,6.937e-02,3.577e-02,1.346e-01,7.462e-01,1.983e-02
CENPF,1857,protein C-terminus binding,GO:0008022,molecular function,43.0,7.0,6.342e-02,4.823e-02,8.339e-02,1.065e-02,2.122e-03,5.345e-02,9.150e-01,2.126e-02
CENPF,1857,transcription factor binding,GO:0008134,molecular function,43.0,19.0,6.342e-02,4.823e-02,8.339e-02,2.838e-02,1.548e-02,5.205e-02,8.452e-01,1.425e-02
CENPF,1857,dynein complex binding,GO:0070840,molecular function,43.0,3.0,6.765e-02,4.966e-02,9.217e-02,3.080e-02,1.348e-02,7.037e-02,8.362e-01,2.008e-02
CENPF,1857,protein homodimerization activity,GO:0042803,molecular function,43.0,15.0,6.894e-02,4.877e-02,9.746e-02,4.798e-02,2.391e-02,9.629e-02,7.899e-01,1.937e-02
CENPF,1857,protein binding,GO:0005515,molecular function,43.0,332.0,7.409e-02,4.610e-02,1.191e-01,6.148e-02,2.412e-02,1.567e-01,7.600e-01,2.606e-02
STAG1,11354,sister chromatid cohesion,GO:0007062,biological process,34.0,7.0,2.403e-02,8.010e-03,7.212e-02,2.178e-02,6.225e-03,7.618e-02,8.656e-01,2.818e-02
STAG1,11354,regulation of mitotic spindle assembly,GO:1901673,biological process,34.0,8.0,2.457e-02,1.615e-02,3.738e-02,1.895e-02,7.271e-03,4.938e-02,8.788e-01,1.713e-02
STAG1,11354,cohesin complex,GO:0008278,cellular component,34.0,6.0,2.070e-02,1.129e-02,3.793e-02,1.021e-02,7.350e-03,1.418e-02,9.231e-01,3.944e-03
STAG1,11354,nuclear body,GO:0016604,cellular component,34.0,30.0,2.070e-02,1.129e-02,3.793e-02,9.924e-03,2.756e-03,3.573e-02,9.214e-01,1.543e-02
STAG1,11354,mitotic spindle pole,GO:0097431,cellular component,34.0,5.0,2.070e-02,1.129e-02,3.793e-02,1.197e-02,9.220e-03,1.554e-02,9.146e-01,3.525e-03
STAG1,11354,nucleus,GO:0005634,cellular component,34.0,151.0,2.070e-02,1.129e-02,3.793e-02,1.243e-02,5.812e-03,2.658e-02,9.105e-01,1.038e-02
STAG1,11354,nuclear matrix,GO:0016363,cellular component,34.0,6.0,2.070e-02,1.129e-02,3.793e-02,1.352e-02,8.921e-03,2.049e-02,9.067e-01,6.195e-03
STAG1,11354,nucleoplasm,GO:0005654,cellular component,34.0,74.0,2.070e-02,1.129e-02,3.793e-02,1.599e-02,9.395e-03,2.722e-02,8.948e-01,9.774e-03
STAG1,11354,chromatin,GO:0000785,cellular component,34.0,15.0,2.238e-02,1.061e-02,4.719e-02,1.905e-02,7.504e-03,4.838e-02,8.787e-01,1.827e-02
STAG1,11354,chromatin binding,GO:0003682,molecular function,34.0,17.0,2.070e-02,1.129e-02,3.793e-02,1.221e-02,5.725e-03,2.606e-02,9.113e-01,1.130e-02
STAG1,11354,protein binding,GO:0005515,molecular function,34.0,332.0,2.152e-02,1.188e-02,3.898e-02,1.874e-02,1.037e-02,3.388e-02,8.822e-01,1.097e-02
PLAGL1,9046,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,10.0,62.0,3.038e-02,1.576e-02,5.855e-02,2.535e-02,9.408e-03,6.829e-02,8.542e-01,2.315e-02
PLAGL1,9046,intracellular membrane-bounded organelle,GO:0043231,cellular component,10.0,40.0,3.038e-02,1.576e-02,5.855e-02,1.979e-02,1.890e-02,2.071e-02,8.795e-01,8.571e-04
PLAGL1,9046,Golgi apparatus,GO:0005794,cellular component,10.0,15.0,3.038e-02,1.576e-02,5.855e-02,2.336e-02,1.511e-02,3.612e-02,8.638e-01,1.001e-02
PLAGL1,9046,nuclear body,GO:0016604,cellular component,10.0,30.0,4.256e-02,3.402e-02,5.325e-02,4.187e-02,3.395e-02,5.164e-02,8.060e-01,5.624e-03
PLAGL1,9046,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,10.0,10.0,2.921e-02,1.731e-02,4.931e-02,5.991e-03,3.176e-03,1.130e-02,9.480e-01,6.852e-03
PLAGL1,9046,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,10.0,7.0,3.038e-02,1.576e-02,5.855e-02,1.008e-02,3.670e-03,2.771e-02,9.210e-01,1.437e-02
PLAGL1,9046,DNA binding,GO:0003677,molecular function,10.0,26.0,3.038e-02,1.576e-02,5.855e-02,2.123e-02,5.565e-03,8.098e-02,8.668e-01,2.830e-02
CCND2,1583,negative regulation of apoptotic process,GO:0043066,biological process,27.0,31.0,8.196e-02,3.570e-02,1.881e-01,2.307e-02,5.095e-03,1.045e-01,8.571e-01,2.842e-02
CCND2,1583,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,27.0,10.0,8.196e-02,3.570e-02,1.881e-01,2.841e-02,1.372e-02,5.886e-02,8.448e-01,1.721e-02
CCND2,1583,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,27.0,7.0,8.196e-02,3.570e-02,1.881e-01,2.868e-02,2.450e-02,3.357e-02,8.446e-01,3.824e-03
CCND2,1583,positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737,biological process,27.0,6.0,8.196e-02,3.570e-02,1.881e-01,2.786e-02,9.448e-03,8.215e-02,8.444e-01,2.340e-02
CCND2,1583,positive regulation of protein phosphorylation,GO:0001934,biological process,27.0,17.0,8.338e-02,3.487e-02,1.994e-01,6.562e-02,2.960e-02,1.455e-01,7.527e-01,2.321e-02
CCND2,1583,mitotic cell cycle phase transition,GO:0044772,biological process,27.0,11.0,8.486e-02,4.146e-02,1.737e-01,3.812e-02,2.144e-02,6.780e-02,8.149e-01,1.500e-02
CCND2,1583,positive regulation of cell population proliferation,GO:0008284,biological process,27.0,40.0,9.501e-02,2.782e-02,3.244e-01,6.907e-02,1.516e-02,3.147e-01,7.405e-01,4.857e-02
CCND2,1583,nucleus,GO:0005634,cellular component,27.0,151.0,8.222e-02,3.555e-02,1.901e-01,4.988e-02,1.580e-02,1.575e-01,7.833e-01,3.003e-02
CCND2,1583,cytosol,GO:0005829,cellular component,27.0,78.0,8.222e-02,3.555e-02,1.901e-01,5.371e-02,2.066e-02,1.396e-01,7.756e-01,2.575e-02
CCND2,1583,cytoplasm,GO:0005737,cellular component,27.0,69.0,8.222e-02,3.555e-02,1.901e-01,5.428e-02,2.059e-02,1.431e-01,7.744e-01,2.599e-02
CCND2,1583,nucleoplasm,GO:0005654,cellular component,27.0,74.0,8.222e-02,3.555e-02,1.901e-01,6.132e-02,3.305e-02,1.138e-01,7.616e-01,1.743e-02
CCND2,1583,nucleolus,GO:0005730,cellular component,27.0,41.0,8.556e-02,3.478e-02,2.104e-01,6.053e-02,1.245e-02,2.943e-01,7.574e-01,4.304e-02
CCND2,1583,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,27.0,27.0,9.041e-02,5.423e-02,1.507e-01,4.943e-02,2.108e-02,1.159e-01,7.856e-01,2.237e-02
CCND2,1583,nuclear membrane,GO:0031965,cellular component,27.0,9.0,9.595e-02,2.729e-02,3.374e-01,7.178e-02,1.370e-02,3.760e-01,7.343e-01,5.309e-02
CCND2,1583,chromatin,GO:0000785,cellular component,27.0,15.0,9.867e-02,3.198e-02,3.045e-01,8.245e-02,1.924e-02,3.532e-01,7.192e-01,4.331e-02
CCND2,1583,protein kinase binding,GO:0019901,molecular function,27.0,32.0,8.196e-02,3.570e-02,1.881e-01,3.474e-02,7.450e-03,1.619e-01,8.193e-01,3.620e-02
CCND2,1583,cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,molecular function,27.0,8.0,8.222e-02,3.555e-02,1.901e-01,4.269e-02,1.311e-02,1.390e-01,8.005e-01,3.179e-02
CCND2,1583,protein binding,GO:0005515,molecular function,27.0,332.0,8.310e-02,3.554e-02,1.943e-01,6.522e-02,2.797e-02,1.521e-01,7.534e-01,2.412e-02
CCND2,1583,protein kinase activity,GO:0004672,molecular function,27.0,38.0,9.379e-02,3.567e-02,2.466e-01,7.403e-02,2.608e-02,2.102e-01,7.359e-01,3.280e-02
RBM18,28413,RNA binding,GO:0003723,molecular function,3.0,63.0,3.127e-02,8.157e-03,1.199e-01,3.127e-02,8.157e-03,1.199e-01,8.323e-01,3.431e-02
SLIRP,20495,mitochondrion morphogenesis,GO:0070584,biological process,9.0,3.0,8.875e-02,3.724e-02,2.115e-01,4.929e-02,1.057e-02,2.298e-01,7.820e-01,4.007e-02
SLIRP,20495,negative regulation of mitochondrial RNA catabolic process,GO:0000961,biological process,9.0,4.0,1.038e-01,5.842e-02,1.845e-01,9.758e-02,5.047e-02,1.887e-01,7.015e-01,2.241e-02
SLIRP,20495,mitochondrion,GO:0005739,cellular component,9.0,19.0,8.704e-02,5.195e-02,1.458e-01,3.950e-02,2.774e-02,5.625e-02,8.120e-01,9.302e-03
SLIRP,20495,ribonucleoprotein complex,GO:1990904,cellular component,9.0,23.0,1.028e-01,5.655e-02,1.870e-01,7.158e-02,1.878e-02,2.728e-01,7.382e-01,4.115e-02
SLIRP,20495,RNA binding,GO:0003723,molecular function,9.0,63.0,6.737e-02,2.492e-02,1.821e-01,1.717e-02,3.265e-03,9.030e-02,8.803e-01,2.990e-02
SLIRP,20495,protein binding,GO:0005515,molecular function,9.0,332.0,1.072e-01,6.001e-02,1.914e-01,9.159e-02,5.256e-02,1.596e-01,7.106e-01,1.752e-02
PLEKHG1,20884,nucleus,GO:0005634,cellular component,3.0,151.0,5.559e-02,4.334e-02,7.130e-02,4.842e-02,4.506e-02,5.202e-02,7.898e-01,1.935e-03
PLEKHG1,20884,nucleoplasm,GO:0005654,cellular component,3.0,74.0,5.559e-02,4.334e-02,7.130e-02,5.125e-02,3.055e-02,8.595e-02,7.830e-01,1.402e-02
SLC10A7,23088,glycoprotein transport,GO:0034436,biological process,10.0,3.0,5.462e-02,3.383e-02,8.816e-02,2.771e-02,1.167e-02,6.583e-02,8.464e-01,1.902e-02
SLC10A7,23088,Golgi vesicle transport,GO:0048193,biological process,10.0,9.0,7.071e-02,4.748e-02,1.053e-01,4.320e-02,1.994e-02,9.358e-02,8.010e-01,1.972e-02
SLC10A7,23088,endoplasmic reticulum,GO:0005783,cellular component,10.0,9.0,4.311e-02,3.128e-02,5.942e-02,1.377e-02,4.643e-03,4.086e-02,9.015e-01,1.666e-02
SLC10A7,23088,cis-Golgi network,GO:0005801,cellular component,10.0,3.0,4.549e-02,2.780e-02,7.445e-02,1.729e-02,4.977e-03,6.005e-02,8.836e-01,2.329e-02
SLC10A7,23088,Golgi medial cisterna,GO:0005797,cellular component,10.0,2.0,5.135e-02,2.688e-02,9.810e-02,1.599e-02,1.919e-03,1.333e-01,8.791e-01,4.303e-02
SLC10A7,23088,intrinsic component of plasma membrane,GO:0031226,cellular component,10.0,9.0,5.135e-02,2.688e-02,9.810e-02,1.895e-02,3.435e-03,1.045e-01,8.719e-01,3.078e-02
SLC10A7,23088,plasma membrane,GO:0005886,cellular component,10.0,24.0,6.617e-02,3.238e-02,1.352e-01,4.891e-02,2.361e-02,1.013e-01,7.875e-01,1.981e-02
SLC10A7,23088,trans-Golgi network,GO:0005802,cellular component,10.0,4.0,9.242e-02,2.432e-02,3.513e-01,7.479e-02,1.457e-02,3.840e-01,7.298e-01,4.830e-02
SLC10A7,23088,bile acid transmembrane transporter activity,GO:0015125,molecular function,10.0,7.0,5.648e-01,3.178e-01,1.004e+00,5.648e-01,3.178e-01,1.004e+00,3.267e-01,4.681e-02
NCAPH,1112,mitotic chromosome condensation,GO:0007076,biological process,15.0,9.0,4.161e-02,2.350e-02,7.368e-02,1.657e-02,3.117e-03,8.811e-02,8.826e-01,2.711e-02
NCAPH,1112,nuclear condensin complex,GO:0000799,cellular component,15.0,2.0,3.372e-02,2.590e-02,4.391e-02,6.410e-03,3.099e-03,1.326e-02,9.451e-01,7.549e-03
NCAPH,1112,condensin complex,GO:0000796,cellular component,15.0,6.0,3.589e-02,2.768e-02,4.654e-02,9.434e-03,5.974e-03,1.490e-02,9.268e-01,5.585e-03
NCAPH,1112,membrane,GO:0016020,cellular component,15.0,53.0,4.546e-02,3.067e-02,6.737e-02,3.726e-02,2.143e-02,6.480e-02,8.176e-01,1.382e-02
NCAPH,1112,nucleus,GO:0005634,cellular component,15.0,151.0,4.546e-02,3.067e-02,6.737e-02,3.796e-02,2.791e-02,5.164e-02,8.163e-01,7.531e-03
NCAPH,1112,cytosol,GO:0005829,cellular component,15.0,78.0,4.602e-02,3.167e-02,6.688e-02,4.503e-02,2.987e-02,6.788e-02,7.978e-01,1.117e-02
NCAPH,1112,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity",GO:0072587,molecular function,15.0,3.0,3.849e-02,2.465e-02,6.009e-02,1.279e-02,5.023e-03,3.256e-02,9.077e-01,1.325e-02
NCAPH,1112,DNA topoisomerase binding,GO:0044547,molecular function,15.0,2.0,4.450e-02,2.885e-02,6.864e-02,2.801e-02,1.421e-02,5.521e-02,8.461e-01,1.542e-02
NCAPH,1112,chromatin binding,GO:0003682,molecular function,15.0,17.0,4.546e-02,3.067e-02,6.737e-02,3.183e-02,2.227e-02,4.550e-02,8.340e-01,8.479e-03
NCAPH,1112,protein binding,GO:0005515,molecular function,15.0,332.0,4.602e-02,3.167e-02,6.688e-02,4.316e-02,2.918e-02,6.384e-02,8.023e-01,1.051e-02
KIF18A,29441,microtubule depolymerization,GO:0007019,biological process,40.0,11.0,4.170e-02,3.157e-02,5.508e-02,1.826e-02,1.062e-02,3.142e-02,8.845e-01,1.046e-02
KIF18A,29441,mitotic metaphase plate congression,GO:0007080,biological process,40.0,9.0,4.174e-02,3.425e-02,5.088e-02,1.540e-02,6.182e-03,3.835e-02,8.950e-01,1.696e-02
KIF18A,29441,mitotic sister chromatid segregation,GO:0000070,biological process,40.0,9.0,4.384e-02,3.390e-02,5.671e-02,2.577e-02,1.462e-02,4.543e-02,8.541e-01,1.270e-02
KIF18A,29441,microtubule-based movement,GO:0007018,biological process,40.0,21.0,5.643e-02,2.876e-02,1.107e-01,4.417e-02,1.613e-02,1.209e-01,7.977e-01,2.564e-02
KIF18A,29441,mitotic spindle midzone,GO:1990023,cellular component,40.0,4.0,4.093e-02,3.301e-02,5.074e-02,6.673e-03,3.613e-03,1.232e-02,9.433e-01,6.372e-03
KIF18A,29441,kinetochore microtubule,GO:0005828,cellular component,40.0,3.0,4.093e-02,3.301e-02,5.074e-02,1.206e-02,9.069e-03,1.604e-02,9.140e-01,3.908e-03
KIF18A,29441,mitotic spindle astral microtubule,GO:0061673,cellular component,40.0,3.0,4.093e-02,3.301e-02,5.074e-02,1.278e-02,1.086e-02,1.504e-02,9.109e-01,2.328e-03
KIF18A,29441,ruffle,GO:0001726,cellular component,40.0,2.0,4.093e-02,3.301e-02,5.074e-02,1.694e-02,1.212e-02,2.369e-02,8.913e-01,6.046e-03
KIF18A,29441,caveola,GO:0005901,cellular component,40.0,2.0,4.093e-02,3.301e-02,5.074e-02,2.014e-02,1.717e-02,2.362e-02,8.779e-01,3.264e-03
KIF18A,29441,microtubule,GO:0005874,cellular component,40.0,22.0,4.093e-02,3.301e-02,5.074e-02,2.205e-02,1.592e-02,3.054e-02,8.695e-01,7.079e-03
KIF18A,29441,kinesin complex,GO:0005871,cellular component,40.0,16.0,4.170e-02,3.157e-02,5.508e-02,2.516e-02,1.891e-02,3.346e-02,8.572e-01,6.781e-03
KIF18A,29441,microtubule cytoskeleton,GO:0015630,cellular component,40.0,17.0,5.910e-02,4.898e-02,7.132e-02,4.865e-02,3.950e-02,5.991e-02,7.891e-01,5.735e-03
KIF18A,29441,nucleus,GO:0005634,cellular component,40.0,151.0,7.790e-02,6.140e-02,9.884e-02,7.198e-02,5.706e-02,9.080e-02,7.429e-01,6.959e-03
KIF18A,29441,cytoplasm,GO:0005737,cellular component,40.0,69.0,8.168e-02,6.491e-02,1.028e-01,7.718e-02,6.002e-02,9.924e-02,7.340e-01,7.815e-03
KIF18A,29441,microtubule plus-end binding,GO:0051010,molecular function,40.0,3.0,4.093e-02,3.301e-02,5.074e-02,3.402e-03,1.501e-03,7.714e-03,9.694e-01,6.562e-03
KIF18A,29441,microtubule motor activity,GO:0003777,molecular function,40.0,13.0,4.093e-02,3.301e-02,5.074e-02,1.583e-02,1.345e-02,1.862e-02,8.965e-01,2.775e-03
KIF18A,29441,microtubule binding,GO:0008017,molecular function,40.0,22.0,4.170e-02,3.157e-02,5.508e-02,2.434e-02,1.821e-02,3.254e-02,8.604e-01,6.697e-03
KIF18A,29441,"ATP-dependent microtubule motor activity, plus-end-directed",GO:0008574,molecular function,40.0,6.0,4.170e-02,3.157e-02,5.508e-02,2.480e-02,1.489e-02,4.128e-02,8.585e-01,1.180e-02
KIF18A,29441,tubulin-dependent ATPase activity,GO:0070463,molecular function,40.0,2.0,4.517e-02,3.504e-02,5.823e-02,2.954e-02,1.611e-02,5.418e-02,8.416e-01,1.411e-02
KIF18A,29441,actin binding,GO:0003779,molecular function,40.0,7.0,4.702e-02,3.219e-02,6.867e-02,3.233e-02,1.473e-02,7.095e-02,8.317e-01,1.892e-02
KIF18A,29441,ATPase activity,GO:0016887,molecular function,40.0,14.0,5.516e-02,4.562e-02,6.670e-02,4.258e-02,3.371e-02,5.379e-02,8.041e-01,6.222e-03
KIF18A,29441,protein binding,GO:0005515,molecular function,40.0,332.0,8.935e-02,7.030e-02,1.136e-01,8.935e-02,7.030e-02,1.136e-01,7.148e-01,7.592e-03
RASL11A,23802,,,,nan,nan,,,,,,,,
MTERF4,28785,mitochondrial ribosome assembly,GO:0061668,biological process,10.0,2.0,1.030e-01,1.003e-01,1.057e-01,2.798e-02,6.996e-03,1.119e-01,8.425e-01,3.416e-02
MTERF4,28785,mitochondrial transcription,GO:0006390,biological process,10.0,4.0,1.030e-01,1.003e-01,1.057e-01,5.692e-02,3.186e-02,1.017e-01,7.704e-01,1.653e-02
MTERF4,28785,mitochondrial translation,GO:0032543,biological process,10.0,2.0,1.050e-01,9.719e-02,1.134e-01,6.812e-02,2.519e-02,1.842e-01,7.471e-01,2.866e-02
MTERF4,28785,mitochondrion,GO:0005739,cellular component,10.0,19.0,1.030e-01,1.003e-01,1.057e-01,5.410e-02,2.701e-02,1.084e-01,7.760e-01,1.947e-02
MTERF4,28785,cytosol,GO:0005829,cellular component,10.0,78.0,1.030e-01,1.003e-01,1.057e-01,8.301e-02,6.383e-02,1.079e-01,7.245e-01,8.176e-03
MTERF4,28785,mitochondrial large ribosomal subunit,GO:0005762,cellular component,10.0,3.0,1.172e-01,8.113e-02,1.693e-01,1.172e-01,8.113e-02,1.693e-01,6.768e-01,1.302e-02
MTERF4,28785,rRNA binding,GO:0019843,molecular function,10.0,10.0,1.030e-01,1.003e-01,1.057e-01,4.221e-02,1.388e-02,1.283e-01,8.021e-01,2.800e-02
MTERF4,28785,protein binding,GO:0005515,molecular function,10.0,332.0,1.030e-01,1.003e-01,1.057e-01,7.885e-02,5.451e-02,1.141e-01,7.311e-01,1.129e-02
CALD1,1441,actin cytoskeleton,GO:0015629,cellular component,11.0,6.0,2.092e-02,7.767e-03,5.636e-02,8.261e-03,8.843e-04,7.716e-02,9.239e-01,2.607e-02
CALD1,1441,plasma membrane,GO:0005886,cellular component,11.0,24.0,2.101e-02,7.907e-03,5.582e-02,1.483e-02,3.989e-03,5.511e-02,8.946e-01,1.993e-02
CALD1,1441,intracellular membrane-bounded organelle,GO:0043231,cellular component,11.0,40.0,2.370e-02,1.328e-02,4.230e-02,1.778e-02,1.235e-02,2.560e-02,8.874e-01,6.555e-03
CALD1,1441,cadherin binding,GO:0045296,molecular function,11.0,9.0,2.101e-02,7.907e-03,5.582e-02,1.409e-02,4.456e-03,4.454e-02,8.999e-01,1.659e-02
CALD1,1441,protein binding,GO:0005515,molecular function,11.0,332.0,3.012e-02,1.059e-02,8.567e-02,3.012e-02,1.059e-02,8.567e-02,8.370e-01,2.441e-02
HJURP,25444,,,,nan,nan,,,,,,,,
TTC21B,25660,,,,nan,nan,,,,,,,,
MCEE,16732,,,,nan,nan,,,,,,,,
RRP36,21374,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000462,biological process,8.0,3.0,7.237e-02,3.533e-02,1.483e-01,2.888e-02,2.163e-02,3.856e-02,8.439e-01,6.878e-03
RRP36,21374,rRNA processing,GO:0006364,biological process,8.0,15.0,9.102e-02,5.820e-02,1.424e-01,7.543e-02,5.037e-02,1.129e-01,7.367e-01,1.207e-02
RRP36,21374,ribosomal small subunit biogenesis,GO:0042274,biological process,8.0,3.0,1.357e-01,3.059e-02,6.018e-01,1.118e-01,1.361e-02,9.181e-01,6.667e-01,7.102e-02
RRP36,21374,90S preribosome,GO:0030686,cellular component,8.0,3.0,7.076e-02,3.294e-02,1.520e-01,1.902e-02,1.252e-02,2.890e-02,8.817e-01,7.976e-03
RRP36,21374,nucleolus,GO:0005730,cellular component,8.0,41.0,8.440e-02,4.205e-02,1.694e-01,5.464e-02,2.225e-02,1.342e-01,7.740e-01,2.421e-02
RRP36,21374,nucleus,GO:0005634,cellular component,8.0,151.0,9.542e-02,5.733e-02,1.588e-01,8.610e-02,4.638e-02,1.598e-01,7.187e-01,1.928e-02
RRP36,21374,RNA binding,GO:0003723,molecular function,8.0,63.0,7.076e-02,3.294e-02,1.520e-01,2.383e-02,3.737e-03,1.519e-01,8.506e-01,3.531e-02
MAD2L1BP,21059,regulation of exit from mitosis,GO:0007096,biological process,11.0,7.0,1.034e-01,4.639e-02,2.304e-01,5.874e-02,4.871e-02,7.082e-02,7.674e-01,5.245e-03
MAD2L1BP,21059,mitotic cell cycle checkpoint,GO:0007093,biological process,11.0,12.0,1.387e-01,8.506e-02,2.263e-01,1.110e-01,4.212e-02,2.926e-01,6.817e-01,3.192e-02
MAD2L1BP,21059,nucleus,GO:0005634,cellular component,11.0,151.0,1.034e-01,4.639e-02,2.304e-01,5.437e-02,2.082e-02,1.420e-01,7.742e-01,2.614e-02
MAD2L1BP,21059,nucleolus,GO:0005730,cellular component,11.0,41.0,1.034e-01,4.639e-02,2.304e-01,5.601e-02,1.222e-02,2.567e-01,7.672e-01,4.103e-02
MAD2L1BP,21059,cytoplasm,GO:0005737,cellular component,11.0,69.0,1.034e-01,4.639e-02,2.304e-01,6.335e-02,2.823e-02,1.422e-01,7.568e-01,2.355e-02
MAD2L1BP,21059,nuclear membrane,GO:0031965,cellular component,11.0,9.0,1.404e-01,4.001e-02,4.929e-01,1.277e-01,2.648e-02,6.155e-01,6.549e-01,5.367e-02
MAD2L1BP,21059,protein binding,GO:0005515,molecular function,11.0,332.0,1.091e-01,4.768e-02,2.496e-01,8.334e-02,3.457e-02,2.009e-01,7.217e-01,2.672e-02
ATXN1,10548,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,27.0,41.0,5.387e-02,2.446e-02,1.186e-01,1.657e-02,2.025e-03,1.355e-01,8.771e-01,4.310e-02
ATXN1,10548,"regulation of transcription, DNA-templated",GO:0006355,biological process,27.0,36.0,5.596e-02,2.251e-02,1.391e-01,3.290e-02,5.045e-03,2.145e-01,8.210e-01,4.330e-02
ATXN1,10548,nuclear export,GO:0051168,biological process,27.0,5.0,6.586e-02,3.544e-02,1.224e-01,3.057e-02,6.211e-03,1.505e-01,8.313e-01,3.753e-02
ATXN1,10548,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,27.0,54.0,7.822e-02,2.362e-02,2.591e-01,5.430e-02,5.710e-03,5.164e-01,7.627e-01,5.737e-02
ATXN1,10548,nervous system development,GO:0007399,biological process,27.0,3.0,8.500e-02,4.240e-02,1.704e-01,7.760e-02,4.105e-02,1.467e-01,7.321e-01,1.927e-02
ATXN1,10548,anatomical structure development,GO:0048856,biological process,27.0,197.0,4.063e-01,2.402e-01,6.871e-01,4.063e-01,2.402e-01,6.871e-01,4.339e-01,3.252e-02
ATXN1,10548,nucleus,GO:0005634,cellular component,27.0,151.0,5.623e-02,2.847e-02,1.110e-01,2.931e-02,1.027e-02,8.365e-02,8.401e-01,2.580e-02
ATXN1,10548,nucleoplasm,GO:0005654,cellular component,27.0,74.0,5.623e-02,2.847e-02,1.110e-01,3.161e-02,1.301e-02,7.680e-02,8.332e-01,2.188e-02
ATXN1,10548,nuclear matrix,GO:0016363,cellular component,27.0,6.0,5.745e-02,2.709e-02,1.218e-01,3.551e-02,1.108e-02,1.137e-01,8.201e-01,3.020e-02
ATXN1,10548,nuclear inclusion body,GO:0042405,cellular component,27.0,2.0,5.752e-02,3.115e-02,1.062e-01,3.579e-02,2.694e-02,4.753e-02,8.225e-01,6.769e-03
ATXN1,10548,nucleolus,GO:0005730,cellular component,27.0,41.0,5.768e-02,3.095e-02,1.075e-01,2.761e-02,5.783e-03,1.318e-01,8.409e-01,3.290e-02
ATXN1,10548,cytosol,GO:0005829,cellular component,27.0,78.0,5.768e-02,3.095e-02,1.075e-01,3.532e-02,1.578e-02,7.905e-02,8.224e-01,2.035e-02
ATXN1,10548,cytoplasm,GO:0005737,cellular component,27.0,69.0,5.894e-02,2.941e-02,1.181e-01,4.167e-02,1.797e-02,9.663e-02,8.046e-01,2.227e-02
ATXN1,10548,protein self-association,GO:0043621,molecular function,27.0,3.0,4.873e-02,2.982e-02,7.964e-02,5.978e-03,8.491e-04,4.209e-02,9.426e-01,2.415e-02
ATXN1,10548,protein C-terminus binding,GO:0008022,molecular function,27.0,7.0,5.240e-02,2.594e-02,1.059e-01,1.033e-02,3.079e-03,3.463e-02,9.183e-01,1.735e-02
ATXN1,10548,poly(G) binding,GO:0034046,molecular function,27.0,2.0,5.240e-02,2.594e-02,1.059e-01,1.937e-02,4.407e-03,8.510e-02,8.727e-01,2.799e-02
ATXN1,10548,poly(U) RNA binding,GO:0008266,molecular function,27.0,2.0,5.240e-02,2.594e-02,1.059e-01,1.925e-02,3.947e-03,9.394e-02,8.719e-01,2.888e-02
ATXN1,10548,identical protein binding,GO:0042802,molecular function,27.0,20.0,5.302e-02,2.711e-02,1.037e-01,1.700e-02,8.916e-03,3.241e-02,8.895e-01,1.208e-02
ATXN1,10548,protein binding,GO:0005515,molecular function,27.0,332.0,5.944e-02,3.380e-02,1.045e-01,3.892e-02,1.830e-02,8.279e-02,8.122e-01,1.893e-02
DOK4,19868,protein binding,GO:0005515,molecular function,2.0,332.0,2.994e-02,2.561e-02,3.501e-02,2.994e-02,2.561e-02,3.501e-02,8.402e-01,3.696e-03
PPDPF,16142,,,,nan,nan,,,,,,,,
FAM110A,16188,protein binding,GO:0005515,molecular function,3.0,332.0,3.227e-02,1.895e-02,5.494e-02,3.227e-02,1.895e-02,5.494e-02,8.324e-01,1.297e-02
ID1,5360,negative regulation of DNA binding,GO:0043392,biological process,20.0,10.0,8.261e-02,5.201e-02,1.312e-01,2.496e-02,3.666e-03,1.699e-01,8.456e-01,3.670e-02
ID1,5360,negative regulation of neuron differentiation,GO:0045665,biological process,20.0,13.0,8.261e-02,5.201e-02,1.312e-01,3.879e-02,1.119e-02,1.345e-01,8.103e-01,3.290e-02
ID1,5360,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,20.0,41.0,8.346e-02,5.089e-02,1.369e-01,3.420e-02,4.470e-03,2.617e-01,8.159e-01,5.346e-02
ID1,5360,circadian rhythm,GO:0007623,biological process,20.0,9.0,8.607e-02,6.013e-02,1.232e-01,3.461e-02,2.091e-02,5.726e-02,8.258e-01,1.227e-02
ID1,5360,neuron differentiation,GO:0030182,biological process,20.0,18.0,8.607e-02,6.013e-02,1.232e-01,4.009e-02,1.957e-02,8.213e-02,8.093e-01,1.805e-02
ID1,5360,regulation of cell cycle,GO:0051726,biological process,20.0,14.0,8.791e-02,6.242e-02,1.238e-01,5.708e-02,4.519e-02,7.211e-02,7.709e-01,6.523e-03
ID1,5360,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,20.0,8.0,1.115e-01,8.897e-02,1.398e-01,1.048e-01,7.538e-02,1.457e-01,6.929e-01,1.127e-02
ID1,5360,Golgi apparatus,GO:0005794,cellular component,20.0,15.0,8.607e-02,6.013e-02,1.232e-01,3.353e-02,1.803e-02,6.235e-02,8.287e-01,1.483e-02
ID1,5360,nucleoplasm,GO:0005654,cellular component,20.0,74.0,9.236e-02,7.320e-02,1.165e-01,7.445e-02,4.601e-02,1.204e-01,7.379e-01,1.491e-02
ID1,5360,nucleus,GO:0005634,cellular component,20.0,151.0,9.236e-02,7.320e-02,1.165e-01,7.733e-02,5.967e-02,1.002e-01,7.337e-01,8.073e-03
ID1,5360,cytoplasm,GO:0005737,cellular component,20.0,69.0,9.727e-02,7.809e-02,1.212e-01,8.273e-02,6.665e-02,1.027e-01,7.251e-01,6.664e-03
ID1,5360,RNA polymerase II transcription factor binding,GO:0001085,molecular function,20.0,6.0,8.261e-02,5.201e-02,1.312e-01,1.359e-02,8.021e-03,2.304e-02,9.059e-01,8.617e-03
ID1,5360,transcription factor binding,GO:0008134,molecular function,20.0,19.0,8.261e-02,5.201e-02,1.312e-01,3.875e-02,1.372e-02,1.094e-01,8.117e-01,2.703e-02
ID1,5360,DNA-binding transcription factor activity,GO:0003700,molecular function,20.0,18.0,8.424e-02,5.314e-02,1.336e-01,4.213e-02,1.909e-02,9.300e-02,8.037e-01,2.021e-02
ID1,5360,protein binding,GO:0005515,molecular function,20.0,332.0,1.017e-01,8.691e-02,1.191e-01,9.399e-02,7.502e-02,1.178e-01,7.081e-01,7.433e-03
UXT,12641,microtubule cytoskeleton organization,GO:0000226,biological process,17.0,25.0,6.595e-02,3.294e-02,1.320e-01,3.839e-02,1.030e-02,1.431e-01,8.108e-01,3.515e-02
UXT,12641,centrosome cycle,GO:0007098,biological process,17.0,4.0,7.126e-02,3.992e-02,1.272e-01,5.180e-02,2.325e-02,1.154e-01,7.806e-01,2.143e-02
UXT,12641,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,17.0,54.0,1.349e-01,5.401e-02,3.372e-01,1.349e-01,5.401e-02,3.372e-01,6.532e-01,3.241e-02
UXT,12641,gamma-tubulin complex,GO:0000930,cellular component,17.0,4.0,6.595e-02,3.294e-02,1.320e-01,3.343e-02,2.185e-02,5.115e-02,8.287e-01,1.035e-02
UXT,12641,cytoskeleton,GO:0005856,cellular component,17.0,12.0,6.595e-02,3.294e-02,1.320e-01,3.727e-02,2.918e-02,4.759e-02,8.185e-01,6.277e-03
UXT,12641,centrosome,GO:0005813,cellular component,17.0,31.0,6.595e-02,3.294e-02,1.320e-01,3.876e-02,2.115e-02,7.103e-02,8.133e-01,1.518e-02
UXT,12641,nucleus,GO:0005634,cellular component,17.0,151.0,6.595e-02,3.294e-02,1.320e-01,4.735e-02,1.963e-02,1.142e-01,7.902e-01,2.357e-02
UXT,12641,cytoplasm,GO:0005737,cellular component,17.0,69.0,6.595e-02,3.294e-02,1.320e-01,5.028e-02,2.465e-02,1.026e-01,7.844e-01,1.996e-02
UXT,12641,chromatin,GO:0000785,cellular component,17.0,15.0,6.658e-02,3.387e-02,1.308e-01,5.829e-02,2.895e-02,1.174e-01,7.670e-01,2.033e-02
UXT,12641,transcription corepressor activity,GO:0003714,molecular function,17.0,6.0,6.595e-02,3.294e-02,1.320e-01,1.947e-02,9.333e-03,4.061e-02,8.782e-01,1.520e-02
UXT,12641,chromatin binding,GO:0003682,molecular function,17.0,17.0,6.595e-02,3.294e-02,1.320e-01,3.267e-02,1.609e-02,6.631e-02,8.307e-01,1.735e-02
UXT,12641,beta-tubulin binding,GO:0048487,molecular function,17.0,4.0,6.595e-02,3.294e-02,1.320e-01,4.264e-02,1.232e-02,1.476e-01,8.002e-01,3.363e-02
UXT,12641,protein binding,GO:0005515,molecular function,17.0,332.0,6.595e-02,3.294e-02,1.320e-01,5.575e-02,2.224e-02,1.398e-01,7.714e-01,2.634e-02
UXT,12641,transcription coregulator activity,GO:0003712,molecular function,17.0,5.0,6.658e-02,3.387e-02,1.308e-01,2.286e-02,5.491e-03,9.513e-02,8.592e-01,2.943e-02
DLGAP5,16864,spindle pole centrosome,GO:0031616,cellular component,10.0,3.0,4.697e-02,3.741e-02,5.897e-02,1.171e-02,4.648e-03,2.952e-02,9.127e-01,1.399e-02
DLGAP5,16864,mitochondrion,GO:0005739,cellular component,10.0,19.0,4.876e-02,3.469e-02,6.853e-02,3.062e-02,1.626e-02,5.766e-02,8.376e-01,1.554e-02
DLGAP5,16864,cytosol,GO:0005829,cellular component,10.0,78.0,4.876e-02,3.469e-02,6.853e-02,3.634e-02,2.088e-02,6.324e-02,8.200e-01,1.412e-02
DLGAP5,16864,nucleus,GO:0005634,cellular component,10.0,151.0,4.876e-02,3.469e-02,6.853e-02,4.134e-02,3.043e-02,5.618e-02,8.072e-01,8.058e-03
DLGAP5,16864,microtubule organizing center,GO:0005815,cellular component,10.0,16.0,4.902e-02,3.430e-02,7.006e-02,2.848e-02,7.596e-03,1.068e-01,8.409e-01,3.180e-02
DLGAP5,16864,protein binding,GO:0005515,molecular function,10.0,332.0,4.876e-02,3.469e-02,6.853e-02,3.832e-02,2.902e-02,5.062e-02,8.154e-01,7.335e-03
DLGAP5,16864,phosphoprotein phosphatase activity,GO:0004721,molecular function,10.0,20.0,8.691e-02,3.628e-02,2.082e-01,5.724e-02,5.854e-03,5.597e-01,7.560e-01,5.920e-02
SGCE,10808,,,,nan,nan,,,,,,,,
CASD1,16014,,,,nan,nan,,,,,,,,
KRT17,6427,signal transduction,GO:0007165,biological process,11.0,47.0,7.732e-02,5.458e-02,1.095e-01,6.099e-02,4.355e-02,8.540e-02,7.629e-01,9.564e-03
KRT17,6427,extracellular exosome,GO:0070062,cellular component,11.0,33.0,3.573e-02,5.541e-03,2.304e-01,1.246e-02,3.514e-03,4.422e-02,9.074e-01,1.719e-02
KRT17,6427,intermediate filament cytoskeleton,GO:0045111,cellular component,11.0,8.0,4.099e-02,4.817e-03,3.488e-01,2.287e-02,2.992e-03,1.749e-01,8.525e-01,4.193e-02
KRT17,6427,protein binding,GO:0005515,molecular function,11.0,332.0,3.573e-02,5.541e-03,2.304e-01,1.735e-02,4.059e-03,7.413e-02,8.814e-01,2.499e-02
KRT17,6427,MHC class II protein binding,GO:0042289,molecular function,11.0,4.0,4.902e-02,3.695e-03,6.502e-01,3.550e-02,1.571e-03,8.024e-01,7.935e-01,7.450e-02
KRT17,6427,MHC class II receptor activity,GO:0032395,molecular function,11.0,2.0,5.348e-02,4.563e-03,6.269e-01,4.803e-02,3.790e-03,6.086e-01,7.719e-01,6.388e-02
KNSTRN,30767,spindle organization,GO:0007051,biological process,14.0,10.0,4.518e-02,3.381e-02,6.038e-02,1.398e-02,3.987e-03,4.901e-02,8.994e-01,1.862e-02
KNSTRN,30767,regulation of attachment of spindle microtubules to kinetochore,GO:0051988,biological process,14.0,9.0,4.585e-02,3.378e-02,6.224e-02,2.677e-02,1.539e-02,4.654e-02,8.512e-01,1.290e-02
KNSTRN,30767,mitotic sister chromatid segregation,GO:0000070,biological process,14.0,9.0,4.689e-02,3.282e-02,6.701e-02,3.038e-02,1.652e-02,5.584e-02,8.387e-01,1.420e-02
KNSTRN,30767,chromosome segregation,GO:0007059,biological process,14.0,7.0,5.233e-02,2.655e-02,1.032e-01,3.728e-02,1.221e-02,1.138e-01,8.156e-01,2.959e-02
KNSTRN,30767,kinetochore,GO:0000776,cellular component,14.0,13.0,4.518e-02,3.381e-02,6.038e-02,1.220e-02,5.274e-03,2.820e-02,9.113e-01,1.117e-02
KNSTRN,30767,microtubule plus-end,GO:0035371,cellular component,14.0,6.0,4.518e-02,3.381e-02,6.038e-02,1.402e-02,1.091e-02,1.802e-02,9.046e-01,3.876e-03
KNSTRN,30767,mitotic spindle,GO:0072686,cellular component,14.0,17.0,4.518e-02,3.381e-02,6.038e-02,2.000e-02,1.296e-02,3.086e-02,8.776e-01,9.017e-03
KNSTRN,30767,microtubule cytoskeleton,GO:0015630,cellular component,14.0,17.0,5.053e-02,4.409e-02,5.790e-02,3.876e-02,3.777e-02,3.977e-02,8.146e-01,6.226e-04
KNSTRN,30767,cytosol,GO:0005829,cellular component,14.0,78.0,6.817e-02,4.551e-02,1.021e-01,5.929e-02,3.476e-02,1.011e-01,7.657e-01,1.500e-02
KNSTRN,30767,protein binding,GO:0005515,molecular function,14.0,332.0,7.747e-02,6.292e-02,9.538e-02,7.747e-02,6.292e-02,9.538e-02,7.336e-01,6.369e-03
CALML4,18445,,,,nan,nan,,,,,,,,
SUMF2,20415,,,,nan,nan,,,,,,,,
KRI1,25769,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000447,biological process,8.0,2.0,2.177e-02,5.874e-03,8.071e-02,1.524e-02,2.377e-03,9.775e-02,8.870e-01,2.763e-02
KRI1,25769,90S preribosome,GO:0030686,cellular component,8.0,3.0,2.177e-02,5.874e-03,8.071e-02,9.881e-03,1.758e-03,5.552e-02,9.192e-01,2.127e-02
KRI1,25769,nucleolus,GO:0005730,cellular component,8.0,41.0,3.289e-02,1.767e-02,6.124e-02,3.289e-02,1.767e-02,6.124e-02,8.303e-01,1.563e-02
KRI1,25769,RNA binding,GO:0003723,molecular function,8.0,63.0,2.600e-02,1.256e-02,5.384e-02,1.564e-02,1.129e-02,2.166e-02,8.971e-01,5.559e-03
ASH2L,744,"transcription, DNA-templated",GO:0006351,biological process,21.0,16.0,7.413e-02,4.504e-02,1.220e-01,3.701e-02,1.133e-02,1.209e-01,8.158e-01,3.136e-02
ASH2L,744,cellular response to DNA damage stimulus,GO:0006974,biological process,21.0,20.0,8.733e-02,6.159e-02,1.238e-01,6.021e-02,4.578e-02,7.918e-02,7.643e-01,7.736e-03
ASH2L,744,histone H3-K4 methylation,GO:0051568,biological process,21.0,5.0,8.773e-02,3.601e-02,2.138e-01,4.951e-02,8.396e-03,2.920e-01,7.791e-01,4.604e-02
ASH2L,744,response to estrogen,GO:0043627,biological process,21.0,3.0,9.904e-02,5.144e-02,1.907e-01,7.891e-02,3.707e-02,1.680e-01,7.292e-01,2.417e-02
ASH2L,744,positive regulation of cell population proliferation,GO:0008284,biological process,21.0,40.0,1.729e-01,6.623e-02,4.515e-01,1.729e-01,6.623e-02,4.515e-01,6.123e-01,3.721e-02
ASH2L,744,MLL3/4 complex,GO:0044666,cellular component,21.0,2.0,6.513e-02,4.217e-02,1.006e-01,2.459e-02,1.434e-02,4.217e-02,8.588e-01,1.202e-02
ASH2L,744,Set1C/COMPASS complex,GO:0048188,cellular component,21.0,2.0,6.513e-02,4.217e-02,1.006e-01,2.467e-02,1.321e-02,4.608e-02,8.583e-01,1.381e-02
ASH2L,744,nucleus,GO:0005634,cellular component,21.0,151.0,7.343e-02,4.542e-02,1.187e-01,3.388e-02,1.420e-02,8.085e-02,8.262e-01,2.199e-02
ASH2L,744,histone methyltransferase complex,GO:0035097,cellular component,21.0,8.0,8.807e-02,3.429e-02,2.262e-01,4.782e-02,1.136e-02,2.012e-01,7.854e-01,4.114e-02
ASH2L,744,beta-catenin binding,GO:0008013,molecular function,21.0,6.0,5.861e-02,5.299e-02,6.483e-02,5.859e-03,3.468e-03,9.897e-03,9.490e-01,5.408e-03
ASH2L,744,protein binding,GO:0005515,molecular function,21.0,332.0,7.343e-02,4.542e-02,1.187e-01,4.015e-02,1.671e-02,9.645e-02,8.087e-01,2.262e-02
ASH2L,744,transcription regulatory region DNA binding,GO:0044212,molecular function,21.0,24.0,8.366e-02,6.596e-02,1.061e-01,5.861e-02,2.960e-02,1.161e-01,7.665e-01,1.979e-02
ASH2L,744,histone methyltransferase activity (H3-K4 specific),GO:0042800,molecular function,21.0,2.0,1.244e-01,6.447e-02,2.401e-01,9.395e-02,2.483e-02,3.554e-01,7.024e-01,4.139e-02
SGO1,25088,"mitotic sister chromatid cohesion, centromeric",GO:0071962,biological process,30.0,3.0,3.145e-02,2.112e-02,4.684e-02,1.085e-02,7.001e-03,1.682e-02,9.194e-01,5.795e-03
SGO1,25088,attachment of spindle microtubules to kinetochore,GO:0008608,biological process,30.0,5.0,3.145e-02,2.112e-02,4.684e-02,1.271e-02,3.243e-03,4.978e-02,9.035e-01,2.340e-02
SGO1,25088,meiotic chromosome segregation,GO:0045132,biological process,30.0,9.0,3.712e-02,3.370e-02,4.088e-02,2.211e-02,1.608e-02,3.040e-02,8.694e-01,6.967e-03
SGO1,25088,centriole-centriole cohesion,GO:0010457,biological process,30.0,4.0,3.712e-02,3.370e-02,4.088e-02,2.280e-02,1.835e-02,2.833e-02,8.669e-01,4.925e-03
SGO1,25088,chromosome segregation,GO:0007059,biological process,30.0,7.0,4.194e-02,2.026e-02,8.682e-02,2.273e-02,5.850e-03,8.830e-02,8.611e-01,3.040e-02
SGO1,25088,"chromosome, centromeric region",GO:0000775,cellular component,30.0,8.0,3.145e-02,2.112e-02,4.684e-02,4.402e-03,1.045e-03,1.854e-02,9.585e-01,1.429e-02
SGO1,25088,"condensed chromosome, centromeric region",GO:0000779,cellular component,30.0,4.0,3.145e-02,2.112e-02,4.684e-02,6.639e-03,3.167e-03,1.392e-02,9.434e-01,7.915e-03
SGO1,25088,kinetochore,GO:0000776,cellular component,30.0,13.0,3.145e-02,2.112e-02,4.684e-02,1.034e-02,8.390e-03,1.275e-02,9.224e-01,2.513e-03
SGO1,25088,centrosome,GO:0005813,cellular component,30.0,31.0,4.076e-02,3.059e-02,5.431e-02,2.363e-02,1.274e-02,4.384e-02,8.620e-01,1.327e-02
SGO1,25088,spindle pole,GO:0000922,cellular component,30.0,15.0,4.498e-02,3.470e-02,5.831e-02,3.316e-02,2.492e-02,4.412e-02,8.303e-01,6.701e-03
SGO1,25088,nucleoplasm,GO:0005654,cellular component,30.0,74.0,6.253e-02,3.637e-02,1.075e-01,5.678e-02,3.518e-02,9.164e-02,7.711e-01,1.334e-02
SGO1,25088,cytosol,GO:0005829,cellular component,30.0,78.0,6.274e-02,3.624e-02,1.086e-01,5.946e-02,3.751e-02,9.427e-02,7.655e-01,1.288e-02
SGO1,25088,kinase binding,GO:0019900,molecular function,30.0,7.0,3.740e-02,2.677e-02,5.224e-02,2.083e-02,7.863e-03,5.518e-02,8.715e-01,2.101e-02
SGO1,25088,protein binding,GO:0005515,molecular function,30.0,332.0,6.504e-02,3.550e-02,1.192e-01,6.328e-02,3.147e-02,1.272e-01,7.575e-01,1.987e-02
TMEM8A,17205,lysosomal membrane,GO:0005765,cellular component,5.0,8.0,4.556e-02,2.940e-02,7.058e-02,2.483e-02,1.685e-02,3.659e-02,8.583e-01,8.738e-03
TMEM8A,17205,plasma membrane,GO:0005886,cellular component,5.0,24.0,4.556e-02,2.940e-02,7.058e-02,2.784e-02,2.451e-02,3.161e-02,8.474e-01,3.197e-03
TMEM8A,17205,extracellular exosome,GO:0070062,cellular component,5.0,33.0,4.556e-02,2.940e-02,7.058e-02,3.414e-02,2.201e-02,5.298e-02,8.266e-01,1.087e-02
TMEM8A,17205,protein binding,GO:0005515,molecular function,5.0,332.0,7.832e-02,5.375e-02,1.141e-01,7.832e-02,5.375e-02,1.141e-01,7.317e-01,1.161e-02
JUND,6206,response to cytokine,GO:0034097,biological process,31.0,33.0,4.754e-02,3.630e-02,6.227e-02,2.070e-02,1.268e-02,3.380e-02,8.744e-01,1.046e-02
JUND,6206,response to organic substance,GO:0010033,biological process,31.0,59.0,4.865e-02,3.813e-02,6.209e-02,2.477e-02,1.021e-02,6.009e-02,8.569e-01,1.992e-02
JUND,6206,response to cAMP,GO:0051591,biological process,31.0,7.0,4.865e-02,3.813e-02,6.209e-02,2.638e-02,1.589e-02,4.380e-02,8.526e-01,1.184e-02
JUND,6206,response to drug,GO:0042493,biological process,31.0,78.0,4.900e-02,3.364e-02,7.139e-02,2.617e-02,7.581e-03,9.034e-02,8.492e-01,2.839e-02
JUND,6206,response to lipopolysaccharide,GO:0032496,biological process,31.0,8.0,4.969e-02,3.947e-02,6.255e-02,2.879e-02,1.276e-02,6.497e-02,8.428e-01,1.872e-02
JUND,6206,response to radiation,GO:0009314,biological process,31.0,6.0,4.994e-02,4.144e-02,6.017e-02,2.271e-02,1.012e-02,5.095e-02,8.645e-01,1.673e-02
JUND,6206,response to mechanical stimulus,GO:0009612,biological process,31.0,10.0,5.149e-02,4.476e-02,5.923e-02,2.655e-02,9.368e-03,7.522e-02,8.492e-01,2.211e-02
JUND,6206,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,31.0,62.0,5.468e-02,4.652e-02,6.426e-02,3.776e-02,2.145e-02,6.647e-02,8.162e-01,1.411e-02
JUND,6206,cellular response to hormone stimulus,GO:0032870,biological process,31.0,30.0,5.714e-02,3.862e-02,8.455e-02,4.510e-02,2.352e-02,8.647e-02,7.970e-01,1.757e-02
JUND,6206,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,31.0,54.0,6.847e-02,3.740e-02,1.254e-01,6.370e-02,3.327e-02,1.220e-01,7.566e-01,1.900e-02
JUND,6206,regulation of cell cycle,GO:0051726,biological process,31.0,14.0,7.233e-02,3.225e-02,1.622e-01,6.008e-02,1.948e-02,1.853e-01,7.615e-01,3.288e-02
JUND,6206,positive regulation of cell differentiation,GO:0045597,biological process,31.0,41.0,1.753e-01,9.006e-02,3.413e-01,1.753e-01,9.006e-02,3.413e-01,6.128e-01,2.576e-02
JUND,6206,nuclear chromatin,GO:0000790,cellular component,31.0,14.0,4.751e-02,3.622e-02,6.230e-02,1.156e-02,2.641e-03,5.060e-02,9.108e-01,1.891e-02
JUND,6206,nucleus,GO:0005634,cellular component,31.0,151.0,4.751e-02,3.622e-02,6.230e-02,1.795e-02,3.505e-03,9.193e-02,8.772e-01,3.024e-02
JUND,6206,nucleoplasm,GO:0005654,cellular component,31.0,74.0,4.852e-02,3.444e-02,6.837e-02,2.454e-02,7.902e-03,7.619e-02,8.563e-01,2.621e-02
JUND,6206,transcription factor complex,GO:0005667,cellular component,31.0,9.0,5.152e-02,3.888e-02,6.828e-02,2.510e-02,4.519e-03,1.394e-01,8.474e-01,3.328e-02
JUND,6206,transcription factor AP-1 complex,GO:0035976,cellular component,31.0,5.0,5.323e-02,3.742e-02,7.572e-02,2.941e-02,1.026e-02,8.433e-02,8.397e-01,2.604e-02
JUND,6206,transcription factor binding,GO:0008134,molecular function,31.0,19.0,4.751e-02,3.622e-02,6.230e-02,6.404e-03,9.661e-04,4.244e-02,9.395e-01,2.389e-02
JUND,6206,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,31.0,10.0,4.751e-02,3.622e-02,6.230e-02,1.200e-02,9.528e-03,1.512e-02,9.144e-01,3.138e-03
JUND,6206,transcription coactivator activity,GO:0003713,molecular function,31.0,8.0,4.751e-02,3.622e-02,6.230e-02,1.289e-02,5.747e-03,2.892e-02,9.076e-01,1.227e-02
JUND,6206,protein binding,GO:0005515,molecular function,31.0,332.0,4.751e-02,3.622e-02,6.230e-02,2.266e-02,7.435e-03,6.905e-02,8.635e-01,2.435e-02
JUND,6206,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,31.0,25.0,4.972e-02,3.907e-02,6.326e-02,2.379e-02,1.315e-02,4.302e-02,8.616e-01,1.299e-02
JUND,6206,transcription regulatory region DNA binding,GO:0044212,molecular function,31.0,24.0,4.972e-02,3.907e-02,6.326e-02,2.876e-02,2.293e-02,3.607e-02,8.442e-01,5.442e-03
JUND,6206,enzyme binding,GO:0019899,molecular function,31.0,33.0,6.420e-02,3.349e-02,1.230e-01,4.809e-02,1.500e-02,1.541e-01,7.869e-01,3.201e-02
CAMSAP1,19946,regulation of microtubule polymerization,GO:0031113,biological process,15.0,7.0,3.018e-02,1.733e-02,5.257e-02,1.385e-02,6.375e-03,3.011e-02,9.033e-01,1.212e-02
CAMSAP1,19946,cytoplasmic microtubule organization,GO:0031122,biological process,15.0,6.0,3.018e-02,1.733e-02,5.257e-02,1.507e-02,6.296e-03,3.607e-02,8.967e-01,1.546e-02
CAMSAP1,19946,negative regulation of microtubule depolymerization,GO:0007026,biological process,15.0,8.0,3.018e-02,1.733e-02,5.257e-02,1.824e-02,1.374e-02,2.422e-02,8.857e-01,5.389e-03
CAMSAP1,19946,cytoskeleton organization,GO:0007010,biological process,15.0,15.0,3.197e-02,1.520e-02,6.726e-02,2.112e-02,5.049e-03,8.832e-02,8.667e-01,3.195e-02
CAMSAP1,19946,regulation of cell morphogenesis,GO:0022604,biological process,15.0,11.0,3.526e-02,2.422e-02,5.134e-02,2.634e-02,2.203e-02,3.150e-02,8.529e-01,4.206e-03
CAMSAP1,19946,neuron projection development,GO:0031175,biological process,15.0,12.0,4.348e-02,1.848e-02,1.023e-01,4.125e-02,1.847e-02,9.214e-02,8.059e-01,2.113e-02
CAMSAP1,19946,microtubule cytoskeleton organization,GO:0000226,biological process,15.0,25.0,4.348e-02,1.848e-02,1.023e-01,4.140e-02,1.645e-02,1.041e-01,8.052e-01,2.442e-02
CAMSAP1,19946,microtubule minus-end,GO:0036449,cellular component,15.0,2.0,2.067e-02,1.198e-02,3.567e-02,3.357e-03,1.932e-03,5.833e-03,9.709e-01,4.077e-03
CAMSAP1,19946,microtubule,GO:0005874,cellular component,15.0,22.0,2.155e-02,1.140e-02,4.075e-02,7.650e-03,1.865e-03,3.138e-02,9.351e-01,1.540e-02
CAMSAP1,19946,microtubule minus-end binding,GO:0051011,molecular function,15.0,2.0,2.067e-02,1.198e-02,3.567e-02,3.514e-03,1.610e-03,7.670e-03,9.689e-01,7.073e-03
CAMSAP1,19946,microtubule binding,GO:0008017,molecular function,15.0,22.0,2.196e-02,1.234e-02,3.907e-02,1.096e-02,3.145e-03,3.822e-02,9.156e-01,1.574e-02
CAMSAP1,19946,spectrin binding,GO:0030507,molecular function,15.0,3.0,4.308e-02,1.785e-02,1.039e-01,3.474e-02,1.155e-02,1.045e-01,8.228e-01,2.725e-02
UBE2M,12491,protein neddylation,GO:0045116,biological process,22.0,2.0,4.209e-02,1.520e-02,1.165e-01,2.447e-02,8.401e-03,7.130e-02,8.569e-01,2.507e-02
UBE2M,12491,cellular protein modification process,GO:0006464,biological process,22.0,65.0,7.076e-02,1.171e-02,4.275e-01,5.968e-02,6.002e-03,5.934e-01,7.502e-01,6.637e-02
UBE2M,12491,protein binding,GO:0005515,molecular function,22.0,332.0,3.601e-02,2.198e-02,5.899e-02,1.495e-02,5.441e-03,4.111e-02,8.962e-01,1.793e-02
UBE2M,12491,ubiquitin-protein transferase activity,GO:0004842,molecular function,22.0,11.0,4.224e-02,1.900e-02,9.391e-02,2.246e-02,1.190e-02,4.238e-02,8.665e-01,1.295e-02
UBE2M,12491,NEDD8 transferase activity,GO:0019788,molecular function,22.0,4.0,5.315e-02,1.719e-02,1.643e-01,4.207e-02,1.089e-02,1.626e-01,8.010e-01,3.495e-02
ZNF426,20725,protein binding,GO:0005515,molecular function,2.0,332.0,4.613e-02,3.465e-02,6.141e-02,4.613e-02,3.465e-02,6.141e-02,7.951e-01,7.771e-03
ZNF341,15992,"regulation of transcription, DNA-templated",GO:0006355,biological process,7.0,36.0,3.163e-02,1.966e-02,5.089e-02,1.472e-02,5.348e-03,4.052e-02,8.975e-01,1.599e-02
ZNF341,15992,nucleus,GO:0005634,cellular component,7.0,151.0,4.919e-02,4.589e-02,5.274e-02,4.099e-02,3.824e-02,4.395e-02,8.086e-01,1.848e-03
ZNF341,15992,DNA-binding transcription activator activity,GO:0001216,molecular function,7.0,3.0,2.556e-02,2.096e-02,3.116e-02,5.604e-03,2.693e-03,1.166e-02,9.507e-01,7.686e-03
ZNF341,15992,DNA-binding transcription factor activity,GO:0003700,molecular function,7.0,18.0,2.976e-02,1.886e-02,4.697e-02,1.667e-02,1.190e-02,2.335e-02,8.925e-01,6.079e-03
ZNF341,15992,DNA binding,GO:0003677,molecular function,7.0,26.0,2.976e-02,1.886e-02,4.697e-02,1.744e-02,9.132e-03,3.332e-02,8.875e-01,1.272e-02
ZNF341,15992,protein binding,GO:0005515,molecular function,7.0,332.0,5.749e-02,4.622e-02,7.152e-02,5.749e-02,4.622e-02,7.152e-02,7.700e-01,6.116e-03
GCH1,4193,neuromuscular process controlling posture,GO:0050884,biological process,27.0,2.0,2.589e-01,1.515e-01,4.423e-01,5.093e-02,4.619e-02,5.617e-02,7.839e-01,2.750e-03
GCH1,4193,protein homooligomerization,GO:0051260,biological process,27.0,4.0,2.589e-01,1.515e-01,4.423e-01,6.044e-02,2.552e-02,1.431e-01,7.621e-01,2.549e-02
GCH1,4193,pteridine-containing compound biosynthetic process,GO:0042559,biological process,27.0,13.0,2.733e-01,1.374e-01,5.435e-01,1.168e-01,2.852e-02,4.786e-01,6.696e-01,4.937e-02
GCH1,4193,positive regulation of nitric-oxide synthase activity,GO:0051000,biological process,27.0,3.0,2.770e-01,1.496e-01,5.132e-01,8.580e-02,6.899e-03,1.067e+00,6.991e-01,7.805e-02
GCH1,4193,tetrahydrobiopterin biosynthetic process,GO:0006729,biological process,27.0,5.0,2.799e-01,1.485e-01,5.276e-01,1.368e-01,3.442e-02,5.437e-01,6.464e-01,4.858e-02
GCH1,4193,response to tumor necrosis factor,GO:0034612,biological process,27.0,3.0,3.456e-01,1.529e-01,7.810e-01,2.548e-01,6.439e-02,1.008e+00,5.269e-01,7.244e-02
GCH1,4193,response to interferon-gamma,GO:0034341,biological process,27.0,3.0,3.478e-01,1.555e-01,7.779e-01,2.724e-01,7.559e-02,9.815e-01,5.135e-01,7.245e-02
GCH1,4193,regulation of removal of superoxide radicals,GO:2000121,biological process,27.0,7.0,3.808e-01,1.531e-01,9.471e-01,2.726e-01,6.636e-02,1.120e+00,5.140e-01,6.670e-02
GCH1,4193,response to lipopolysaccharide,GO:0032496,biological process,27.0,8.0,4.169e-01,2.482e-01,7.002e-01,3.751e-01,1.715e-01,8.201e-01,4.498e-01,4.896e-02
GCH1,4193,dopamine biosynthetic process,GO:0042416,biological process,27.0,4.0,4.270e-01,1.081e-01,1.688e+00,2.524e-01,1.749e-02,3.643e+00,4.818e-01,1.296e-01
GCH1,4193,regulation of blood pressure,GO:0008217,biological process,27.0,8.0,4.525e-01,3.126e-01,6.551e-01,3.994e-01,2.853e-01,5.591e-01,4.410e-01,2.192e-02
GCH1,4193,cytoplasm,GO:0005737,cellular component,27.0,69.0,2.734e-01,1.893e-01,3.950e-01,1.165e-01,8.716e-02,1.558e-01,6.778e-01,1.025e-02
GCH1,4193,cytosol,GO:0005829,cellular component,27.0,78.0,2.734e-01,1.893e-01,3.950e-01,1.277e-01,9.208e-02,1.770e-01,6.643e-01,1.157e-02
GCH1,4193,nucleus,GO:0005634,cellular component,27.0,151.0,2.734e-01,1.893e-01,3.950e-01,1.303e-01,1.095e-01,1.551e-01,6.616e-01,6.317e-03
GCH1,4193,cytoplasmic vesicle,GO:0031410,cellular component,27.0,28.0,2.828e-01,2.145e-01,3.727e-01,6.871e-02,1.193e-02,3.959e-01,7.387e-01,5.521e-02
GCH1,4193,nucleoplasm,GO:0005654,cellular component,27.0,74.0,2.843e-01,2.165e-01,3.734e-01,1.437e-01,8.220e-02,2.513e-01,6.455e-01,2.076e-02
GCH1,4193,nuclear membrane,GO:0031965,cellular component,27.0,9.0,3.076e-01,1.805e-01,5.242e-01,1.927e-01,1.189e-01,3.124e-01,5.977e-01,1.956e-02
GCH1,4193,protein-containing complex,GO:0032991,cellular component,27.0,481.0,3.880e-01,1.532e-01,9.826e-01,2.954e-01,7.466e-02,1.169e+00,4.964e-01,6.703e-02
GCH1,4193,mitogen-activated protein kinase binding,GO:0051019,molecular function,27.0,4.0,2.589e-01,1.515e-01,4.423e-01,3.598e-02,6.290e-03,2.058e-01,8.139e-01,4.288e-02
GCH1,4193,zinc ion binding,GO:0008270,molecular function,27.0,6.0,2.734e-01,1.893e-01,3.950e-01,1.046e-01,5.692e-02,1.923e-01,6.921e-01,1.995e-02
GCH1,4193,protein homodimerization activity,GO:0042803,molecular function,27.0,15.0,2.762e-01,1.855e-01,4.115e-01,1.328e-01,7.334e-02,2.404e-01,6.575e-01,2.114e-02
GCH1,4193,protein binding,GO:0005515,molecular function,27.0,332.0,2.828e-01,2.145e-01,3.727e-01,1.410e-01,9.185e-02,2.165e-01,6.490e-01,1.568e-02
GCH1,4193,GTP cyclohydrolase I activity,GO:0003934,molecular function,27.0,2.0,3.605e-01,1.211e-01,1.073e+00,1.756e-01,6.944e-03,4.440e+00,5.544e-01,1.240e-01
GCH1,4193,GTP binding,GO:0005525,molecular function,27.0,7.0,4.027e-01,2.306e-01,7.034e-01,3.462e-01,1.588e-01,7.544e-01,4.705e-01,4.801e-02
GCH1,4193,GTPase activity,GO:0003924,molecular function,27.0,7.0,4.113e-01,1.977e-01,8.556e-01,3.450e-01,1.717e-01,6.931e-01,4.741e-01,3.850e-02
TBC1D14,29246,recycling endosome to Golgi transport,GO:0071955,biological process,16.0,3.0,5.310e-02,2.569e-02,1.097e-01,8.861e-03,2.523e-03,3.111e-02,9.267e-01,1.674e-02
TBC1D14,29246,activation of GTPase activity,GO:0090630,biological process,16.0,3.0,7.164e-02,3.462e-02,1.483e-01,3.275e-02,8.455e-03,1.269e-01,8.268e-01,3.333e-02
TBC1D14,29246,intracellular protein transport,GO:0006886,biological process,16.0,22.0,7.837e-02,6.005e-02,1.023e-01,4.056e-02,1.571e-02,1.047e-01,8.072e-01,2.419e-02
TBC1D14,29246,negative regulation of autophagy,GO:0010507,biological process,16.0,9.0,9.604e-02,2.331e-02,3.956e-01,6.078e-02,7.896e-03,4.678e-01,7.509e-01,6.231e-02
TBC1D14,29246,regulation of autophagosome assembly,GO:2000785,biological process,16.0,6.0,1.026e-01,1.686e-02,6.249e-01,4.346e-02,1.783e-03,1.059e+00,7.688e-01,1.001e-01
TBC1D14,29246,autophagosome,GO:0005776,cellular component,16.0,4.0,5.310e-02,2.569e-02,1.097e-01,1.227e-02,2.400e-03,6.269e-02,9.039e-01,2.656e-02
TBC1D14,29246,recycling endosome,GO:0055037,cellular component,16.0,8.0,5.746e-02,3.244e-02,1.018e-01,2.161e-02,6.380e-03,7.317e-02,8.659e-01,2.329e-02
TBC1D14,29246,intracellular membrane-bounded organelle,GO:0043231,cellular component,16.0,40.0,5.979e-02,3.521e-02,1.015e-01,2.272e-02,1.232e-02,4.189e-02,8.654e-01,1.298e-02
TBC1D14,29246,Golgi apparatus,GO:0005794,cellular component,16.0,15.0,1.027e-01,8.637e-02,1.222e-01,7.314e-02,6.537e-02,8.183e-02,7.409e-01,3.432e-03
TBC1D14,29246,nucleoplasm,GO:0005654,cellular component,16.0,74.0,1.719e-01,1.510e-01,1.957e-01,1.470e-01,1.106e-01,1.954e-01,6.430e-01,1.068e-02
TBC1D14,29246,Rab GTPase binding,GO:0017137,molecular function,16.0,6.0,8.408e-02,2.973e-02,2.378e-01,4.642e-02,1.197e-02,1.801e-01,7.899e-01,3.715e-02
TBC1D14,29246,GTPase activator activity,GO:0005096,molecular function,16.0,6.0,1.203e-01,3.908e-02,3.704e-01,8.285e-02,1.434e-02,4.787e-01,7.132e-01,6.038e-02
TBC1D14,29246,protein kinase binding,GO:0019901,molecular function,16.0,32.0,1.254e-01,5.482e-02,2.867e-01,9.867e-02,3.576e-02,2.722e-01,6.979e-01,3.459e-02
TBC1D14,29246,protein binding,GO:0005515,molecular function,16.0,332.0,1.999e-01,1.428e-01,2.799e-01,1.853e-01,1.156e-01,2.970e-01,6.044e-01,2.002e-02
PRMT7,25557,histone arginine methylation,GO:0034969,biological process,18.0,7.0,9.206e-02,4.228e-02,2.005e-01,7.138e-03,2.184e-03,2.333e-02,9.392e-01,1.290e-02
PRMT7,25557,"regulation of transcription, DNA-templated",GO:0006355,biological process,18.0,36.0,1.003e-01,4.514e-02,2.227e-01,3.393e-02,4.862e-03,2.368e-01,8.176e-01,4.966e-02
PRMT7,25557,histone methylation,GO:0016571,biological process,18.0,6.0,1.021e-01,5.424e-02,1.920e-01,5.613e-02,2.749e-02,1.146e-01,7.714e-01,2.051e-02
PRMT7,25557,peptidyl-arginine methylation,GO:0018216,biological process,18.0,6.0,1.054e-01,6.690e-02,1.660e-01,6.874e-02,3.437e-02,1.375e-01,7.470e-01,2.107e-02
PRMT7,25557,spliceosomal snRNP assembly,GO:0000387,biological process,18.0,3.0,1.061e-01,7.739e-02,1.454e-01,5.974e-02,3.400e-02,1.050e-01,7.647e-01,1.603e-02
PRMT7,25557,nucleus,GO:0005634,cellular component,18.0,151.0,1.143e-01,5.414e-02,2.415e-01,7.833e-02,2.959e-02,2.074e-01,7.290e-01,3.146e-02
PRMT7,25557,nucleoplasm,GO:0005654,cellular component,18.0,74.0,1.221e-01,5.715e-02,2.610e-01,8.594e-02,2.287e-02,3.229e-01,7.144e-01,4.207e-02
PRMT7,25557,cytosol,GO:0005829,cellular component,18.0,78.0,1.275e-01,5.173e-02,3.143e-01,1.055e-01,3.431e-02,3.241e-01,6.875e-01,3.977e-02
PRMT7,25557,fibrillar center,GO:0001650,cellular component,18.0,9.0,1.376e-01,4.327e-02,4.376e-01,1.066e-01,2.066e-02,5.500e-01,6.789e-01,6.022e-02
PRMT7,25557,protein-arginine omega-N monomethyltransferase activity,GO:0035241,molecular function,18.0,2.0,9.514e-02,4.877e-02,1.856e-01,5.405e-02,1.825e-02,1.601e-01,7.740e-01,2.943e-02
PRMT7,25557,protein-arginine omega-N symmetric methyltransferase activity,GO:0035243,molecular function,18.0,2.0,9.514e-02,4.877e-02,1.856e-01,5.608e-02,1.997e-02,1.575e-01,7.702e-01,2.817e-02
PRMT7,25557,[myelin basic protein]-arginine N-methyltransferase activity,GO:0016277,molecular function,18.0,2.0,9.514e-02,4.877e-02,1.856e-01,5.653e-02,2.176e-02,1.468e-01,7.698e-01,2.627e-02
PRMT7,25557,protein-arginine omega-N asymmetric methyltransferase activity,GO:0035242,molecular function,18.0,2.0,9.514e-02,4.877e-02,1.856e-01,5.638e-02,1.847e-02,1.721e-01,7.690e-01,3.015e-02
PRMT7,25557,histone-arginine N-methyltransferase activity,GO:0008469,molecular function,18.0,7.0,1.027e-01,4.667e-02,2.259e-01,5.704e-02,1.197e-02,2.718e-01,7.642e-01,4.473e-02
PRMT7,25557,ribonucleoprotein complex binding,GO:0043021,molecular function,18.0,12.0,1.062e-01,4.074e-02,2.768e-01,5.122e-02,4.748e-03,5.525e-01,7.674e-01,6.155e-02
PRMT7,25557,S-adenosylmethionine-dependent methyltransferase activity,GO:0008757,molecular function,18.0,134.0,1.673e-01,1.820e-02,1.538e+00,1.036e-01,5.370e-03,2.000e+00,6.420e-01,1.302e-01
DPH2,3004,,,,nan,nan,,,,,,,,
CCNB1,1579,regulation of mitotic cell cycle spindle assembly checkpoint,GO:0090266,biological process,57.0,5.0,4.075e-02,3.572e-02,4.648e-02,1.123e-02,4.346e-03,2.902e-02,9.149e-01,1.424e-02
CCNB1,1579,mitotic spindle organization,GO:0007052,biological process,57.0,12.0,4.075e-02,3.572e-02,4.648e-02,1.264e-02,1.007e-02,1.586e-02,9.113e-01,3.380e-03
CCNB1,1579,mitotic cell cycle phase transition,GO:0044772,biological process,57.0,11.0,4.075e-02,3.572e-02,4.648e-02,1.902e-02,9.574e-03,3.778e-02,8.805e-01,1.411e-02
CCNB1,1579,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,57.0,10.0,4.121e-02,3.584e-02,4.740e-02,2.587e-02,2.046e-02,3.271e-02,8.546e-01,5.525e-03
CCNB1,1579,positive regulation of mitotic cell cycle,GO:0045931,biological process,57.0,18.0,4.155e-02,3.888e-02,4.439e-02,1.773e-02,8.272e-03,3.801e-02,8.856e-01,1.405e-02
CCNB1,1579,mitotic metaphase plate congression,GO:0007080,biological process,57.0,9.0,4.222e-02,3.466e-02,5.142e-02,2.688e-02,1.126e-02,6.415e-02,8.494e-01,2.044e-02
CCNB1,1579,positive regulation of attachment of spindle microtubules to kinetochore,GO:0051987,biological process,57.0,6.0,4.264e-02,4.164e-02,4.366e-02,1.655e-02,3.870e-03,7.077e-02,8.852e-01,2.670e-02
CCNB1,1579,positive regulation of G2/M transition of mitotic cell cycle,GO:0010971,biological process,57.0,9.0,4.509e-02,2.932e-02,6.934e-02,2.241e-02,8.670e-03,5.792e-02,8.656e-01,2.129e-02
CCNB1,1579,positive regulation of mitochondrial ATP synthesis coupled electron transport,GO:1905448,biological process,57.0,5.0,4.815e-02,3.199e-02,7.247e-02,3.500e-02,1.273e-02,9.625e-02,8.227e-01,2.529e-02
CCNB1,1579,cyclin B1-CDK1 complex,GO:0097125,cellular component,57.0,2.0,4.075e-02,3.572e-02,4.648e-02,3.878e-03,2.578e-03,5.835e-03,9.663e-01,3.981e-03
CCNB1,1579,condensed nuclear chromosome outer kinetochore,GO:0000942,cellular component,57.0,3.0,4.075e-02,3.572e-02,4.648e-02,8.913e-03,2.869e-03,2.769e-02,9.271e-01,1.518e-02
CCNB1,1579,centrosome,GO:0005813,cellular component,57.0,31.0,4.075e-02,3.572e-02,4.648e-02,1.540e-02,9.314e-03,2.547e-02,8.976e-01,8.250e-03
CCNB1,1579,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,57.0,27.0,4.187e-02,3.458e-02,5.069e-02,2.142e-02,7.539e-03,6.084e-02,8.687e-01,2.243e-02
CCNB1,1579,spindle pole,GO:0000922,cellular component,57.0,15.0,4.297e-02,3.262e-02,5.662e-02,2.369e-02,1.397e-02,4.018e-02,8.625e-01,1.204e-02
CCNB1,1579,cytoplasm,GO:0005737,cellular component,57.0,69.0,4.943e-02,3.435e-02,7.113e-02,4.298e-02,3.060e-02,6.038e-02,8.029e-01,9.100e-03
CCNB1,1579,cytosol,GO:0005829,cellular component,57.0,78.0,4.947e-02,3.429e-02,7.138e-02,4.168e-02,2.196e-02,7.913e-02,8.052e-01,1.636e-02
CCNB1,1579,nucleus,GO:0005634,cellular component,57.0,151.0,4.976e-02,3.575e-02,6.926e-02,4.092e-02,2.869e-02,5.836e-02,8.083e-01,9.222e-03
CCNB1,1579,mitochondrial matrix,GO:0005759,cellular component,57.0,2.0,6.428e-02,3.037e-02,1.360e-01,5.786e-02,2.396e-02,1.398e-01,7.671e-01,2.592e-02
CCNB1,1579,cyclin-dependent protein serine/threonine kinase activator activity,GO:0061575,molecular function,57.0,3.0,4.075e-02,3.572e-02,4.648e-02,5.554e-03,2.624e-03,1.176e-02,9.511e-01,8.077e-03
CCNB1,1579,ubiquitin-like protein ligase binding,GO:0044389,molecular function,57.0,5.0,4.075e-02,3.572e-02,4.648e-02,2.102e-02,1.797e-02,2.459e-02,8.741e-01,3.346e-03
CCNB1,1579,cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,molecular function,57.0,8.0,4.087e-02,3.618e-02,4.617e-02,1.874e-02,1.062e-02,3.307e-02,8.825e-01,1.043e-02
CCNB1,1579,patched binding,GO:0005113,molecular function,57.0,2.0,4.715e-02,2.645e-02,8.405e-02,3.342e-02,9.794e-03,1.140e-01,8.257e-01,3.090e-02
CCNB1,1579,protein kinase binding,GO:0019901,molecular function,57.0,32.0,4.774e-02,3.266e-02,6.978e-02,3.475e-02,2.356e-02,5.125e-02,8.250e-01,9.657e-03
CCNB1,1579,protein binding,GO:0005515,molecular function,57.0,332.0,5.237e-02,3.940e-02,6.963e-02,5.016e-02,3.645e-02,6.903e-02,7.857e-01,8.754e-03
CCNB1,1579,protein kinase activity,GO:0004672,molecular function,57.0,38.0,5.410e-02,2.358e-02,1.241e-01,3.576e-02,8.218e-03,1.556e-01,8.175e-01,3.900e-02
KATNBL1,26199,positive regulation of cytoskeleton organization,GO:0051495,biological process,6.0,20.0,3.747e-02,2.289e-02,6.134e-02,1.190e-02,3.379e-03,4.188e-02,9.105e-01,1.666e-02
KATNBL1,26199,mitotic spindle pole,GO:0097431,cellular component,6.0,5.0,4.447e-02,3.616e-02,5.470e-02,1.562e-02,1.110e-02,2.198e-02,8.972e-01,6.006e-03
KATNBL1,26199,nucleolus,GO:0005730,cellular component,6.0,41.0,7.198e-02,2.674e-02,1.938e-01,5.408e-02,1.990e-02,1.469e-01,7.744e-01,2.807e-02
KATNBL1,26199,nucleus,GO:0005634,cellular component,6.0,151.0,7.198e-02,2.674e-02,1.938e-01,6.008e-02,2.196e-02,1.643e-01,7.623e-01,2.797e-02
KATNBL1,26199,protein binding,GO:0005515,molecular function,6.0,332.0,8.734e-02,5.061e-02,1.507e-01,8.734e-02,5.061e-02,1.507e-01,7.170e-01,1.778e-02
TRIM45,19018,intercellular bridge,GO:0045171,cellular component,4.0,25.0,6.442e-02,4.012e-02,1.034e-01,5.944e-02,3.966e-02,8.908e-02,7.658e-01,1.155e-02
TRIM45,19018,cytosol,GO:0005829,cellular component,4.0,78.0,6.442e-02,4.012e-02,1.034e-01,6.106e-02,4.189e-02,8.899e-02,7.627e-01,1.063e-02
TRIM45,19018,nucleoplasm,GO:0005654,cellular component,4.0,74.0,6.442e-02,4.012e-02,1.034e-01,6.185e-02,3.360e-02,1.139e-01,7.606e-01,1.729e-02
STK26,18174,signal transduction by protein phosphorylation,GO:0023014,biological process,34.0,6.0,1.449e-01,9.166e-02,2.292e-01,2.369e-02,8.409e-03,6.673e-02,8.598e-01,2.230e-02
STK26,18174,protein phosphorylation,GO:0006468,biological process,34.0,33.0,1.449e-01,9.166e-02,2.292e-01,2.351e-02,7.248e-03,7.622e-02,8.592e-01,2.412e-02
STK26,18174,protein autophosphorylation,GO:0046777,biological process,34.0,12.0,1.631e-01,1.161e-01,2.290e-01,6.847e-02,2.476e-02,1.893e-01,7.464e-01,2.936e-02
STK26,18174,regulation of apoptotic process,GO:0042981,biological process,34.0,24.0,1.631e-01,1.161e-01,2.290e-01,8.468e-02,3.247e-02,2.208e-01,7.190e-01,3.127e-02
STK26,18174,MAPK cascade,GO:0000165,biological process,34.0,11.0,1.631e-01,1.161e-01,2.290e-01,8.832e-02,6.148e-02,1.269e-01,7.161e-01,1.151e-02
STK26,18174,cellular response to starvation,GO:0009267,biological process,34.0,28.0,1.631e-01,1.161e-01,2.290e-01,8.733e-02,3.231e-02,2.361e-01,7.147e-01,3.047e-02
STK26,18174,stress-activated protein kinase signaling cascade,GO:0031098,biological process,34.0,4.0,1.631e-01,1.161e-01,2.290e-01,9.906e-02,8.979e-02,1.093e-01,7.011e-01,3.324e-03
STK26,18174,regulation of hydrogen peroxide-induced cell death,GO:1903205,biological process,34.0,8.0,1.676e-01,1.204e-01,2.332e-01,1.096e-01,5.739e-02,2.093e-01,6.853e-01,2.149e-02
STK26,18174,activation of protein kinase activity,GO:0032147,biological process,34.0,13.0,1.843e-01,1.150e-01,2.955e-01,1.014e-01,3.217e-02,3.199e-01,6.929e-01,3.901e-02
STK26,18174,response to hydrogen peroxide,GO:0042542,biological process,34.0,7.0,1.860e-01,1.134e-01,3.052e-01,1.274e-01,5.903e-02,2.750e-01,6.626e-01,2.848e-02
STK26,18174,microvillus assembly,GO:0030033,biological process,34.0,3.0,2.782e-01,1.762e-01,4.393e-01,2.595e-01,1.588e-01,4.239e-01,5.407e-01,2.441e-02
STK26,18174,neuron projection morphogenesis,GO:0048812,biological process,34.0,7.0,2.852e-01,1.976e-01,4.117e-01,2.716e-01,2.004e-01,3.680e-01,5.329e-01,1.562e-02
STK26,18174,negative regulation of cell migration,GO:0030336,biological process,34.0,28.0,3.122e-01,1.868e-01,5.217e-01,3.122e-01,1.868e-01,5.217e-01,5.004e-01,2.795e-02
STK26,18174,extracellular exosome,GO:0070062,cellular component,34.0,33.0,1.480e-01,8.761e-02,2.501e-01,4.894e-02,2.567e-02,9.330e-02,7.878e-01,1.783e-02
STK26,18174,membrane,GO:0016020,cellular component,34.0,53.0,1.480e-01,8.761e-02,2.501e-01,6.265e-02,8.600e-03,4.564e-01,7.490e-01,5.537e-02
STK26,18174,cytoplasm,GO:0005737,cellular component,34.0,69.0,1.480e-01,8.761e-02,2.501e-01,6.827e-02,1.544e-02,3.018e-01,7.427e-01,4.425e-02
STK26,18174,cytosol,GO:0005829,cellular component,34.0,78.0,1.480e-01,8.761e-02,2.501e-01,6.956e-02,1.516e-02,3.192e-01,7.400e-01,4.623e-02
STK26,18174,Golgi-associated vesicle,GO:0005798,cellular component,34.0,5.0,1.513e-01,1.067e-01,2.147e-01,2.661e-02,7.932e-03,8.927e-02,8.478e-01,2.762e-02
STK26,18174,perinuclear region of cytoplasm,GO:0048471,cellular component,34.0,5.0,1.559e-01,1.042e-01,2.333e-01,8.959e-02,3.554e-02,2.258e-01,7.118e-01,2.995e-02
STK26,18174,apical plasma membrane,GO:0016324,cellular component,34.0,2.0,1.631e-01,1.161e-01,2.290e-01,9.485e-02,5.788e-02,1.554e-01,7.061e-01,1.583e-02
STK26,18174,Golgi apparatus,GO:0005794,cellular component,34.0,15.0,1.655e-01,6.804e-02,4.026e-01,5.873e-02,5.235e-03,6.590e-01,7.493e-01,7.580e-02
STK26,18174,cell periphery,GO:0071944,cellular component,34.0,2.0,1.871e-01,8.627e-02,4.056e-01,1.457e-01,4.676e-02,4.539e-01,6.373e-01,4.631e-02
STK26,18174,identical protein binding,GO:0042802,molecular function,34.0,20.0,1.480e-01,8.761e-02,2.501e-01,3.979e-02,1.813e-02,8.733e-02,8.097e-01,1.976e-02
STK26,18174,protein homodimerization activity,GO:0042803,molecular function,34.0,15.0,1.480e-01,8.761e-02,2.501e-01,6.601e-02,1.513e-02,2.879e-01,7.470e-01,4.355e-02
STK26,18174,protein binding,GO:0005515,molecular function,34.0,332.0,1.480e-01,8.761e-02,2.501e-01,8.041e-02,2.116e-02,3.056e-01,7.233e-01,4.179e-02
STK26,18174,protein serine/threonine kinase activity,GO:0004674,molecular function,34.0,34.0,1.603e-01,1.236e-01,2.081e-01,6.296e-02,1.180e-02,3.360e-01,7.517e-01,4.612e-02
STK26,18174,ATP binding,GO:0005524,molecular function,34.0,4.0,1.656e-01,1.221e-01,2.245e-01,1.056e-01,7.392e-02,1.507e-01,6.918e-01,1.197e-02
STK26,18174,protein kinase activity,GO:0004672,molecular function,34.0,38.0,2.023e-01,1.861e-01,2.200e-01,1.521e-01,9.495e-02,2.438e-01,6.370e-01,1.771e-02
STK26,18174,magnesium ion binding,GO:0000287,molecular function,34.0,2.0,2.545e-01,1.305e-01,4.961e-01,2.243e-01,1.106e-01,4.548e-01,5.674e-01,3.103e-02
CDCA8,14629,mitotic metaphase plate congression,GO:0007080,biological process,33.0,9.0,4.437e-02,3.139e-02,6.272e-02,1.407e-02,5.261e-03,3.763e-02,9.011e-01,1.454e-02
CDCA8,14629,mitotic sister chromatid segregation,GO:0000070,biological process,33.0,9.0,4.755e-02,4.157e-02,5.440e-02,2.625e-02,1.829e-02,3.769e-02,8.532e-01,8.467e-03
CDCA8,14629,chromosome organization,GO:0051276,biological process,33.0,21.0,5.070e-02,3.579e-02,7.181e-02,3.421e-02,1.282e-02,9.132e-02,8.252e-01,2.445e-02
CDCA8,14629,chromosome passenger complex,GO:0032133,cellular component,33.0,4.0,4.437e-02,3.139e-02,6.272e-02,1.330e-02,9.554e-03,1.851e-02,9.079e-01,5.168e-03
CDCA8,14629,"chromosome, centromeric region",GO:0000775,cellular component,33.0,8.0,4.437e-02,3.139e-02,6.272e-02,1.368e-02,1.121e-02,1.670e-02,9.064e-01,3.050e-03
CDCA8,14629,midbody,GO:0030496,cellular component,33.0,26.0,4.437e-02,3.139e-02,6.272e-02,2.324e-02,1.024e-02,5.273e-02,8.627e-01,1.725e-02
CDCA8,14629,spindle midzone,GO:0051233,cellular component,33.0,8.0,4.709e-02,3.024e-02,7.333e-02,3.120e-02,8.933e-03,1.090e-01,8.321e-01,2.832e-02
CDCA8,14629,intercellular bridge,GO:0045171,cellular component,33.0,25.0,4.755e-02,4.157e-02,5.440e-02,2.800e-02,1.963e-02,3.994e-02,8.471e-01,8.262e-03
CDCA8,14629,nucleus,GO:0005634,cellular component,33.0,151.0,4.874e-02,4.229e-02,5.618e-02,3.498e-02,3.090e-02,3.960e-02,8.252e-01,3.095e-03
CDCA8,14629,nucleolus,GO:0005730,cellular component,33.0,41.0,4.987e-02,4.671e-02,5.325e-02,4.290e-02,4.087e-02,4.504e-02,8.035e-01,1.376e-03
CDCA8,14629,protein-containing complex,GO:0032991,cellular component,33.0,481.0,1.541e-01,9.259e-02,2.565e-01,1.541e-01,9.259e-02,2.565e-01,6.348e-01,1.951e-02
CDCA8,14629,protein binding,GO:0005515,molecular function,33.0,332.0,4.914e-02,4.382e-02,5.511e-02,3.936e-02,3.511e-02,4.411e-02,8.129e-01,2.901e-03
RNFT2,25905,,,,nan,nan,,,,,,,,
RINT1,21876,regulation of ER to Golgi vesicle-mediated transport,GO:0060628,biological process,9.0,7.0,7.076e-02,3.167e-02,1.581e-01,2.751e-02,9.187e-03,8.236e-02,8.450e-01,2.456e-02
RINT1,21876,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,GO:1902504,biological process,9.0,6.0,7.076e-02,3.167e-02,1.581e-01,3.644e-02,6.942e-03,1.913e-01,8.130e-01,3.856e-02
RINT1,21876,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",GO:0006890,biological process,9.0,3.0,7.076e-02,3.167e-02,1.581e-01,4.066e-02,2.988e-02,5.533e-02,8.091e-01,8.204e-03
RINT1,21876,endoplasmic reticulum,GO:0005783,cellular component,9.0,9.0,7.076e-02,3.167e-02,1.581e-01,3.966e-02,1.722e-02,9.132e-02,8.100e-01,2.191e-02
RINT1,21876,Dsl1/NZR complex,GO:0070939,cellular component,9.0,2.0,9.052e-02,2.668e-02,3.071e-01,7.375e-02,1.215e-02,4.475e-01,7.304e-01,5.232e-02
RINT1,21876,protein binding,GO:0005515,molecular function,9.0,332.0,1.054e-01,6.646e-02,1.671e-01,9.917e-02,7.197e-02,1.367e-01,7.005e-01,1.055e-02
PRR5L,25878,,,,nan,nan,,,,,,,,
NAT10,29830,negative regulation of telomere maintenance via telomerase,GO:0032211,biological process,17.0,4.0,1.112e-01,2.903e-02,4.258e-01,1.931e-02,1.672e-03,2.230e-01,8.608e-01,4.287e-02
NAT10,29830,positive regulation of translation,GO:0045727,biological process,17.0,20.0,1.307e-01,4.920e-02,3.471e-01,4.891e-02,3.321e-02,7.203e-02,7.885e-01,1.069e-02
NAT10,29830,rRNA acetylation involved in maturation of SSU-rRNA,GO:1904812,biological process,17.0,2.0,1.496e-01,3.887e-02,5.760e-01,1.175e-01,2.245e-02,6.154e-01,6.651e-01,5.871e-02
NAT10,29830,telomerase holoenzyme complex,GO:0005697,cellular component,17.0,3.0,1.313e-01,4.929e-02,3.496e-01,9.462e-02,2.526e-02,3.545e-01,7.015e-01,4.107e-02
NAT10,29830,midbody,GO:0030496,cellular component,17.0,26.0,1.313e-01,4.929e-02,3.496e-01,9.705e-02,2.767e-02,3.404e-01,6.984e-01,3.929e-02
NAT10,29830,nucleolus,GO:0005730,cellular component,17.0,41.0,1.416e-01,6.740e-02,2.973e-01,8.289e-02,6.378e-02,1.077e-01,7.249e-01,8.172e-03
NAT10,29830,membrane,GO:0016020,cellular component,17.0,53.0,1.430e-01,7.025e-02,2.911e-01,1.138e-01,7.657e-02,1.691e-01,6.809e-01,1.353e-02
NAT10,29830,"nuclear chromosome, telomeric region",GO:0000784,cellular component,17.0,4.0,1.505e-01,6.860e-02,3.300e-01,1.213e-01,5.158e-02,2.853e-01,6.695e-01,2.947e-02
NAT10,29830,rRNA cytidine N-acetyltransferase activity,GO:1990883,molecular function,17.0,2.0,7.492e-02,6.433e-03,8.725e-01,2.207e-02,2.454e-04,1.985e+00,8.048e-01,1.154e-01
NAT10,29830,mRNA N-acetyltransferase activity,GO:0106162,molecular function,17.0,2.0,7.492e-02,6.433e-03,8.725e-01,2.294e-02,2.588e-04,2.033e+00,8.002e-01,1.184e-01
NAT10,29830,N-acetyltransferase activity,GO:0008080,molecular function,17.0,34.0,1.313e-01,4.929e-02,3.496e-01,6.097e-02,1.293e-02,2.874e-01,7.567e-01,4.264e-02
NAT10,29830,RNA binding,GO:0003723,molecular function,17.0,63.0,1.313e-01,4.929e-02,3.496e-01,7.425e-02,2.505e-02,2.201e-01,7.355e-01,3.302e-02
NAT10,29830,DNA polymerase binding,GO:0070182,molecular function,17.0,2.0,1.478e-01,6.596e-02,3.312e-01,1.172e-01,5.835e-02,2.354e-01,6.754e-01,2.502e-02
NAT10,29830,protein binding,GO:0005515,molecular function,17.0,332.0,1.513e-01,8.746e-02,2.616e-01,1.163e-01,1.150e-01,1.175e-01,6.785e-01,3.511e-04
AGAP2,16921,negative regulation of protein catabolic process,GO:0042177,biological process,11.0,8.0,9.612e-02,4.266e-02,2.166e-01,2.249e-02,2.311e-03,2.189e-01,8.511e-01,4.874e-02
AGAP2,16921,negative regulation of neuron apoptotic process,GO:0043524,biological process,11.0,11.0,1.036e-01,4.218e-02,2.545e-01,8.651e-02,3.396e-02,2.204e-01,7.163e-01,3.101e-02
AGAP2,16921,extracellular exosome,GO:0070062,cellular component,11.0,33.0,9.738e-02,4.517e-02,2.100e-01,4.854e-02,3.320e-02,7.095e-02,7.893e-01,1.046e-02
AGAP2,16921,mitochondrion,GO:0005739,cellular component,11.0,19.0,9.738e-02,4.517e-02,2.100e-01,5.761e-02,4.399e-02,7.545e-02,7.697e-01,7.568e-03
AGAP2,16921,membrane,GO:0016020,cellular component,11.0,53.0,9.738e-02,4.517e-02,2.100e-01,6.535e-02,2.446e-02,1.746e-01,7.520e-01,2.978e-02
AGAP2,16921,nucleolus,GO:0005730,cellular component,11.0,41.0,9.738e-02,4.517e-02,2.100e-01,7.238e-02,2.842e-02,1.844e-01,7.396e-01,2.796e-02
AGAP2,16921,nucleus,GO:0005634,cellular component,11.0,151.0,9.738e-02,4.517e-02,2.100e-01,7.770e-02,3.411e-02,1.770e-01,7.311e-01,2.456e-02
AGAP2,16921,protein binding,GO:0005515,molecular function,11.0,332.0,1.007e-01,4.371e-02,2.319e-01,9.450e-02,4.193e-02,2.130e-01,7.052e-01,2.566e-02
TSPAN31,10539,,,,nan,nan,,,,,,,,
PWP1,17015,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,GO:1901838,biological process,8.0,3.0,5.445e-02,3.755e-02,7.894e-02,3.754e-02,1.568e-02,8.988e-02,8.157e-01,2.146e-02
PWP1,17015,Golgi apparatus,GO:0005794,cellular component,8.0,15.0,5.445e-02,3.755e-02,7.894e-02,4.165e-02,1.983e-02,8.747e-02,8.051e-01,1.913e-02
PWP1,17015,nucleolus,GO:0005730,cellular component,8.0,41.0,5.445e-02,3.755e-02,7.894e-02,4.552e-02,3.484e-02,5.948e-02,7.966e-01,7.336e-03
PWP1,17015,nucleus,GO:0005634,cellular component,8.0,151.0,5.445e-02,3.755e-02,7.894e-02,5.423e-02,3.764e-02,7.814e-02,7.766e-01,9.998e-03
NUDT15,23063,,,,nan,nan,,,,,,,,
SCRN1,22192,exocytosis,GO:0006887,biological process,5.0,7.0,2.061e-01,1.557e-01,2.728e-01,8.205e-02,5.656e-02,1.190e-01,7.257e-01,1.145e-02
SCRN1,22192,nucleus,GO:0005634,cellular component,5.0,151.0,2.061e-01,1.557e-01,2.728e-01,1.434e-01,1.212e-01,1.696e-01,6.471e-01,6.185e-03
SCRN1,22192,nuclear membrane,GO:0031965,cellular component,5.0,9.0,2.076e-01,1.533e-01,2.811e-01,1.819e-01,8.889e-02,3.721e-01,6.059e-01,2.845e-02
SCRN1,22192,protein binding,GO:0005515,molecular function,5.0,332.0,2.061e-01,1.557e-01,2.728e-01,1.717e-01,1.475e-01,1.998e-01,6.186e-01,5.967e-03
ZFHX2,20152,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,7.0,41.0,5.854e-02,4.306e-02,7.959e-02,1.194e-02,7.739e-03,1.842e-02,9.142e-01,5.629e-03
ZFHX2,20152,regulation of sensory perception of pain,GO:0051930,biological process,7.0,5.0,6.062e-02,4.515e-02,8.141e-02,2.531e-02,1.087e-02,5.895e-02,8.551e-01,1.932e-02
ZFHX2,20152,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,7.0,54.0,8.146e-02,3.890e-02,1.706e-01,8.139e-02,3.883e-02,1.706e-01,7.254e-01,2.383e-02
ZFHX2,20152,nucleus,GO:0005634,cellular component,7.0,151.0,8.146e-02,3.890e-02,1.706e-01,7.151e-02,3.171e-02,1.612e-01,7.416e-01,2.464e-02
ZFHX2,20152,transcription regulatory region DNA binding,GO:0044212,molecular function,7.0,24.0,7.650e-02,4.502e-02,1.300e-01,4.757e-02,3.555e-02,6.365e-02,7.916e-01,7.948e-03
ZFHX2,20152,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,7.0,25.0,8.146e-02,3.890e-02,1.706e-01,5.596e-02,2.347e-02,1.334e-01,7.714e-01,2.470e-02
SMC2,14011,mitotic chromosome condensation,GO:0007076,biological process,21.0,9.0,1.935e-02,1.602e-02,2.335e-02,1.103e-02,5.023e-03,2.423e-02,9.172e-01,1.119e-02
SMC2,14011,nuclear chromosome,GO:0000228,cellular component,21.0,7.0,1.935e-02,1.602e-02,2.335e-02,1.077e-02,6.182e-03,1.877e-02,9.192e-01,7.551e-03
SMC2,14011,condensed chromosome,GO:0000793,cellular component,21.0,6.0,1.935e-02,1.602e-02,2.335e-02,1.120e-02,6.448e-03,1.944e-02,9.172e-01,7.734e-03
SMC2,14011,extracellular exosome,GO:0070062,cellular component,21.0,33.0,1.935e-02,1.602e-02,2.335e-02,1.289e-02,4.698e-03,3.537e-02,9.068e-01,1.386e-02
SMC2,14011,nucleolus,GO:0005730,cellular component,21.0,41.0,1.935e-02,1.602e-02,2.335e-02,1.357e-02,5.979e-03,3.078e-02,9.046e-01,1.167e-02
SMC2,14011,nucleus,GO:0005634,cellular component,21.0,151.0,1.935e-02,1.602e-02,2.335e-02,1.446e-02,9.511e-03,2.199e-02,9.023e-01,6.932e-03
SMC2,14011,condensin complex,GO:0000796,cellular component,21.0,6.0,1.935e-02,1.602e-02,2.335e-02,1.578e-02,1.079e-02,2.307e-02,8.963e-01,6.441e-03
SMC2,14011,cytoplasm,GO:0005737,cellular component,21.0,69.0,1.935e-02,1.602e-02,2.335e-02,1.578e-02,7.430e-03,3.350e-02,8.945e-01,1.226e-02
SMC2,14011,protein heterodimerization activity,GO:0046982,molecular function,21.0,6.0,1.935e-02,1.602e-02,2.335e-02,1.110e-02,5.098e-03,2.415e-02,9.167e-01,1.119e-02
SMC2,14011,protein binding,GO:0005515,molecular function,21.0,332.0,1.935e-02,1.602e-02,2.335e-02,1.532e-02,8.573e-03,2.739e-02,8.976e-01,9.592e-03
XPA,12814,UV-damage excision repair,GO:0070914,biological process,21.0,3.0,4.816e-02,1.000e-02,2.319e-01,1.108e-02,3.234e-03,3.799e-02,9.134e-01,1.891e-02
XPA,12814,base-excision repair,GO:0006284,biological process,21.0,3.0,4.816e-02,1.000e-02,2.319e-01,1.169e-02,3.051e-03,4.475e-02,9.097e-01,2.100e-02
XPA,12814,UV protection,GO:0009650,biological process,21.0,2.0,4.816e-02,1.000e-02,2.319e-01,1.272e-02,1.874e-03,8.638e-02,8.991e-01,3.095e-02
XPA,12814,nucleotide-excision repair involved in interstrand cross-link repair,GO:1901255,biological process,21.0,2.0,4.816e-02,1.000e-02,2.319e-01,2.205e-02,3.216e-03,1.511e-01,8.572e-01,3.986e-02
XPA,12814,"nucleotide-excision repair, DNA incision",GO:0033683,biological process,21.0,4.0,4.877e-02,1.035e-02,2.297e-01,3.035e-02,7.198e-03,1.280e-01,8.340e-01,3.565e-02
XPA,12814,"nucleotide-excision repair, DNA damage recognition",GO:0000715,biological process,21.0,3.0,4.877e-02,1.035e-02,2.297e-01,3.016e-02,4.616e-03,1.971e-01,8.307e-01,4.837e-02
XPA,12814,DNA repair,GO:0006281,biological process,21.0,18.0,4.888e-02,1.042e-02,2.293e-01,3.564e-02,7.346e-03,1.729e-01,8.168e-01,4.192e-02
XPA,12814,protein localization to nucleus,GO:0034504,biological process,21.0,10.0,5.764e-02,1.420e-02,2.340e-01,3.196e-02,1.691e-03,6.039e-01,8.074e-01,6.319e-02
XPA,12814,nucleus,GO:0005634,cellular component,21.0,151.0,5.238e-02,1.239e-02,2.214e-01,3.643e-02,1.131e-02,1.173e-01,8.174e-01,3.037e-02
XPA,12814,DNA replication factor A complex,GO:0005662,cellular component,21.0,2.0,5.300e-02,1.272e-02,2.208e-01,3.431e-02,8.360e-03,1.408e-01,8.219e-01,3.472e-02
XPA,12814,intercellular bridge,GO:0045171,cellular component,21.0,25.0,5.473e-02,1.346e-02,2.226e-01,4.153e-02,6.577e-03,2.622e-01,7.977e-01,4.779e-02
XPA,12814,nucleotide-excision repair factor 1 complex,GO:0000110,cellular component,21.0,2.0,6.588e-02,8.039e-03,5.400e-01,5.619e-02,4.928e-03,6.406e-01,7.546e-01,7.612e-02
XPA,12814,protein homodimerization activity,GO:0042803,molecular function,21.0,15.0,4.888e-02,1.042e-02,2.293e-01,3.550e-02,7.914e-03,1.593e-01,8.180e-01,3.976e-02
XPA,12814,protein binding,GO:0005515,molecular function,21.0,332.0,5.188e-02,1.198e-02,2.248e-01,4.118e-02,7.916e-03,2.143e-01,8.005e-01,4.588e-02
XPA,12814,damaged DNA binding,GO:0003684,molecular function,21.0,6.0,6.215e-02,1.545e-02,2.500e-01,3.155e-02,6.184e-03,1.609e-01,8.279e-01,3.741e-02
XPA,12814,protein domain specific binding,GO:0019904,molecular function,21.0,82.0,6.215e-02,1.545e-02,2.500e-01,3.311e-02,6.083e-03,1.803e-01,8.220e-01,3.814e-02
NUSAP1,18538,mitotic cytokinesis,GO:0000281,biological process,13.0,12.0,1.017e-01,7.595e-02,1.362e-01,5.641e-02,2.793e-02,1.139e-01,7.710e-01,2.023e-02
NUSAP1,18538,establishment of mitotic spindle localization,GO:0040001,biological process,13.0,4.0,1.017e-01,7.595e-02,1.362e-01,6.268e-02,4.453e-02,8.821e-02,7.596e-01,9.654e-03
NUSAP1,18538,positive regulation of mitotic nuclear division,GO:0045840,biological process,13.0,8.0,1.043e-01,7.520e-02,1.446e-01,6.643e-02,2.125e-02,2.077e-01,7.494e-01,3.229e-02
NUSAP1,18538,mitotic sister chromatid segregation,GO:0000070,biological process,13.0,9.0,1.043e-01,7.519e-02,1.447e-01,7.803e-02,3.039e-02,2.003e-01,7.299e-01,2.797e-02
NUSAP1,18538,mitotic chromosome condensation,GO:0007076,biological process,13.0,9.0,1.044e-01,8.500e-02,1.283e-01,8.446e-02,4.957e-02,1.439e-01,7.215e-01,1.713e-02
NUSAP1,18538,spindle microtubule,GO:0005876,cellular component,13.0,11.0,1.017e-01,7.595e-02,1.362e-01,2.362e-02,1.660e-02,3.361e-02,8.631e-01,7.711e-03
NUSAP1,18538,mitotic spindle,GO:0072686,cellular component,13.0,17.0,1.017e-01,7.595e-02,1.362e-01,5.036e-02,3.334e-02,7.606e-02,7.852e-01,1.135e-02
NUSAP1,18538,nucleolus,GO:0005730,cellular component,13.0,41.0,1.107e-01,1.036e-01,1.183e-01,8.263e-02,6.161e-02,1.108e-01,7.250e-01,9.279e-03
NUSAP1,18538,microtubule binding,GO:0008017,molecular function,13.0,22.0,1.017e-01,7.595e-02,1.362e-01,5.814e-02,4.501e-02,7.510e-02,7.685e-01,7.218e-03
NUSAP1,18538,RNA binding,GO:0003723,molecular function,13.0,63.0,1.107e-01,1.036e-01,1.183e-01,8.222e-02,4.655e-02,1.452e-01,7.250e-01,1.739e-02
NUSAP1,18538,protein binding,GO:0005515,molecular function,13.0,332.0,1.211e-01,1.012e-01,1.449e-01,1.184e-01,9.418e-02,1.489e-01,6.756e-01,8.038e-03
KIF23,6392,mitotic spindle midzone assembly,GO:0051256,biological process,33.0,6.0,3.847e-02,2.358e-02,6.276e-02,1.816e-02,1.091e-02,3.025e-02,8.851e-01,9.868e-03
KIF23,6392,positive regulation of cytokinesis,GO:0032467,biological process,33.0,16.0,3.847e-02,2.358e-02,6.276e-02,2.392e-02,1.508e-02,3.794e-02,8.615e-01,1.034e-02
KIF23,6392,mitotic cytokinesis,GO:0000281,biological process,33.0,12.0,3.981e-02,2.290e-02,6.923e-02,2.488e-02,1.089e-02,5.684e-02,8.567e-01,1.830e-02
KIF23,6392,microtubule-based movement,GO:0007018,biological process,33.0,21.0,4.402e-02,2.302e-02,8.419e-02,3.053e-02,1.187e-02,7.855e-02,8.364e-01,2.285e-02
KIF23,6392,centralspindlin complex,GO:0097149,cellular component,33.0,3.0,3.847e-02,2.358e-02,6.276e-02,8.916e-03,7.100e-03,1.120e-02,9.300e-01,2.713e-03
KIF23,6392,spindle,GO:0005819,cellular component,33.0,15.0,3.847e-02,2.358e-02,6.276e-02,1.085e-02,4.455e-03,2.641e-02,9.174e-01,1.289e-02
KIF23,6392,centrosome,GO:0005813,cellular component,33.0,31.0,3.847e-02,2.358e-02,6.276e-02,1.324e-02,4.971e-03,3.527e-02,9.052e-01,1.407e-02
KIF23,6392,mitotic spindle,GO:0072686,cellular component,33.0,17.0,3.847e-02,2.358e-02,6.276e-02,1.532e-02,1.302e-02,1.803e-02,8.988e-01,2.793e-03
KIF23,6392,microtubule,GO:0005874,cellular component,33.0,22.0,3.847e-02,2.358e-02,6.276e-02,2.101e-02,1.367e-02,3.229e-02,8.735e-01,9.189e-03
KIF23,6392,kinesin complex,GO:0005871,cellular component,33.0,16.0,3.935e-02,2.604e-02,5.945e-02,2.541e-02,2.124e-02,3.040e-02,8.564e-01,4.150e-03
KIF23,6392,midbody,GO:0030496,cellular component,33.0,26.0,4.024e-02,2.259e-02,7.166e-02,2.157e-02,4.999e-03,9.309e-02,8.633e-01,2.748e-02
KIF23,6392,focal adhesion,GO:0005925,cellular component,33.0,11.0,4.468e-02,2.383e-02,8.376e-02,3.772e-02,2.314e-02,6.149e-02,8.164e-01,1.228e-02
KIF23,6392,nucleoplasm,GO:0005654,cellular component,33.0,74.0,5.383e-02,1.781e-02,1.627e-01,4.380e-02,8.696e-03,2.206e-01,7.943e-01,4.008e-02
KIF23,6392,nucleus,GO:0005634,cellular component,33.0,151.0,5.474e-02,1.911e-02,1.568e-01,4.844e-02,1.370e-02,1.713e-01,7.860e-01,3.314e-02
KIF23,6392,microtubule motor activity,GO:0003777,molecular function,33.0,13.0,3.847e-02,2.358e-02,6.276e-02,1.683e-02,1.232e-02,2.297e-02,8.918e-01,5.490e-03
KIF23,6392,microtubule binding,GO:0008017,molecular function,33.0,22.0,3.847e-02,2.358e-02,6.276e-02,1.929e-02,1.268e-02,2.935e-02,8.806e-01,8.458e-03
KIF23,6392,ATPase activity,GO:0016887,molecular function,33.0,14.0,4.138e-02,2.240e-02,7.644e-02,3.029e-02,1.593e-02,5.762e-02,8.390e-01,1.504e-02
KIF23,6392,protein binding,GO:0005515,molecular function,33.0,332.0,5.888e-02,2.354e-02,1.472e-01,5.785e-02,2.324e-02,1.440e-01,7.672e-01,2.591e-02
PARP6,26921,,,,nan,nan,,,,,,,,
RMDN3,25550,cellular calcium ion homeostasis,GO:0006874,biological process,6.0,9.0,1.340e-01,6.601e-02,2.720e-01,1.217e-01,4.542e-02,3.263e-01,6.680e-01,3.469e-02
RMDN3,25550,mitochondrial outer membrane,GO:0005741,cellular component,6.0,3.0,4.542e-02,1.015e-02,2.032e-01,1.350e-02,1.820e-03,1.001e-01,8.938e-01,3.409e-02
RMDN3,25550,mitochondrion,GO:0005739,cellular component,6.0,19.0,7.973e-02,4.464e-02,1.424e-01,4.548e-02,1.930e-02,1.072e-01,7.948e-01,2.239e-02
RMDN3,25550,protein binding,GO:0005515,molecular function,6.0,332.0,9.728e-02,8.515e-02,1.111e-01,8.031e-02,5.080e-02,1.270e-01,7.284e-01,1.456e-02
THUMPD2,14890,tRNA methylation,GO:0030488,biological process,3.0,12.0,4.079e-02,3.255e-02,5.112e-02,3.238e-02,1.231e-02,8.518e-02,8.306e-01,2.265e-02
THUMPD2,14890,tRNA (guanine) methyltransferase activity,GO:0016423,molecular function,3.0,7.0,6.511e-02,1.569e-02,2.702e-01,6.045e-02,1.292e-02,2.829e-01,7.573e-01,4.779e-02
KIF11,6388,mitotic spindle assembly,GO:0090307,biological process,27.0,6.0,4.913e-02,2.571e-02,9.389e-02,1.674e-02,5.515e-03,5.083e-02,8.871e-01,1.805e-02
KIF11,6388,spindle organization,GO:0007051,biological process,27.0,10.0,5.245e-02,3.062e-02,8.985e-02,2.298e-02,4.642e-03,1.137e-01,8.566e-01,2.990e-02
KIF11,6388,regulation of mitotic centrosome separation,GO:0046602,biological process,27.0,5.0,6.340e-02,2.412e-02,1.667e-01,4.484e-02,9.413e-03,2.136e-01,7.922e-01,4.268e-02
KIF11,6388,microtubule-based movement,GO:0007018,biological process,27.0,21.0,7.027e-02,5.394e-02,9.154e-02,5.566e-02,3.085e-02,1.004e-01,7.733e-01,1.634e-02
KIF11,6388,spindle microtubule,GO:0005876,cellular component,27.0,11.0,4.913e-02,2.571e-02,9.389e-02,9.890e-03,4.668e-03,2.096e-02,9.240e-01,8.970e-03
KIF11,6388,spindle,GO:0005819,cellular component,27.0,15.0,4.913e-02,2.571e-02,9.389e-02,1.144e-02,3.434e-03,3.813e-02,9.118e-01,1.864e-02
KIF11,6388,mitotic spindle,GO:0072686,cellular component,27.0,17.0,5.343e-02,2.919e-02,9.779e-02,2.166e-02,1.096e-02,4.282e-02,8.697e-01,1.491e-02
KIF11,6388,microtubule,GO:0005874,cellular component,27.0,22.0,5.343e-02,2.919e-02,9.779e-02,2.175e-02,7.370e-03,6.419e-02,8.672e-01,2.304e-02
KIF11,6388,kinesin complex,GO:0005871,cellular component,27.0,16.0,5.523e-02,2.961e-02,1.030e-01,3.018e-02,1.686e-02,5.400e-02,8.391e-01,1.391e-02
KIF11,6388,membrane,GO:0016020,cellular component,27.0,53.0,5.638e-02,2.958e-02,1.075e-01,3.691e-02,2.050e-02,6.644e-02,8.188e-01,1.468e-02
KIF11,6388,spindle pole,GO:0000922,cellular component,27.0,15.0,5.856e-02,2.780e-02,1.233e-01,2.935e-02,4.634e-03,1.859e-01,8.318e-01,3.852e-02
KIF11,6388,cytosol,GO:0005829,cellular component,27.0,78.0,6.716e-02,3.187e-02,1.415e-01,5.685e-02,2.359e-02,1.370e-01,7.696e-01,2.424e-02
KIF11,6388,nucleus,GO:0005634,cellular component,27.0,151.0,7.390e-02,3.903e-02,1.399e-01,6.630e-02,3.216e-02,1.367e-01,7.514e-01,2.129e-02
KIF11,6388,protein-containing complex,GO:0032991,cellular component,27.0,481.0,1.258e-01,4.332e-02,3.652e-01,1.173e-01,3.536e-02,3.893e-01,6.709e-01,4.440e-02
KIF11,6388,microtubule motor activity,GO:0003777,molecular function,27.0,13.0,5.343e-02,2.919e-02,9.779e-02,1.819e-02,5.361e-03,6.173e-02,8.798e-01,2.221e-02
KIF11,6388,microtubule binding,GO:0008017,molecular function,27.0,22.0,5.480e-02,2.956e-02,1.016e-01,2.238e-02,8.194e-03,6.111e-02,8.647e-01,2.039e-02
KIF11,6388,"ATP-dependent microtubule motor activity, plus-end-directed",GO:0008574,molecular function,27.0,6.0,5.602e-02,2.961e-02,1.060e-01,3.412e-02,1.867e-02,6.237e-02,8.269e-01,1.449e-02
KIF11,6388,ATPase activity,GO:0016887,molecular function,27.0,14.0,6.294e-02,2.759e-02,1.436e-01,4.058e-02,1.215e-02,1.355e-01,8.058e-01,2.993e-02
KIF11,6388,protein kinase binding,GO:0019901,molecular function,27.0,32.0,7.166e-02,3.011e-02,1.705e-01,6.190e-02,2.078e-02,1.843e-01,7.581e-01,3.028e-02
CEP55,1161,mitotic cytokinesis,GO:0000281,biological process,15.0,12.0,7.038e-02,3.354e-02,1.476e-01,2.577e-02,9.647e-03,6.882e-02,8.521e-01,2.109e-02
CEP55,1161,midbody abscission,GO:0061952,biological process,15.0,6.0,7.038e-02,3.354e-02,1.476e-01,4.107e-02,1.556e-02,1.084e-01,8.055e-01,2.595e-02
CEP55,1161,establishment of protein localization,GO:0045184,biological process,15.0,9.0,7.203e-02,3.426e-02,1.514e-01,5.142e-02,1.676e-02,1.577e-01,7.797e-01,3.031e-02
CEP55,1161,renal system development,GO:0072001,biological process,15.0,2.0,7.819e-02,3.466e-02,1.764e-01,5.768e-02,2.157e-02,1.542e-01,7.672e-01,2.680e-02
CEP55,1161,cranial skeletal system development,GO:1904888,biological process,15.0,2.0,1.278e-01,3.613e-02,4.520e-01,1.278e-01,3.613e-02,4.520e-01,6.573e-01,4.687e-02
CEP55,1161,centrosome,GO:0005813,cellular component,15.0,31.0,7.038e-02,3.354e-02,1.476e-01,2.387e-02,1.911e-02,2.982e-02,8.625e-01,5.064e-03
CEP55,1161,plasma membrane,GO:0005886,cellular component,15.0,24.0,7.038e-02,3.354e-02,1.476e-01,2.865e-02,1.928e-02,4.257e-02,8.449e-01,9.393e-03
CEP55,1161,microtubule organizing center,GO:0005815,cellular component,15.0,16.0,7.038e-02,3.354e-02,1.476e-01,3.258e-02,9.041e-03,1.174e-01,8.284e-01,3.291e-02
CEP55,1161,midbody,GO:0030496,cellular component,15.0,26.0,7.038e-02,3.354e-02,1.476e-01,4.223e-02,2.340e-02,7.623e-02,8.041e-01,1.522e-02
CEP55,1161,membrane,GO:0016020,cellular component,15.0,53.0,7.328e-02,3.911e-02,1.373e-01,5.082e-02,3.590e-02,7.193e-02,7.840e-01,9.534e-03
CEP55,1161,Flemming body,GO:0090543,cellular component,15.0,4.0,7.328e-02,3.911e-02,1.373e-01,5.292e-02,1.894e-02,1.478e-01,7.770e-01,2.938e-02
CEP55,1161,protein binding,GO:0005515,molecular function,15.0,332.0,9.004e-02,5.185e-02,1.564e-01,7.963e-02,4.770e-02,1.329e-01,7.294e-01,1.566e-02
KIF20B,7212,positive regulation of cytokinesis,GO:0032467,biological process,23.0,16.0,1.141e-01,9.445e-02,1.379e-01,3.627e-02,2.089e-02,6.297e-02,8.207e-01,1.386e-02
KIF20B,7212,microtubule-based movement,GO:0007018,biological process,23.0,21.0,1.229e-01,9.375e-02,1.611e-01,7.687e-02,1.955e-02,3.022e-01,7.291e-01,4.021e-02
KIF20B,7212,positive regulation of cell population proliferation,GO:0008284,biological process,23.0,40.0,1.566e-01,7.824e-02,3.134e-01,1.416e-01,6.366e-02,3.149e-01,6.461e-01,3.094e-02
KIF20B,7212,mitotic spindle pole,GO:0097431,cellular component,23.0,5.0,1.141e-01,9.445e-02,1.379e-01,1.190e-02,2.683e-03,5.274e-02,9.066e-01,2.460e-02
KIF20B,7212,mitotic spindle midzone,GO:1990023,cellular component,23.0,4.0,1.141e-01,9.445e-02,1.379e-01,2.426e-02,1.052e-02,5.594e-02,8.587e-01,1.760e-02
KIF20B,7212,centrosome,GO:0005813,cellular component,23.0,31.0,1.141e-01,9.445e-02,1.379e-01,3.904e-02,1.144e-02,1.333e-01,8.098e-01,2.998e-02
KIF20B,7212,contractile ring,GO:0070938,cellular component,23.0,4.0,1.141e-01,9.445e-02,1.379e-01,5.499e-02,4.686e-02,6.453e-02,7.753e-01,4.423e-03
KIF20B,7212,kinesin complex,GO:0005871,cellular component,23.0,16.0,1.141e-01,9.445e-02,1.379e-01,7.001e-02,4.145e-02,1.183e-01,7.456e-01,1.600e-02
KIF20B,7212,microtubule,GO:0005874,cellular component,23.0,22.0,1.146e-01,9.472e-02,1.388e-01,5.718e-02,3.657e-02,8.942e-02,7.702e-01,1.258e-02
KIF20B,7212,midbody,GO:0030496,cellular component,23.0,26.0,1.250e-01,8.599e-02,1.817e-01,6.804e-02,3.058e-02,1.514e-01,7.479e-01,2.452e-02
KIF20B,7212,nucleus,GO:0005634,cellular component,23.0,151.0,1.250e-01,8.599e-02,1.817e-01,9.513e-02,5.693e-02,1.590e-01,7.057e-01,1.705e-02
KIF20B,7212,nucleolus,GO:0005730,cellular component,23.0,41.0,1.253e-01,8.620e-02,1.822e-01,9.888e-02,5.621e-02,1.739e-01,7.002e-01,1.854e-02
KIF20B,7212,cytoplasm,GO:0005737,cellular component,23.0,69.0,1.263e-01,8.424e-02,1.894e-01,1.032e-01,5.425e-02,1.963e-01,6.939e-01,2.199e-02
KIF20B,7212,nucleoplasm,GO:0005654,cellular component,23.0,74.0,1.267e-01,8.528e-02,1.883e-01,9.814e-02,4.946e-02,1.947e-01,7.007e-01,2.294e-02
KIF20B,7212,microtubule motor activity,GO:0003777,molecular function,23.0,13.0,1.141e-01,9.445e-02,1.379e-01,4.257e-02,3.070e-02,5.903e-02,8.039e-01,8.553e-03
KIF20B,7212,microtubule binding,GO:0008017,molecular function,23.0,22.0,1.141e-01,9.445e-02,1.379e-01,5.570e-02,3.369e-02,9.209e-02,7.733e-01,1.396e-02
KIF20B,7212,"ATP-dependent microtubule motor activity, plus-end-directed",GO:0008574,molecular function,23.0,6.0,1.141e-01,9.445e-02,1.379e-01,6.329e-02,3.505e-02,1.143e-01,7.578e-01,1.745e-02
KIF20B,7212,ATPase activity,GO:0016887,molecular function,23.0,14.0,1.141e-01,9.445e-02,1.379e-01,7.240e-02,5.747e-02,9.122e-02,7.421e-01,6.961e-03
KIF20B,7212,WW domain binding,GO:0050699,molecular function,23.0,2.0,1.211e-01,8.341e-02,1.757e-01,8.122e-02,2.883e-02,2.288e-01,7.240e-01,3.226e-02
KIF20B,7212,protein homodimerization activity,GO:0042803,molecular function,23.0,15.0,1.250e-01,8.599e-02,1.817e-01,8.639e-02,4.339e-02,1.720e-01,7.180e-01,2.259e-02
KIF20B,7212,protein binding,GO:0005515,molecular function,23.0,332.0,1.369e-01,8.434e-02,2.223e-01,1.280e-01,6.766e-02,2.421e-01,6.629e-01,2.231e-02
MYPN,23246,sarcomere organization,GO:0045214,biological process,14.0,3.0,8.946e-02,3.736e-02,2.142e-01,3.866e-02,1.549e-02,9.645e-02,8.127e-01,2.358e-02
MYPN,23246,homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,biological process,14.0,3.0,9.003e-02,3.727e-02,2.175e-01,5.643e-02,1.305e-02,2.440e-01,7.668e-01,3.919e-02
MYPN,23246,axon guidance,GO:0007411,biological process,14.0,23.0,1.298e-01,5.247e-02,3.213e-01,1.264e-01,5.016e-02,3.186e-01,6.625e-01,3.429e-02
MYPN,23246,dendrite self-avoidance,GO:0070593,biological process,14.0,3.0,1.335e-01,6.080e-02,2.931e-01,1.266e-01,5.457e-02,2.935e-01,6.634e-01,2.906e-02
MYPN,23246,plasma membrane,GO:0005886,cellular component,14.0,24.0,7.978e-02,2.263e-02,2.813e-01,4.154e-02,4.834e-03,3.569e-01,7.937e-01,5.007e-02
MYPN,23246,Z disc,GO:0030018,cellular component,14.0,4.0,9.110e-02,4.046e-02,2.051e-01,6.346e-02,2.557e-02,1.575e-01,7.561e-01,2.683e-02
MYPN,23246,I band,GO:0031674,cellular component,14.0,2.0,9.168e-02,4.036e-02,2.083e-01,7.357e-02,3.025e-02,1.789e-01,7.379e-01,2.604e-02
MYPN,23246,axon,GO:0030424,cellular component,14.0,11.0,9.945e-02,5.927e-02,1.669e-01,5.890e-02,2.623e-02,1.323e-01,7.657e-01,2.288e-02
MYPN,23246,cytoskeletal protein binding,GO:0008092,molecular function,14.0,23.0,7.434e-02,1.660e-02,3.330e-01,1.407e-02,1.721e-03,1.151e-01,8.909e-01,3.302e-02
MYPN,23246,cell-cell adhesion mediator activity,GO:0098632,molecular function,14.0,6.0,7.434e-02,1.660e-02,3.330e-01,1.773e-02,1.479e-03,2.127e-01,8.679e-01,4.535e-02
MYPN,23246,SH3 domain binding,GO:0017124,molecular function,14.0,2.0,7.978e-02,2.263e-02,2.813e-01,2.146e-02,6.213e-03,7.415e-02,8.663e-01,2.430e-02
MYPN,23246,muscle alpha-actinin binding,GO:0051371,molecular function,14.0,3.0,9.048e-02,3.927e-02,2.085e-01,5.433e-02,1.965e-02,1.502e-01,7.739e-01,2.716e-02
MYPN,23246,protein binding,GO:0005515,molecular function,14.0,332.0,9.110e-02,4.046e-02,2.051e-01,4.568e-02,3.446e-02,6.057e-02,7.962e-01,7.722e-03
PAPSS1,8603,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,GO:0050428,biological process,8.0,5.0,1.507e-01,5.409e-02,4.199e-01,5.898e-02,2.138e-02,1.627e-01,7.642e-01,3.012e-02
PAPSS1,8603,sulfate assimilation,GO:0000103,biological process,8.0,4.0,1.574e-01,4.909e-02,5.049e-01,1.259e-01,3.929e-02,4.037e-01,6.605e-01,4.372e-02
PAPSS1,8603,protein homodimerization activity,GO:0042803,molecular function,8.0,15.0,1.507e-01,5.409e-02,4.199e-01,7.494e-02,6.156e-02,9.124e-02,7.378e-01,5.976e-03
PAPSS1,8603,adenylylsulfate kinase activity,GO:0004020,molecular function,8.0,3.0,1.634e-01,5.203e-02,5.133e-01,1.303e-01,3.250e-02,5.227e-01,6.534e-01,4.933e-02
PAPSS1,8603,sulfate adenylyltransferase (ATP) activity,GO:0004781,molecular function,8.0,2.0,1.763e-01,5.534e-02,5.617e-01,1.373e-01,2.558e-02,7.365e-01,6.380e-01,6.778e-02
BRCA2,1101,double-strand break repair via homologous recombination,GO:0000724,biological process,40.0,8.0,7.609e-02,3.619e-02,1.600e-01,2.841e-02,7.237e-03,1.115e-01,8.404e-01,3.177e-02
BRCA2,1101,mitotic cytokinesis,GO:0000281,biological process,40.0,12.0,7.666e-02,4.503e-02,1.305e-01,1.983e-02,7.045e-03,5.584e-02,8.749e-01,2.061e-02
BRCA2,1101,double-strand break repair,GO:0006302,biological process,40.0,10.0,7.724e-02,4.592e-02,1.299e-01,3.401e-02,2.286e-02,5.059e-02,8.272e-01,9.766e-03
BRCA2,1101,centrosome duplication,GO:0051298,biological process,40.0,2.0,7.996e-02,3.221e-02,1.985e-01,2.210e-02,2.039e-03,2.395e-01,8.512e-01,5.465e-02
BRCA2,1101,establishment of protein localization to telomere,GO:0070200,biological process,40.0,4.0,7.996e-02,3.221e-02,1.985e-01,3.104e-02,4.328e-03,2.226e-01,8.255e-01,4.482e-02
BRCA2,1101,mitotic recombination-dependent replication fork processing,GO:1990426,biological process,40.0,3.0,8.226e-02,3.011e-02,2.247e-01,1.892e-02,8.200e-04,4.367e-01,8.521e-01,6.673e-02
BRCA2,1101,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,40.0,41.0,8.663e-02,3.489e-02,2.151e-01,5.474e-02,1.855e-02,1.616e-01,7.728e-01,3.121e-02
BRCA2,1101,nucleotide-excision repair,GO:0006289,biological process,40.0,6.0,1.337e-01,2.989e-02,5.983e-01,7.244e-02,4.322e-03,1.214e+00,7.178e-01,7.798e-02
BRCA2,1101,histone H3 acetylation,GO:0043966,biological process,40.0,13.0,1.442e-01,9.328e-02,2.229e-01,1.191e-01,5.829e-02,2.435e-01,6.730e-01,2.506e-02
BRCA2,1101,histone H4 acetylation,GO:0043967,biological process,40.0,7.0,1.443e-01,3.576e-02,5.824e-01,1.159e-01,2.536e-02,5.302e-01,6.699e-01,5.151e-02
BRCA2,1101,negative regulation of mammary gland epithelial cell proliferation,GO:0033600,biological process,40.0,5.0,1.443e-01,4.369e-02,4.768e-01,1.254e-01,3.325e-02,4.732e-01,6.591e-01,4.928e-02
BRCA2,1101,BRCA2-MAGE-D1 complex,GO:0033593,cellular component,40.0,2.0,7.334e-02,3.944e-02,1.364e-01,1.242e-02,1.367e-03,1.127e-01,8.957e-01,4.006e-02
BRCA2,1101,nucleoplasm,GO:0005654,cellular component,40.0,74.0,7.724e-02,4.592e-02,1.299e-01,3.549e-02,1.843e-02,6.832e-02,8.226e-01,1.646e-02
BRCA2,1101,"nuclear chromosome, telomeric region",GO:0000784,cellular component,40.0,4.0,7.724e-02,4.592e-02,1.299e-01,3.644e-02,3.079e-02,4.314e-02,8.210e-01,4.192e-03
BRCA2,1101,centrosome,GO:0005813,cellular component,40.0,31.0,7.749e-02,4.635e-02,1.296e-01,3.954e-02,2.463e-02,6.347e-02,8.114e-01,1.228e-02
BRCA2,1101,nucleus,GO:0005634,cellular component,40.0,151.0,8.024e-02,5.051e-02,1.275e-01,3.663e-02,1.785e-02,7.517e-02,8.188e-01,1.767e-02
BRCA2,1101,cytosol,GO:0005829,cellular component,40.0,78.0,8.125e-02,5.253e-02,1.257e-01,4.519e-02,2.259e-02,9.042e-02,7.963e-01,1.812e-02
BRCA2,1101,lateral element,GO:0000800,cellular component,40.0,2.0,9.581e-02,2.918e-02,3.146e-01,6.450e-02,1.456e-02,2.858e-01,7.496e-01,4.498e-02
BRCA2,1101,secretory granule,GO:0030141,cellular component,40.0,18.0,1.754e-01,3.355e-02,9.166e-01,1.579e-01,2.404e-02,1.038e+00,6.142e-01,6.916e-02
BRCA2,1101,protein-containing complex,GO:0032991,cellular component,40.0,481.0,1.801e-01,4.537e-02,7.152e-01,1.688e-01,4.205e-02,6.774e-01,6.111e-01,5.210e-02
BRCA2,1101,protein C-terminus binding,GO:0008022,molecular function,40.0,7.0,7.334e-02,3.944e-02,1.364e-01,1.270e-02,6.252e-03,2.578e-02,9.091e-01,1.121e-02
BRCA2,1101,identical protein binding,GO:0042802,molecular function,40.0,20.0,7.666e-02,4.503e-02,1.305e-01,1.987e-02,1.481e-02,2.668e-02,8.786e-01,5.896e-03
BRCA2,1101,protease binding,GO:0002020,molecular function,40.0,7.0,8.013e-02,4.206e-02,1.527e-01,4.041e-02,1.970e-02,8.288e-02,8.085e-01,1.848e-02
BRCA2,1101,gamma-tubulin binding,GO:0043015,molecular function,40.0,3.0,8.039e-02,4.173e-02,1.549e-01,3.734e-02,1.435e-02,9.716e-02,8.161e-01,2.469e-02
BRCA2,1101,protein binding,GO:0005515,molecular function,40.0,332.0,8.125e-02,5.253e-02,1.257e-01,4.192e-02,1.616e-02,1.088e-01,8.036e-01,2.418e-02
BRCA2,1101,single-stranded DNA binding,GO:0003697,molecular function,40.0,7.0,8.342e-02,5.384e-02,1.292e-01,4.456e-02,2.736e-02,7.259e-02,7.989e-01,1.321e-02
BRCA2,1101,H4 histone acetyltransferase activity,GO:0010485,molecular function,40.0,6.0,1.519e-01,3.134e-02,7.360e-01,9.761e-02,7.543e-03,1.263e+00,6.783e-01,8.408e-02
BRCA2,1101,H3 histone acetyltransferase activity,GO:0010484,molecular function,40.0,11.0,1.550e-01,3.209e-02,7.490e-01,1.194e-01,1.248e-02,1.142e+00,6.523e-01,8.004e-02
DET1,25477,protein ubiquitination,GO:0016567,biological process,14.0,8.0,2.615e-02,1.590e-02,4.301e-02,4.291e-03,2.583e-03,7.128e-03,9.625e-01,5.063e-03
DET1,25477,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436,biological process,14.0,10.0,5.874e-02,5.034e-02,6.854e-02,3.450e-02,1.495e-02,7.965e-02,8.248e-01,2.023e-02
DET1,25477,protein-containing complex assembly,GO:0065003,biological process,14.0,44.0,1.910e-01,7.807e-02,4.671e-01,1.878e-01,7.395e-02,4.769e-01,5.968e-01,4.149e-02
DET1,25477,Cul4A-RING E3 ubiquitin ligase complex,GO:0031464,cellular component,14.0,3.0,3.195e-02,1.050e-02,9.729e-02,8.442e-03,3.354e-03,2.125e-02,9.310e-01,1.164e-02
DET1,25477,Cul4-RING E3 ubiquitin ligase complex,GO:0080008,cellular component,14.0,5.0,3.290e-02,9.824e-03,1.102e-01,1.161e-02,1.506e-03,8.950e-02,9.028e-01,3.396e-02
DET1,25477,ubiquitin protein ligase binding,GO:0031625,molecular function,14.0,4.0,3.729e-02,1.655e-02,8.401e-02,1.657e-02,7.357e-03,3.734e-02,8.905e-01,1.561e-02
DET1,25477,"protein binding, bridging involved in substrate recognition for ubiquitination",GO:1990756,molecular function,14.0,2.0,6.387e-02,1.477e-02,2.762e-01,4.309e-02,6.729e-03,2.759e-01,7.936e-01,4.944e-02
DET1,25477,protein binding,GO:0005515,molecular function,14.0,332.0,9.855e-02,3.530e-02,2.751e-01,7.623e-02,3.265e-02,1.780e-01,7.334e-01,2.519e-02
DET1,25477,protein-containing complex binding,GO:0044877,molecular function,14.0,79.0,9.866e-02,3.526e-02,2.760e-01,8.852e-02,2.650e-02,2.957e-01,7.115e-01,3.698e-02
MED9,25487,mediator complex,GO:0016592,cellular component,5.0,3.0,2.387e-02,1.181e-02,4.825e-02,1.451e-02,6.521e-03,3.229e-02,8.998e-01,1.408e-02
MED9,25487,protein binding,GO:0005515,molecular function,5.0,332.0,2.556e-02,1.298e-02,5.034e-02,2.556e-02,1.298e-02,5.034e-02,8.547e-01,1.518e-02
CLTC,2092,"retrograde transport, endosome to Golgi",GO:0042147,biological process,54.0,8.0,8.712e-02,5.531e-02,1.372e-01,2.212e-02,1.244e-02,3.933e-02,8.682e-01,1.256e-02
CLTC,2092,clathrin-dependent endocytosis,GO:0072583,biological process,54.0,6.0,8.745e-02,5.794e-02,1.320e-01,2.179e-02,3.609e-03,1.315e-01,8.601e-01,3.986e-02
CLTC,2092,amyloid-beta clearance by transcytosis,GO:0150093,biological process,54.0,3.0,9.000e-02,6.302e-02,1.285e-01,1.726e-02,4.895e-03,6.089e-02,8.839e-01,2.530e-02
CLTC,2092,receptor-mediated endocytosis,GO:0006898,biological process,54.0,8.0,9.222e-02,4.832e-02,1.760e-01,2.747e-02,6.908e-03,1.093e-01,8.430e-01,2.936e-02
CLTC,2092,receptor internalization,GO:0031623,biological process,54.0,10.0,9.559e-02,5.215e-02,1.752e-01,4.671e-02,1.497e-02,1.457e-01,7.908e-01,2.939e-02
CLTC,2092,regulation of mitotic spindle organization,GO:0060236,biological process,54.0,9.0,9.716e-02,5.257e-02,1.796e-01,5.471e-02,2.357e-02,1.270e-01,7.742e-01,2.315e-02
CLTC,2092,clathrin coat assembly,GO:0048268,biological process,54.0,4.0,1.011e-01,5.951e-02,1.719e-01,5.363e-02,2.017e-02,1.426e-01,7.757e-01,2.785e-02
CLTC,2092,transferrin transport,GO:0033572,biological process,54.0,3.0,1.018e-01,4.057e-02,2.552e-01,4.780e-02,3.573e-03,6.395e-01,7.716e-01,6.649e-02
CLTC,2092,mitotic cell cycle,GO:0000278,biological process,54.0,13.0,1.060e-01,5.273e-02,2.131e-01,8.144e-02,3.072e-02,2.160e-01,7.241e-01,3.048e-02
CLTC,2092,negative regulation of protein localization to plasma membrane,GO:1903077,biological process,54.0,7.0,1.169e-01,3.575e-02,3.824e-01,8.397e-02,1.532e-02,4.601e-01,7.123e-01,5.855e-02
CLTC,2092,osteoblast differentiation,GO:0001649,biological process,54.0,4.0,1.266e-01,6.244e-02,2.568e-01,1.120e-01,5.307e-02,2.366e-01,6.818e-01,2.650e-02
CLTC,2092,negative regulation of hyaluronan biosynthetic process,GO:1900126,biological process,54.0,7.0,1.455e-01,4.161e-02,5.084e-01,8.125e-02,4.345e-03,1.520e+00,6.987e-01,8.645e-02
CLTC,2092,clathrin-coated endocytic vesicle,GO:0045334,cellular component,54.0,4.0,8.637e-02,5.645e-02,1.322e-01,9.695e-03,2.109e-03,4.456e-02,9.200e-01,2.091e-02
CLTC,2092,extracellular vesicle,GO:1903561,cellular component,54.0,9.0,8.637e-02,5.645e-02,1.322e-01,1.914e-02,1.333e-02,2.747e-02,8.815e-01,7.279e-03
CLTC,2092,endosome,GO:0005768,cellular component,54.0,14.0,8.637e-02,5.645e-02,1.322e-01,1.939e-02,1.119e-02,3.360e-02,8.796e-01,1.110e-02
CLTC,2092,clathrin-coated vesicle,GO:0030136,cellular component,54.0,6.0,9.000e-02,6.302e-02,1.285e-01,2.352e-02,8.166e-03,6.775e-02,8.603e-01,2.299e-02
CLTC,2092,spindle,GO:0005819,cellular component,54.0,15.0,9.609e-02,5.397e-02,1.711e-01,3.507e-02,1.014e-02,1.213e-01,8.209e-01,2.965e-02
CLTC,2092,intracellular membrane-bounded organelle,GO:0043231,cellular component,54.0,40.0,9.609e-02,5.397e-02,1.711e-01,5.135e-02,3.588e-02,7.348e-02,7.830e-01,9.819e-03
CLTC,2092,mitotic spindle,GO:0072686,cellular component,54.0,17.0,9.692e-02,5.288e-02,1.776e-01,4.448e-02,1.637e-02,1.209e-01,7.968e-01,2.571e-02
CLTC,2092,extracellular exosome,GO:0070062,cellular component,54.0,33.0,9.694e-02,5.285e-02,1.778e-01,4.693e-02,2.306e-02,9.551e-02,7.922e-01,1.933e-02
CLTC,2092,mitotic spindle microtubule,GO:1990498,cellular component,54.0,4.0,9.816e-02,5.130e-02,1.878e-01,5.515e-02,2.061e-02,1.476e-01,7.725e-01,2.883e-02
CLTC,2092,focal adhesion,GO:0005925,cellular component,54.0,11.0,9.816e-02,5.130e-02,1.878e-01,6.481e-02,2.814e-02,1.493e-01,7.538e-01,2.477e-02
CLTC,2092,membrane,GO:0016020,cellular component,54.0,53.0,9.855e-02,5.381e-02,1.805e-01,6.692e-02,4.348e-02,1.030e-01,7.515e-01,1.284e-02
CLTC,2092,lysosome,GO:0005764,cellular component,54.0,9.0,1.014e-01,4.753e-02,2.162e-01,6.486e-02,1.910e-02,2.203e-01,7.512e-01,3.734e-02
CLTC,2092,clathrin coat,GO:0030118,cellular component,54.0,4.0,1.014e-01,4.753e-02,2.162e-01,6.745e-02,2.104e-02,2.162e-01,7.469e-01,3.520e-02
CLTC,2092,clathrin complex,GO:0071439,cellular component,54.0,2.0,1.599e-01,8.480e-02,3.014e-01,1.504e-01,7.866e-02,2.876e-01,6.377e-01,2.515e-02
CLTC,2092,protein-containing complex,GO:0032991,cellular component,54.0,481.0,2.265e-01,1.034e-01,4.961e-01,2.243e-01,9.941e-02,5.060e-01,5.661e-01,3.724e-02
CLTC,2092,ubiquitin-specific protease binding,GO:1990381,molecular function,54.0,2.0,8.649e-02,5.626e-02,1.330e-01,2.442e-02,1.829e-02,3.259e-02,8.604e-01,6.511e-03
CLTC,2092,double-stranded RNA binding,GO:0003725,molecular function,54.0,6.0,8.731e-02,5.776e-02,1.320e-01,2.946e-02,9.455e-03,9.177e-02,8.394e-01,2.826e-02
CLTC,2092,low-density lipoprotein particle receptor binding,GO:0050750,molecular function,54.0,2.0,9.156e-02,6.218e-02,1.348e-01,4.200e-02,2.861e-02,6.167e-02,8.052e-01,1.001e-02
CLTC,2092,disordered domain specific binding,GO:0097718,molecular function,54.0,2.0,9.421e-02,4.593e-02,1.933e-01,3.637e-02,4.531e-03,2.919e-01,8.084e-01,4.959e-02
CLTC,2092,protein binding,GO:0005515,molecular function,54.0,332.0,1.059e-01,6.276e-02,1.786e-01,8.569e-02,5.869e-02,1.251e-01,7.202e-01,1.210e-02
CLTC,2092,clathrin light chain binding,GO:0032051,molecular function,54.0,2.0,1.171e-01,7.929e-02,1.729e-01,8.629e-02,5.873e-02,1.268e-01,7.192e-01,1.243e-02
CLTC,2092,RNA binding,GO:0003723,molecular function,54.0,63.0,1.210e-01,7.895e-02,1.853e-01,9.789e-02,6.410e-02,1.495e-01,7.022e-01,1.429e-02
GATA6,4174,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,30.0,41.0,1.111e-01,9.872e-02,1.251e-01,1.423e-02,7.876e-03,2.570e-02,9.026e-01,9.992e-03
GATA6,4174,negative regulation of apoptotic process,GO:0043066,biological process,30.0,31.0,1.111e-01,9.872e-02,1.251e-01,2.539e-02,7.768e-03,8.296e-02,8.519e-01,2.511e-02
GATA6,4174,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,30.0,41.0,1.111e-01,9.872e-02,1.251e-01,3.158e-02,2.006e-02,4.971e-02,8.351e-01,1.068e-02
GATA6,4174,cardiac vascular smooth muscle cell differentiation,GO:0060947,biological process,30.0,4.0,1.139e-01,9.323e-02,1.392e-01,3.306e-02,1.891e-02,5.780e-02,8.298e-01,1.400e-02
GATA6,4174,negative regulation of transforming growth factor beta1 production,GO:0032911,biological process,30.0,4.0,1.225e-01,7.852e-02,1.911e-01,3.200e-02,3.870e-03,2.647e-01,8.219e-01,5.481e-02
GATA6,4174,negative regulation of transforming growth factor beta2 production,GO:0032912,biological process,30.0,4.0,1.225e-01,7.852e-02,1.911e-01,3.181e-02,3.407e-03,2.969e-01,8.206e-01,5.760e-02
GATA6,4174,smooth muscle cell differentiation,GO:0051145,biological process,30.0,7.0,1.225e-01,7.852e-02,1.911e-01,5.209e-02,1.302e-02,2.083e-01,7.761e-01,3.989e-02
GATA6,4174,response to growth factor,GO:0070848,biological process,30.0,11.0,1.322e-01,9.645e-02,1.811e-01,7.715e-02,4.193e-02,1.420e-01,7.329e-01,1.914e-02
GATA6,4174,cellular response to hypoxia,GO:0071456,biological process,30.0,5.0,1.340e-01,9.861e-02,1.822e-01,7.762e-02,3.603e-02,1.672e-01,7.316e-01,2.307e-02
GATA6,4174,response to drug,GO:0042493,biological process,30.0,78.0,1.391e-01,8.359e-02,2.313e-01,7.290e-02,1.777e-02,2.991e-01,7.349e-01,4.524e-02
GATA6,4174,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,30.0,54.0,1.403e-01,1.101e-01,1.788e-01,9.018e-02,4.965e-02,1.638e-01,7.126e-01,1.964e-02
GATA6,4174,outflow tract septum morphogenesis,GO:0003148,biological process,30.0,2.0,1.427e-01,6.465e-02,3.151e-01,8.767e-02,2.442e-02,3.147e-01,7.118e-01,4.224e-02
GATA6,4174,intestinal epithelial cell differentiation,GO:0060575,biological process,30.0,4.0,1.557e-01,7.398e-02,3.277e-01,9.411e-02,2.648e-02,3.345e-01,7.020e-01,4.396e-02
GATA6,4174,male gonad development,GO:0008584,biological process,30.0,2.0,1.694e-01,8.831e-02,3.250e-01,1.432e-01,7.208e-02,2.844e-01,6.452e-01,2.619e-02
GATA6,4174,positive regulation of cell cycle arrest,GO:0071158,biological process,30.0,5.0,1.827e-01,7.417e-02,4.499e-01,1.539e-01,5.591e-02,4.239e-01,6.301e-01,4.126e-02
GATA6,4174,positive regulation of angiogenesis,GO:0045766,biological process,30.0,6.0,1.868e-01,6.559e-02,5.322e-01,1.052e-01,7.800e-03,1.419e+00,6.674e-01,8.411e-02
GATA6,4174,epithelial cell differentiation,GO:0030855,biological process,30.0,25.0,1.934e-01,3.146e-02,1.189e+00,1.271e-01,9.854e-03,1.640e+00,6.218e-01,1.162e-01
GATA6,4174,transcription by RNA polymerase II,GO:0006366,biological process,30.0,16.0,2.018e-01,1.249e-01,3.261e-01,1.684e-01,5.888e-02,4.815e-01,6.158e-01,4.048e-02
GATA6,4174,positive regulation of cardiac muscle myoblast proliferation,GO:0110024,biological process,30.0,3.0,2.524e-01,1.222e-01,5.215e-01,2.434e-01,1.178e-01,5.029e-01,5.507e-01,3.659e-02
GATA6,4174,nucleus,GO:0005634,cellular component,30.0,151.0,1.233e-01,1.131e-01,1.343e-01,6.555e-02,2.132e-02,2.016e-01,7.512e-01,3.175e-02
GATA6,4174,nuclear membrane,GO:0031965,cellular component,30.0,9.0,1.479e-01,8.496e-02,2.575e-01,8.980e-02,1.892e-02,4.263e-01,7.062e-01,5.001e-02
GATA6,4174,transcription factor binding,GO:0008134,molecular function,30.0,19.0,1.111e-01,9.872e-02,1.251e-01,2.638e-02,1.443e-02,4.824e-02,8.518e-01,1.355e-02
GATA6,4174,DNA-binding transcription factor activity,GO:0003700,molecular function,30.0,18.0,1.111e-01,9.872e-02,1.251e-01,3.040e-02,1.116e-02,8.284e-02,8.365e-01,2.281e-02
GATA6,4174,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,30.0,10.0,1.111e-01,9.872e-02,1.251e-01,3.216e-02,2.163e-02,4.782e-02,8.332e-01,9.652e-03
GATA6,4174,protein binding,GO:0005515,molecular function,30.0,332.0,1.273e-01,1.127e-01,1.438e-01,7.188e-02,2.012e-02,2.568e-01,7.385e-01,3.672e-02
GATA6,4174,transcription regulatory region DNA binding,GO:0044212,molecular function,30.0,24.0,1.332e-01,1.080e-01,1.644e-01,7.712e-02,5.660e-02,1.051e-01,7.341e-01,9.291e-03
GATA6,4174,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,30.0,25.0,1.359e-01,1.033e-01,1.787e-01,7.913e-02,4.883e-02,1.282e-01,7.303e-01,1.464e-02
GATA6,4174,protein kinase binding,GO:0019901,molecular function,30.0,32.0,1.472e-01,1.181e-01,1.834e-01,1.168e-01,8.201e-02,1.664e-01,6.773e-01,1.227e-02
CEP131,29511,protein localization to centrosome,GO:0071539,biological process,25.0,3.0,1.696e-01,1.260e-01,2.283e-01,9.186e-02,5.665e-02,1.490e-01,7.105e-01,1.540e-02
CEP131,29511,positive regulation of intracellular protein transport,GO:0090316,biological process,25.0,17.0,1.748e-01,1.108e-01,2.757e-01,6.394e-02,1.009e-02,4.052e-01,7.472e-01,5.639e-02
CEP131,29511,intraciliary transport involved in cilium assembly,GO:0035735,biological process,25.0,2.0,1.959e-01,1.159e-01,3.311e-01,1.007e-01,2.065e-02,4.907e-01,6.903e-01,5.043e-02
CEP131,29511,cilium assembly,GO:0060271,biological process,25.0,12.0,2.058e-01,1.097e-01,3.862e-01,1.291e-01,4.342e-02,3.839e-01,6.583e-01,3.830e-02
CEP131,29511,positive regulation of cell population proliferation,GO:0008284,biological process,25.0,40.0,2.073e-01,1.086e-01,3.957e-01,1.784e-01,8.155e-02,3.901e-01,6.080e-01,3.281e-02
CEP131,29511,regulation of centrosome duplication,GO:0010824,biological process,25.0,7.0,2.131e-01,1.086e-01,4.183e-01,1.762e-01,5.219e-02,5.951e-01,6.060e-01,4.695e-02
CEP131,29511,centrosome,GO:0005813,cellular component,25.0,31.0,1.603e-01,1.320e-01,1.947e-01,3.366e-02,2.443e-02,4.637e-02,8.289e-01,7.542e-03
CEP131,29511,microtubule organizing center,GO:0005815,cellular component,25.0,16.0,1.603e-01,1.320e-01,1.947e-01,4.228e-02,2.851e-02,6.271e-02,8.046e-01,1.061e-02
CEP131,29511,intracellular membrane-bounded organelle,GO:0043231,cellular component,25.0,40.0,1.603e-01,1.320e-01,1.947e-01,4.261e-02,2.103e-02,8.632e-02,8.027e-01,1.839e-02
CEP131,29511,microtubule cytoskeleton,GO:0015630,cellular component,25.0,17.0,1.604e-01,1.322e-01,1.945e-01,5.099e-02,2.905e-02,8.950e-02,7.834e-01,1.581e-02
CEP131,29511,intercellular bridge,GO:0045171,cellular component,25.0,25.0,1.604e-01,1.322e-01,1.945e-01,7.638e-02,5.131e-02,1.137e-01,7.350e-01,1.233e-02
CEP131,29511,ciliary basal body,GO:0036064,cellular component,25.0,12.0,1.880e-01,1.021e-01,3.463e-01,1.018e-01,3.975e-02,2.606e-01,6.941e-01,3.213e-02
CEP131,29511,centriolar satellite,GO:0034451,cellular component,25.0,4.0,2.109e-01,1.087e-01,4.093e-01,1.862e-01,9.588e-02,3.616e-01,6.023e-01,2.658e-02
CEP131,29511,ciliary transition zone,GO:0035869,cellular component,25.0,5.0,2.220e-01,1.263e-01,3.903e-01,2.040e-01,1.187e-01,3.505e-01,5.870e-01,2.282e-02
CEP131,29511,protein homodimerization activity,GO:0042803,molecular function,25.0,15.0,1.604e-01,1.322e-01,1.945e-01,7.609e-02,5.744e-02,1.008e-01,7.357e-01,8.692e-03
CEP131,29511,protein binding,GO:0005515,molecular function,25.0,332.0,1.604e-01,1.322e-01,1.945e-01,9.486e-02,5.796e-02,1.553e-01,7.061e-01,1.636e-02
CEP131,29511,protein-containing complex binding,GO:0044877,molecular function,25.0,79.0,2.599e-01,2.026e-01,3.333e-01,2.070e-01,1.058e-01,4.051e-01,5.828e-01,2.935e-02
MYOM3,26679,skeletal muscle myosin thick filament assembly,GO:0030241,biological process,17.0,2.0,1.169e-01,5.747e-02,2.380e-01,2.454e-02,1.593e-02,3.780e-02,8.595e-01,1.008e-02
MYOM3,26679,striated muscle myosin thick filament assembly,GO:0071688,biological process,17.0,5.0,1.389e-01,6.234e-02,3.096e-01,4.382e-02,2.317e-02,8.287e-02,7.998e-01,1.659e-02
MYOM3,26679,sarcomere organization,GO:0045214,biological process,17.0,3.0,1.389e-01,6.234e-02,3.096e-01,5.739e-02,1.521e-02,2.165e-01,7.655e-01,3.693e-02
MYOM3,26679,cardiac muscle tissue morphogenesis,GO:0055008,biological process,17.0,4.0,1.566e-01,1.042e-01,2.355e-01,1.188e-01,4.834e-02,2.922e-01,6.724e-01,3.029e-02
MYOM3,26679,cardiac myofibril assembly,GO:0055003,biological process,17.0,4.0,1.585e-01,1.112e-01,2.259e-01,7.122e-02,4.176e-02,1.215e-01,7.434e-01,1.597e-02
MYOM3,26679,cardiac muscle fiber development,GO:0048739,biological process,17.0,3.0,1.606e-01,1.179e-01,2.187e-01,9.737e-02,3.392e-02,2.795e-01,6.994e-01,3.363e-02
MYOM3,26679,skeletal muscle thin filament assembly,GO:0030240,biological process,17.0,2.0,1.610e-01,1.177e-01,2.203e-01,1.097e-01,5.573e-02,2.160e-01,6.851e-01,2.316e-02
MYOM3,26679,muscle contraction,GO:0006936,biological process,17.0,4.0,3.044e-01,2.580e-01,3.591e-01,3.044e-01,2.580e-01,3.591e-01,5.086e-01,9.006e-03
MYOM3,26679,striated muscle thin filament,GO:0005865,cellular component,17.0,2.0,1.170e-01,5.690e-02,2.407e-01,3.977e-02,4.000e-03,3.954e-01,7.964e-01,6.068e-02
MYOM3,26679,Z disc,GO:0030018,cellular component,17.0,4.0,1.393e-01,6.222e-02,3.118e-01,8.182e-02,1.761e-02,3.803e-01,7.193e-01,4.576e-02
MYOM3,26679,sarcomere,GO:0030017,cellular component,17.0,2.0,1.566e-01,1.042e-01,2.355e-01,1.195e-01,5.914e-02,2.413e-01,6.728e-01,2.403e-02
MYOM3,26679,M band,GO:0031430,cellular component,17.0,2.0,1.566e-01,1.042e-01,2.355e-01,1.231e-01,6.062e-02,2.502e-01,6.682e-01,2.454e-02
MYOM3,26679,actin filament binding,GO:0051015,molecular function,17.0,4.0,1.167e-01,5.725e-02,2.379e-01,3.403e-02,6.862e-03,1.687e-01,8.208e-01,3.754e-02
MYOM3,26679,muscle alpha-actinin binding,GO:0051371,molecular function,17.0,3.0,1.393e-01,6.222e-02,3.118e-01,5.580e-02,7.645e-03,4.073e-01,7.631e-01,5.196e-02
MYOM3,26679,structural constituent of muscle,GO:0008307,molecular function,17.0,2.0,1.845e-01,1.107e-01,3.075e-01,1.455e-01,6.402e-02,3.309e-01,6.417e-01,3.147e-02
SH3BGRL3,15568,,,,nan,nan,,,,,,,,
KIF2C,6393,establishment or maintenance of microtubule cytoskeleton polarity,GO:0030951,biological process,41.0,4.0,3.277e-02,1.807e-02,5.946e-02,1.329e-02,2.806e-03,6.299e-02,8.987e-01,2.779e-02
KIF2C,6393,mitotic metaphase plate congression,GO:0007080,biological process,41.0,9.0,3.359e-02,2.124e-02,5.312e-02,1.647e-02,1.129e-02,2.404e-02,8.933e-01,6.784e-03
KIF2C,6393,microtubule depolymerization,GO:0007019,biological process,41.0,11.0,3.364e-02,1.917e-02,5.902e-02,1.796e-02,8.823e-03,3.655e-02,8.851e-01,1.387e-02
KIF2C,6393,metaphase plate congression,GO:0051310,biological process,41.0,6.0,3.802e-02,1.999e-02,7.230e-02,2.519e-02,9.680e-03,6.555e-02,8.544e-01,2.019e-02
KIF2C,6393,attachment of mitotic spindle microtubules to kinetochore,GO:0051315,biological process,41.0,7.0,4.057e-02,3.102e-02,5.305e-02,2.548e-02,2.013e-02,3.225e-02,8.561e-01,5.592e-03
KIF2C,6393,regulation of chromosome segregation,GO:0051983,biological process,41.0,11.0,4.272e-02,3.597e-02,5.073e-02,3.022e-02,2.823e-02,3.234e-02,8.392e-01,1.558e-03
KIF2C,6393,microtubule-based movement,GO:0007018,biological process,41.0,21.0,4.943e-02,2.685e-02,9.103e-02,4.098e-02,1.612e-02,1.042e-01,8.061e-01,2.344e-02
KIF2C,6393,kinetochore,GO:0000776,cellular component,41.0,13.0,2.909e-02,2.351e-02,3.599e-02,3.960e-03,3.590e-03,4.367e-03,9.657e-01,9.483e-04
KIF2C,6393,"chromosome, centromeric region",GO:0000775,cellular component,41.0,8.0,2.909e-02,2.351e-02,3.599e-02,5.298e-03,3.609e-03,7.776e-03,9.535e-01,3.903e-03
KIF2C,6393,microtubule plus-end,GO:0035371,cellular component,41.0,6.0,2.909e-02,2.351e-02,3.599e-02,6.838e-03,4.481e-03,1.044e-02,9.423e-01,4.777e-03
KIF2C,6393,microtubule,GO:0005874,cellular component,41.0,22.0,3.154e-02,1.974e-02,5.040e-02,1.303e-02,1.145e-02,1.483e-02,9.096e-01,1.918e-03
KIF2C,6393,centrosome,GO:0005813,cellular component,41.0,31.0,3.221e-02,1.881e-02,5.515e-02,1.519e-02,7.038e-03,3.277e-02,8.970e-01,1.265e-02
KIF2C,6393,kinesin complex,GO:0005871,cellular component,41.0,16.0,3.315e-02,1.978e-02,5.557e-02,1.771e-02,1.149e-02,2.731e-02,8.873e-01,8.395e-03
KIF2C,6393,microtubule cytoskeleton,GO:0015630,cellular component,41.0,17.0,4.621e-02,3.774e-02,5.658e-02,3.813e-02,3.277e-02,4.436e-02,8.163e-01,3.849e-03
KIF2C,6393,membrane,GO:0016020,cellular component,41.0,53.0,5.094e-02,3.656e-02,7.099e-02,4.447e-02,3.298e-02,5.998e-02,7.993e-01,8.185e-03
KIF2C,6393,nucleus,GO:0005634,cellular component,41.0,151.0,6.256e-02,5.230e-02,7.484e-02,5.958e-02,4.981e-02,7.128e-02,7.657e-01,4.983e-03
KIF2C,6393,microtubule plus-end binding,GO:0051010,molecular function,41.0,3.0,2.909e-02,2.351e-02,3.599e-02,2.673e-03,1.367e-03,5.225e-03,9.770e-01,4.592e-03
KIF2C,6393,microtubule motor activity,GO:0003777,molecular function,41.0,13.0,3.154e-02,1.974e-02,5.040e-02,1.076e-02,8.464e-03,1.368e-02,9.204e-01,2.866e-03
KIF2C,6393,microtubule binding,GO:0008017,molecular function,41.0,22.0,3.221e-02,1.881e-02,5.515e-02,1.501e-02,1.052e-02,2.142e-02,8.998e-01,5.783e-03
KIF2C,6393,ATPase activity,GO:0016887,molecular function,41.0,14.0,4.432e-02,3.500e-02,5.612e-02,3.343e-02,2.722e-02,4.105e-02,8.296e-01,4.790e-03
KIF2C,6393,protein binding,GO:0005515,molecular function,41.0,332.0,7.100e-02,5.536e-02,9.106e-02,7.100e-02,5.536e-02,9.106e-02,7.446e-01,7.415e-03
LMO4,6644,protein binding,GO:0005515,molecular function,7.0,332.0,2.670e-02,2.267e-02,3.145e-02,2.670e-02,2.267e-02,3.145e-02,8.515e-01,3.998e-03
NUF2,14621,kinetochore organization,GO:0051383,biological process,29.0,4.0,1.684e-02,8.422e-03,3.367e-02,5.625e-03,2.214e-03,1.429e-02,9.501e-01,1.002e-02
NUF2,14621,mitotic spindle organization,GO:0007052,biological process,29.0,12.0,1.684e-02,8.422e-03,3.367e-02,7.089e-03,3.903e-03,1.288e-02,9.405e-01,6.819e-03
NUF2,14621,attachment of mitotic spindle microtubules to kinetochore,GO:0051315,biological process,29.0,7.0,2.329e-02,7.455e-03,7.276e-02,1.377e-02,5.070e-03,3.740e-02,9.026e-01,1.471e-02
NUF2,14621,meiotic chromosome segregation,GO:0045132,biological process,29.0,9.0,2.462e-02,6.679e-03,9.074e-02,1.591e-02,4.207e-03,6.014e-02,8.890e-01,2.287e-02
NUF2,14621,condensed nuclear chromosome kinetochore,GO:0000778,cellular component,29.0,3.0,1.684e-02,8.422e-03,3.367e-02,4.173e-03,2.721e-03,6.401e-03,9.635e-01,4.321e-03
NUF2,14621,Ndc80 complex,GO:0031262,cellular component,29.0,2.0,1.684e-02,8.422e-03,3.367e-02,5.145e-03,4.374e-03,6.051e-03,9.546e-01,1.534e-03
NUF2,14621,nucleus,GO:0005634,cellular component,29.0,151.0,3.623e-02,1.665e-02,7.883e-02,3.200e-02,1.604e-02,6.381e-02,8.333e-01,1.630e-02
NUF2,14621,membrane,GO:0016020,cellular component,29.0,53.0,3.623e-02,1.665e-02,7.883e-02,3.623e-02,1.665e-02,7.883e-02,8.200e-01,1.926e-02
NUF2,14621,protein-containing complex binding,GO:0044877,molecular function,29.0,79.0,3.379e-02,1.647e-02,6.934e-02,2.493e-02,1.405e-02,4.424e-02,8.578e-01,1.304e-02
NUF2,14621,protein binding,GO:0005515,molecular function,29.0,332.0,3.544e-02,1.646e-02,7.629e-02,3.251e-02,1.458e-02,7.249e-02,8.306e-01,1.991e-02
HORMAD1,25245,,,,nan,nan,,,,,,,,
DTL,30288,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,26.0,9.0,9.420e-02,6.807e-02,1.304e-01,2.769e-02,3.902e-03,1.965e-01,8.361e-01,4.386e-02
DTL,30288,response to UV,GO:0009411,biological process,26.0,9.0,9.689e-02,7.062e-02,1.329e-01,2.773e-02,6.540e-03,1.176e-01,8.426e-01,3.496e-02
DTL,30288,positive regulation of protein catabolic process,GO:0045732,biological process,26.0,9.0,9.728e-02,7.065e-02,1.340e-01,2.729e-02,1.409e-03,5.285e-01,8.224e-01,5.935e-02
DTL,30288,protein polyubiquitination,GO:0000209,biological process,26.0,11.0,9.737e-02,7.010e-02,1.353e-01,3.871e-02,1.106e-02,1.355e-01,8.104e-01,3.353e-02
DTL,30288,translesion synthesis,GO:0019985,biological process,26.0,5.0,9.737e-02,7.010e-02,1.353e-01,5.803e-02,2.534e-02,1.329e-01,7.673e-01,2.375e-02
DTL,30288,regulation of cell cycle,GO:0051726,biological process,26.0,14.0,1.019e-01,8.692e-02,1.195e-01,5.057e-02,3.025e-02,8.455e-02,7.845e-01,1.391e-02
DTL,30288,protein monoubiquitination,GO:0006513,biological process,26.0,4.0,1.022e-01,6.426e-02,1.625e-01,5.018e-02,1.143e-02,2.202e-01,7.800e-01,4.255e-02
DTL,30288,cellular response to DNA damage stimulus,GO:0006974,biological process,26.0,20.0,1.025e-01,8.618e-02,1.218e-01,7.808e-02,6.398e-02,9.529e-02,7.327e-01,6.094e-03
DTL,30288,signal transduction involved in G2 DNA damage checkpoint,GO:0072425,biological process,26.0,4.0,1.093e-01,7.444e-02,1.605e-01,8.785e-02,4.554e-02,1.694e-01,7.158e-01,2.161e-02
DTL,30288,positive regulation of G2/M transition of mitotic cell cycle,GO:0010971,biological process,26.0,9.0,1.106e-01,7.234e-02,1.692e-01,7.884e-02,2.857e-02,2.176e-01,7.277e-01,3.266e-02
DTL,30288,Cul4A-RING E3 ubiquitin ligase complex,GO:0031464,cellular component,26.0,3.0,9.373e-02,6.879e-02,1.277e-01,1.469e-02,5.520e-03,3.910e-02,8.976e-01,1.785e-02
DTL,30288,Cul4B-RING E3 ubiquitin ligase complex,GO:0031465,cellular component,26.0,3.0,9.373e-02,6.879e-02,1.277e-01,2.838e-02,1.450e-02,5.554e-02,8.449e-01,1.533e-02
DTL,30288,Cul4-RING E3 ubiquitin ligase complex,GO:0080008,cellular component,26.0,5.0,9.858e-02,8.067e-02,1.205e-01,2.887e-02,7.763e-03,1.074e-01,8.397e-01,3.149e-02
DTL,30288,centrosome,GO:0005813,cellular component,26.0,31.0,1.024e-01,8.603e-02,1.219e-01,4.766e-02,4.011e-02,5.664e-02,7.915e-01,4.757e-03
DTL,30288,nucleus,GO:0005634,cellular component,26.0,151.0,1.025e-01,8.618e-02,1.218e-01,8.275e-02,7.065e-02,9.692e-02,7.251e-01,4.994e-03
DTL,30288,cytosol,GO:0005829,cellular component,26.0,78.0,1.025e-01,8.618e-02,1.218e-01,8.593e-02,7.947e-02,9.291e-02,7.203e-01,2.505e-03
DTL,30288,nucleolus,GO:0005730,cellular component,26.0,41.0,1.153e-01,9.079e-02,1.464e-01,1.091e-01,9.623e-02,1.237e-01,6.875e-01,4.356e-03
DTL,30288,ubiquitin-protein transferase activity,GO:0004842,molecular function,26.0,11.0,9.689e-02,7.062e-02,1.329e-01,3.394e-02,1.130e-02,1.020e-01,8.252e-01,2.779e-02
DTL,30288,protein binding,GO:0005515,molecular function,26.0,332.0,1.025e-01,8.618e-02,1.218e-01,8.510e-02,7.612e-02,9.514e-02,7.216e-01,3.510e-03
ATP8B2,13534,,,,nan,nan,,,,,,,,
NUP210L,29915,,,,nan,nan,,,,,,,,
LYST,1968,endosome to lysosome transport via multivesicular body sorting pathway,GO:0032510,biological process,6.0,4.0,1.122e-01,1.000e-01,1.259e-01,3.347e-02,1.564e-02,7.160e-02,8.283e-01,1.862e-02
LYST,1968,natural killer cell mediated cytotoxicity,GO:0042267,biological process,6.0,4.0,1.127e-01,1.007e-01,1.262e-01,7.392e-02,3.608e-02,1.515e-01,7.380e-01,2.166e-02
LYST,1968,pigmentation,GO:0043473,biological process,6.0,6.0,1.282e-01,9.038e-02,1.818e-01,1.185e-01,7.162e-02,1.962e-01,6.748e-01,1.783e-02
LYST,1968,microtubule cytoskeleton,GO:0015630,cellular component,6.0,17.0,1.127e-01,1.007e-01,1.262e-01,7.637e-02,5.099e-02,1.144e-01,7.350e-01,1.250e-02
LYST,1968,protein binding,GO:0005515,molecular function,6.0,332.0,1.250e-01,7.936e-02,1.967e-01,1.100e-01,5.588e-02,2.165e-01,6.849e-01,2.381e-02
CEP170,28920,centrosome,GO:0005813,cellular component,23.0,31.0,8.615e-03,3.884e-03,1.911e-02,3.402e-03,3.019e-03,3.833e-03,9.717e-01,9.692e-04
CEP170,28920,centriolar subdistal appendage,GO:0120103,cellular component,23.0,4.0,8.615e-03,3.884e-03,1.911e-02,3.387e-03,2.038e-03,5.630e-03,9.709e-01,4.576e-03
CEP170,28920,centriole,GO:0005814,cellular component,23.0,5.0,1.019e-02,2.606e-03,3.987e-02,4.739e-03,1.072e-03,2.094e-02,9.561e-01,1.558e-02
CEP170,28920,plasma membrane,GO:0005886,cellular component,23.0,24.0,1.921e-02,7.377e-03,5.003e-02,1.332e-02,4.696e-03,3.777e-02,9.046e-01,1.500e-02
CEP170,28920,cytosol,GO:0005829,cellular component,23.0,78.0,2.435e-02,1.494e-02,3.968e-02,2.118e-02,1.207e-02,3.715e-02,8.719e-01,1.119e-02
CEP170,28920,protein binding,GO:0005515,molecular function,23.0,332.0,2.604e-02,1.997e-02,3.396e-02,2.604e-02,1.997e-02,3.396e-02,8.540e-01,6.232e-03
WDPCP,28027,,,,nan,nan,,,,,,,,
DUSP11,3066,polynucleotide 5' dephosphorylation,GO:0098507,biological process,15.0,2.0,1.075e-01,1.739e-02,6.642e-01,5.864e-02,3.750e-03,9.170e-01,7.453e-01,7.247e-02
DUSP11,3066,protein dephosphorylation,GO:0006470,biological process,15.0,11.0,1.576e-01,3.453e-02,7.193e-01,1.434e-01,2.697e-02,7.621e-01,6.346e-01,5.935e-02
DUSP11,3066,RNA metabolic process,GO:0016070,biological process,15.0,17.0,1.589e-01,2.803e-02,9.005e-01,1.250e-01,1.620e-02,9.642e-01,6.453e-01,8.213e-02
DUSP11,3066,nuclear speck,GO:0016607,cellular component,15.0,6.0,8.790e-02,2.049e-02,3.771e-01,1.690e-02,2.644e-03,1.081e-01,8.794e-01,3.011e-02
DUSP11,3066,nucleus,GO:0005634,cellular component,15.0,151.0,1.092e-01,4.605e-02,2.591e-01,5.394e-02,3.825e-02,7.606e-02,7.772e-01,9.441e-03
DUSP11,3066,intercellular bridge,GO:0045171,cellular component,15.0,25.0,1.092e-01,4.605e-02,2.591e-01,6.035e-02,3.445e-02,1.057e-01,7.635e-01,1.594e-02
DUSP11,3066,fibrillar center,GO:0001650,cellular component,15.0,9.0,1.104e-01,4.544e-02,2.684e-01,7.264e-02,2.355e-02,2.241e-01,7.382e-01,3.282e-02
DUSP11,3066,"nucleotide phosphatase activity, acting on free nucleotides",GO:0098519,molecular function,15.0,4.0,8.790e-02,2.049e-02,3.771e-01,1.681e-02,5.002e-03,5.651e-02,8.858e-01,2.245e-02
DUSP11,3066,RNA binding,GO:0003723,molecular function,15.0,63.0,8.790e-02,2.049e-02,3.771e-01,3.072e-02,4.270e-03,2.211e-01,8.269e-01,4.854e-02
DUSP11,3066,polynucleotide 5'-phosphatase activity,GO:0004651,molecular function,15.0,2.0,1.104e-01,4.544e-02,2.684e-01,7.836e-02,3.725e-02,1.648e-01,7.303e-01,2.320e-02
DUSP11,3066,protein tyrosine phosphatase activity,GO:0004725,molecular function,15.0,10.0,1.255e-01,6.145e-02,2.562e-01,1.076e-01,5.190e-02,2.230e-01,6.876e-01,2.526e-02
DUSP11,3066,phosphatase activity,GO:0016791,molecular function,15.0,74.0,1.316e-01,7.542e-02,2.295e-01,8.893e-02,2.954e-02,2.677e-01,7.116e-01,3.468e-02
EAF1,20907,intracellular membrane-bounded organelle,GO:0043231,cellular component,9.0,40.0,2.982e-02,2.672e-02,3.329e-02,4.970e-03,4.453e-03,5.548e-03,9.561e-01,1.110e-03
EAF1,20907,nucleoplasm,GO:0005654,cellular component,9.0,74.0,5.733e-02,4.543e-02,7.234e-02,4.549e-02,2.865e-02,7.224e-02,7.965e-01,1.253e-02
EAF1,20907,intercellular bridge,GO:0045171,cellular component,9.0,25.0,5.733e-02,4.543e-02,7.234e-02,4.849e-02,2.862e-02,8.218e-02,7.891e-01,1.442e-02
EAF1,20907,nuclear body,GO:0016604,cellular component,9.0,30.0,5.733e-02,4.543e-02,7.234e-02,4.931e-02,3.139e-02,7.745e-02,7.874e-01,1.224e-02
EAF1,20907,transcription elongation factor complex,GO:0008023,cellular component,9.0,11.0,6.703e-02,4.782e-02,9.396e-02,6.362e-02,4.206e-02,9.624e-02,7.576e-01,1.214e-02
EAF1,20907,protein binding,GO:0005515,molecular function,9.0,332.0,5.733e-02,4.543e-02,7.234e-02,4.602e-02,3.068e-02,6.902e-02,7.953e-01,1.093e-02
CORIN,19012,,,,nan,nan,,,,,,,,
CCNA2,1578,G2/M transition of mitotic cell cycle,GO:0000086,biological process,45.0,4.0,3.776e-02,2.550e-02,5.591e-02,9.024e-03,4.624e-03,1.761e-02,9.288e-01,7.831e-03
CCNA2,1578,cell cycle G1/S phase transition,GO:0044843,biological process,45.0,3.0,3.776e-02,2.550e-02,5.591e-02,9.101e-03,4.207e-03,1.969e-02,9.282e-01,9.044e-03
CCNA2,1578,mitotic cell cycle phase transition,GO:0044772,biological process,45.0,11.0,3.776e-02,2.550e-02,5.591e-02,1.668e-02,9.845e-03,2.826e-02,8.917e-01,8.877e-03
CCNA2,1578,Ras protein signal transduction,GO:0007265,biological process,45.0,12.0,3.776e-02,2.550e-02,5.591e-02,1.974e-02,1.054e-02,3.694e-02,8.777e-01,1.202e-02
CCNA2,1578,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,45.0,10.0,3.776e-02,2.550e-02,5.591e-02,2.011e-02,7.968e-03,5.076e-02,8.740e-01,1.747e-02
CCNA2,1578,histone phosphorylation,GO:0016572,biological process,45.0,7.0,4.366e-02,2.223e-02,8.572e-02,3.535e-02,1.655e-02,7.547e-02,8.223e-01,1.940e-02
CCNA2,1578,regulation of DNA replication,GO:0006275,biological process,45.0,8.0,4.677e-02,1.564e-02,1.398e-01,3.485e-02,7.759e-03,1.565e-01,8.200e-01,3.955e-02
CCNA2,1578,cyclin A2-CDK2 complex,GO:0097124,cellular component,45.0,2.0,3.776e-02,2.550e-02,5.591e-02,6.124e-03,1.444e-03,2.597e-02,9.449e-01,1.619e-02
CCNA2,1578,nucleus,GO:0005634,cellular component,45.0,151.0,3.776e-02,2.550e-02,5.591e-02,2.134e-02,6.396e-03,7.122e-02,8.667e-01,2.282e-02
CCNA2,1578,cytoplasm,GO:0005737,cellular component,45.0,69.0,3.776e-02,2.550e-02,5.591e-02,2.427e-02,1.024e-02,5.752e-02,8.581e-01,1.806e-02
CCNA2,1578,cytosol,GO:0005829,cellular component,45.0,78.0,3.808e-02,2.576e-02,5.629e-02,2.509e-02,1.133e-02,5.555e-02,8.557e-01,1.710e-02
CCNA2,1578,nucleoplasm,GO:0005654,cellular component,45.0,74.0,3.808e-02,2.576e-02,5.629e-02,2.762e-02,1.278e-02,5.968e-02,8.471e-01,1.723e-02
CCNA2,1578,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,45.0,27.0,4.633e-02,2.990e-02,7.179e-02,3.039e-02,8.542e-03,1.081e-01,8.348e-01,2.994e-02
CCNA2,1578,cyclin-dependent protein kinase activity,GO:0097472,molecular function,45.0,3.0,3.776e-02,2.550e-02,5.591e-02,1.025e-02,8.763e-03,1.198e-02,9.231e-01,1.812e-03
CCNA2,1578,protein kinase binding,GO:0019901,molecular function,45.0,32.0,3.776e-02,2.550e-02,5.591e-02,2.582e-02,1.438e-02,4.636e-02,8.543e-01,1.348e-02
CCNA2,1578,protein binding,GO:0005515,molecular function,45.0,332.0,3.808e-02,2.576e-02,5.629e-02,2.731e-02,1.144e-02,6.519e-02,8.477e-01,1.903e-02
CCNA2,1578,cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,molecular function,45.0,8.0,3.876e-02,2.802e-02,5.361e-02,2.125e-02,1.061e-02,4.259e-02,8.708e-01,1.409e-02
CCNA2,1578,protein kinase activity,GO:0004672,molecular function,45.0,38.0,4.332e-02,1.871e-02,1.003e-01,3.105e-02,9.327e-03,1.034e-01,8.338e-01,3.042e-02
CCNA2,1578,protein domain specific binding,GO:0019904,molecular function,45.0,82.0,5.741e-02,2.156e-02,1.529e-01,5.639e-02,2.021e-02,1.573e-01,7.696e-01,2.963e-02
ADAMTS16,17108,,,,nan,nan,,,,,,,,
FBXO38,28844,,,,nan,nan,,,,,,,,
CDCA5,14626,mitotic metaphase plate congression,GO:0007080,biological process,27.0,9.0,2.953e-02,2.098e-02,4.156e-02,1.096e-02,1.074e-03,1.119e-01,9.063e-01,3.043e-02
CDCA5,14626,mitotic chromosome condensation,GO:0007076,biological process,27.0,9.0,2.953e-02,2.098e-02,4.156e-02,1.345e-02,3.286e-03,5.504e-02,9.011e-01,1.975e-02
CDCA5,14626,mitotic sister chromatid cohesion,GO:0007064,biological process,27.0,7.0,2.953e-02,2.098e-02,4.156e-02,1.377e-02,3.521e-03,5.388e-02,8.997e-01,1.955e-02
CDCA5,14626,double-strand break repair,GO:0006302,biological process,27.0,10.0,3.595e-02,2.386e-02,5.418e-02,1.801e-02,1.015e-02,3.192e-02,8.856e-01,1.075e-02
CDCA5,14626,positive regulation of exit from mitosis,GO:0031536,biological process,27.0,5.0,3.671e-02,2.282e-02,5.905e-02,1.117e-02,1.362e-03,9.156e-02,9.039e-01,3.603e-02
CDCA5,14626,mitotic cell cycle,GO:0000278,biological process,27.0,13.0,3.671e-02,2.282e-02,5.905e-02,2.595e-02,1.510e-02,4.461e-02,8.535e-01,1.225e-02
CDCA5,14626,regulation of cohesin loading,GO:0071922,biological process,27.0,7.0,3.784e-02,2.134e-02,6.713e-02,2.067e-02,4.286e-03,9.970e-02,8.670e-01,3.511e-02
CDCA5,14626,cohesin complex,GO:0008278,cellular component,27.0,6.0,3.023e-02,2.295e-02,3.983e-02,5.817e-03,2.692e-03,1.257e-02,9.489e-01,8.242e-03
CDCA5,14626,nucleus,GO:0005634,cellular component,27.0,151.0,4.444e-02,2.979e-02,6.630e-02,3.812e-02,2.396e-02,6.064e-02,8.152e-01,1.144e-02
CDCA5,14626,nucleoplasm,GO:0005654,cellular component,27.0,74.0,4.796e-02,3.447e-02,6.673e-02,4.320e-02,3.114e-02,5.993e-02,8.024e-01,8.864e-03
CDCA5,14626,protein-containing complex binding,GO:0044877,molecular function,27.0,79.0,4.408e-02,2.986e-02,6.507e-02,2.809e-02,1.473e-02,5.358e-02,8.463e-01,1.530e-02
CDCA5,14626,protein binding,GO:0005515,molecular function,27.0,332.0,4.811e-02,3.425e-02,6.758e-02,4.453e-02,2.885e-02,6.872e-02,7.991e-01,1.178e-02
HMBOX1,26137,positive regulation of telomere maintenance via telomerase,GO:0032212,biological process,21.0,6.0,6.141e-02,4.577e-02,8.239e-02,8.678e-03,3.279e-03,2.297e-02,9.299e-01,1.102e-02
HMBOX1,26137,positive regulation of telomerase activity,GO:0051973,biological process,21.0,7.0,6.141e-02,4.577e-02,8.239e-02,1.193e-02,6.551e-03,2.171e-02,9.135e-01,8.250e-03
HMBOX1,26137,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,21.0,41.0,6.258e-02,4.774e-02,8.202e-02,2.918e-02,1.390e-02,6.126e-02,8.420e-01,1.791e-02
HMBOX1,26137,regulation of telomerase activity,GO:0051972,biological process,21.0,6.0,6.258e-02,4.774e-02,8.202e-02,3.887e-02,1.764e-02,8.564e-02,8.126e-01,1.991e-02
HMBOX1,26137,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,21.0,54.0,8.965e-02,7.940e-02,1.012e-01,8.965e-02,7.940e-02,1.012e-01,7.146e-01,3.980e-03
HMBOX1,26137,"nuclear chromosome, telomeric region",GO:0000784,cellular component,21.0,4.0,6.258e-02,4.774e-02,8.202e-02,3.620e-02,1.661e-02,7.888e-02,8.195e-01,1.996e-02
HMBOX1,26137,nucleus,GO:0005634,cellular component,21.0,151.0,6.258e-02,4.774e-02,8.202e-02,3.676e-02,2.530e-02,5.340e-02,8.195e-01,8.946e-03
HMBOX1,26137,cytoplasm,GO:0005737,cellular component,21.0,69.0,6.277e-02,4.823e-02,8.169e-02,4.564e-02,2.858e-02,7.288e-02,7.962e-01,1.283e-02
HMBOX1,26137,nucleoplasm,GO:0005654,cellular component,21.0,74.0,6.315e-02,4.920e-02,8.106e-02,4.253e-02,2.673e-02,6.769e-02,8.035e-01,1.191e-02
HMBOX1,26137,cytosol,GO:0005829,cellular component,21.0,78.0,6.454e-02,5.011e-02,8.312e-02,5.023e-02,3.704e-02,6.812e-02,7.855e-01,8.349e-03
HMBOX1,26137,nuclear body,GO:0016604,cellular component,21.0,30.0,7.548e-02,4.786e-02,1.190e-01,6.869e-02,3.956e-02,1.193e-01,7.477e-01,1.648e-02
HMBOX1,26137,double-stranded telomeric DNA binding,GO:0003691,molecular function,21.0,3.0,6.141e-02,4.577e-02,8.239e-02,1.133e-02,9.057e-03,1.417e-02,9.177e-01,2.896e-03
HMBOX1,26137,telomeric DNA binding,GO:0042162,molecular function,21.0,6.0,6.258e-02,4.774e-02,8.202e-02,1.807e-02,1.271e-02,2.569e-02,8.862e-01,6.478e-03
HMBOX1,26137,identical protein binding,GO:0042802,molecular function,21.0,20.0,6.258e-02,4.774e-02,8.202e-02,2.425e-02,2.161e-02,2.722e-02,8.610e-01,2.610e-03
HMBOX1,26137,sequence-specific DNA binding,GO:0043565,molecular function,21.0,12.0,6.277e-02,4.823e-02,8.169e-02,3.232e-02,2.228e-02,4.688e-02,8.331e-01,8.836e-03
HMBOX1,26137,protein binding,GO:0005515,molecular function,21.0,332.0,6.463e-02,5.016e-02,8.328e-02,4.977e-02,3.888e-02,6.370e-02,7.865e-01,6.781e-03
HMBOX1,26137,protein-containing complex binding,GO:0044877,molecular function,21.0,79.0,8.791e-02,7.515e-02,1.028e-01,8.427e-02,6.782e-02,1.047e-01,7.227e-01,6.893e-03
MRRF,7234,ribosome disassembly,GO:0032790,biological process,8.0,2.0,1.603e-01,8.021e-02,3.202e-01,1.456e-01,9.041e-02,2.345e-01,6.439e-01,1.730e-02
MRRF,7234,translation,GO:0006412,biological process,8.0,8.0,1.749e-01,4.313e-02,7.089e-01,1.558e-01,2.902e-02,8.369e-01,6.176e-01,6.799e-02
MRRF,7234,mitochondrion,GO:0005739,cellular component,8.0,19.0,6.802e-02,8.396e-03,5.510e-01,2.142e-02,1.554e-03,2.954e-01,8.495e-01,4.902e-02
MRRF,7234,ribosomal large subunit binding,GO:0043023,molecular function,8.0,2.0,9.230e-02,1.006e-02,8.471e-01,3.992e-02,4.810e-03,3.313e-01,7.982e-01,5.299e-02
TCF7L2,11641,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0044334,biological process,52.0,2.0,8.630e-02,7.300e-02,1.020e-01,4.008e-03,3.136e-03,5.121e-03,9.654e-01,2.330e-03
TCF7L2,11641,positive regulation of protein binding,GO:0032092,biological process,52.0,13.0,8.841e-02,8.115e-02,9.632e-02,1.470e-02,1.632e-03,1.324e-01,8.866e-01,3.501e-02
TCF7L2,11641,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,52.0,41.0,9.011e-02,7.907e-02,1.027e-01,2.369e-02,7.417e-03,7.565e-02,8.589e-01,2.593e-02
TCF7L2,11641,"regulation of transcription, DNA-templated",GO:0006355,biological process,52.0,36.0,9.011e-02,7.907e-02,1.027e-01,2.613e-02,9.414e-03,7.253e-02,8.508e-01,2.303e-02
TCF7L2,11641,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,52.0,14.0,9.011e-02,7.907e-02,1.027e-01,3.213e-02,8.129e-03,1.270e-01,8.282e-01,3.090e-02
TCF7L2,11641,positive regulation of protein export from nucleus,GO:0046827,biological process,52.0,9.0,9.554e-02,8.660e-02,1.054e-01,3.557e-02,1.889e-02,6.696e-02,8.224e-01,1.598e-02
TCF7L2,11641,positive regulation of epithelial cell proliferation,GO:0050679,biological process,52.0,18.0,9.986e-02,7.874e-02,1.267e-01,4.597e-02,1.299e-02,1.627e-01,7.917e-01,3.286e-02
TCF7L2,11641,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,52.0,62.0,9.986e-02,7.874e-02,1.267e-01,4.960e-02,3.129e-02,7.862e-02,7.867e-01,1.250e-02
TCF7L2,11641,canonical Wnt signaling pathway,GO:0060070,biological process,52.0,22.0,1.014e-01,8.253e-02,1.245e-01,6.069e-02,3.398e-02,1.084e-01,7.628e-01,1.646e-02
TCF7L2,11641,regulation of transcription by RNA polymerase II,GO:0006357,biological process,52.0,46.0,1.033e-01,5.806e-02,1.838e-01,4.116e-02,6.413e-03,2.641e-01,7.984e-01,5.180e-02
TCF7L2,11641,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,52.0,54.0,1.076e-01,8.811e-02,1.314e-01,7.295e-02,6.821e-02,7.802e-02,7.414e-01,2.036e-03
TCF7L2,11641,maintenance of DNA repeat elements,GO:0043570,biological process,52.0,6.0,1.123e-01,7.889e-02,1.598e-01,6.187e-02,1.493e-02,2.564e-01,7.562e-01,3.922e-02
TCF7L2,11641,positive regulation of insulin secretion,GO:0032024,biological process,52.0,5.0,1.135e-01,7.941e-02,1.621e-01,7.857e-02,3.479e-02,1.774e-01,7.298e-01,2.438e-02
TCF7L2,11641,positive regulation of protein kinase B signaling,GO:0051897,biological process,52.0,3.0,1.157e-01,7.099e-02,1.885e-01,5.208e-02,7.570e-03,3.583e-01,7.715e-01,5.235e-02
TCF7L2,11641,cell cycle arrest,GO:0007050,biological process,52.0,8.0,1.269e-01,7.850e-02,2.051e-01,1.018e-01,6.079e-02,1.706e-01,6.962e-01,1.683e-02
TCF7L2,11641,positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909,biological process,52.0,4.0,1.291e-01,5.683e-02,2.931e-01,9.415e-02,2.398e-02,3.696e-01,7.011e-01,4.639e-02
TCF7L2,11641,regulation of smooth muscle cell proliferation,GO:0048660,biological process,52.0,5.0,1.303e-01,1.011e-01,1.679e-01,1.069e-01,7.912e-02,1.445e-01,6.903e-01,1.035e-02
TCF7L2,11641,fat cell differentiation,GO:0045444,biological process,52.0,5.0,1.367e-01,5.693e-02,3.282e-01,9.560e-02,2.400e-02,3.808e-01,6.989e-01,4.641e-02
TCF7L2,11641,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,52.0,8.0,1.457e-01,8.028e-02,2.643e-01,1.127e-01,3.673e-02,3.458e-01,6.781e-01,3.816e-02
TCF7L2,11641,blood vessel development,GO:0001568,biological process,52.0,7.0,1.813e-01,7.612e-02,4.319e-01,1.683e-01,6.258e-02,4.527e-01,6.150e-01,4.236e-02
TCF7L2,11641,myoblast fate commitment,GO:0048625,biological process,52.0,5.0,1.865e-01,1.181e-01,2.947e-01,1.779e-01,1.128e-01,2.808e-01,6.116e-01,1.784e-02
TCF7L2,11641,regulation of hormone metabolic process,GO:0032350,biological process,52.0,18.0,2.173e-01,7.893e-02,5.981e-01,1.989e-01,5.814e-02,6.804e-01,5.815e-01,5.574e-02
TCF7L2,11641,glucose homeostasis,GO:0042593,biological process,52.0,3.0,2.231e-01,1.875e-01,2.654e-01,2.160e-01,1.727e-01,2.702e-01,5.785e-01,1.005e-02
TCF7L2,11641,nuclear chromatin,GO:0000790,cellular component,52.0,14.0,9.011e-02,7.907e-02,1.027e-01,1.914e-02,1.527e-02,2.400e-02,8.819e-01,4.445e-03
TCF7L2,11641,transcription factor complex,GO:0005667,cellular component,52.0,9.0,9.986e-02,7.874e-02,1.267e-01,4.120e-02,1.782e-02,9.527e-02,8.061e-01,2.188e-02
TCF7L2,11641,nucleus,GO:0005634,cellular component,52.0,151.0,1.003e-01,8.420e-02,1.196e-01,4.715e-02,2.272e-02,9.784e-02,7.915e-01,1.897e-02
TCF7L2,11641,nucleoplasm,GO:0005654,cellular component,52.0,74.0,1.037e-01,8.210e-02,1.310e-01,5.509e-02,3.799e-02,7.988e-02,7.748e-01,1.025e-02
TCF7L2,11641,beta-catenin-TCF7L2 complex,GO:0070369,cellular component,52.0,3.0,1.271e-01,6.598e-02,2.450e-01,9.055e-02,3.015e-02,2.719e-01,7.092e-01,3.536e-02
TCF7L2,11641,protein-DNA complex,GO:0032993,cellular component,52.0,20.0,1.320e-01,9.503e-02,1.835e-01,1.089e-01,7.770e-02,1.527e-01,6.873e-01,1.144e-02
TCF7L2,11641,beta-catenin binding,GO:0008013,molecular function,52.0,6.0,8.796e-02,7.148e-02,1.082e-01,9.092e-03,1.971e-03,4.194e-02,9.244e-01,1.926e-02
TCF7L2,11641,gamma-catenin binding,GO:0045295,molecular function,52.0,3.0,8.796e-02,7.148e-02,1.082e-01,1.016e-02,3.541e-03,2.915e-02,9.212e-01,1.311e-02
TCF7L2,11641,transcription factor binding,GO:0008134,molecular function,52.0,19.0,9.011e-02,7.907e-02,1.027e-01,2.052e-02,1.479e-02,2.849e-02,8.757e-01,6.892e-03
TCF7L2,11641,DNA-binding transcription factor activity,GO:0003700,molecular function,52.0,18.0,9.968e-02,7.907e-02,1.257e-01,3.219e-02,2.440e-02,4.247e-02,8.331e-01,6.524e-03
TCF7L2,11641,transcription regulatory region DNA binding,GO:0044212,molecular function,52.0,24.0,9.968e-02,7.907e-02,1.257e-01,4.273e-02,3.342e-02,5.464e-02,8.038e-01,6.612e-03
TCF7L2,11641,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,52.0,25.0,9.986e-02,7.874e-02,1.267e-01,4.799e-02,2.947e-02,7.815e-02,7.904e-01,1.304e-02
TCF7L2,11641,armadillo repeat domain binding,GO:0070016,molecular function,52.0,2.0,9.986e-02,7.874e-02,1.267e-01,5.256e-02,2.870e-02,9.627e-02,7.795e-01,1.712e-02
TCF7L2,11641,sequence-specific DNA binding,GO:0043565,molecular function,52.0,12.0,9.986e-02,7.874e-02,1.267e-01,5.394e-02,2.928e-02,9.937e-02,7.767e-01,1.705e-02
TCF7L2,11641,chromatin binding,GO:0003682,molecular function,52.0,17.0,1.014e-01,8.253e-02,1.245e-01,6.171e-02,4.698e-02,8.107e-02,7.615e-01,7.686e-03
TCF7L2,11641,RNA polymerase II repressing transcription factor binding,GO:0001103,molecular function,52.0,3.0,1.051e-01,8.171e-02,1.352e-01,4.252e-02,1.020e-02,1.773e-01,7.993e-01,3.550e-02
TCF7L2,11641,protein binding,GO:0005515,molecular function,52.0,332.0,1.065e-01,8.744e-02,1.297e-01,5.775e-02,3.026e-02,1.102e-01,7.688e-01,1.801e-02
TCF7L2,11641,protein kinase binding,GO:0019901,molecular function,52.0,32.0,1.110e-01,7.634e-02,1.613e-01,6.086e-02,2.574e-02,1.439e-01,7.611e-01,2.555e-02
TCF7L2,11641,nuclear hormone receptor binding,GO:0035257,molecular function,52.0,8.0,1.372e-01,4.059e-02,4.635e-01,9.596e-02,1.496e-02,6.157e-01,6.910e-01,6.675e-02
MKI67,7107,regulation of mitotic nuclear division,GO:0007088,biological process,32.0,10.0,2.108e-02,1.872e-02,2.374e-02,1.868e-02,1.733e-02,2.014e-02,8.841e-01,1.402e-03
MKI67,7107,regulation of chromosome segregation,GO:0051983,biological process,32.0,11.0,2.820e-02,1.449e-02,5.491e-02,2.534e-02,1.004e-02,6.398e-02,8.545e-01,2.095e-02
MKI67,7107,nuclear body,GO:0016604,cellular component,32.0,30.0,2.107e-02,1.866e-02,2.378e-02,8.951e-03,3.826e-03,2.094e-02,9.284e-01,1.076e-02
MKI67,7107,nucleolus,GO:0005730,cellular component,32.0,41.0,2.107e-02,1.866e-02,2.378e-02,9.867e-03,6.662e-03,1.461e-02,9.244e-01,4.891e-03
MKI67,7107,nucleus,GO:0005634,cellular component,32.0,151.0,2.107e-02,1.866e-02,2.378e-02,1.115e-02,6.845e-03,1.815e-02,9.181e-01,6.173e-03
MKI67,7107,condensed chromosome,GO:0000793,cellular component,32.0,6.0,2.107e-02,1.866e-02,2.378e-02,1.461e-02,9.873e-03,2.162e-02,9.017e-01,6.629e-03
MKI67,7107,membrane,GO:0016020,cellular component,32.0,53.0,2.107e-02,1.866e-02,2.378e-02,1.445e-02,7.720e-03,2.703e-02,9.014e-01,1.017e-02
MKI67,7107,protein C-terminus binding,GO:0008022,molecular function,32.0,7.0,2.107e-02,1.866e-02,2.378e-02,7.006e-03,4.307e-03,1.140e-02,9.410e-01,5.381e-03
MKI67,7107,protein binding,GO:0005515,molecular function,32.0,332.0,2.107e-02,1.866e-02,2.378e-02,1.754e-02,1.367e-02,2.250e-02,8.888e-01,4.625e-03
MKI67,7107,RNA binding,GO:0003723,molecular function,32.0,63.0,2.293e-02,1.538e-02,3.419e-02,2.006e-02,1.068e-02,3.768e-02,8.763e-01,1.357e-02
INCENP,6058,mitotic cytokinesis,GO:0000281,biological process,33.0,12.0,5.186e-02,3.760e-02,7.153e-02,2.354e-02,7.786e-03,7.118e-02,8.601e-01,2.470e-02
INCENP,6058,chromosome segregation,GO:0007059,biological process,33.0,7.0,6.002e-02,4.949e-02,7.278e-02,3.142e-02,1.237e-02,7.982e-02,8.338e-01,2.348e-02
INCENP,6058,"chromosome, centromeric region",GO:0000775,cellular component,33.0,8.0,5.186e-02,3.760e-02,7.153e-02,1.217e-02,5.864e-03,2.525e-02,9.120e-01,9.844e-03
INCENP,6058,kinetochore,GO:0000776,cellular component,33.0,13.0,5.186e-02,3.760e-02,7.153e-02,1.703e-02,1.360e-02,2.133e-02,8.909e-01,4.044e-03
INCENP,6058,spindle,GO:0005819,cellular component,33.0,15.0,5.186e-02,3.760e-02,7.153e-02,1.836e-02,8.717e-03,3.866e-02,8.831e-01,1.426e-02
INCENP,6058,midbody,GO:0030496,cellular component,33.0,26.0,5.327e-02,3.870e-02,7.333e-02,3.134e-02,1.435e-02,6.843e-02,8.346e-01,1.895e-02
INCENP,6058,nuclear body,GO:0016604,cellular component,33.0,30.0,5.864e-02,3.617e-02,9.507e-02,3.203e-02,9.239e-03,1.111e-01,8.304e-01,3.185e-02
INCENP,6058,nucleus,GO:0005634,cellular component,33.0,151.0,5.949e-02,5.549e-02,6.378e-02,4.110e-02,3.605e-02,4.684e-02,8.082e-01,3.530e-03
INCENP,6058,cytosol,GO:0005829,cellular component,33.0,78.0,5.949e-02,5.549e-02,6.378e-02,4.406e-02,3.210e-02,6.048e-02,8.002e-01,8.536e-03
INCENP,6058,pericentric heterochromatin,GO:0005721,cellular component,33.0,5.0,6.289e-02,4.661e-02,8.486e-02,4.488e-02,1.938e-02,1.039e-01,7.964e-01,2.201e-02
INCENP,6058,protein-containing complex,GO:0032991,cellular component,33.0,481.0,1.364e-01,4.373e-02,4.253e-01,1.364e-01,4.373e-02,4.253e-01,6.488e-01,4.194e-02
INCENP,6058,protein binding,GO:0005515,molecular function,33.0,332.0,6.219e-02,5.376e-02,7.193e-02,5.265e-02,4.039e-02,6.863e-02,7.801e-01,7.351e-03
DSN1,16165,mitotic sister chromatid segregation,GO:0000070,biological process,29.0,9.0,5.294e-02,4.090e-02,6.852e-02,2.702e-02,2.174e-02,3.357e-02,8.506e-01,5.166e-03
DSN1,16165,MIS12/MIND type complex,GO:0000444,cellular component,29.0,3.0,2.627e-02,2.089e-02,3.305e-02,5.208e-03,3.021e-03,8.975e-03,9.541e-01,5.649e-03
DSN1,16165,nuclear MIS12/MIND complex,GO:0000818,cellular component,29.0,2.0,2.627e-02,2.089e-02,3.305e-02,5.350e-03,3.408e-03,8.397e-03,9.530e-01,4.712e-03
DSN1,16165,condensed chromosome kinetochore,GO:0000777,cellular component,29.0,6.0,2.636e-02,2.087e-02,3.328e-02,5.416e-03,2.972e-03,9.870e-03,9.525e-01,6.124e-03
DSN1,16165,condensed nuclear chromosome inner kinetochore,GO:0000941,cellular component,29.0,2.0,4.064e-02,2.044e-02,8.081e-02,1.481e-02,5.785e-03,3.793e-02,8.972e-01,1.582e-02
DSN1,16165,spindle pole,GO:0000922,cellular component,29.0,15.0,5.770e-02,3.488e-02,9.546e-02,3.119e-02,1.718e-02,5.663e-02,8.357e-01,1.468e-02
DSN1,16165,nuclear body,GO:0016604,cellular component,29.0,30.0,5.828e-02,3.535e-02,9.610e-02,3.307e-02,1.130e-02,9.680e-02,8.280e-01,2.627e-02
DSN1,16165,nucleolus,GO:0005730,cellular component,29.0,41.0,6.207e-02,3.651e-02,1.055e-01,4.586e-02,2.267e-02,9.279e-02,7.945e-01,1.827e-02
DSN1,16165,nucleus,GO:0005634,cellular component,29.0,151.0,6.457e-02,4.330e-02,9.628e-02,5.112e-02,3.288e-02,7.948e-02,7.835e-01,1.203e-02
DSN1,16165,cytosol,GO:0005829,cellular component,29.0,78.0,6.457e-02,4.330e-02,9.628e-02,5.689e-02,3.459e-02,9.356e-02,7.706e-01,1.421e-02
DSN1,16165,fibrillar center,GO:0001650,cellular component,29.0,9.0,6.457e-02,4.330e-02,9.628e-02,5.903e-02,3.691e-02,9.439e-02,7.664e-01,1.310e-02
DSN1,16165,protein binding,GO:0005515,molecular function,29.0,332.0,6.749e-02,4.513e-02,1.009e-01,6.709e-02,4.529e-02,9.938e-02,7.511e-01,1.131e-02
CD226,16961,,,,nan,nan,,,,,,,,
PARP8,26124,,,,nan,nan,,,,,,,,
UHMK1,19683,,,,nan,nan,,,,,,,,
JPH3,14203,,,,nan,nan,,,,,,,,
SLFN13,26481,,,,nan,nan,,,,,,,,
KIF5A,6323,microtubule-based movement,GO:0007018,biological process,18.0,21.0,9.031e-02,6.695e-02,1.218e-01,4.863e-02,2.755e-02,8.584e-02,7.886e-01,1.530e-02
KIF5A,6323,anterograde dendritic transport of neurotransmitter receptor complex,GO:0098971,biological process,18.0,5.0,9.753e-02,5.800e-02,1.640e-01,6.110e-02,1.279e-02,2.918e-01,7.564e-01,4.289e-02
KIF5A,6323,synaptic vesicle transport,GO:0048489,biological process,18.0,5.0,1.187e-01,4.146e-02,3.398e-01,1.032e-01,2.818e-02,3.781e-01,6.887e-01,4.633e-02
KIF5A,6323,axon guidance,GO:0007411,biological process,18.0,23.0,1.870e-01,1.312e-01,2.664e-01,1.817e-01,1.350e-01,2.445e-01,6.089e-01,1.180e-02
KIF5A,6323,microtubule,GO:0005874,cellular component,18.0,22.0,8.628e-02,6.947e-02,1.071e-01,4.188e-02,1.907e-02,9.195e-02,8.044e-01,2.044e-02
KIF5A,6323,kinesin complex,GO:0005871,cellular component,18.0,16.0,8.628e-02,6.947e-02,1.071e-01,4.470e-02,2.827e-02,7.067e-02,7.985e-01,1.241e-02
KIF5A,6323,membrane,GO:0016020,cellular component,18.0,53.0,9.213e-02,7.286e-02,1.165e-01,6.994e-02,6.318e-02,7.742e-02,7.466e-01,3.063e-03
KIF5A,6323,microtubule motor activity,GO:0003777,molecular function,18.0,13.0,8.628e-02,6.947e-02,1.071e-01,3.050e-02,1.098e-02,8.470e-02,8.365e-01,2.559e-02
KIF5A,6323,"ATP-dependent microtubule motor activity, plus-end-directed",GO:0008574,molecular function,18.0,6.0,8.628e-02,6.947e-02,1.071e-01,3.656e-02,1.911e-02,6.996e-02,8.194e-01,1.664e-02
KIF5A,6323,ATPase activity,GO:0016887,molecular function,18.0,14.0,8.628e-02,6.947e-02,1.071e-01,4.082e-02,2.680e-02,6.218e-02,8.080e-01,1.069e-02
KIF5A,6323,microtubule binding,GO:0008017,molecular function,18.0,22.0,8.628e-02,6.947e-02,1.071e-01,4.636e-02,2.205e-02,9.748e-02,7.936e-01,2.027e-02
KIF5A,6323,protein binding,GO:0005515,molecular function,18.0,332.0,1.064e-01,8.523e-02,1.327e-01,8.492e-02,5.494e-02,1.313e-01,7.212e-01,1.398e-02
PSD3,19093,ruffle membrane,GO:0032587,cellular component,3.0,3.0,4.898e-02,2.156e-02,1.112e-01,4.290e-02,1.205e-02,1.528e-01,7.995e-01,3.186e-02
PSD3,19093,ARF guanyl-nucleotide exchange factor activity,GO:0005086,molecular function,3.0,2.0,4.898e-02,2.156e-02,1.112e-01,3.334e-02,2.723e-02,4.082e-02,8.298e-01,4.724e-03
N6AMT1,16021,,,,nan,nan,,,,,,,,
NPTN,17867,homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,biological process,9.0,3.0,1.511e-01,5.912e-02,3.859e-01,7.949e-02,2.450e-02,2.579e-01,7.261e-01,3.550e-02
NPTN,17867,dendrite self-avoidance,GO:0070593,biological process,9.0,3.0,2.083e-01,1.173e-01,3.701e-01,1.993e-01,1.212e-01,3.277e-01,5.917e-01,2.042e-02
NPTN,17867,axon guidance,GO:0007411,biological process,9.0,23.0,2.113e-01,1.097e-01,4.067e-01,1.917e-01,9.122e-02,4.029e-01,5.957e-01,3.239e-02
NPTN,17867,plasma membrane,GO:0005886,cellular component,9.0,24.0,1.300e-01,4.394e-02,3.845e-01,4.757e-02,8.477e-03,2.669e-01,7.842e-01,4.342e-02
NPTN,17867,axon,GO:0030424,cellular component,9.0,11.0,1.688e-01,1.223e-01,2.331e-01,9.571e-02,4.158e-02,2.203e-01,7.033e-01,2.672e-02
NPTN,17867,cell surface,GO:0009986,cellular component,9.0,5.0,1.877e-01,1.260e-01,2.798e-01,1.542e-01,1.024e-01,2.323e-01,6.351e-01,1.564e-02
NPTN,17867,cell-cell adhesion mediator activity,GO:0098632,molecular function,9.0,6.0,1.281e-01,4.409e-02,3.721e-01,2.425e-02,6.474e-03,9.083e-02,8.548e-01,2.708e-02
NPTN,17867,protein binding,GO:0005515,molecular function,9.0,332.0,1.384e-01,6.167e-02,3.107e-01,4.812e-02,3.959e-02,5.849e-02,7.904e-01,5.348e-03
RAB11FIP1,30265,regulated exocytosis,GO:0045055,biological process,7.0,7.0,3.382e-02,8.668e-03,1.320e-01,1.636e-02,2.322e-03,1.152e-01,8.810e-01,3.424e-02
RAB11FIP1,30265,negative regulation of adiponectin secretion,GO:0070164,biological process,7.0,6.0,3.847e-02,1.511e-02,9.792e-02,1.664e-02,9.085e-03,3.049e-02,8.913e-01,1.156e-02
RAB11FIP1,30265,intracellular membrane-bounded organelle,GO:0043231,cellular component,7.0,40.0,5.033e-02,4.090e-02,6.193e-02,2.637e-02,8.645e-03,8.044e-02,8.494e-01,2.346e-02
RAB11FIP1,30265,cytosol,GO:0005829,cellular component,7.0,78.0,8.195e-02,4.665e-02,1.440e-01,8.195e-02,4.665e-02,1.440e-01,7.254e-01,1.770e-02
RAB11FIP1,30265,Rab GTPase binding,GO:0017137,molecular function,7.0,6.0,3.488e-02,8.594e-03,1.416e-01,2.215e-02,2.497e-03,1.965e-01,8.528e-01,3.885e-02
ATAD2,30123,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,14.0,41.0,6.186e-02,3.650e-02,1.048e-01,2.085e-02,1.242e-02,3.500e-02,8.738e-01,1.092e-02
ATAD2,30123,negative regulation of chromatin silencing,GO:0031936,biological process,14.0,13.0,6.300e-02,3.495e-02,1.136e-01,2.969e-02,5.343e-03,1.650e-01,8.338e-01,4.300e-02
ATAD2,30123,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,14.0,62.0,8.560e-02,8.071e-02,9.079e-02,6.937e-02,3.953e-02,1.217e-01,7.467e-01,1.629e-02
ATAD2,30123,nucleoplasm,GO:0005654,cellular component,14.0,74.0,6.873e-02,4.222e-02,1.119e-01,4.539e-02,2.728e-02,7.552e-02,7.967e-01,1.386e-02
ATAD2,30123,nucleus,GO:0005634,cellular component,14.0,151.0,7.139e-02,4.184e-02,1.218e-01,4.042e-02,2.019e-02,8.093e-02,8.087e-01,1.758e-02
ATAD2,30123,extracellular exosome,GO:0070062,cellular component,14.0,33.0,7.172e-02,4.172e-02,1.233e-01,4.656e-02,2.201e-02,9.851e-02,7.927e-01,1.975e-02
ATAD2,30123,histone binding,GO:0042393,molecular function,14.0,9.0,6.186e-02,3.650e-02,1.048e-01,1.167e-02,4.087e-03,3.332e-02,9.130e-01,1.420e-02
ATAD2,30123,chromatin binding,GO:0003682,molecular function,14.0,17.0,6.873e-02,4.222e-02,1.119e-01,4.123e-02,2.631e-02,6.462e-02,8.073e-01,1.191e-02
ATAD2,30123,protein binding,GO:0005515,molecular function,14.0,332.0,7.172e-02,4.172e-02,1.233e-01,5.680e-02,2.514e-02,1.283e-01,7.699e-01,2.246e-02
ATAD2,30123,ATPase activity,GO:0016887,molecular function,14.0,14.0,1.062e-01,6.000e-02,1.879e-01,1.053e-01,5.829e-02,1.901e-01,6.914e-01,2.033e-02
BUB1B,1149,mitotic spindle assembly checkpoint,GO:0007094,biological process,38.0,5.0,2.868e-02,2.319e-02,3.547e-02,1.869e-02,1.240e-02,2.817e-02,8.832e-01,8.287e-03
BUB1B,1149,"meiotic sister chromatid cohesion, centromeric",GO:0051754,biological process,38.0,3.0,2.940e-02,2.198e-02,3.932e-02,1.854e-02,1.379e-02,2.492e-02,8.844e-01,5.420e-03
BUB1B,1149,condensed nuclear chromosome kinetochore,GO:0000778,cellular component,38.0,3.0,1.834e-02,1.577e-02,2.132e-02,4.678e-03,3.763e-03,5.816e-03,9.589e-01,2.283e-03
BUB1B,1149,condensed chromosome kinetochore,GO:0000777,cellular component,38.0,6.0,1.834e-02,1.577e-02,2.132e-02,5.363e-03,4.641e-03,6.198e-03,9.530e-01,1.308e-03
BUB1B,1149,kinetochore,GO:0000776,cellular component,38.0,13.0,1.834e-02,1.577e-02,2.132e-02,6.113e-03,5.258e-03,7.107e-03,9.476e-01,1.626e-03
BUB1B,1149,condensed chromosome outer kinetochore,GO:0000940,cellular component,38.0,5.0,2.235e-02,1.188e-02,4.206e-02,5.718e-03,8.198e-04,3.988e-02,9.440e-01,2.088e-02
BUB1B,1149,spindle,GO:0005819,cellular component,38.0,15.0,2.266e-02,1.496e-02,3.431e-02,8.407e-03,3.403e-03,2.077e-02,9.319e-01,9.982e-03
BUB1B,1149,cytosol,GO:0005829,cellular component,38.0,78.0,3.235e-02,1.760e-02,5.945e-02,2.587e-02,1.929e-02,3.470e-02,8.547e-01,6.918e-03
BUB1B,1149,cytoplasm,GO:0005737,cellular component,38.0,69.0,3.256e-02,1.733e-02,6.118e-02,2.687e-02,1.691e-02,4.270e-02,8.509e-01,1.087e-02
BUB1B,1149,perinuclear region of cytoplasm,GO:0048471,cellular component,38.0,5.0,3.483e-02,1.477e-02,8.215e-02,2.549e-02,7.155e-03,9.081e-02,8.517e-01,2.985e-02
BUB1B,1149,protein binding,GO:0005515,molecular function,38.0,332.0,3.295e-02,1.750e-02,6.204e-02,3.012e-02,1.878e-02,4.831e-02,8.399e-01,1.138e-02
BUB1B,1149,protein kinase activity,GO:0004672,molecular function,38.0,38.0,3.914e-02,1.185e-02,1.292e-01,3.797e-02,1.080e-02,1.336e-01,8.123e-01,3.339e-02
CPT2,2330,fatty acid beta-oxidation,GO:0006635,biological process,11.0,7.0,6.956e-02,2.283e-02,2.119e-01,2.717e-02,9.405e-03,7.849e-02,8.467e-01,2.318e-02
CPT2,2330,mitochondrion,GO:0005739,cellular component,11.0,19.0,6.956e-02,2.283e-02,2.119e-01,4.654e-02,2.118e-02,1.023e-01,7.926e-01,2.025e-02
CPT2,2330,nucleolus,GO:0005730,cellular component,11.0,41.0,6.956e-02,2.283e-02,2.119e-01,4.808e-02,1.546e-02,1.495e-01,7.876e-01,2.942e-02
CPT2,2330,nucleoplasm,GO:0005654,cellular component,11.0,74.0,7.033e-02,2.394e-02,2.066e-01,6.528e-02,2.583e-02,1.650e-01,7.528e-01,2.624e-02
CPT2,2330,carnitine O-palmitoyltransferase activity,GO:0004095,molecular function,11.0,3.0,7.873e-02,1.886e-02,3.286e-01,3.788e-02,2.885e-03,4.973e-01,7.969e-01,6.885e-02
GATAD1,29941,chromatin assembly,GO:0031497,biological process,4.0,6.0,6.097e-02,2.851e-02,1.304e-01,2.995e-02,1.840e-02,4.875e-02,8.401e-01,1.159e-02
GATAD1,29941,nucleoplasm,GO:0005654,cellular component,4.0,74.0,6.149e-02,2.844e-02,1.329e-01,5.011e-02,2.124e-02,1.182e-01,7.841e-01,2.275e-02
GATAD1,29941,nucleus,GO:0005634,cellular component,4.0,151.0,6.149e-02,2.844e-02,1.329e-01,5.428e-02,1.647e-02,1.789e-01,7.734e-01,3.194e-02
CCNB2,1580,mitotic cell cycle phase transition,GO:0044772,biological process,34.0,11.0,4.400e-02,3.648e-02,5.308e-02,1.864e-02,8.472e-03,4.102e-02,8.811e-01,1.645e-02
CCNB2,1580,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,34.0,10.0,4.400e-02,3.648e-02,5.308e-02,2.726e-02,1.847e-02,4.023e-02,8.497e-01,9.093e-03
CCNB2,1580,centrosome,GO:0005813,cellular component,34.0,31.0,4.400e-02,3.648e-02,5.308e-02,1.502e-02,1.130e-02,1.996e-02,9.002e-01,4.875e-03
CCNB2,1580,microtubule cytoskeleton,GO:0015630,cellular component,34.0,17.0,4.400e-02,3.648e-02,5.308e-02,2.305e-02,1.663e-02,3.195e-02,8.655e-01,7.114e-03
CCNB2,1580,nucleus,GO:0005634,cellular component,34.0,151.0,4.556e-02,3.369e-02,6.161e-02,3.523e-02,1.999e-02,6.207e-02,8.235e-01,1.400e-02
CCNB2,1580,cytoplasm,GO:0005737,cellular component,34.0,69.0,4.556e-02,3.369e-02,6.161e-02,3.669e-02,2.510e-02,5.364e-02,8.194e-01,9.741e-03
CCNB2,1580,cytosol,GO:0005829,cellular component,34.0,78.0,4.595e-02,3.302e-02,6.395e-02,3.711e-02,2.090e-02,6.590e-02,8.176e-01,1.476e-02
CCNB2,1580,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,34.0,27.0,4.625e-02,4.070e-02,5.255e-02,2.178e-02,4.908e-03,9.663e-02,8.630e-01,3.089e-02
CCNB2,1580,cyclin-dependent protein serine/threonine kinase regulator activity,GO:0016538,molecular function,34.0,8.0,4.400e-02,3.648e-02,5.308e-02,1.825e-02,1.292e-02,2.580e-02,8.853e-01,6.384e-03
CCNB2,1580,cadherin binding,GO:0045296,molecular function,34.0,9.0,4.556e-02,3.369e-02,6.161e-02,2.941e-02,1.983e-02,4.362e-02,8.422e-01,9.316e-03
CCNB2,1580,protein kinase binding,GO:0019901,molecular function,34.0,32.0,4.556e-02,3.369e-02,6.161e-02,3.776e-02,2.755e-02,5.175e-02,8.168e-01,7.757e-03
CCNB2,1580,protein binding,GO:0005515,molecular function,34.0,332.0,4.612e-02,3.339e-02,6.369e-02,4.245e-02,2.677e-02,6.733e-02,8.041e-01,1.241e-02
CCNB2,1580,protein kinase activity,GO:0004672,molecular function,34.0,38.0,4.894e-02,3.374e-02,7.097e-02,3.492e-02,1.396e-02,8.735e-02,8.228e-01,2.336e-02
APPL1,24035,protein import into nucleus,GO:0006606,biological process,34.0,10.0,1.018e-01,5.915e-02,1.751e-01,3.237e-02,5.905e-03,1.775e-01,8.254e-01,4.362e-02
APPL1,24035,regulation of protein localization to plasma membrane,GO:1903076,biological process,34.0,8.0,1.059e-01,6.212e-02,1.806e-01,4.275e-02,1.629e-02,1.122e-01,8.011e-01,2.620e-02
APPL1,24035,regulation of glucose import,GO:0046324,biological process,34.0,4.0,1.119e-01,6.290e-02,1.992e-01,3.808e-02,2.002e-02,7.243e-02,8.150e-01,1.602e-02
APPL1,24035,positive regulation of glucose import,GO:0046326,biological process,34.0,3.0,1.157e-01,6.175e-02,2.168e-01,5.759e-02,3.087e-02,1.074e-01,7.691e-01,1.736e-02
APPL1,24035,insulin receptor signaling pathway,GO:0008286,biological process,34.0,6.0,1.157e-01,6.175e-02,2.168e-01,6.009e-02,2.111e-02,1.711e-01,7.620e-01,2.985e-02
APPL1,24035,transforming growth factor beta receptor signaling pathway,GO:0007179,biological process,34.0,11.0,1.165e-01,6.140e-02,2.210e-01,5.780e-02,9.792e-03,3.412e-01,7.613e-01,4.801e-02
APPL1,24035,cell population proliferation,GO:0008283,biological process,34.0,35.0,1.285e-01,5.462e-02,3.025e-01,6.806e-02,1.554e-02,2.982e-01,7.432e-01,4.377e-02
APPL1,24035,adiponectin-activated signaling pathway,GO:0033211,biological process,34.0,3.0,1.337e-01,5.291e-02,3.380e-01,8.369e-02,1.320e-02,5.306e-01,7.124e-01,5.728e-02
APPL1,24035,positive regulation of melanin biosynthetic process,GO:0048023,biological process,34.0,4.0,1.570e-01,4.470e-02,5.513e-01,9.354e-02,5.723e-03,1.529e+00,6.814e-01,8.697e-02
APPL1,24035,signaling,GO:0023052,biological process,34.0,8.0,1.804e-01,1.300e-01,2.504e-01,1.679e-01,1.161e-01,2.427e-01,6.215e-01,1.475e-02
APPL1,24035,early endosome,GO:0005769,cellular component,34.0,4.0,1.015e-01,5.892e-02,1.749e-01,2.011e-02,2.026e-03,1.997e-01,8.602e-01,4.461e-02
APPL1,24035,endosome,GO:0005768,cellular component,34.0,14.0,1.018e-01,5.915e-02,1.751e-01,3.322e-02,1.076e-02,1.025e-01,8.272e-01,2.862e-02
APPL1,24035,intracellular vesicle,GO:0097708,cellular component,34.0,7.0,1.018e-01,5.915e-02,1.751e-01,3.675e-02,7.838e-03,1.723e-01,8.137e-01,3.842e-02
APPL1,24035,cytoplasmic vesicle,GO:0031410,cellular component,34.0,28.0,1.127e-01,7.814e-02,1.625e-01,2.085e-02,2.108e-03,2.062e-01,8.571e-01,4.555e-02
APPL1,24035,plasma membrane,GO:0005886,cellular component,34.0,24.0,1.296e-01,1.017e-01,1.653e-01,6.020e-02,4.012e-02,9.033e-02,7.642e-01,1.170e-02
APPL1,24035,extracellular exosome,GO:0070062,cellular component,34.0,33.0,1.296e-01,1.017e-01,1.653e-01,7.300e-02,7.078e-02,7.529e-02,7.412e-01,9.851e-04
APPL1,24035,cytoplasm,GO:0005737,cellular component,34.0,69.0,1.340e-01,1.174e-01,1.529e-01,8.884e-02,7.996e-02,9.870e-02,7.158e-01,3.450e-03
APPL1,24035,nucleus,GO:0005634,cellular component,34.0,151.0,1.340e-01,1.174e-01,1.529e-01,9.867e-02,7.978e-02,1.220e-01,7.015e-01,7.003e-03
APPL1,24035,cytosol,GO:0005829,cellular component,34.0,78.0,1.349e-01,1.163e-01,1.563e-01,9.669e-02,6.312e-02,1.481e-01,7.037e-01,1.384e-02
APPL1,24035,vesicle membrane,GO:0012506,cellular component,34.0,4.0,1.381e-01,7.059e-02,2.703e-01,7.712e-02,9.935e-03,5.987e-01,7.217e-01,5.880e-02
APPL1,24035,endosome membrane,GO:0010008,cellular component,34.0,10.0,1.504e-01,4.899e-02,4.615e-01,9.168e-02,8.616e-03,9.756e-01,6.908e-01,7.768e-02
APPL1,24035,membrane,GO:0016020,cellular component,34.0,53.0,1.506e-01,1.322e-01,1.716e-01,1.215e-01,1.074e-01,1.375e-01,6.720e-01,4.325e-03
APPL1,24035,protein kinase B binding,GO:0043422,molecular function,34.0,2.0,1.018e-01,5.915e-02,1.751e-01,1.486e-02,2.326e-03,9.490e-02,8.886e-01,3.402e-02
APPL1,24035,identical protein binding,GO:0042802,molecular function,34.0,20.0,1.222e-01,9.744e-02,1.532e-01,4.836e-02,2.903e-02,8.055e-02,7.895e-01,1.417e-02
APPL1,24035,phosphatidylserine binding,GO:0001786,molecular function,34.0,3.0,1.309e-01,5.300e-02,3.235e-01,7.365e-02,1.275e-02,4.253e-01,7.303e-01,5.315e-02
APPL1,24035,protein homodimerization activity,GO:0042803,molecular function,34.0,15.0,1.340e-01,1.174e-01,1.529e-01,7.795e-02,4.802e-02,1.265e-01,7.323e-01,1.473e-02
APPL1,24035,protein binding,GO:0005515,molecular function,34.0,332.0,1.340e-01,1.174e-01,1.529e-01,9.120e-02,6.570e-02,1.266e-01,7.120e-01,1.037e-02
APPL1,24035,beta-tubulin binding,GO:0048487,molecular function,34.0,4.0,1.425e-01,8.304e-02,2.444e-01,9.523e-02,3.595e-02,2.523e-01,7.032e-01,3.203e-02
APPL1,24035,phosphatidylinositol binding,GO:0035091,molecular function,34.0,5.0,1.600e-01,4.831e-02,5.300e-01,1.197e-01,1.690e-02,8.482e-01,6.599e-01,6.458e-02
APPL1,24035,protein-containing complex binding,GO:0044877,molecular function,34.0,79.0,2.075e-01,1.249e-01,3.448e-01,1.933e-01,1.038e-01,3.600e-01,5.963e-01,2.507e-02
RER1,30309,,,,nan,nan,,,,,,,,
XDH,12805,negative regulation of endothelial cell proliferation,GO:0001937,biological process,21.0,5.0,1.296e-01,1.226e-02,1.370e+00,2.621e-02,1.344e-03,5.111e-01,8.261e-01,6.081e-02
XDH,12805,activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,biological process,21.0,4.0,1.296e-01,1.226e-02,1.370e+00,4.306e-02,4.832e-03,3.837e-01,7.893e-01,5.203e-02
XDH,12805,positive regulation of p38MAPK cascade,GO:1900745,biological process,21.0,3.0,1.296e-01,1.226e-02,1.370e+00,4.279e-02,4.523e-03,4.048e-01,7.891e-01,5.268e-02
XDH,12805,negative regulation of gene expression,GO:0010629,biological process,21.0,21.0,1.323e-01,1.199e-02,1.461e+00,4.843e-02,2.454e-03,9.560e-01,7.632e-01,6.951e-02
XDH,12805,negative regulation of endothelial cell differentiation,GO:0045602,biological process,21.0,5.0,1.360e-01,1.511e-02,1.223e+00,3.652e-02,1.285e-02,1.038e-01,8.177e-01,2.535e-02
XDH,12805,negative regulation of protein phosphorylation,GO:0001933,biological process,21.0,17.0,1.454e-01,1.419e-02,1.490e+00,7.673e-02,7.322e-03,8.041e-01,7.186e-01,6.667e-02
XDH,12805,negative regulation of vasculogenesis,GO:2001213,biological process,21.0,4.0,1.521e-01,1.747e-02,1.324e+00,6.980e-02,9.534e-03,5.110e-01,7.342e-01,6.256e-02
XDH,12805,negative regulation of vascular endothelial growth factor signaling pathway,GO:1900747,biological process,21.0,4.0,1.591e-01,2.995e-02,8.451e-01,6.271e-02,2.960e-02,1.329e-01,7.582e-01,2.208e-02
XDH,12805,negative regulation of protein kinase B signaling,GO:0051898,biological process,21.0,3.0,1.592e-01,2.006e-02,1.263e+00,8.118e-02,1.442e-02,4.571e-01,7.178e-01,5.487e-02
XDH,12805,xanthine catabolic process,GO:0009115,biological process,21.0,4.0,2.971e-01,1.982e-02,4.454e+00,2.806e-01,1.542e-02,5.104e+00,4.424e-01,1.419e-01
XDH,12805,positive regulation of reactive oxygen species metabolic process,GO:2000379,biological process,21.0,8.0,6.309e-01,4.683e-01,8.498e-01,6.085e-01,4.252e-01,8.710e-01,3.028e-01,3.676e-02
XDH,12805,cytosol,GO:0005829,cellular component,21.0,78.0,1.875e-01,3.994e-02,8.800e-01,1.340e-01,4.115e-02,4.365e-01,6.508e-01,4.440e-02
XDH,12805,extracellular space,GO:0005615,cellular component,21.0,6.0,1.933e-01,3.802e-02,9.827e-01,1.172e-01,1.869e-02,7.351e-01,6.595e-01,7.349e-02
XDH,12805,flavin adenine dinucleotide binding,GO:0050660,molecular function,21.0,6.0,1.461e-01,1.387e-02,1.538e+00,7.553e-02,5.867e-03,9.724e-01,7.170e-01,7.273e-02
XDH,12805,molybdopterin cofactor binding,GO:0043546,molecular function,21.0,4.0,1.573e-01,1.086e-02,2.280e+00,8.271e-02,1.838e-03,3.721e+00,6.752e-01,1.043e-01
XDH,12805,"2 iron, 2 sulfur cluster binding",GO:0051537,molecular function,21.0,2.0,1.662e-01,1.475e-02,1.873e+00,1.154e-01,7.066e-03,1.883e+00,6.436e-01,1.015e-01
XDH,12805,protein homodimerization activity,GO:0042803,molecular function,21.0,15.0,1.715e-01,2.738e-02,1.074e+00,1.117e-01,2.300e-02,5.427e-01,6.738e-01,5.569e-02
XDH,12805,xanthine dehydrogenase activity,GO:0004854,molecular function,21.0,2.0,1.813e-01,9.791e-03,3.356e+00,9.762e-02,1.320e-03,7.221e+00,6.302e-01,1.270e-01
XDH,12805,xanthine oxidase activity,GO:0004855,molecular function,21.0,2.0,1.813e-01,9.791e-03,3.356e+00,9.323e-02,9.466e-04,9.183e+00,6.271e-01,1.320e-01
DZIP1L,26551,,,,nan,nan,,,,,,,,
CLSTN2,17448,,,,nan,nan,,,,,,,,
EPB41,3377,actomyosin structure organization,GO:0031032,biological process,23.0,9.0,1.274e-01,3.549e-02,4.571e-01,9.206e-02,1.217e-02,6.966e-01,6.976e-01,6.128e-02
EPB41,3377,positive regulation of protein binding,GO:0032092,biological process,23.0,13.0,1.564e-01,8.123e-02,3.011e-01,9.060e-02,1.458e-02,5.630e-01,7.017e-01,5.858e-02
EPB41,3377,positive regulation of protein localization to cell cortex,GO:1904778,biological process,23.0,5.0,1.704e-01,9.126e-02,3.184e-01,1.213e-01,3.649e-02,4.031e-01,6.657e-01,4.560e-02
EPB41,3377,regulation of cell shape,GO:0008360,biological process,23.0,9.0,1.773e-01,8.806e-02,3.572e-01,1.389e-01,5.015e-02,3.848e-01,6.473e-01,3.796e-02
EPB41,3377,plasma membrane,GO:0005886,cellular component,23.0,24.0,6.979e-02,2.722e-02,1.789e-01,1.826e-02,1.979e-03,1.684e-01,8.687e-01,4.581e-02
EPB41,3377,cytosol,GO:0005829,cellular component,23.0,78.0,7.698e-02,3.415e-02,1.735e-01,2.472e-02,4.286e-03,1.426e-01,8.498e-01,3.978e-02
EPB41,3377,cell cortex region,GO:0099738,cellular component,23.0,17.0,9.370e-02,2.504e-02,3.507e-01,4.984e-02,6.013e-03,4.132e-01,7.742e-01,6.116e-02
EPB41,3377,cortical cytoskeleton,GO:0030863,cellular component,23.0,5.0,1.013e-01,3.226e-02,3.181e-01,5.461e-02,6.588e-03,4.527e-01,7.631e-01,6.408e-02
EPB41,3377,cell junction,GO:0030054,cellular component,23.0,9.0,1.139e-01,3.054e-02,4.248e-01,7.140e-02,7.295e-03,6.989e-01,7.287e-01,6.508e-02
EPB41,3377,protein-containing complex,GO:0032991,cellular component,23.0,481.0,2.482e-01,1.338e-01,4.602e-01,2.366e-01,1.115e-01,5.020e-01,5.564e-01,3.563e-02
EPB41,3377,protein binding,GO:0005515,molecular function,23.0,332.0,7.698e-02,3.415e-02,1.735e-01,3.148e-02,9.864e-03,1.005e-01,8.326e-01,2.937e-02
EPB41,3377,protein C-terminus binding,GO:0008022,molecular function,23.0,7.0,7.955e-02,3.586e-02,1.765e-01,3.224e-02,8.996e-03,1.156e-01,8.289e-01,2.944e-02
EPB41,3377,1-phosphatidylinositol binding,GO:0005545,molecular function,23.0,2.0,9.079e-02,3.504e-02,2.352e-01,2.144e-02,1.287e-03,3.572e-01,8.471e-01,5.658e-02
EPB41,3377,protein N-terminus binding,GO:0047485,molecular function,23.0,4.0,9.113e-02,5.579e-02,1.489e-01,4.665e-02,3.588e-02,6.065e-02,7.939e-01,7.157e-03
EPB41,3377,phosphoprotein binding,GO:0051219,molecular function,23.0,3.0,1.403e-01,1.038e-01,1.895e-01,7.432e-02,1.423e-02,3.881e-01,7.306e-01,4.749e-02
ZDHHC12,19159,,,,nan,nan,,,,,,,,
ADAR,225,miRNA loading onto RISC involved in gene silencing by miRNA,GO:0035280,biological process,25.0,2.0,7.856e-02,2.047e-02,3.015e-01,2.035e-02,5.955e-04,6.958e-01,8.389e-01,7.761e-02
ADAR,225,positive regulation of viral genome replication,GO:0045070,biological process,25.0,5.0,8.117e-02,3.246e-02,2.030e-01,3.916e-02,6.296e-03,2.436e-01,8.038e-01,4.395e-02
ADAR,225,adenosine to inosine editing,GO:0006382,biological process,25.0,3.0,8.255e-02,3.761e-02,1.812e-01,3.768e-02,1.412e-02,1.006e-01,8.150e-01,2.494e-02
ADAR,225,base conversion or substitution editing,GO:0016553,biological process,25.0,5.0,8.449e-02,3.573e-02,1.998e-01,4.941e-02,1.606e-02,1.520e-01,7.843e-01,3.040e-02
ADAR,225,response to interferon-alpha,GO:0035455,biological process,25.0,3.0,9.335e-02,4.251e-02,2.050e-01,7.717e-02,4.151e-02,1.434e-01,7.329e-01,1.960e-02
ADAR,225,pre-miRNA processing,GO:0031054,biological process,25.0,2.0,9.371e-02,2.823e-02,3.111e-01,4.330e-02,4.689e-03,3.998e-01,7.886e-01,6.438e-02
ADAR,225,RNA processing,GO:0006396,biological process,25.0,13.0,9.813e-02,2.537e-02,3.795e-01,7.181e-02,1.082e-02,4.765e-01,7.317e-01,5.881e-02
ADAR,225,negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0044387,biological process,25.0,2.0,1.353e-01,3.387e-02,5.404e-01,1.074e-01,1.507e-02,7.661e-01,6.731e-01,7.056e-02
ADAR,225,response to virus,GO:0009615,biological process,25.0,7.0,2.310e-01,1.405e-01,3.798e-01,2.296e-01,1.422e-01,3.706e-01,5.653e-01,2.206e-02
ADAR,225,supraspliceosomal complex,GO:0044530,cellular component,25.0,2.0,7.267e-02,2.460e-02,2.146e-01,1.674e-02,1.530e-03,1.832e-01,8.722e-01,5.004e-02
ADAR,225,nucleolus,GO:0005730,cellular component,25.0,41.0,8.472e-02,4.121e-02,1.742e-01,2.761e-02,1.524e-02,5.001e-02,8.480e-01,1.388e-02
ADAR,225,membrane,GO:0016020,cellular component,25.0,53.0,8.472e-02,4.121e-02,1.742e-01,2.852e-02,1.562e-02,5.207e-02,8.447e-01,1.391e-02
ADAR,225,nucleus,GO:0005634,cellular component,25.0,151.0,8.815e-02,4.687e-02,1.658e-01,4.488e-02,2.412e-02,8.353e-02,7.972e-01,1.623e-02
ADAR,225,cytoplasm,GO:0005737,cellular component,25.0,69.0,8.815e-02,4.687e-02,1.658e-01,5.588e-02,3.838e-02,8.135e-02,7.730e-01,1.039e-02
ADAR,225,nucleoplasm,GO:0005654,cellular component,25.0,74.0,9.007e-02,4.910e-02,1.652e-01,5.860e-02,3.527e-02,9.738e-02,7.671e-01,1.449e-02
ADAR,225,double-stranded RNA binding,GO:0003725,molecular function,25.0,6.0,7.106e-02,2.594e-02,1.947e-01,2.409e-02,4.478e-03,1.296e-01,8.518e-01,3.475e-02
ADAR,225,RNA binding,GO:0003723,molecular function,25.0,63.0,7.106e-02,2.594e-02,1.947e-01,2.357e-02,3.263e-03,1.702e-01,8.500e-01,3.919e-02
ADAR,225,double-stranded RNA adenosine deaminase activity,GO:0003726,molecular function,25.0,2.0,8.449e-02,3.573e-02,1.998e-01,4.889e-02,1.050e-02,2.277e-01,7.829e-01,4.070e-02
ADAR,225,tRNA-specific adenosine deaminase activity,GO:0008251,molecular function,25.0,4.0,8.449e-02,3.573e-02,1.998e-01,5.066e-02,1.213e-02,2.115e-01,7.796e-01,3.792e-02
ADAR,225,protein binding,GO:0005515,molecular function,25.0,332.0,8.815e-02,4.687e-02,1.658e-01,4.611e-02,1.816e-02,1.171e-01,7.934e-01,2.424e-02
PAQR6,30132,,,,nan,nan,,,,,,,,
ZNF394,18832,,,,nan,nan,,,,,,,,
DVL3,3087,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,36.0,41.0,4.733e-02,3.056e-02,7.331e-02,1.062e-02,4.619e-03,2.442e-02,9.198e-01,1.028e-02
DVL3,3087,planar cell polarity pathway involved in neural tube closure,GO:0090179,biological process,36.0,3.0,4.733e-02,3.056e-02,7.331e-02,1.489e-02,5.884e-03,3.768e-02,8.973e-01,1.416e-02
DVL3,3087,positive regulation of JUN kinase activity,GO:0043507,biological process,36.0,7.0,4.733e-02,3.056e-02,7.331e-02,2.452e-02,1.096e-02,5.483e-02,8.581e-01,1.754e-02
DVL3,3087,"Wnt signaling pathway, planar cell polarity pathway",GO:0060071,biological process,36.0,11.0,5.099e-02,3.846e-02,6.760e-02,2.899e-02,2.236e-02,3.757e-02,8.435e-01,6.205e-03
DVL3,3087,protein stabilization,GO:0050821,biological process,36.0,2.0,5.178e-02,3.982e-02,6.734e-02,2.586e-02,8.821e-03,7.581e-02,8.512e-01,2.280e-02
DVL3,3087,positive regulation of protein phosphorylation,GO:0001934,biological process,36.0,17.0,5.215e-02,3.607e-02,7.540e-02,3.213e-02,1.802e-02,5.727e-02,8.327e-01,1.440e-02
DVL3,3087,non-canonical Wnt signaling pathway,GO:0035567,biological process,36.0,9.0,5.579e-02,4.085e-02,7.619e-02,4.379e-02,3.170e-02,6.049e-02,8.009e-01,8.791e-03
DVL3,3087,canonical Wnt signaling pathway,GO:0060070,biological process,36.0,22.0,5.728e-02,3.941e-02,8.327e-02,4.808e-02,2.624e-02,8.809e-02,7.898e-01,1.666e-02
DVL3,3087,positive regulation of GTPase activity,GO:0043547,biological process,36.0,6.0,5.818e-02,4.552e-02,7.437e-02,4.969e-02,3.510e-02,7.035e-02,7.868e-01,9.554e-03
DVL3,3087,regulation of cellular protein localization,GO:1903827,biological process,36.0,31.0,1.129e-01,3.789e-02,3.361e-01,9.509e-02,1.955e-02,4.625e-01,6.985e-01,4.938e-02
DVL3,3087,nuclear chromatin,GO:0000790,cellular component,36.0,14.0,4.733e-02,3.056e-02,7.331e-02,1.644e-02,7.618e-03,3.546e-02,8.912e-01,1.366e-02
DVL3,3087,cytosol,GO:0005829,cellular component,36.0,78.0,4.847e-02,2.900e-02,8.102e-02,2.352e-02,6.505e-03,8.501e-02,8.587e-01,2.864e-02
DVL3,3087,beta-catenin binding,GO:0008013,molecular function,36.0,6.0,4.733e-02,3.056e-02,7.331e-02,7.351e-03,1.783e-03,3.031e-02,9.352e-01,1.780e-02
DVL3,3087,protein heterodimerization activity,GO:0046982,molecular function,36.0,6.0,4.733e-02,3.056e-02,7.331e-02,1.568e-02,5.735e-03,4.287e-02,8.929e-01,1.597e-02
DVL3,3087,protease binding,GO:0002020,molecular function,36.0,7.0,4.738e-02,3.067e-02,7.319e-02,1.666e-02,1.097e-02,2.530e-02,8.923e-01,7.246e-03
DVL3,3087,protein binding,GO:0005515,molecular function,36.0,332.0,4.902e-02,2.828e-02,8.495e-02,2.700e-02,6.889e-03,1.058e-01,8.460e-01,3.308e-02
DVL3,3087,frizzled binding,GO:0005109,molecular function,36.0,3.0,5.338e-02,4.027e-02,7.075e-02,2.122e-02,3.384e-03,1.330e-01,8.608e-01,3.431e-02
DVL3,3087,Rac GTPase binding,GO:0048365,molecular function,36.0,3.0,5.884e-02,4.289e-02,8.072e-02,4.133e-02,1.927e-02,8.865e-02,8.059e-01,2.038e-02
DVL3,3087,signaling receptor binding,GO:0005102,molecular function,36.0,58.0,1.540e-01,3.013e-02,7.870e-01,1.500e-01,2.723e-02,8.267e-01,6.233e-01,6.877e-02
RACGAP1,9804,actomyosin contractile ring assembly,GO:0000915,biological process,39.0,5.0,7.197e-02,6.191e-02,8.366e-02,2.469e-02,5.894e-03,1.034e-01,8.521e-01,2.982e-02
RACGAP1,9804,mitotic spindle midzone assembly,GO:0051256,biological process,39.0,6.0,7.197e-02,6.191e-02,8.366e-02,3.132e-02,1.044e-02,9.396e-02,8.329e-01,2.505e-02
RACGAP1,9804,regulation of attachment of spindle microtubules to kinetochore,GO:0051988,biological process,39.0,9.0,7.197e-02,6.191e-02,8.366e-02,3.667e-02,1.663e-02,8.085e-02,8.186e-01,1.941e-02
RACGAP1,9804,positive regulation of cytokinesis,GO:0032467,biological process,39.0,16.0,7.197e-02,6.191e-02,8.366e-02,3.748e-02,2.134e-02,6.583e-02,8.169e-01,1.421e-02
RACGAP1,9804,mitotic cytokinesis,GO:0000281,biological process,39.0,12.0,7.287e-02,6.467e-02,8.211e-02,3.396e-02,1.572e-02,7.336e-02,8.267e-01,1.892e-02
RACGAP1,9804,spermatogenesis,GO:0007283,biological process,39.0,3.0,8.511e-02,5.385e-02,1.345e-01,7.092e-02,3.520e-02,1.429e-01,7.432e-01,2.148e-02
RACGAP1,9804,sulfate transport,GO:0008272,biological process,39.0,4.0,3.680e-01,2.630e-02,5.149e+00,2.907e-01,9.355e-03,9.037e+00,3.839e-01,1.786e-01
RACGAP1,9804,centralspindlin complex,GO:0097149,cellular component,39.0,3.0,7.197e-02,6.191e-02,8.366e-02,1.836e-02,1.061e-02,3.177e-02,8.841e-01,1.032e-02
RACGAP1,9804,mitotic spindle,GO:0072686,cellular component,39.0,17.0,7.197e-02,6.191e-02,8.366e-02,2.664e-02,1.399e-02,5.072e-02,8.509e-01,1.453e-02
RACGAP1,9804,spindle midzone,GO:0051233,cellular component,39.0,8.0,7.197e-02,6.191e-02,8.366e-02,3.159e-02,7.245e-03,1.377e-01,8.293e-01,3.471e-02
RACGAP1,9804,midbody,GO:0030496,cellular component,39.0,26.0,7.197e-02,6.191e-02,8.366e-02,3.715e-02,1.456e-02,9.478e-02,8.167e-01,2.398e-02
RACGAP1,9804,extracellular exosome,GO:0070062,cellular component,39.0,33.0,7.209e-02,6.229e-02,8.343e-02,5.379e-02,3.805e-02,7.602e-02,7.774e-01,9.511e-03
RACGAP1,9804,cleavage furrow,GO:0032154,cellular component,39.0,5.0,7.525e-02,6.157e-02,9.198e-02,3.762e-02,1.020e-02,1.388e-01,8.132e-01,3.221e-02
RACGAP1,9804,extrinsic component of cytoplasmic side of plasma membrane,GO:0031234,cellular component,39.0,3.0,7.722e-02,6.655e-02,8.960e-02,4.554e-02,2.172e-02,9.546e-02,7.952e-01,1.917e-02
RACGAP1,9804,nucleoplasm,GO:0005654,cellular component,39.0,74.0,9.468e-02,5.696e-02,1.574e-01,6.760e-02,1.901e-02,2.404e-01,7.460e-01,3.606e-02
RACGAP1,9804,nucleus,GO:0005634,cellular component,39.0,151.0,9.490e-02,5.647e-02,1.595e-01,7.414e-02,2.822e-02,1.948e-01,7.364e-01,2.896e-02
RACGAP1,9804,microtubule binding,GO:0008017,molecular function,39.0,22.0,7.197e-02,6.191e-02,8.366e-02,2.962e-02,1.191e-02,7.369e-02,8.398e-01,2.054e-02
RACGAP1,9804,alpha-tubulin binding,GO:0043014,molecular function,39.0,2.0,7.197e-02,6.191e-02,8.366e-02,3.162e-02,1.099e-02,9.097e-02,8.323e-01,2.546e-02
RACGAP1,9804,gamma-tubulin binding,GO:0043015,molecular function,39.0,3.0,7.197e-02,6.191e-02,8.366e-02,3.202e-02,1.134e-02,9.035e-02,8.313e-01,2.426e-02
RACGAP1,9804,beta-tubulin binding,GO:0048487,molecular function,39.0,4.0,7.197e-02,6.191e-02,8.366e-02,4.701e-02,2.798e-02,7.898e-02,7.926e-01,1.382e-02
RACGAP1,9804,protein kinase binding,GO:0019901,molecular function,39.0,32.0,7.755e-02,6.053e-02,9.936e-02,5.611e-02,2.161e-02,1.457e-01,7.705e-01,2.581e-02
RACGAP1,9804,"phosphatidylinositol-3,4,5-trisphosphate binding",GO:0005547,molecular function,39.0,2.0,8.276e-02,5.119e-02,1.338e-01,5.117e-02,1.484e-02,1.764e-01,7.794e-01,3.544e-02
RACGAP1,9804,GTPase activator activity,GO:0005096,molecular function,39.0,6.0,8.315e-02,5.683e-02,1.217e-01,4.576e-02,1.098e-02,1.906e-01,7.911e-01,3.842e-02
RACGAP1,9804,protein binding,GO:0005515,molecular function,39.0,332.0,1.044e-01,6.332e-02,1.722e-01,9.545e-02,5.113e-02,1.782e-01,7.048e-01,2.102e-02
SNRNP25,14161,,,,nan,nan,,,,,,,,
MEGF6,3232,,,,nan,nan,,,,,,,,
ATF3,785,positive regulation of TRAIL-activated apoptotic signaling pathway,GO:1903984,biological process,40.0,3.0,2.850e-02,2.257e-02,3.599e-02,2.118e-02,1.578e-02,2.843e-02,8.732e-01,6.430e-03
ATF3,785,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990440,biological process,40.0,4.0,2.965e-02,1.549e-02,5.677e-02,1.723e-02,2.994e-03,9.919e-02,8.790e-01,3.232e-02
ATF3,785,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,40.0,62.0,3.340e-02,1.978e-02,5.642e-02,3.069e-02,1.394e-02,6.756e-02,8.369e-01,1.853e-02
ATF3,785,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,40.0,54.0,3.714e-02,2.503e-02,5.511e-02,3.393e-02,2.166e-02,5.316e-02,8.274e-01,1.108e-02
ATF3,785,nucleus,GO:0005634,cellular component,40.0,151.0,2.252e-02,1.689e-02,3.002e-02,7.747e-03,4.042e-03,1.485e-02,9.363e-01,7.158e-03
ATF3,785,nucleolus,GO:0005730,cellular component,40.0,41.0,2.292e-02,1.669e-02,3.149e-02,1.084e-02,2.790e-03,4.214e-02,9.152e-01,1.838e-02
ATF3,785,CHOP-ATF3 complex,GO:1990622,cellular component,40.0,2.0,3.135e-02,1.981e-02,4.961e-02,2.566e-02,1.205e-02,5.466e-02,8.538e-01,1.646e-02
ATF3,785,identical protein binding,GO:0042802,molecular function,40.0,20.0,2.252e-02,1.689e-02,3.002e-02,3.505e-03,2.688e-03,4.568e-03,9.703e-01,2.349e-03
ATF3,785,protein heterodimerization activity,GO:0046982,molecular function,40.0,6.0,2.252e-02,1.689e-02,3.002e-02,4.742e-03,1.358e-03,1.656e-02,9.569e-01,1.313e-02
ATF3,785,protein homodimerization activity,GO:0042803,molecular function,40.0,15.0,2.252e-02,1.689e-02,3.002e-02,6.393e-03,4.161e-03,9.821e-03,9.453e-01,4.581e-03
ATF3,785,protein binding,GO:0005515,molecular function,40.0,332.0,2.484e-02,2.349e-02,2.626e-02,1.050e-02,7.040e-03,1.565e-02,9.213e-01,5.109e-03
ATF3,785,DNA-binding transcription factor activity,GO:0003700,molecular function,40.0,18.0,2.677e-02,1.977e-02,3.627e-02,1.146e-02,4.500e-03,2.920e-02,9.144e-01,1.337e-02
ATF3,785,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,40.0,10.0,2.677e-02,1.977e-02,3.627e-02,1.438e-02,1.032e-02,2.004e-02,9.028e-01,5.343e-03
ATF3,785,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,40.0,25.0,2.743e-02,1.866e-02,4.033e-02,1.871e-02,1.078e-02,3.246e-02,8.824e-01,1.122e-02
ATF3,785,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,40.0,11.0,2.838e-02,2.133e-02,3.776e-02,2.003e-02,1.156e-02,3.469e-02,8.770e-01,1.127e-02
ATF3,785,transcription regulatory region DNA binding,GO:0044212,molecular function,40.0,24.0,2.908e-02,2.051e-02,4.121e-02,2.113e-02,1.119e-02,3.990e-02,8.717e-01,1.257e-02
DUSP19,18894,regulation of MAP kinase activity,GO:0043405,biological process,6.0,8.0,4.941e-02,2.010e-02,1.214e-01,2.470e-02,2.989e-03,2.042e-01,8.457e-01,4.980e-02
DUSP19,18894,cytoplasm,GO:0005737,cellular component,6.0,69.0,6.272e-02,2.896e-02,1.358e-01,3.821e-02,2.150e-02,6.791e-02,8.147e-01,1.484e-02
DUSP19,18894,JUN kinase phosphatase activity,GO:0008579,molecular function,6.0,2.0,5.978e-02,2.348e-02,1.522e-01,4.152e-02,7.681e-03,2.245e-01,7.992e-01,4.077e-02
DUSP19,18894,protein binding,GO:0005515,molecular function,6.0,332.0,6.490e-02,3.362e-02,1.253e-01,5.071e-02,3.061e-02,8.398e-02,7.841e-01,1.406e-02
PRKCI,9404,protein phosphorylation,GO:0006468,biological process,24.0,33.0,6.224e-02,5.526e-02,7.010e-02,1.113e-02,4.965e-03,2.497e-02,9.163e-01,1.177e-02
PRKCI,9404,positive regulation of endothelial cell apoptotic process,GO:2000353,biological process,24.0,3.0,6.224e-02,5.526e-02,7.010e-02,1.507e-02,2.173e-03,1.044e-01,8.869e-01,3.544e-02
PRKCI,9404,intracellular signal transduction,GO:0035556,biological process,24.0,30.0,6.580e-02,5.657e-02,7.654e-02,3.081e-02,1.164e-02,8.155e-02,8.354e-01,2.327e-02
PRKCI,9404,negative regulation of neuron apoptotic process,GO:0043524,biological process,24.0,11.0,6.655e-02,5.544e-02,7.988e-02,3.029e-02,2.549e-02,3.600e-02,8.392e-01,4.049e-03
PRKCI,9404,peptidyl-serine phosphorylation,GO:0018105,biological process,24.0,13.0,6.655e-02,5.544e-02,7.988e-02,3.398e-02,1.816e-02,6.357e-02,8.270e-01,1.560e-02
PRKCI,9404,positive regulation of glial cell proliferation,GO:0060252,biological process,24.0,5.0,6.655e-02,5.544e-02,7.988e-02,3.506e-02,1.721e-02,7.141e-02,8.235e-01,1.768e-02
PRKCI,9404,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,24.0,3.0,7.019e-02,4.947e-02,9.960e-02,1.791e-02,1.754e-03,1.828e-01,8.680e-01,4.988e-02
PRKCI,9404,negative regulation of glial cell apoptotic process,GO:0034351,biological process,24.0,4.0,7.019e-02,4.947e-02,9.960e-02,2.621e-02,5.305e-03,1.295e-01,8.464e-01,3.821e-02
PRKCI,9404,cell-cell junction organization,GO:0045216,biological process,24.0,7.0,8.516e-02,4.761e-02,1.523e-01,6.876e-02,2.034e-02,2.324e-01,7.445e-01,3.480e-02
PRKCI,9404,positive regulation of neuron projection development,GO:0010976,biological process,24.0,10.0,9.252e-02,7.166e-02,1.194e-01,8.915e-02,6.114e-02,1.300e-01,7.149e-01,1.197e-02
PRKCI,9404,microtubule cytoskeleton,GO:0015630,cellular component,24.0,17.0,6.655e-02,5.544e-02,7.988e-02,3.039e-02,1.888e-02,4.892e-02,8.387e-01,1.133e-02
PRKCI,9404,extracellular exosome,GO:0070062,cellular component,24.0,33.0,6.851e-02,6.487e-02,7.234e-02,3.093e-02,1.046e-02,9.145e-02,8.344e-01,2.501e-02
PRKCI,9404,cytosol,GO:0005829,cellular component,24.0,78.0,6.995e-02,6.190e-02,7.905e-02,4.792e-02,3.631e-02,6.323e-02,7.909e-01,7.508e-03
PRKCI,9404,nucleus,GO:0005634,cellular component,24.0,151.0,7.048e-02,6.082e-02,8.166e-02,5.593e-02,4.742e-02,6.595e-02,7.731e-01,4.561e-03
PRKCI,9404,intercellular bridge,GO:0045171,cellular component,24.0,25.0,7.308e-02,5.582e-02,9.568e-02,5.583e-02,3.270e-02,9.531e-02,7.731e-01,1.499e-02
PRKCI,9404,protein serine/threonine kinase activity,GO:0004674,molecular function,24.0,34.0,6.224e-02,5.526e-02,7.010e-02,2.502e-02,4.645e-03,1.347e-01,8.480e-01,3.314e-02
PRKCI,9404,protein binding,GO:0005515,molecular function,24.0,332.0,6.929e-02,6.328e-02,7.586e-02,5.047e-02,3.020e-02,8.435e-02,7.845e-01,1.406e-02
PRKCI,9404,phospholipid binding,GO:0005543,molecular function,24.0,12.0,7.048e-02,6.082e-02,8.166e-02,5.662e-02,4.585e-02,6.993e-02,7.718e-01,5.909e-03
PRKCI,9404,protein kinase activity,GO:0004672,molecular function,24.0,38.0,8.080e-02,4.904e-02,1.332e-01,6.416e-02,2.262e-02,1.820e-01,7.543e-01,2.941e-02
KIAA1143,29198,,,,nan,nan,,,,,,,,
SLBP,10904,mRNA 3'-end processing by stem-loop binding and cleavage,GO:0006398,biological process,29.0,3.0,3.816e-02,2.652e-02,5.490e-02,2.014e-02,7.407e-03,5.475e-02,8.732e-01,1.876e-02
SLBP,10904,nuclear DNA replication,GO:0033260,biological process,29.0,4.0,3.906e-02,2.838e-02,5.376e-02,2.454e-02,1.341e-02,4.491e-02,8.589e-01,1.339e-02
SLBP,10904,mRNA transport,GO:0051028,biological process,29.0,3.0,4.159e-02,2.112e-02,8.187e-02,3.495e-02,9.923e-03,1.231e-01,8.207e-01,2.960e-02
SLBP,10904,cell cycle phase transition,GO:0044770,biological process,29.0,9.0,4.436e-02,2.983e-02,6.598e-02,2.778e-02,9.448e-03,8.166e-02,8.453e-01,2.640e-02
SLBP,10904,cytosol,GO:0005829,cellular component,29.0,78.0,3.610e-02,2.178e-02,5.982e-02,2.216e-02,7.825e-03,6.273e-02,8.660e-01,2.283e-02
SLBP,10904,nucleolus,GO:0005730,cellular component,29.0,41.0,3.610e-02,2.178e-02,5.982e-02,2.237e-02,9.334e-03,5.360e-02,8.660e-01,1.837e-02
SLBP,10904,cytoplasm,GO:0005737,cellular component,29.0,69.0,3.610e-02,2.178e-02,5.982e-02,2.397e-02,9.986e-03,5.752e-02,8.602e-01,2.012e-02
SLBP,10904,nucleus,GO:0005634,cellular component,29.0,151.0,3.610e-02,2.178e-02,5.982e-02,2.504e-02,1.142e-02,5.487e-02,8.559e-01,1.691e-02
SLBP,10904,histone pre-mRNA 3'end processing complex,GO:0071204,cellular component,29.0,2.0,3.649e-02,2.270e-02,5.866e-02,2.814e-02,1.676e-02,4.726e-02,8.463e-01,1.200e-02
SLBP,10904,identical protein binding,GO:0042802,molecular function,29.0,20.0,3.610e-02,2.178e-02,5.982e-02,1.226e-02,2.613e-03,5.756e-02,9.063e-01,2.052e-02
SLBP,10904,mRNA binding,GO:0003729,molecular function,29.0,12.0,3.610e-02,2.178e-02,5.982e-02,1.800e-02,1.386e-02,2.339e-02,8.869e-01,4.918e-03
SLBP,10904,histone pre-mRNA stem-loop binding,GO:0071207,molecular function,29.0,2.0,3.610e-02,2.178e-02,5.982e-02,1.729e-02,6.285e-03,4.759e-02,8.855e-01,1.984e-02
SLBP,10904,protein binding,GO:0005515,molecular function,29.0,332.0,3.610e-02,2.178e-02,5.982e-02,2.598e-02,1.012e-02,6.669e-02,8.517e-01,2.074e-02
SLBP,10904,RNA binding,GO:0003723,molecular function,29.0,63.0,3.903e-02,2.330e-02,6.538e-02,3.428e-02,1.779e-02,6.606e-02,8.259e-01,1.638e-02
ITGA2,6137,cell-matrix adhesion,GO:0007160,biological process,20.0,9.0,4.915e-02,2.823e-02,8.557e-02,3.082e-02,1.734e-02,5.476e-02,8.372e-01,1.364e-02
ITGA2,6137,collagen-activated signaling pathway,GO:0038065,biological process,20.0,3.0,5.063e-02,2.675e-02,9.583e-02,3.473e-02,2.003e-02,6.019e-02,8.244e-01,1.377e-02
ITGA2,6137,integrin-mediated signaling pathway,GO:0007229,biological process,20.0,3.0,5.360e-02,2.384e-02,1.205e-01,4.209e-02,1.673e-02,1.059e-01,8.031e-01,2.468e-02
ITGA2,6137,cell-substrate adhesion,GO:0031589,biological process,20.0,9.0,5.380e-02,2.771e-02,1.045e-01,2.975e-02,9.415e-03,9.398e-02,8.385e-01,2.875e-02
ITGA2,6137,cell adhesion mediated by integrin,GO:0033627,biological process,20.0,3.0,5.647e-02,2.621e-02,1.216e-01,3.151e-02,7.442e-03,1.334e-01,8.303e-01,3.653e-02
ITGA2,6137,substrate-dependent cell migration,GO:0006929,biological process,20.0,4.0,6.930e-02,5.099e-02,9.420e-02,6.006e-02,4.086e-02,8.828e-02,7.646e-01,1.080e-02
ITGA2,6137,mesodermal cell differentiation,GO:0048333,biological process,20.0,7.0,9.085e-02,3.564e-02,2.316e-01,8.891e-02,3.243e-02,2.438e-01,7.123e-01,3.104e-02
ITGA2,6137,plasma membrane,GO:0005886,cellular component,20.0,24.0,4.687e-02,2.678e-02,8.202e-02,8.792e-03,2.241e-03,3.450e-02,9.262e-01,1.864e-02
ITGA2,6137,focal adhesion,GO:0005925,cellular component,20.0,11.0,4.687e-02,2.678e-02,8.202e-02,2.216e-02,1.528e-02,3.213e-02,8.688e-01,7.862e-03
ITGA2,6137,cell surface,GO:0009986,cellular component,20.0,5.0,4.687e-02,2.678e-02,8.202e-02,2.338e-02,1.224e-02,4.464e-02,8.630e-01,1.412e-02
ITGA2,6137,integrin alpha2-beta1 complex,GO:0034666,cellular component,20.0,2.0,6.107e-02,2.519e-02,1.480e-01,4.340e-02,9.035e-03,2.085e-01,7.957e-01,4.148e-02
ITGA2,6137,collagen binding,GO:0005518,molecular function,20.0,4.0,4.687e-02,2.678e-02,8.202e-02,8.996e-03,2.470e-03,3.277e-02,9.270e-01,1.507e-02
ITGA2,6137,protein binding,GO:0005515,molecular function,20.0,332.0,4.687e-02,2.678e-02,8.202e-02,2.002e-02,8.545e-03,4.691e-02,8.754e-01,1.799e-02
ITGA2,6137,collagen binding involved in cell-matrix adhesion,GO:0098639,molecular function,20.0,3.0,4.855e-02,2.797e-02,8.426e-02,1.851e-02,9.482e-03,3.613e-02,8.828e-01,1.235e-02
ITGA2,6137,collagen receptor activity,GO:0038064,molecular function,20.0,3.0,5.111e-02,2.201e-02,1.187e-01,2.988e-02,6.467e-03,1.380e-01,8.350e-01,3.833e-02
ITGA2,6137,protein-containing complex binding,GO:0044877,molecular function,20.0,79.0,5.246e-02,2.822e-02,9.753e-02,2.968e-02,7.670e-03,1.149e-01,8.362e-01,2.984e-02
NIPBL,28862,replication-born double-strand break repair via sister chromatid exchange,GO:1990414,biological process,53.0,2.0,1.293e-01,6.732e-02,2.485e-01,2.545e-02,1.053e-02,6.149e-02,8.540e-01,1.924e-02
NIPBL,28862,transcriptional activation by promoter-enhancer looping,GO:0071733,biological process,53.0,3.0,1.293e-01,6.732e-02,2.485e-01,2.823e-02,2.196e-02,3.630e-02,8.459e-01,6.008e-03
NIPBL,28862,embryonic forelimb morphogenesis,GO:0035115,biological process,53.0,3.0,1.293e-01,6.732e-02,2.485e-01,4.488e-02,3.291e-02,6.120e-02,7.980e-01,8.357e-03
NIPBL,28862,forelimb morphogenesis,GO:0035136,biological process,53.0,4.0,1.293e-01,6.732e-02,2.485e-01,4.506e-02,3.628e-02,5.596e-02,7.979e-01,5.899e-03
NIPBL,28862,double-strand break repair,GO:0006302,biological process,53.0,10.0,1.293e-01,6.732e-02,2.485e-01,4.787e-02,2.237e-02,1.024e-01,7.899e-01,2.120e-02
NIPBL,28862,external genitalia morphogenesis,GO:0035261,biological process,53.0,2.0,1.293e-01,6.732e-02,2.485e-01,4.949e-02,2.832e-02,8.646e-02,7.867e-01,1.535e-02
NIPBL,28862,mitotic chromosome condensation,GO:0007076,biological process,53.0,9.0,1.294e-01,6.727e-02,2.489e-01,5.184e-02,2.568e-02,1.046e-01,7.811e-01,2.001e-02
NIPBL,28862,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,53.0,41.0,1.302e-01,6.633e-02,2.556e-01,4.324e-02,1.122e-02,1.666e-01,7.977e-01,3.739e-02
NIPBL,28862,embryonic digestive tract morphogenesis,GO:0048557,biological process,53.0,2.0,1.336e-01,7.141e-02,2.498e-01,5.385e-02,3.647e-02,7.951e-02,7.773e-01,1.082e-02
NIPBL,28862,cellular response to X-ray,GO:0071481,biological process,53.0,4.0,1.337e-01,6.926e-02,2.580e-01,5.865e-02,2.573e-02,1.336e-01,7.662e-01,2.322e-02
NIPBL,28862,ear morphogenesis,GO:0042471,biological process,53.0,3.0,1.364e-01,7.719e-02,2.410e-01,5.814e-02,4.407e-02,7.669e-02,7.686e-01,7.726e-03
NIPBL,28862,outflow tract morphogenesis,GO:0003151,biological process,53.0,2.0,1.398e-01,7.289e-02,2.683e-01,6.320e-02,3.035e-02,1.316e-01,7.572e-01,2.195e-02
NIPBL,28862,face morphogenesis,GO:0060325,biological process,53.0,2.0,1.398e-01,7.289e-02,2.683e-01,6.510e-02,3.444e-02,1.231e-01,7.540e-01,1.902e-02
NIPBL,28862,rDNA condensation,GO:0070550,biological process,53.0,2.0,1.398e-01,7.289e-02,2.683e-01,6.686e-02,3.060e-02,1.461e-01,7.503e-01,2.303e-02
NIPBL,28862,sensory perception of sound,GO:0007605,biological process,53.0,4.0,1.418e-01,5.457e-02,3.686e-01,7.254e-02,1.448e-02,3.633e-01,7.333e-01,5.264e-02
NIPBL,28862,heart morphogenesis,GO:0003007,biological process,53.0,2.0,1.448e-01,6.882e-02,3.045e-01,8.036e-02,2.616e-02,2.469e-01,7.251e-01,3.370e-02
NIPBL,28862,mitotic sister chromatid cohesion,GO:0007064,biological process,53.0,7.0,1.448e-01,6.882e-02,3.045e-01,8.161e-02,3.542e-02,1.881e-01,7.245e-01,2.570e-02
NIPBL,28862,eye morphogenesis,GO:0048592,biological process,53.0,7.0,1.534e-01,8.075e-02,2.912e-01,1.016e-01,4.628e-02,2.231e-01,6.954e-01,2.704e-02
NIPBL,28862,cellular response to DNA damage stimulus,GO:0006974,biological process,53.0,20.0,1.590e-01,8.995e-02,2.811e-01,1.084e-01,4.952e-02,2.374e-01,6.862e-01,2.692e-02
NIPBL,28862,cellular protein localization,GO:0034613,biological process,53.0,23.0,1.616e-01,6.636e-02,3.934e-01,4.847e-02,4.882e-03,4.812e-01,7.744e-01,6.931e-02
NIPBL,28862,embryonic viscerocranium morphogenesis,GO:0048703,biological process,53.0,2.0,1.636e-01,6.750e-02,3.963e-01,9.115e-02,2.519e-02,3.298e-01,7.069e-01,4.004e-02
NIPBL,28862,uterus morphogenesis,GO:0061038,biological process,53.0,3.0,1.651e-01,6.703e-02,4.068e-01,1.061e-01,2.777e-02,4.050e-01,6.852e-01,4.319e-02
NIPBL,28862,establishment of protein localization to chromatin,GO:0071169,biological process,53.0,4.0,1.674e-01,8.282e-02,3.382e-01,1.009e-01,4.469e-02,2.280e-01,6.961e-01,2.776e-02
NIPBL,28862,developmental growth,GO:0048589,biological process,53.0,19.0,1.688e-01,6.599e-02,4.318e-01,1.193e-01,3.642e-02,3.906e-01,6.686e-01,4.386e-02
NIPBL,28862,cognition,GO:0050890,biological process,53.0,4.0,1.867e-01,3.647e-02,9.558e-01,1.148e-01,1.038e-02,1.269e+00,6.475e-01,1.004e-01
NIPBL,28862,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,53.0,54.0,1.920e-01,6.882e-02,5.356e-01,1.387e-01,3.525e-02,5.457e-01,6.446e-01,4.772e-02
NIPBL,28862,positive regulation of histone deacetylation,GO:0031065,biological process,53.0,6.0,2.089e-01,1.861e-01,2.345e-01,1.598e-01,1.280e-01,1.994e-01,6.301e-01,8.336e-03
NIPBL,28862,establishment of mitotic sister chromatid cohesion,GO:0034087,biological process,53.0,3.0,2.245e-01,1.612e-01,3.126e-01,1.785e-01,1.097e-01,2.904e-01,6.107e-01,1.961e-02
NIPBL,28862,positive regulation of mitotic cohesin loading,GO:1905406,biological process,53.0,6.0,2.364e-01,1.548e-01,3.609e-01,1.982e-01,1.261e-01,3.116e-01,5.926e-01,2.001e-02
NIPBL,28862,brain development,GO:0007420,biological process,53.0,2.0,2.460e-01,1.518e-01,3.989e-01,2.063e-01,1.275e-01,3.338e-01,5.856e-01,2.019e-02
NIPBL,28862,gall bladder development,GO:0061010,biological process,53.0,2.0,2.542e-01,1.484e-01,4.354e-01,2.158e-01,1.205e-01,3.865e-01,5.761e-01,2.496e-02
NIPBL,28862,maintenance of mitotic sister chromatid cohesion,GO:0034088,biological process,53.0,6.0,3.092e-01,2.157e-01,4.431e-01,2.860e-01,2.225e-01,3.677e-01,5.219e-01,1.312e-02
NIPBL,28862,cohesin loading,GO:0071921,biological process,53.0,4.0,3.223e-01,1.677e-01,6.196e-01,2.986e-01,1.593e-01,5.597e-01,5.090e-01,3.204e-02
NIPBL,28862,heart development,GO:0007507,biological process,53.0,4.0,3.263e-01,1.768e-01,6.025e-01,3.045e-01,1.730e-01,5.359e-01,5.055e-01,2.935e-02
NIPBL,28862,regulation of embryonic development,GO:0045995,biological process,53.0,31.0,3.443e-01,5.026e-02,2.359e+00,2.987e-01,2.885e-02,3.093e+00,4.516e-01,1.225e-01
NIPBL,28862,regulation of developmental growth,GO:0048638,biological process,53.0,31.0,4.350e-01,1.588e-01,1.191e+00,4.234e-01,1.569e-01,1.142e+00,4.107e-01,6.297e-02
NIPBL,28862,regulation of hair cycle,GO:0042634,biological process,53.0,7.0,4.650e-01,1.105e-01,1.956e+00,4.492e-01,9.836e-02,2.051e+00,3.671e-01,9.832e-02
NIPBL,28862,Scc2-Scc4 cohesin loading complex,GO:0090694,cellular component,53.0,2.0,1.293e-01,6.732e-02,2.485e-01,3.359e-02,2.223e-02,5.075e-02,8.285e-01,1.003e-02
NIPBL,28862,SMC loading complex,GO:0032116,cellular component,53.0,4.0,1.293e-01,6.732e-02,2.485e-01,3.587e-02,2.266e-02,5.678e-02,8.220e-01,1.119e-02
NIPBL,28862,nuclear chromosome,GO:0000228,cellular component,53.0,7.0,1.293e-01,6.732e-02,2.485e-01,4.464e-02,1.896e-02,1.051e-01,7.971e-01,2.214e-02
NIPBL,28862,nuclear chromatin,GO:0000790,cellular component,53.0,14.0,1.293e-01,6.732e-02,2.485e-01,4.579e-02,2.667e-02,7.861e-02,7.957e-01,1.480e-02
NIPBL,28862,chromatin,GO:0000785,cellular component,53.0,15.0,1.339e-01,6.228e-02,2.878e-01,6.254e-02,1.944e-02,2.012e-01,7.561e-01,3.572e-02
NIPBL,28862,extracellular exosome,GO:0070062,cellular component,53.0,33.0,1.398e-01,8.331e-02,2.346e-01,7.481e-02,3.794e-02,1.475e-01,7.366e-01,2.012e-02
NIPBL,28862,nucleus,GO:0005634,cellular component,53.0,151.0,1.439e-01,7.774e-02,2.664e-01,7.366e-02,2.504e-02,2.166e-01,7.367e-01,3.181e-02
NIPBL,28862,protein C-terminus binding,GO:0008022,molecular function,53.0,7.0,1.293e-01,6.732e-02,2.485e-01,2.471e-02,1.888e-02,3.234e-02,8.591e-01,6.166e-03
NIPBL,28862,chromatin binding,GO:0003682,molecular function,53.0,17.0,1.293e-01,6.732e-02,2.485e-01,3.732e-02,1.206e-02,1.155e-01,8.150e-01,2.985e-02
NIPBL,28862,protein N-terminus binding,GO:0047485,molecular function,53.0,4.0,1.348e-01,7.115e-02,2.552e-01,5.335e-02,2.625e-02,1.085e-01,7.777e-01,1.931e-02
NIPBL,28862,chromo shadow domain binding,GO:0070087,molecular function,53.0,2.0,1.377e-01,5.936e-02,3.193e-01,7.389e-02,1.898e-02,2.877e-01,7.333e-01,4.385e-02
NIPBL,28862,histone deacetylase binding,GO:0042826,molecular function,53.0,4.0,1.388e-01,8.407e-02,2.291e-01,6.155e-02,3.324e-02,1.140e-01,7.610e-01,1.772e-02
NIPBL,28862,protein binding,GO:0005515,molecular function,53.0,332.0,1.535e-01,8.777e-02,2.685e-01,8.976e-02,3.087e-02,2.611e-01,7.106e-01,3.294e-02
SLC29A4,23097,plasma membrane,GO:0005886,cellular component,3.0,24.0,9.832e-02,5.823e-02,1.660e-01,6.194e-02,4.528e-02,8.472e-02,7.609e-01,9.001e-03
SLC29A4,23097,monoamine transmembrane transporter activity,GO:0008504,molecular function,3.0,7.0,1.388e-01,1.321e-02,1.458e+00,1.101e-01,4.784e-03,2.536e+00,6.494e-01,9.820e-02
ALDH7A1,877,extracellular exosome,GO:0070062,cellular component,10.0,33.0,2.093e-02,1.308e-02,3.349e-02,1.113e-02,6.454e-03,1.921e-02,9.179e-01,7.324e-03
ALDH7A1,877,mitochondrion,GO:0005739,cellular component,10.0,19.0,2.093e-02,1.308e-02,3.349e-02,1.432e-02,7.548e-03,2.719e-02,9.017e-01,1.002e-02
ALDH7A1,877,cytosol,GO:0005829,cellular component,10.0,78.0,2.093e-02,1.308e-02,3.349e-02,1.871e-02,1.182e-02,2.962e-02,8.829e-01,9.046e-03
ALDH7A1,877,protein binding,GO:0005515,molecular function,10.0,332.0,2.093e-02,1.308e-02,3.349e-02,2.093e-02,1.308e-02,3.349e-02,8.736e-01,1.026e-02
INTS8,26048,snRNA 3'-end processing,GO:0034472,biological process,5.0,8.0,3.731e-02,1.751e-02,7.951e-02,1.301e-02,3.559e-03,4.754e-02,9.031e-01,2.198e-02
INTS8,26048,snRNA processing,GO:0016180,biological process,5.0,5.0,4.115e-02,2.526e-02,6.702e-02,2.197e-02,1.254e-02,3.849e-02,8.688e-01,1.145e-02
INTS8,26048,integrator complex,GO:0032039,cellular component,5.0,2.0,4.966e-02,9.438e-03,2.613e-01,3.581e-02,3.558e-03,3.604e-01,8.070e-01,6.041e-02
INTS8,26048,protein binding,GO:0005515,molecular function,5.0,332.0,9.554e-02,8.401e-02,1.086e-01,8.680e-02,6.036e-02,1.248e-01,7.184e-01,1.148e-02
CCDC171,29828,,,,nan,nan,,,,,,,,
LETM2,14648,,,,nan,nan,,,,,,,,
SKA3,20262,mitotic cell cycle,GO:0000278,biological process,10.0,13.0,3.387e-02,2.965e-02,3.869e-02,2.259e-02,1.532e-02,3.331e-02,8.670e-01,8.198e-03
SKA3,20262,regulation of microtubule polymerization or depolymerization,GO:0031110,biological process,10.0,6.0,4.554e-02,2.775e-02,7.475e-02,3.293e-02,1.469e-02,7.383e-02,8.298e-01,1.959e-02
SKA3,20262,chromosome segregation,GO:0007059,biological process,10.0,7.0,5.252e-02,1.342e-02,2.056e-01,3.975e-02,7.960e-03,1.985e-01,8.048e-01,4.375e-02
SKA3,20262,spindle microtubule,GO:0005876,cellular component,10.0,11.0,3.370e-02,2.904e-02,3.911e-02,1.041e-02,2.885e-03,3.754e-02,9.179e-01,1.745e-02
SKA3,20262,kinetochore,GO:0000776,cellular component,10.0,13.0,3.370e-02,2.904e-02,3.911e-02,1.245e-02,4.243e-03,3.652e-02,9.087e-01,1.456e-02
SKA3,20262,condensed chromosome outer kinetochore,GO:0000940,cellular component,10.0,5.0,3.370e-02,2.904e-02,3.911e-02,1.391e-02,1.254e-02,1.543e-02,9.056e-01,1.723e-03
SKA3,20262,protein binding,GO:0005515,molecular function,10.0,332.0,1.277e-01,9.092e-02,1.794e-01,1.277e-01,9.092e-02,1.794e-01,6.643e-01,1.214e-02
BEND7,23514,extracellular exosome,GO:0070062,cellular component,7.0,33.0,9.395e-03,3.106e-03,2.841e-02,6.830e-03,2.775e-03,1.681e-02,9.417e-01,9.988e-03
BEND7,23514,protein binding,GO:0005515,molecular function,7.0,332.0,9.395e-03,3.106e-03,2.841e-02,9.395e-03,3.106e-03,2.841e-02,9.252e-01,1.305e-02
DDX21,2744,osteoblast differentiation,GO:0001649,biological process,20.0,4.0,9.520e-02,6.821e-02,1.329e-01,6.522e-02,1.952e-02,2.180e-01,7.510e-01,3.419e-02
DDX21,2744,transcription by RNA polymerase II,GO:0006366,biological process,20.0,16.0,1.038e-01,7.210e-02,1.494e-01,8.977e-02,5.780e-02,1.394e-01,7.137e-01,1.442e-02
DDX21,2744,nucleolus,GO:0005730,cellular component,20.0,41.0,8.957e-02,7.243e-02,1.108e-01,4.081e-02,1.973e-02,8.443e-02,8.073e-01,1.856e-02
DDX21,2744,nucleus,GO:0005634,cellular component,20.0,151.0,8.957e-02,7.243e-02,1.108e-01,4.628e-02,2.856e-02,7.499e-02,7.944e-01,1.285e-02
DDX21,2744,membrane,GO:0016020,cellular component,20.0,53.0,9.277e-02,7.600e-02,1.133e-01,4.808e-02,2.418e-02,9.560e-02,7.893e-01,1.814e-02
DDX21,2744,rRNA binding,GO:0019843,molecular function,20.0,10.0,8.957e-02,7.243e-02,1.108e-01,2.801e-02,1.399e-02,5.609e-02,8.461e-01,1.609e-02
DDX21,2744,RNA binding,GO:0003723,molecular function,20.0,63.0,8.957e-02,7.243e-02,1.108e-01,3.212e-02,1.381e-02,7.469e-02,8.322e-01,1.973e-02
DDX21,2744,protein binding,GO:0005515,molecular function,20.0,332.0,8.957e-02,7.243e-02,1.108e-01,5.590e-02,2.711e-02,1.153e-01,7.722e-01,2.084e-02
DDX21,2744,snoRNA binding,GO:0030515,molecular function,20.0,6.0,9.073e-02,7.509e-02,1.096e-01,3.976e-02,1.311e-02,1.206e-01,8.085e-01,2.797e-02
DDX21,2744,miRNA binding,GO:0035198,molecular function,20.0,2.0,9.657e-02,7.974e-02,1.169e-01,7.115e-02,4.968e-02,1.019e-01,7.441e-01,1.076e-02
DDX21,2744,7SK snRNA binding,GO:0097322,molecular function,20.0,2.0,9.657e-02,7.974e-02,1.169e-01,7.293e-02,5.239e-02,1.015e-01,7.410e-01,9.904e-03
DDX21,2744,RNA helicase activity,GO:0003724,molecular function,20.0,5.0,1.761e-01,8.124e-02,3.816e-01,1.761e-01,8.124e-02,3.816e-01,6.104e-01,3.242e-02
TAF1D,28759,nucleoplasm,GO:0005654,cellular component,6.0,74.0,4.821e-02,2.049e-02,1.134e-01,3.807e-02,1.690e-02,8.574e-02,8.144e-01,2.012e-02
TAF1D,28759,microtubule organizing center,GO:0005815,cellular component,6.0,16.0,4.868e-02,2.008e-02,1.180e-01,4.471e-02,1.623e-02,1.232e-01,7.961e-01,2.742e-02
TAF1D,28759,protein binding,GO:0005515,molecular function,6.0,332.0,4.821e-02,2.049e-02,1.134e-01,3.755e-02,2.752e-02,5.123e-02,8.173e-01,7.814e-03
LARP6,24012,,,,nan,nan,,,,,,,,
COPS2,30747,protein deneddylation,GO:0000338,biological process,17.0,2.0,3.330e-02,1.236e-02,8.966e-02,2.567e-02,8.907e-03,7.395e-02,8.520e-01,2.284e-02
COPS2,30747,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,17.0,41.0,3.472e-02,1.458e-02,8.270e-02,2.976e-02,1.249e-02,7.088e-02,8.392e-01,2.075e-02
COPS2,30747,protein phosphorylation,GO:0006468,biological process,17.0,33.0,4.350e-02,2.952e-02,6.409e-02,4.066e-02,3.469e-02,4.766e-02,8.093e-01,4.283e-03
COPS2,30747,cytoplasm,GO:0005737,cellular component,17.0,69.0,3.138e-02,1.149e-02,8.566e-02,1.673e-02,7.892e-03,3.548e-02,8.901e-01,1.385e-02
COPS2,30747,COP9 signalosome,GO:0008180,cellular component,17.0,2.0,3.210e-02,1.093e-02,9.431e-02,2.001e-02,3.218e-03,1.244e-01,8.666e-01,4.027e-02
COPS2,30747,transcription corepressor activity,GO:0003714,molecular function,17.0,6.0,3.138e-02,1.149e-02,8.566e-02,6.202e-03,1.901e-03,2.024e-02,9.455e-01,1.225e-02
COPS2,30747,protein binding,GO:0005515,molecular function,17.0,332.0,3.138e-02,1.149e-02,8.566e-02,1.598e-02,9.830e-03,2.597e-02,8.950e-01,8.761e-03
NUDT13,18827,,,,nan,nan,,,,,,,,
CENPV,29920,,,,nan,nan,,,,,,,,
DUSP18,18484,peptidyl-threonine dephosphorylation,GO:0035970,biological process,10.0,2.0,1.211e-01,3.450e-02,4.251e-01,3.325e-02,3.257e-03,3.394e-01,8.154e-01,6.206e-02
DUSP18,18484,peptidyl-tyrosine dephosphorylation,GO:0035335,biological process,10.0,4.0,1.287e-01,3.002e-02,5.517e-01,5.770e-02,5.429e-03,6.131e-01,7.516e-01,7.565e-02
DUSP18,18484,dephosphorylation,GO:0016311,biological process,10.0,10.0,1.361e-01,2.639e-02,7.017e-01,7.983e-02,6.717e-03,9.487e-01,7.039e-01,9.031e-02
DUSP18,18484,nucleoplasm,GO:0005654,cellular component,10.0,74.0,1.488e-01,4.164e-02,5.316e-01,9.206e-02,1.471e-02,5.760e-01,7.001e-01,5.552e-02
DUSP18,18484,cytoplasm,GO:0005737,cellular component,10.0,69.0,1.488e-01,4.164e-02,5.316e-01,9.722e-02,2.856e-02,3.310e-01,6.985e-01,3.861e-02
DUSP18,18484,nucleus,GO:0005634,cellular component,10.0,151.0,1.488e-01,4.164e-02,5.316e-01,9.885e-02,2.169e-02,4.505e-01,6.938e-01,4.744e-02
DUSP18,18484,protein tyrosine phosphatase activity,GO:0004725,molecular function,10.0,10.0,1.678e-01,8.631e-02,3.263e-01,1.013e-01,6.772e-02,1.516e-01,6.974e-01,1.337e-02
DUSP18,18484,protein tyrosine/serine/threonine phosphatase activity,GO:0008138,molecular function,10.0,4.0,1.678e-01,8.631e-02,3.263e-01,1.112e-01,4.895e-02,2.527e-01,6.824e-01,2.793e-02
DUSP18,18484,phosphatase activity,GO:0016791,molecular function,10.0,74.0,2.788e-01,1.627e-01,4.778e-01,2.788e-01,1.627e-01,4.778e-01,5.251e-01,2.703e-02
ZNF226,13019,,,,nan,nan,,,,,,,,
MIDN,16298,,,,nan,nan,,,,,,,,
ZNF444,16052,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,5.0,41.0,2.073e-02,1.073e-02,4.005e-02,7.912e-03,5.246e-03,1.193e-02,9.357e-01,4.808e-03
ZNF444,16052,nucleus,GO:0005634,cellular component,5.0,151.0,2.559e-02,1.932e-02,3.389e-02,2.361e-02,2.194e-02,2.542e-02,8.636e-01,1.654e-03
ZNF444,16052,DNA binding,GO:0003677,molecular function,5.0,26.0,2.073e-02,1.073e-02,4.005e-02,1.582e-02,5.238e-03,4.777e-02,8.912e-01,2.114e-02
KLK6,6367,,,,nan,nan,,,,,,,,
MGAT5B,24140,protein O-linked glycosylation via serine,GO:0018242,biological process,7.0,4.0,2.127e-01,1.397e-01,3.239e-01,1.132e-01,4.382e-02,2.924e-01,6.789e-01,3.342e-02
MGAT5B,24140,protein N-linked glycosylation,GO:0006487,biological process,7.0,6.0,2.200e-01,1.571e-01,3.080e-01,1.234e-01,9.284e-02,1.640e-01,6.695e-01,9.942e-03
MGAT5B,24140,Golgi apparatus,GO:0005794,cellular component,7.0,15.0,2.127e-01,1.397e-01,3.239e-01,1.072e-01,3.942e-02,2.917e-01,6.864e-01,3.262e-02
MGAT5B,24140,protein binding,GO:0005515,molecular function,7.0,332.0,2.127e-01,1.397e-01,3.239e-01,1.467e-01,6.024e-02,3.575e-01,6.404e-01,3.225e-02
MGAT5B,24140,manganese ion binding,GO:0030145,molecular function,7.0,2.0,2.246e-01,1.497e-01,3.370e-01,1.989e-01,1.355e-01,2.919e-01,5.928e-01,1.609e-02
MGAT5B,24140,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity",GO:0030144,molecular function,7.0,3.0,2.844e-01,1.603e-01,5.044e-01,2.661e-01,1.207e-01,5.869e-01,5.318e-01,3.791e-02
RNF187,27146,protein K48-linked ubiquitination,GO:0070936,biological process,12.0,4.0,6.186e-02,3.115e-02,1.228e-01,1.310e-02,5.221e-03,3.287e-02,9.056e-01,1.524e-02
RNF187,27146,protein autoubiquitination,GO:0051865,biological process,12.0,2.0,6.287e-02,3.277e-02,1.206e-01,1.763e-02,1.325e-02,2.345e-02,8.883e-01,5.155e-03
RNF187,27146,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,12.0,17.0,6.614e-02,3.460e-02,1.264e-01,2.290e-02,4.570e-03,1.147e-01,8.566e-01,3.021e-02
RNF187,27146,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,12.0,41.0,7.231e-02,4.275e-02,1.223e-01,4.099e-02,1.293e-02,1.300e-01,8.050e-01,2.937e-02
RNF187,27146,nucleus,GO:0005634,cellular component,12.0,151.0,7.826e-02,5.846e-02,1.048e-01,6.907e-02,5.306e-02,8.990e-02,7.480e-01,7.832e-03
RNF187,27146,nucleoplasm,GO:0005654,cellular component,12.0,74.0,7.826e-02,5.846e-02,1.048e-01,7.467e-02,5.486e-02,1.016e-01,7.381e-01,9.363e-03
RNF187,27146,cytoplasm,GO:0005737,cellular component,12.0,69.0,7.826e-02,5.846e-02,1.048e-01,7.629e-02,6.049e-02,9.623e-02,7.355e-01,7.104e-03
RNF187,27146,cytosol,GO:0005829,cellular component,12.0,78.0,7.826e-02,5.846e-02,1.048e-01,7.670e-02,5.423e-02,1.085e-01,7.346e-01,1.067e-02
RNF187,27146,ubiquitin-protein transferase activity,GO:0004842,molecular function,12.0,11.0,7.231e-02,4.275e-02,1.223e-01,2.750e-02,6.987e-03,1.082e-01,8.431e-01,2.938e-02
RNF187,27146,protein binding,GO:0005515,molecular function,12.0,332.0,7.826e-02,5.846e-02,1.048e-01,7.038e-02,5.483e-02,9.034e-02,7.456e-01,7.480e-03
THAP11,23194,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,9.0,54.0,7.042e-02,3.487e-02,1.422e-01,6.585e-02,2.910e-02,1.490e-01,7.520e-01,2.407e-02
THAP11,23194,nucleoplasm,GO:0005654,cellular component,9.0,74.0,5.572e-02,4.134e-02,7.510e-02,3.703e-02,1.929e-02,7.106e-02,8.180e-01,1.607e-02
THAP11,23194,intercellular bridge,GO:0045171,cellular component,9.0,25.0,5.572e-02,4.134e-02,7.510e-02,3.708e-02,9.730e-03,1.413e-01,8.143e-01,3.257e-02
THAP11,23194,zinc ion binding,GO:0008270,molecular function,9.0,6.0,5.572e-02,4.134e-02,7.510e-02,2.972e-02,1.429e-02,6.183e-02,8.401e-01,1.763e-02
THAP11,23194,DNA binding,GO:0003677,molecular function,9.0,26.0,5.572e-02,4.134e-02,7.510e-02,3.026e-02,1.231e-02,7.436e-02,8.378e-01,2.219e-02
THAP11,23194,protein binding,GO:0005515,molecular function,9.0,332.0,5.762e-02,4.426e-02,7.500e-02,4.550e-02,2.613e-02,7.924e-02,7.962e-01,1.497e-02
THAP11,23194,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,9.0,3.0,6.303e-02,4.308e-02,9.223e-02,3.614e-02,1.408e-02,9.280e-02,8.197e-01,2.336e-02
THAP11,23194,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,9.0,25.0,7.042e-02,3.487e-02,1.422e-01,5.201e-02,1.568e-02,1.724e-01,7.778e-01,3.444e-02
TRAPPC11,25751,endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006888,biological process,11.0,3.0,1.045e-01,4.811e-02,2.271e-01,4.323e-02,1.092e-02,1.712e-01,7.978e-01,3.437e-02
TRAPPC11,25751,protein complex oligomerization,GO:0051259,biological process,11.0,8.0,1.103e-01,6.063e-02,2.007e-01,4.316e-02,2.626e-02,7.093e-02,8.024e-01,1.339e-02
TRAPPC11,25751,Golgi organization,GO:0007030,biological process,11.0,8.0,1.312e-01,3.988e-02,4.316e-01,8.494e-02,1.329e-02,5.429e-01,7.109e-01,5.491e-02
TRAPPC11,25751,regulation of protein complex stability,GO:0061635,biological process,11.0,2.0,1.330e-01,4.899e-02,3.608e-01,1.099e-01,4.284e-02,2.819e-01,6.831e-01,3.314e-02
TRAPPC11,25751,Golgi apparatus,GO:0005794,cellular component,11.0,15.0,1.045e-01,4.811e-02,2.271e-01,3.879e-02,1.288e-02,1.168e-01,8.111e-01,2.716e-02
TRAPPC11,25751,TRAPP complex,GO:0030008,cellular component,11.0,5.0,1.812e-01,4.371e-02,7.510e-01,1.812e-01,4.371e-02,7.510e-01,5.978e-01,5.482e-02
TRAPPC11,25751,protein binding,GO:0005515,molecular function,11.0,332.0,1.123e-01,5.901e-02,2.139e-01,6.079e-02,3.261e-02,1.133e-01,7.625e-01,1.795e-02
CD2BP2,1656,negative regulation of phosphatase activity,GO:0010923,biological process,11.0,10.0,3.302e-01,1.221e-01,8.934e-01,3.302e-01,1.221e-01,8.934e-01,4.785e-01,5.371e-02
CD2BP2,1656,nuclear speck,GO:0016607,cellular component,11.0,6.0,1.280e-01,3.235e-02,5.067e-01,1.470e-02,3.338e-03,6.472e-02,8.933e-01,2.707e-02
CD2BP2,1656,nucleus,GO:0005634,cellular component,11.0,151.0,1.720e-01,7.491e-02,3.949e-01,1.068e-01,5.831e-02,1.957e-01,6.893e-01,2.078e-02
CD2BP2,1656,nucleoplasm,GO:0005654,cellular component,11.0,74.0,1.720e-01,7.491e-02,3.949e-01,1.155e-01,5.695e-02,2.341e-01,6.776e-01,2.480e-02
CD2BP2,1656,U5 snRNP,GO:0005682,cellular component,11.0,2.0,1.720e-01,7.491e-02,3.949e-01,1.157e-01,3.306e-02,4.047e-01,6.729e-01,4.430e-02
CD2BP2,1656,cytosol,GO:0005829,cellular component,11.0,78.0,1.720e-01,7.491e-02,3.949e-01,1.292e-01,6.758e-02,2.468e-01,6.614e-01,2.392e-02
CD2BP2,1656,fibrillar center,GO:0001650,cellular component,11.0,9.0,1.720e-01,7.491e-02,3.949e-01,1.380e-01,5.097e-02,3.735e-01,6.479e-01,3.895e-02
CD2BP2,1656,ribonucleoprotein complex binding,GO:0043021,molecular function,11.0,12.0,1.567e-01,5.398e-02,4.548e-01,5.922e-02,9.401e-03,3.731e-01,7.575e-01,5.095e-02
CD2BP2,1656,protein binding,GO:0005515,molecular function,11.0,332.0,1.752e-01,7.770e-02,3.949e-01,1.306e-01,7.478e-02,2.281e-01,6.602e-01,1.985e-02
SH3TC2,29427,,,,nan,nan,,,,,,,,
CKAP2L,26877,centrosome,GO:0005813,cellular component,4.0,31.0,3.684e-02,2.724e-02,4.982e-02,1.543e-02,1.055e-02,2.257e-02,8.979e-01,6.607e-03
CKAP2L,26877,mitotic spindle,GO:0072686,cellular component,4.0,17.0,3.684e-02,2.724e-02,4.982e-02,2.456e-02,1.816e-02,3.321e-02,8.595e-01,7.063e-03
CKAP2L,26877,cytosol,GO:0005829,cellular component,4.0,78.0,6.283e-02,5.566e-02,7.093e-02,6.283e-02,5.566e-02,7.093e-02,7.596e-01,3.516e-03
ZNF32,13095,,,,nan,nan,,,,,,,,
NFRKB,7802,nucleus,GO:0005634,cellular component,6.0,151.0,9.949e-02,2.974e-02,3.328e-01,7.270e-02,2.591e-02,2.040e-01,7.381e-01,3.257e-02
NFRKB,7802,Ino80 complex,GO:0031011,cellular component,6.0,3.0,1.006e-01,2.706e-02,3.741e-01,7.986e-02,1.019e-02,6.258e-01,7.166e-01,6.136e-02
NFRKB,7802,protease binding,GO:0002020,molecular function,6.0,7.0,8.681e-02,3.142e-02,2.399e-01,2.767e-02,8.919e-03,8.585e-02,8.447e-01,2.461e-02
NFRKB,7802,protein binding,GO:0005515,molecular function,6.0,332.0,9.949e-02,2.974e-02,3.328e-01,8.330e-02,3.086e-02,2.249e-01,7.208e-01,3.218e-02
FOS,3796,SMAD protein signal transduction,GO:0060395,biological process,32.0,3.0,2.320e-02,1.153e-02,4.667e-02,1.156e-02,8.217e-03,1.625e-02,9.163e-01,4.468e-03
FOS,3796,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,32.0,62.0,2.690e-02,1.049e-02,6.901e-02,2.022e-02,6.163e-03,6.632e-02,8.722e-01,2.467e-02
FOS,3796,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,32.0,41.0,2.726e-02,1.406e-02,5.286e-02,1.175e-02,2.380e-03,5.798e-02,9.076e-01,2.374e-02
FOS,3796,cellular response to reactive oxygen species,GO:0034614,biological process,32.0,11.0,2.745e-02,1.404e-02,5.368e-02,1.718e-02,7.312e-03,4.035e-02,8.872e-01,1.703e-02
FOS,3796,cellular response to cadmium ion,GO:0071276,biological process,32.0,4.0,2.963e-02,1.886e-02,4.656e-02,2.558e-02,1.800e-02,3.634e-02,8.556e-01,8.167e-03
FOS,3796,transforming growth factor beta receptor signaling pathway,GO:0007179,biological process,32.0,11.0,3.311e-02,6.909e-03,1.587e-01,2.660e-02,3.665e-03,1.930e-01,8.403e-01,4.598e-02
FOS,3796,transcription factor AP-1 complex,GO:0035976,cellular component,32.0,5.0,2.570e-02,9.031e-03,7.314e-02,1.458e-02,2.384e-03,8.916e-02,8.897e-01,3.454e-02
FOS,3796,nucleus,GO:0005634,cellular component,32.0,151.0,2.649e-02,1.404e-02,4.999e-02,1.204e-02,4.892e-03,2.964e-02,9.116e-01,1.309e-02
FOS,3796,nucleoplasm,GO:0005654,cellular component,32.0,74.0,2.795e-02,1.691e-02,4.618e-02,1.819e-02,1.226e-02,2.699e-02,8.854e-01,7.852e-03
FOS,3796,protein-DNA complex,GO:0032993,cellular component,32.0,20.0,5.610e-02,1.184e-02,2.659e-01,5.394e-02,9.965e-03,2.920e-01,7.704e-01,4.436e-02
FOS,3796,protein heterodimerization activity,GO:0046982,molecular function,32.0,6.0,2.320e-02,1.153e-02,4.667e-02,4.755e-03,2.922e-03,7.738e-03,9.581e-01,4.953e-03
FOS,3796,R-SMAD binding,GO:0070412,molecular function,32.0,3.0,2.320e-02,1.153e-02,4.667e-02,8.017e-03,2.795e-03,2.299e-02,9.332e-01,1.322e-02
FOS,3796,DNA-binding transcription factor activity,GO:0003700,molecular function,32.0,18.0,2.320e-02,1.153e-02,4.667e-02,1.186e-02,3.271e-03,4.300e-02,9.087e-01,2.115e-02
FOS,3796,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,32.0,5.0,2.320e-02,1.153e-02,4.667e-02,1.268e-02,3.881e-03,4.144e-02,9.059e-01,1.922e-02
FOS,3796,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,32.0,25.0,2.320e-02,1.153e-02,4.667e-02,1.391e-02,6.135e-03,3.155e-02,9.024e-01,1.417e-02
FOS,3796,transcription regulatory region DNA binding,GO:0044212,molecular function,32.0,24.0,2.320e-02,1.153e-02,4.667e-02,1.414e-02,5.348e-03,3.737e-02,9.002e-01,1.721e-02
FOS,3796,RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,molecular function,32.0,3.0,2.380e-02,1.086e-02,5.217e-02,1.196e-02,2.413e-03,5.924e-02,9.053e-01,2.648e-02
FOS,3796,protein binding,GO:0005515,molecular function,32.0,332.0,2.675e-02,1.407e-02,5.086e-02,1.606e-02,9.906e-03,2.604e-02,8.946e-01,8.839e-03
PYM1,30258,positive regulation of translation,GO:0045727,biological process,15.0,20.0,1.339e-01,4.976e-02,3.604e-01,8.403e-02,1.881e-02,3.754e-01,7.151e-01,5.041e-02
PYM1,30258,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",GO:0000184,biological process,15.0,4.0,1.501e-01,5.815e-02,3.873e-01,7.431e-02,4.278e-03,1.291e+00,7.130e-01,8.173e-02
PYM1,30258,exon-exon junction complex disassembly,GO:1903259,biological process,15.0,2.0,1.891e-01,5.878e-02,6.081e-01,1.371e-01,1.493e-02,1.258e+00,6.320e-01,7.836e-02
PYM1,30258,nucleolus,GO:0005730,cellular component,15.0,41.0,1.205e-01,6.408e-02,2.266e-01,4.845e-02,2.378e-02,9.870e-02,7.885e-01,1.870e-02
PYM1,30258,cell junction,GO:0030054,cellular component,15.0,9.0,1.205e-01,6.408e-02,2.266e-01,6.474e-02,5.076e-02,8.257e-02,7.559e-01,7.155e-03
PYM1,30258,nucleus,GO:0005634,cellular component,15.0,151.0,1.214e-01,6.538e-02,2.255e-01,6.916e-02,3.448e-02,1.387e-01,7.465e-01,2.001e-02
PYM1,30258,cytosol,GO:0005829,cellular component,15.0,78.0,1.214e-01,6.538e-02,2.255e-01,8.431e-02,5.111e-02,1.391e-01,7.218e-01,1.595e-02
PYM1,30258,cytoplasm,GO:0005737,cellular component,15.0,69.0,1.283e-01,7.451e-02,2.209e-01,1.036e-01,6.888e-02,1.557e-01,6.944e-01,1.392e-02
PYM1,30258,exon-exon junction complex,GO:0035145,cellular component,15.0,3.0,1.331e-01,7.874e-02,2.250e-01,1.067e-01,8.027e-02,1.418e-01,6.904e-01,9.526e-03
PYM1,30258,RNA binding,GO:0003723,molecular function,15.0,63.0,1.205e-01,6.408e-02,2.266e-01,3.745e-02,1.605e-02,8.738e-02,8.162e-01,2.121e-02
PYM1,30258,ribosome binding,GO:0043022,molecular function,15.0,3.0,1.205e-01,6.408e-02,2.266e-01,7.017e-02,2.830e-02,1.740e-01,7.434e-01,2.753e-02
PYM1,30258,protein binding,GO:0005515,molecular function,15.0,332.0,1.214e-01,6.538e-02,2.255e-01,8.793e-02,3.768e-02,2.052e-01,7.146e-01,2.627e-02
ZNF672,26179,,,,nan,nan,,,,,,,,
SHCBP1,29547,fibroblast growth factor receptor signaling pathway,GO:0008543,biological process,7.0,20.0,7.477e-02,4.093e-02,1.366e-01,7.477e-02,4.093e-02,1.366e-01,7.370e-01,1.821e-02
SHCBP1,29547,protein binding,GO:0005515,molecular function,7.0,332.0,4.074e-02,7.854e-03,2.113e-01,2.044e-02,3.926e-03,1.064e-01,8.660e-01,2.979e-02
ESCO2,27230,post-translational protein acetylation,GO:0034421,biological process,11.0,3.0,1.020e-01,6.501e-02,1.601e-01,2.539e-02,1.454e-02,4.435e-02,8.553e-01,1.248e-02
ESCO2,27230,sister chromatid cohesion,GO:0007062,biological process,11.0,7.0,1.020e-01,6.501e-02,1.601e-01,4.810e-02,2.943e-02,7.864e-02,7.901e-01,1.339e-02
ESCO2,27230,regulation of DNA replication,GO:0006275,biological process,11.0,8.0,1.057e-01,6.131e-02,1.824e-01,7.096e-02,2.239e-02,2.249e-01,7.405e-01,3.597e-02
ESCO2,27230,chromosome,GO:0005694,cellular component,11.0,9.0,1.020e-01,6.501e-02,1.601e-01,2.819e-02,1.572e-02,5.055e-02,8.461e-01,1.392e-02
ESCO2,27230,nucleus,GO:0005634,cellular component,11.0,151.0,1.068e-01,6.407e-02,1.780e-01,7.543e-02,6.489e-02,8.769e-02,7.370e-01,4.586e-03
ESCO2,27230,chromatin,GO:0000785,cellular component,11.0,15.0,1.068e-01,6.407e-02,1.780e-01,8.193e-02,6.053e-02,1.109e-01,7.262e-01,9.561e-03
ESCO2,27230,Golgi apparatus,GO:0005794,cellular component,11.0,15.0,1.107e-01,6.199e-02,1.977e-01,9.180e-02,4.406e-02,1.913e-01,7.095e-01,2.416e-02
ESCO2,27230,cell junction,GO:0030054,cellular component,11.0,9.0,1.222e-01,5.250e-02,2.846e-01,8.738e-02,2.928e-02,2.608e-01,7.137e-01,3.672e-02
ESCO2,27230,acetyltransferase activity,GO:0016407,molecular function,11.0,12.0,1.414e-01,4.397e-02,4.549e-01,1.085e-01,1.924e-02,6.113e-01,6.759e-01,6.062e-02
PIK3CD,8977,phosphatidylinositol 3-kinase signaling,GO:0014065,biological process,23.0,3.0,9.974e-02,5.177e-02,1.922e-01,1.276e-02,8.016e-03,2.032e-02,9.101e-01,7.096e-03
PIK3CD,8977,phosphatidylinositol-mediated signaling,GO:0048015,biological process,23.0,4.0,1.050e-01,6.490e-02,1.699e-01,1.968e-02,1.126e-02,3.441e-02,8.783e-01,1.093e-02
PIK3CD,8977,positive regulation of neutrophil apoptotic process,GO:0033031,biological process,23.0,6.0,1.070e-01,6.364e-02,1.801e-01,2.930e-02,1.981e-02,4.332e-02,8.424e-01,9.164e-03
PIK3CD,8977,phosphatidylinositol phosphorylation,GO:0046854,biological process,23.0,5.0,1.090e-01,4.716e-02,2.520e-01,3.263e-02,2.736e-03,3.890e-01,8.130e-01,5.162e-02
PIK3CD,8977,phosphatidylinositol-3-phosphate biosynthetic process,GO:0036092,biological process,23.0,3.0,1.115e-01,7.601e-02,1.636e-01,3.724e-02,2.509e-02,5.527e-02,8.180e-01,1.009e-02
PIK3CD,8977,positive regulation of gene expression,GO:0010628,biological process,23.0,20.0,1.154e-01,8.803e-02,1.513e-01,2.781e-02,7.849e-03,9.852e-02,8.433e-01,2.693e-02
PIK3CD,8977,phosphorylation,GO:0016310,biological process,23.0,12.0,1.163e-01,4.373e-02,3.093e-01,4.799e-02,2.234e-03,1.031e+00,7.626e-01,7.091e-02
PIK3CD,8977,cell migration,GO:0016477,biological process,23.0,38.0,1.261e-01,8.586e-02,1.854e-01,5.848e-02,3.810e-02,8.978e-02,7.676e-01,1.223e-02
PIK3CD,8977,positive regulation of cell migration,GO:0030335,biological process,23.0,26.0,7.220e-01,4.669e-01,1.116e+00,7.220e-01,4.669e-01,1.116e+00,2.172e-01,5.445e-02
PIK3CD,8977,plasma membrane,GO:0005886,cellular component,23.0,24.0,1.595e-01,1.168e-01,2.179e-01,1.077e-01,7.785e-02,1.489e-01,6.890e-01,1.098e-02
PIK3CD,8977,cytoplasm,GO:0005737,cellular component,23.0,69.0,1.716e-01,1.067e-01,2.760e-01,1.295e-01,1.001e-01,1.676e-01,6.623e-01,9.169e-03
PIK3CD,8977,membrane,GO:0016020,cellular component,23.0,53.0,1.886e-01,1.033e-01,3.441e-01,1.638e-01,8.679e-02,3.092e-01,6.242e-01,2.453e-02
PIK3CD,8977,phosphatidylinositol 3-kinase complex,GO:0005942,cellular component,23.0,8.0,2.140e-01,1.118e-01,4.096e-01,1.930e-01,1.078e-01,3.454e-01,5.964e-01,2.431e-02
PIK3CD,8977,1-phosphatidylinositol-3-kinase activity,GO:0016303,molecular function,23.0,4.0,1.609e-01,9.655e-02,2.680e-01,8.949e-02,2.919e-02,2.744e-01,7.103e-01,3.760e-02
PIK3CD,8977,1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0035005,molecular function,23.0,4.0,1.609e-01,9.655e-02,2.680e-01,9.358e-02,3.107e-02,2.818e-01,7.044e-01,3.754e-02
PIK3CD,8977,protein binding,GO:0005515,molecular function,23.0,332.0,1.753e-01,1.075e-01,2.858e-01,1.406e-01,8.253e-02,2.397e-01,6.491e-01,1.923e-02
PIK3CD,8977,kinase activity,GO:0016301,molecular function,23.0,138.0,1.989e-01,7.519e-02,5.264e-01,1.554e-01,4.398e-02,5.494e-01,6.244e-01,5.365e-02
RRM2,10452,deoxyribonucleotide biosynthetic process,GO:0009263,biological process,10.0,5.0,1.129e-01,6.866e-02,1.858e-01,1.092e-01,6.179e-02,1.931e-01,6.863e-01,1.983e-02
RRM2,10452,cytosol,GO:0005829,cellular component,10.0,78.0,5.899e-02,1.760e-02,1.977e-01,3.792e-02,7.337e-03,1.960e-01,8.091e-01,3.901e-02
RRM2,10452,"ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor",GO:0004748,molecular function,10.0,5.0,5.710e-02,2.817e-02,1.158e-01,2.528e-02,4.530e-03,1.410e-01,8.468e-01,3.429e-02
RRM2,10452,protein binding,GO:0005515,molecular function,10.0,332.0,5.899e-02,1.760e-02,1.977e-01,3.983e-02,4.888e-03,3.245e-01,7.986e-01,4.997e-02
KLF11,11811,positive regulation of apoptotic process,GO:0043065,biological process,14.0,28.0,8.284e-02,4.225e-02,1.624e-01,2.701e-02,4.736e-03,1.541e-01,8.421e-01,4.136e-02
KLF11,11811,regulation of transcription by RNA polymerase II,GO:0006357,biological process,14.0,46.0,8.284e-02,4.225e-02,1.624e-01,5.306e-02,1.896e-02,1.485e-01,7.766e-01,2.962e-02
KLF11,11811,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,14.0,54.0,8.918e-02,5.504e-02,1.445e-01,5.915e-02,3.832e-02,9.131e-02,7.662e-01,1.254e-02
KLF11,11811,regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000083,biological process,14.0,5.0,8.957e-02,5.769e-02,1.391e-01,5.533e-02,4.602e-02,6.651e-02,7.744e-01,5.144e-03
KLF11,11811,negative regulation of cell population proliferation,GO:0008285,biological process,14.0,34.0,1.626e-01,1.058e-01,2.499e-01,1.626e-01,1.058e-01,2.499e-01,6.264e-01,1.707e-02
KLF11,11811,nucleus,GO:0005634,cellular component,14.0,151.0,8.284e-02,4.225e-02,1.624e-01,4.417e-02,1.449e-02,1.346e-01,7.971e-01,2.833e-02
KLF11,11811,nucleoplasm,GO:0005654,cellular component,14.0,74.0,8.284e-02,4.225e-02,1.624e-01,4.689e-02,2.303e-02,9.544e-02,7.920e-01,1.861e-02
KLF11,11811,cytosol,GO:0005829,cellular component,14.0,78.0,8.284e-02,4.225e-02,1.624e-01,4.797e-02,1.553e-02,1.482e-01,7.879e-01,2.951e-02
KLF11,11811,focal adhesion,GO:0005925,cellular component,14.0,11.0,9.303e-02,3.374e-02,2.565e-01,5.441e-02,9.183e-03,3.224e-01,7.675e-01,5.274e-02
KLF11,11811,nuclear body,GO:0016604,cellular component,14.0,30.0,1.041e-01,6.030e-02,1.798e-01,9.291e-02,5.483e-02,1.574e-01,7.089e-01,1.712e-02
KLF11,11811,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,14.0,10.0,8.284e-02,4.225e-02,1.624e-01,3.203e-02,1.670e-02,6.144e-02,8.327e-01,1.616e-02
KLF11,11811,protein binding,GO:0005515,molecular function,14.0,332.0,8.284e-02,4.225e-02,1.624e-01,5.396e-02,1.553e-02,1.875e-01,7.735e-01,3.415e-02
KLF11,11811,transcription regulatory region DNA binding,GO:0044212,molecular function,14.0,24.0,8.422e-02,4.351e-02,1.630e-01,6.200e-02,2.953e-02,1.302e-01,7.599e-01,2.098e-02
MTBP,7417,protein localization to kinetochore,GO:0034501,biological process,4.0,8.0,2.395e-02,1.164e-02,4.928e-02,1.139e-02,1.660e-03,7.818e-02,9.047e-01,3.297e-02
MTBP,7417,kinetochore,GO:0000776,cellular component,4.0,13.0,2.379e-02,1.703e-02,3.323e-02,1.259e-02,5.461e-03,2.902e-02,9.093e-01,1.207e-02
MTBP,7417,chromatin,GO:0000785,cellular component,4.0,15.0,4.665e-02,2.831e-02,7.688e-02,4.665e-02,2.831e-02,7.688e-02,7.935e-01,1.355e-02
MALT1,6819,,,,nan,nan,,,,,,,,
CEBPB,1834,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990440,biological process,27.0,4.0,3.120e-02,2.079e-02,4.681e-02,8.413e-03,5.069e-03,1.396e-02,9.326e-01,5.903e-03
CEBPB,1834,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,27.0,62.0,3.120e-02,2.079e-02,4.681e-02,1.467e-02,8.760e-03,2.456e-02,9.008e-01,7.984e-03
CEBPB,1834,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,27.0,41.0,3.120e-02,2.079e-02,4.681e-02,1.416e-02,5.461e-03,3.671e-02,9.008e-01,1.450e-02
CEBPB,1834,positive regulation of sodium-dependent phosphate transport,GO:2000120,biological process,27.0,3.0,3.194e-02,2.143e-02,4.761e-02,1.601e-02,1.353e-02,1.894e-02,8.956e-01,2.862e-03
CEBPB,1834,positive regulation of biomineral tissue development,GO:0070169,biological process,27.0,8.0,3.261e-02,2.246e-02,4.735e-02,2.155e-02,1.743e-02,2.664e-02,8.718e-01,4.596e-03
CEBPB,1834,"regulation of transcription, DNA-templated",GO:0006355,biological process,27.0,36.0,3.481e-02,1.866e-02,6.497e-02,2.231e-02,6.993e-03,7.119e-02,8.639e-01,2.374e-02
CEBPB,1834,response to endoplasmic reticulum stress,GO:0034976,biological process,27.0,11.0,3.562e-02,1.698e-02,7.470e-02,2.249e-02,4.835e-03,1.046e-01,8.602e-01,3.461e-02
CEBPB,1834,nucleus,GO:0005634,cellular component,27.0,151.0,4.383e-02,3.046e-02,6.307e-02,3.616e-02,2.445e-02,5.349e-02,8.211e-01,9.465e-03
CEBPB,1834,nucleoplasm,GO:0005654,cellular component,27.0,74.0,4.602e-02,3.125e-02,6.777e-02,4.367e-02,2.791e-02,6.833e-02,8.009e-01,1.172e-02
CEBPB,1834,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,27.0,10.0,3.120e-02,2.079e-02,4.681e-02,8.281e-03,4.810e-03,1.426e-02,9.334e-01,6.347e-03
CEBPB,1834,protein binding,GO:0005515,molecular function,27.0,332.0,4.814e-02,4.598e-02,5.040e-02,4.446e-02,3.717e-02,5.317e-02,7.994e-01,4.851e-03
CFAP53,26530,,,,nan,nan,,,,,,,,
FUT9,4020,,,,nan,nan,,,,,,,,
GXYLT2,33383,,,,nan,nan,,,,,,,,
ESRRA,3471,"regulation of transcription, DNA-templated",GO:0006355,biological process,41.0,36.0,2.817e-02,2.066e-02,3.841e-02,2.437e-02,1.885e-02,3.152e-02,8.604e-01,5.841e-03
ESRRA,3471,nucleus,GO:0005634,cellular component,41.0,151.0,1.865e-02,9.131e-03,3.809e-02,6.166e-03,2.328e-03,1.633e-02,9.461e-01,1.076e-02
ESRRA,3471,cytoplasm,GO:0005737,cellular component,41.0,69.0,1.865e-02,9.131e-03,3.809e-02,9.123e-03,3.501e-03,2.378e-02,9.267e-01,1.263e-02
ESRRA,3471,intercellular bridge,GO:0045171,cellular component,41.0,25.0,1.865e-02,9.131e-03,3.809e-02,1.045e-02,3.507e-03,3.112e-02,9.184e-01,1.608e-02
ESRRA,3471,microtubule cytoskeleton,GO:0015630,cellular component,41.0,17.0,1.961e-02,1.014e-02,3.792e-02,1.202e-02,4.857e-03,2.976e-02,9.118e-01,1.213e-02
ESRRA,3471,fibrillar center,GO:0001650,cellular component,41.0,9.0,2.176e-02,8.796e-03,5.381e-02,1.497e-02,3.851e-03,5.817e-02,8.928e-01,2.547e-02
ESRRA,3471,protein binding,GO:0005515,molecular function,41.0,332.0,1.865e-02,9.131e-03,3.809e-02,9.296e-03,3.312e-03,2.609e-02,9.256e-01,1.301e-02
ESRRA,3471,DNA-binding transcription factor activity,GO:0003700,molecular function,41.0,18.0,2.116e-02,1.176e-02,3.809e-02,1.265e-02,5.627e-03,2.843e-02,9.091e-01,1.126e-02
ESRRA,3471,sequence-specific DNA binding,GO:0043565,molecular function,41.0,12.0,2.377e-02,1.156e-02,4.887e-02,1.731e-02,7.570e-03,3.958e-02,8.870e-01,1.458e-02
ESRRA,3471,protein domain specific binding,GO:0019904,molecular function,41.0,82.0,4.164e-02,3.235e-02,5.361e-02,4.164e-02,3.235e-02,5.361e-02,8.066e-01,6.729e-03
PC,8636,,,,nan,nan,,,,,,,,
NET1,14592,positive regulation of apoptotic process,GO:0043065,biological process,6.0,28.0,6.010e-02,3.199e-02,1.129e-01,3.554e-02,1.336e-02,9.453e-02,8.210e-01,2.539e-02
NET1,14592,cellular response to ionizing radiation,GO:0071479,biological process,6.0,6.0,6.099e-02,3.250e-02,1.145e-01,3.011e-02,8.594e-03,1.055e-01,8.357e-01,2.956e-02
NET1,14592,cellular response to hydrogen peroxide,GO:0070301,biological process,6.0,7.0,6.099e-02,3.250e-02,1.145e-01,4.474e-02,3.869e-02,5.173e-02,7.987e-01,3.998e-03
NET1,14592,positive regulation of GTPase activity,GO:0043547,biological process,6.0,6.0,9.387e-02,1.925e-02,4.577e-01,9.387e-02,1.925e-02,4.577e-01,6.994e-01,5.286e-02
NET1,14592,protein binding,GO:0005515,molecular function,6.0,332.0,5.921e-02,3.267e-02,1.073e-01,2.287e-02,7.054e-03,7.415e-02,8.617e-01,2.465e-02
C12orf66,26517,cellular response to glucose starvation,GO:0042149,biological process,8.0,6.0,2.360e-02,1.779e-02,3.132e-02,1.118e-02,1.952e-03,6.405e-02,9.109e-01,2.276e-02
C12orf66,26517,negative regulation of TORC1 signaling,GO:1904262,biological process,8.0,4.0,2.375e-02,1.821e-02,3.098e-02,1.213e-02,3.816e-03,3.857e-02,9.085e-01,1.887e-02
C12orf66,26517,protein localization to lysosome,GO:0061462,biological process,8.0,4.0,2.604e-02,2.249e-02,3.016e-02,1.772e-02,1.523e-02,2.062e-02,8.882e-01,2.764e-03
C12orf66,26517,cellular response to amino acid starvation,GO:0034198,biological process,8.0,7.0,2.823e-02,1.941e-02,4.106e-02,2.039e-02,1.191e-02,3.489e-02,8.754e-01,1.155e-02
C12orf66,26517,KICSTOR complex,GO:0140007,cellular component,8.0,3.0,4.833e-02,1.361e-02,1.716e-01,4.483e-02,9.907e-03,2.029e-01,7.928e-01,3.867e-02
MSL2,25544,,,,nan,nan,,,,,,,,
ATR,882,cellular response to gamma radiation,GO:0071480,biological process,37.0,3.0,5.076e-02,4.074e-02,6.325e-02,1.420e-02,4.088e-03,4.935e-02,8.971e-01,2.279e-02
ATR,882,DNA damage checkpoint,GO:0000077,biological process,37.0,6.0,5.076e-02,4.074e-02,6.325e-02,1.548e-02,2.770e-03,8.657e-02,8.872e-01,3.132e-02
ATR,882,peptidyl-serine phosphorylation,GO:0018105,biological process,37.0,13.0,5.076e-02,4.074e-02,6.325e-02,2.439e-02,1.001e-02,5.943e-02,8.582e-01,1.968e-02
ATR,882,"protein localization to chromosome, telomeric region",GO:0070198,biological process,37.0,4.0,5.076e-02,4.074e-02,6.325e-02,3.142e-02,1.441e-02,6.850e-02,8.347e-01,1.843e-02
ATR,882,cellular response to UV,GO:0034644,biological process,37.0,12.0,5.208e-02,4.453e-02,6.090e-02,2.969e-02,1.759e-02,5.013e-02,8.410e-01,1.237e-02
ATR,882,cellular response to DNA damage stimulus,GO:0006974,biological process,37.0,20.0,5.318e-02,4.682e-02,6.040e-02,3.532e-02,2.509e-02,4.970e-02,8.237e-01,8.177e-03
ATR,882,negative regulation of DNA replication,GO:0008156,biological process,37.0,5.0,5.468e-02,4.648e-02,6.433e-02,1.786e-02,1.683e-03,1.896e-01,8.687e-01,4.011e-02
ATR,882,protein autophosphorylation,GO:0046777,biological process,37.0,12.0,5.572e-02,3.299e-02,9.412e-02,2.766e-02,7.082e-03,1.080e-01,8.433e-01,3.207e-02
ATR,882,establishment of RNA localization to telomere,GO:0097694,biological process,37.0,2.0,6.039e-02,2.729e-02,1.336e-01,2.628e-02,2.522e-03,2.739e-01,8.361e-01,5.247e-02
ATR,882,replicative senescence,GO:0090399,biological process,37.0,2.0,6.059e-02,2.750e-02,1.335e-01,4.787e-02,1.495e-02,1.533e-01,7.877e-01,3.184e-02
ATR,882,telomere maintenance,GO:0000723,biological process,37.0,12.0,6.611e-02,2.824e-02,1.548e-01,5.148e-02,1.398e-02,1.896e-01,7.782e-01,3.761e-02
ATR,882,positive regulation of telomerase catalytic core complex assembly,GO:1904884,biological process,37.0,3.0,7.237e-02,3.298e-02,1.588e-01,5.529e-02,1.389e-02,2.202e-01,7.699e-01,3.723e-02
ATR,882,"positive regulation of DNA damage response, signal transduction by p53 class mediator",GO:0043517,biological process,37.0,5.0,7.988e-02,4.836e-02,1.319e-01,7.499e-02,4.295e-02,1.309e-01,7.367e-01,1.651e-02
ATR,882,PML body,GO:0016605,cellular component,37.0,3.0,5.011e-02,4.180e-02,6.008e-02,7.558e-03,1.431e-03,3.991e-02,9.321e-01,2.201e-02
ATR,882,Golgi apparatus,GO:0005794,cellular component,37.0,15.0,5.318e-02,4.682e-02,6.040e-02,3.354e-02,1.938e-02,5.807e-02,8.288e-01,1.313e-02
ATR,882,nucleus,GO:0005634,cellular component,37.0,151.0,5.550e-02,4.659e-02,6.611e-02,3.288e-02,1.011e-02,1.069e-01,8.276e-01,2.770e-02
ATR,882,nucleoplasm,GO:0005654,cellular component,37.0,74.0,5.833e-02,4.250e-02,8.004e-02,4.130e-02,1.807e-02,9.442e-02,8.056e-01,2.190e-02
ATR,882,MutSalpha complex binding,GO:0032407,molecular function,37.0,2.0,5.076e-02,4.074e-02,6.325e-02,2.851e-02,1.436e-02,5.658e-02,8.448e-01,1.635e-02
ATR,882,MutLalpha complex binding,GO:0032405,molecular function,37.0,2.0,5.076e-02,4.074e-02,6.325e-02,2.871e-02,1.572e-02,5.243e-02,8.443e-01,1.443e-02
ATR,882,protein kinase activity,GO:0004672,molecular function,37.0,38.0,5.076e-02,4.074e-02,6.325e-02,2.992e-02,2.003e-02,4.469e-02,8.403e-01,9.543e-03
ATR,882,protein serine/threonine kinase activity,GO:0004674,molecular function,37.0,34.0,5.203e-02,3.862e-02,7.010e-02,2.448e-02,7.545e-03,7.946e-02,8.556e-01,2.583e-02
ATR,882,protein binding,GO:0005515,molecular function,37.0,332.0,5.887e-02,4.166e-02,8.321e-02,4.131e-02,1.542e-02,1.106e-01,8.052e-01,2.617e-02
UBE2C,15937,protein ubiquitination,GO:0016567,biological process,29.0,8.0,3.184e-02,2.009e-02,5.048e-02,7.425e-03,4.655e-03,1.184e-02,9.385e-01,5.329e-03
UBE2C,15937,protein K11-linked ubiquitination,GO:0070979,biological process,29.0,3.0,3.184e-02,2.009e-02,5.048e-02,8.645e-03,5.610e-03,1.332e-02,9.312e-01,4.997e-03
UBE2C,15937,anaphase-promoting complex-dependent catabolic process,GO:0031145,biological process,29.0,2.0,3.184e-02,2.009e-02,5.048e-02,9.980e-03,4.658e-03,2.138e-02,9.234e-01,9.272e-03
UBE2C,15937,protein K48-linked ubiquitination,GO:0070936,biological process,29.0,4.0,3.184e-02,2.009e-02,5.048e-02,1.391e-02,7.611e-03,2.542e-02,9.039e-01,9.956e-03
UBE2C,15937,exit from mitosis,GO:0010458,biological process,29.0,2.0,3.296e-02,1.851e-02,5.868e-02,1.046e-02,1.327e-03,8.244e-02,9.115e-01,2.868e-02
UBE2C,15937,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,29.0,9.0,3.324e-02,1.971e-02,5.608e-02,1.997e-02,9.194e-03,4.337e-02,8.758e-01,1.464e-02
UBE2C,15937,positive regulation of exit from mitosis,GO:0031536,biological process,29.0,5.0,3.850e-02,2.539e-02,5.839e-02,1.778e-02,7.000e-03,4.516e-02,8.839e-01,1.808e-02
UBE2C,15937,free ubiquitin chain polymerization,GO:0010994,biological process,29.0,2.0,3.876e-02,2.517e-02,5.970e-02,2.494e-02,1.368e-02,4.547e-02,8.573e-01,1.329e-02
UBE2C,15937,anaphase-promoting complex,GO:0005680,cellular component,29.0,3.0,3.566e-02,1.909e-02,6.660e-02,2.517e-02,1.029e-02,6.158e-02,8.547e-01,1.906e-02
UBE2C,15937,plasma membrane,GO:0005886,cellular component,29.0,24.0,4.525e-02,9.495e-03,2.156e-01,3.107e-02,3.280e-03,2.942e-01,8.229e-01,5.805e-02
UBE2C,15937,cytosol,GO:0005829,cellular component,29.0,78.0,4.926e-02,1.913e-02,1.268e-01,4.193e-02,1.354e-02,1.298e-01,8.027e-01,2.895e-02
UBE2C,15937,nucleus,GO:0005634,cellular component,29.0,151.0,5.171e-02,2.036e-02,1.314e-01,4.536e-02,1.842e-02,1.117e-01,7.953e-01,2.330e-02
UBE2C,15937,ubiquitin ligase complex,GO:0000151,cellular component,29.0,13.0,5.720e-02,2.596e-02,1.260e-01,4.849e-02,1.682e-02,1.398e-01,7.865e-01,2.894e-02
UBE2C,15937,ubiquitin-like protein ligase binding,GO:0044389,molecular function,29.0,5.0,3.184e-02,2.009e-02,5.048e-02,8.183e-03,2.454e-03,2.729e-02,9.318e-01,1.458e-02
UBE2C,15937,ubiquitin conjugating enzyme activity,GO:0061631,molecular function,29.0,5.0,3.821e-02,2.316e-02,6.305e-02,1.897e-02,5.115e-03,7.035e-02,8.762e-01,2.608e-02
UBE2C,15937,ubiquitin-protein transferase activity,GO:0004842,molecular function,29.0,11.0,3.955e-02,2.289e-02,6.832e-02,1.991e-02,3.439e-03,1.153e-01,8.668e-01,3.052e-02
UBE2C,15937,protein binding,GO:0005515,molecular function,29.0,332.0,4.875e-02,1.951e-02,1.218e-01,4.108e-02,1.525e-02,1.107e-01,8.056e-01,2.522e-02
PHYKPL,28249,identical protein binding,GO:0042802,molecular function,3.0,20.0,1.235e-02,5.168e-03,2.951e-02,6.174e-03,2.584e-03,1.475e-02,9.461e-01,9.480e-03
PHYKPL,28249,protein binding,GO:0005515,molecular function,3.0,332.0,1.774e-02,1.007e-02,3.124e-02,1.774e-02,1.007e-02,3.124e-02,8.867e-01,1.022e-02
C11orf68,28801,RNA binding,GO:0003723,molecular function,3.0,63.0,3.347e-02,2.485e-02,4.508e-02,2.268e-02,1.866e-02,2.756e-02,8.672e-01,4.330e-03
C11orf68,28801,protein binding,GO:0005515,molecular function,3.0,332.0,3.347e-02,2.485e-02,4.508e-02,3.347e-02,2.485e-02,4.508e-02,8.291e-01,7.055e-03
UNC119B,16488,lipoprotein transport,GO:0042953,biological process,7.0,3.0,8.757e-02,5.324e-02,1.440e-01,2.326e-02,1.515e-02,3.569e-02,8.644e-01,9.926e-03
UNC119B,16488,cilium assembly,GO:0060271,biological process,7.0,12.0,8.757e-02,5.324e-02,1.440e-01,4.329e-02,2.845e-02,6.586e-02,8.019e-01,1.119e-02
UNC119B,16488,nervous system development,GO:0007399,biological process,7.0,3.0,9.230e-02,4.964e-02,1.716e-01,6.050e-02,2.998e-02,1.221e-01,7.625e-01,2.074e-02
UNC119B,16488,ciliary transition zone,GO:0035869,cellular component,7.0,5.0,1.028e-01,5.213e-02,2.027e-01,8.164e-02,6.095e-02,1.093e-01,7.267e-01,9.053e-03
UNC119B,16488,protein binding,GO:0005515,molecular function,7.0,332.0,1.035e-01,4.703e-02,2.278e-01,9.350e-02,3.622e-02,2.414e-01,7.057e-01,3.003e-02
UNC119B,16488,lipid binding,GO:0008289,molecular function,7.0,15.0,1.035e-01,4.703e-02,2.278e-01,9.520e-02,3.602e-02,2.516e-01,7.031e-01,3.049e-02
ATAD5,25752,positive regulation of DNA replication,GO:0045740,biological process,10.0,5.0,6.550e-02,2.681e-02,1.600e-01,1.816e-02,5.278e-03,6.252e-02,8.804e-01,2.518e-02
ATAD5,25752,positive regulation of cell cycle G2/M phase transition,GO:1902751,biological process,10.0,5.0,8.978e-02,2.494e-02,3.233e-01,4.194e-02,3.257e-03,5.401e-01,7.862e-01,6.448e-02
ATAD5,25752,DNA clamp unloading,GO:0090618,biological process,10.0,2.0,1.040e-01,3.170e-02,3.409e-01,7.802e-02,1.472e-02,4.137e-01,7.228e-01,5.585e-02
ATAD5,25752,Elg1 RFC-like complex,GO:0031391,cellular component,10.0,2.0,1.040e-01,3.170e-02,3.409e-01,8.403e-02,1.920e-02,3.679e-01,7.152e-01,4.983e-02
ATAD5,25752,nucleus,GO:0005634,cellular component,10.0,151.0,1.068e-01,1.016e-01,1.123e-01,8.156e-02,5.283e-02,1.259e-01,7.265e-01,1.329e-02
ATAD5,25752,DNA clamp unloader activity,GO:0061860,molecular function,10.0,3.0,6.548e-02,1.833e-02,2.339e-01,2.226e-02,1.158e-03,4.278e-01,8.415e-01,5.146e-02
ATAD5,25752,DNA binding,GO:0003677,molecular function,10.0,26.0,7.711e-02,4.300e-02,1.383e-01,3.542e-02,1.720e-02,7.293e-02,8.226e-01,1.785e-02
ATAD5,25752,protein binding,GO:0005515,molecular function,10.0,332.0,1.166e-01,9.081e-02,1.497e-01,9.968e-02,5.016e-02,1.981e-01,6.985e-01,2.248e-02
SGF29,25156,histone H3 acetylation,GO:0043966,biological process,24.0,13.0,1.968e-02,1.432e-02,2.704e-02,8.158e-03,3.883e-03,1.714e-02,9.336e-01,8.213e-03
SGF29,25156,histone acetylation,GO:0016573,biological process,24.0,8.0,2.573e-02,1.570e-02,4.218e-02,1.538e-02,1.934e-03,1.223e-01,8.843e-01,3.188e-02
SGF29,25156,Ada2/Gcn5/Ada3 transcription activator complex,GO:0005671,cellular component,24.0,2.0,1.968e-02,1.432e-02,2.704e-02,6.419e-03,4.727e-03,8.715e-03,9.452e-01,3.192e-03
SGF29,25156,SAGA complex,GO:0000124,cellular component,24.0,3.0,2.175e-02,1.331e-02,3.554e-02,1.334e-02,5.303e-03,3.354e-02,9.050e-01,1.438e-02
SGF29,25156,SAGA-type complex,GO:0070461,cellular component,24.0,7.0,2.339e-02,1.966e-02,2.782e-02,1.660e-02,1.531e-02,1.800e-02,8.932e-01,1.425e-03
SGF29,25156,methylated histone binding,GO:0035064,molecular function,24.0,8.0,2.092e-02,1.329e-02,3.293e-02,1.249e-02,7.976e-03,1.955e-02,9.113e-01,6.100e-03
SGF29,25156,RNA polymerase II transcription regulator recruiting activity,GO:0001135,molecular function,24.0,2.0,2.302e-02,1.102e-02,4.809e-02,1.526e-02,4.755e-03,4.896e-02,8.932e-01,2.208e-02
SGF29,25156,protein binding,GO:0005515,molecular function,24.0,332.0,2.609e-02,1.896e-02,3.590e-02,2.300e-02,1.928e-02,2.745e-02,8.661e-01,3.967e-03
JUN,6204,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,146.0,41.0,3.900e-02,3.436e-02,4.427e-02,1.393e-02,3.912e-03,4.958e-02,8.992e-01,2.099e-02
JUN,6204,SMAD protein signal transduction,GO:0060395,biological process,146.0,3.0,4.170e-02,2.996e-02,5.804e-02,1.363e-02,5.280e-03,3.519e-02,9.035e-01,1.373e-02
JUN,6204,positive regulation of pri-miRNA transcription by RNA polymerase II,GO:1902895,biological process,146.0,3.0,4.170e-02,2.996e-02,5.804e-02,1.736e-02,1.150e-02,2.622e-02,8.892e-01,7.602e-03
JUN,6204,cellular response to reactive oxygen species,GO:0034614,biological process,146.0,11.0,4.335e-02,3.425e-02,5.486e-02,2.112e-02,1.386e-02,3.218e-02,8.731e-01,9.165e-03
JUN,6204,response to lipopolysaccharide,GO:0032496,biological process,146.0,8.0,4.448e-02,3.587e-02,5.516e-02,2.382e-02,1.541e-02,3.682e-02,8.622e-01,9.404e-03
JUN,6204,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990441,biological process,146.0,3.0,4.635e-02,2.363e-02,9.091e-02,1.952e-02,3.368e-03,1.132e-01,8.694e-01,3.815e-02
JUN,6204,"positive regulation of DNA-templated transcription, initiation",GO:2000144,biological process,146.0,5.0,4.657e-02,2.405e-02,9.018e-02,2.627e-02,8.574e-03,8.051e-02,8.503e-01,2.671e-02
JUN,6204,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,146.0,41.0,4.669e-02,2.406e-02,9.062e-02,1.338e-02,4.806e-04,3.723e-01,8.771e-01,5.380e-02
JUN,6204,response to cytokine,GO:0034097,biological process,146.0,33.0,4.781e-02,3.008e-02,7.599e-02,3.011e-02,1.485e-02,6.106e-02,8.391e-01,1.687e-02
JUN,6204,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,146.0,62.0,4.807e-02,2.530e-02,9.135e-02,3.238e-02,1.088e-02,9.637e-02,8.300e-01,2.741e-02
JUN,6204,response to cAMP,GO:0051591,biological process,146.0,7.0,4.903e-02,3.196e-02,7.521e-02,3.228e-02,2.346e-02,4.441e-02,8.327e-01,7.611e-03
JUN,6204,response to radiation,GO:0009314,biological process,146.0,6.0,5.106e-02,2.688e-02,9.696e-02,3.215e-02,8.023e-03,1.288e-01,8.280e-01,3.120e-02
JUN,6204,response to mechanical stimulus,GO:0009612,biological process,146.0,10.0,5.131e-02,2.652e-02,9.928e-02,3.542e-02,9.165e-03,1.369e-01,8.188e-01,3.181e-02
JUN,6204,response to drug,GO:0042493,biological process,146.0,78.0,5.255e-02,4.654e-02,5.935e-02,3.407e-02,1.704e-02,6.810e-02,8.266e-01,1.687e-02
JUN,6204,positive regulation of vascular smooth muscle cell proliferation,GO:1904707,biological process,146.0,3.0,5.352e-02,3.206e-02,8.932e-02,4.088e-02,2.023e-02,8.259e-02,8.072e-01,1.815e-02
JUN,6204,positive regulation of apoptotic process,GO:0043065,biological process,146.0,28.0,5.438e-02,4.621e-02,6.399e-02,3.363e-02,1.026e-02,1.102e-01,8.251e-01,2.759e-02
JUN,6204,response to organic substance,GO:0010033,biological process,146.0,59.0,5.445e-02,4.021e-02,7.372e-02,3.946e-02,2.885e-02,5.398e-02,8.121e-01,7.842e-03
JUN,6204,cellular response to cadmium ion,GO:0071276,biological process,146.0,4.0,5.462e-02,4.078e-02,7.316e-02,3.968e-02,3.287e-02,4.789e-02,8.119e-01,4.818e-03
JUN,6204,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,146.0,54.0,5.602e-02,3.272e-02,9.592e-02,3.920e-02,1.208e-02,1.272e-01,8.096e-01,2.885e-02
JUN,6204,cellular response to hormone stimulus,GO:0032870,biological process,146.0,30.0,5.620e-02,3.649e-02,8.657e-02,4.075e-02,1.847e-02,8.990e-02,8.073e-01,1.997e-02
JUN,6204,negative regulation of DNA binding,GO:0043392,biological process,146.0,10.0,5.774e-02,4.401e-02,7.575e-02,4.367e-02,1.943e-02,9.818e-02,7.996e-01,2.089e-02
JUN,6204,regulation of cell cycle,GO:0051726,biological process,146.0,14.0,5.791e-02,3.762e-02,8.916e-02,3.979e-02,1.375e-02,1.152e-01,8.088e-01,2.728e-02
JUN,6204,transforming growth factor beta receptor signaling pathway,GO:0007179,biological process,146.0,11.0,5.974e-02,2.069e-02,1.724e-01,4.460e-02,8.613e-03,2.309e-01,7.920e-01,4.387e-02
JUN,6204,positive regulation by host of viral transcription,GO:0043923,biological process,146.0,4.0,7.128e-02,5.108e-02,9.946e-02,5.970e-02,3.602e-02,9.896e-02,7.649e-01,1.458e-02
JUN,6204,Ras protein signal transduction,GO:0007265,biological process,146.0,12.0,7.972e-02,2.467e-02,2.576e-01,6.691e-02,1.217e-02,3.678e-01,7.438e-01,4.747e-02
JUN,6204,negative regulation by host of viral transcription,GO:0043922,biological process,146.0,4.0,8.178e-02,5.775e-02,1.158e-01,7.519e-02,4.518e-02,1.252e-01,7.367e-01,1.535e-02
JUN,6204,positive regulation of cell differentiation,GO:0045597,biological process,146.0,41.0,1.572e-01,8.059e-02,3.068e-01,1.572e-01,8.059e-02,3.068e-01,6.308e-01,2.494e-02
JUN,6204,nucleus,GO:0005634,cellular component,146.0,151.0,3.678e-02,3.382e-02,3.999e-02,6.478e-03,1.720e-03,2.440e-02,9.429e-01,1.509e-02
JUN,6204,nucleoplasm,GO:0005654,cellular component,146.0,74.0,3.678e-02,3.382e-02,3.999e-02,8.825e-03,2.750e-03,2.832e-02,9.274e-01,1.540e-02
JUN,6204,nuclear chromatin,GO:0000790,cellular component,146.0,14.0,3.752e-02,3.228e-02,4.360e-02,9.982e-03,3.457e-03,2.883e-02,9.222e-01,1.269e-02
JUN,6204,nuclear euchromatin,GO:0005719,cellular component,146.0,4.0,4.043e-02,3.648e-02,4.480e-02,1.624e-02,4.515e-03,5.842e-02,8.878e-01,2.296e-02
JUN,6204,transcription factor AP-1 complex,GO:0035976,cellular component,146.0,5.0,4.932e-02,2.286e-02,1.064e-01,3.099e-02,6.898e-03,1.393e-01,8.308e-01,3.626e-02
JUN,6204,transcription factor complex,GO:0005667,cellular component,146.0,9.0,5.058e-02,2.626e-02,9.740e-02,3.475e-02,1.158e-02,1.043e-01,8.227e-01,2.839e-02
JUN,6204,identical protein binding,GO:0042802,molecular function,146.0,20.0,3.678e-02,3.382e-02,3.999e-02,4.045e-03,2.662e-03,6.145e-03,9.647e-01,4.297e-03
JUN,6204,protein homodimerization activity,GO:0042803,molecular function,146.0,15.0,3.678e-02,3.382e-02,3.999e-02,5.306e-03,3.176e-03,8.866e-03,9.533e-01,5.298e-03
JUN,6204,transcription factor binding,GO:0008134,molecular function,146.0,19.0,3.678e-02,3.382e-02,3.999e-02,5.741e-03,1.788e-03,1.843e-02,9.489e-01,1.259e-02
JUN,6204,protein binding,GO:0005515,molecular function,146.0,332.0,3.678e-02,3.382e-02,3.999e-02,7.935e-03,2.765e-03,2.277e-02,9.337e-01,1.314e-02
JUN,6204,protein heterodimerization activity,GO:0046982,molecular function,146.0,6.0,3.752e-02,3.228e-02,4.360e-02,3.529e-03,6.338e-04,1.965e-02,9.635e-01,1.421e-02
JUN,6204,transcription coactivator activity,GO:0003713,molecular function,146.0,8.0,4.088e-02,2.899e-02,5.763e-02,9.965e-03,2.878e-03,3.450e-02,9.214e-01,1.485e-02
JUN,6204,DNA-binding transcription factor activity,GO:0003700,molecular function,146.0,18.0,4.088e-02,2.899e-02,5.763e-02,1.225e-02,3.093e-03,4.850e-02,9.074e-01,1.944e-02
JUN,6204,ubiquitin-like protein ligase binding,GO:0044389,molecular function,146.0,5.0,4.170e-02,2.996e-02,5.804e-02,1.130e-02,5.068e-03,2.518e-02,9.157e-01,1.163e-02
JUN,6204,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,146.0,10.0,4.170e-02,2.996e-02,5.804e-02,1.329e-02,5.295e-03,3.333e-02,9.049e-01,1.463e-02
JUN,6204,R-SMAD binding,GO:0070412,molecular function,146.0,3.0,4.170e-02,2.996e-02,5.804e-02,1.362e-02,5.687e-03,3.262e-02,9.040e-01,1.266e-02
JUN,6204,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,146.0,7.0,4.170e-02,2.996e-02,5.804e-02,1.758e-02,1.277e-02,2.419e-02,8.886e-01,5.778e-03
JUN,6204,cAMP response element binding,GO:0035497,molecular function,146.0,2.0,4.224e-02,2.915e-02,6.120e-02,1.399e-02,4.403e-03,4.443e-02,8.998e-01,1.944e-02
JUN,6204,ubiquitin protein ligase binding,GO:0031625,molecular function,146.0,4.0,4.224e-02,2.915e-02,6.120e-02,1.876e-02,8.503e-03,4.139e-02,8.808e-01,1.504e-02
JUN,6204,RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000980,molecular function,146.0,4.0,4.368e-02,3.092e-02,6.170e-02,2.363e-02,1.917e-02,2.913e-02,8.634e-01,4.720e-03
JUN,6204,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,146.0,25.0,4.511e-02,2.516e-02,8.086e-02,1.989e-02,6.420e-03,6.162e-02,8.742e-01,2.414e-02
JUN,6204,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,146.0,11.0,4.517e-02,2.844e-02,7.173e-02,2.488e-02,1.066e-02,5.807e-02,8.558e-01,1.790e-02
JUN,6204,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,146.0,5.0,4.523e-02,2.500e-02,8.185e-02,2.313e-02,7.870e-03,6.796e-02,8.619e-01,2.463e-02
JUN,6204,transcription regulatory region DNA binding,GO:0044212,molecular function,146.0,24.0,4.620e-02,2.595e-02,8.225e-02,2.475e-02,8.877e-03,6.900e-02,8.559e-01,2.287e-02
JUN,6204,RNA binding,GO:0003723,molecular function,146.0,63.0,4.652e-02,2.730e-02,7.927e-02,2.285e-02,2.969e-03,1.759e-01,8.517e-01,3.927e-02
JUN,6204,enzyme binding,GO:0019899,molecular function,146.0,33.0,5.771e-02,2.632e-02,1.265e-01,4.571e-02,1.483e-02,1.408e-01,7.934e-01,3.052e-02
JUN,6204,GTPase activator activity,GO:0005096,molecular function,146.0,6.0,8.524e-02,7.323e-02,9.922e-02,8.049e-02,7.096e-02,9.131e-02,7.288e-01,3.808e-03
SOX12,11198,"regulation of transcription, DNA-templated",GO:0006355,biological process,9.0,36.0,6.285e-02,3.303e-02,1.196e-01,1.150e-02,2.535e-03,5.216e-02,9.094e-01,2.335e-02
SOX12,11198,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,9.0,62.0,7.161e-02,3.759e-02,1.364e-01,4.111e-02,1.923e-02,8.790e-02,8.064e-01,1.991e-02
SOX12,11198,cell differentiation,GO:0030154,biological process,9.0,83.0,7.832e-02,3.606e-02,1.701e-01,5.471e-02,9.272e-03,3.228e-01,7.677e-01,4.684e-02
SOX12,11198,cell fate commitment,GO:0045165,biological process,9.0,37.0,8.717e-02,2.841e-02,2.675e-01,8.266e-02,2.633e-02,2.595e-01,7.208e-01,3.711e-02
SOX12,11198,nuclear transcription factor complex,GO:0044798,cellular component,9.0,9.0,7.116e-02,3.872e-02,1.308e-01,4.408e-02,2.345e-02,8.286e-02,7.993e-01,1.668e-02
SOX12,11198,nucleus,GO:0005634,cellular component,9.0,151.0,7.340e-02,3.758e-02,1.434e-01,5.600e-02,2.799e-02,1.120e-01,7.721e-01,1.919e-02
SOX12,11198,nucleoplasm,GO:0005654,cellular component,9.0,74.0,7.340e-02,3.758e-02,1.434e-01,5.595e-02,1.899e-02,1.648e-01,7.701e-01,2.897e-02
SOX12,11198,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,9.0,10.0,6.518e-02,3.820e-02,1.112e-01,1.874e-02,1.379e-02,2.548e-02,8.835e-01,5.963e-03
ZNF518A,29009,nucleus,GO:0005634,cellular component,2.0,151.0,3.748e-02,2.562e-02,5.482e-02,3.748e-02,2.562e-02,5.482e-02,8.174e-01,9.244e-03
DTX3,24457,protein binding,GO:0005515,molecular function,2.0,332.0,5.324e-02,4.532e-02,6.255e-02,5.324e-02,4.532e-02,6.255e-02,7.789e-01,4.419e-03
SUZ12,17101,negative regulation of cell differentiation,GO:0045596,biological process,21.0,44.0,3.607e-01,1.232e-01,1.056e+00,3.607e-01,1.232e-01,1.056e+00,4.500e-01,7.065e-02
SUZ12,17101,nucleolus,GO:0005730,cellular component,21.0,41.0,4.532e-02,1.644e-02,1.250e-01,1.654e-02,7.937e-03,3.447e-02,8.910e-01,1.256e-02
SUZ12,17101,nucleus,GO:0005634,cellular component,21.0,151.0,4.532e-02,1.644e-02,1.250e-01,2.041e-02,9.620e-03,4.332e-02,8.741e-01,1.486e-02
SUZ12,17101,nuclear body,GO:0016604,cellular component,21.0,30.0,4.532e-02,1.644e-02,1.250e-01,2.202e-02,9.862e-03,4.916e-02,8.679e-01,1.784e-02
SUZ12,17101,ESC/E(Z) complex,GO:0035098,cellular component,21.0,3.0,4.532e-02,1.644e-02,1.250e-01,3.317e-02,1.513e-02,7.272e-02,8.289e-01,1.939e-02
SUZ12,17101,RSC-type complex,GO:0016586,cellular component,21.0,2.0,5.212e-02,1.595e-02,1.703e-01,4.024e-02,1.266e-02,1.279e-01,8.071e-01,2.940e-02
SUZ12,17101,chromatin DNA binding,GO:0031490,molecular function,21.0,6.0,4.532e-02,1.644e-02,1.250e-01,7.491e-03,3.324e-03,1.688e-02,9.375e-01,8.797e-03
SUZ12,17101,methylated histone binding,GO:0035064,molecular function,21.0,8.0,4.532e-02,1.644e-02,1.250e-01,2.338e-02,5.923e-03,9.232e-02,8.585e-01,3.190e-02
SUZ12,17101,protein binding,GO:0005515,molecular function,21.0,332.0,4.532e-02,1.644e-02,1.250e-01,2.771e-02,1.173e-02,6.547e-02,8.462e-01,1.900e-02
SUZ12,17101,histone methyltransferase activity (H3-K27 specific),GO:0046976,molecular function,21.0,2.0,4.992e-02,1.379e-02,1.807e-01,3.920e-02,8.492e-03,1.810e-01,8.073e-01,3.977e-02
SUZ12,17101,histone methyltransferase activity,GO:0042054,molecular function,21.0,5.0,4.992e-02,1.379e-02,1.807e-01,4.367e-02,1.211e-02,1.574e-01,7.974e-01,3.444e-02
AURKB,11390,mitotic spindle organization,GO:0007052,biological process,72.0,12.0,4.309e-02,2.925e-02,6.350e-02,1.141e-02,5.883e-03,2.212e-02,9.163e-01,8.536e-03
AURKB,11390,mitotic spindle midzone assembly,GO:0051256,biological process,72.0,6.0,4.309e-02,2.925e-02,6.350e-02,1.209e-02,4.180e-03,3.499e-02,9.106e-01,1.446e-02
AURKB,11390,protein phosphorylation,GO:0006468,biological process,72.0,33.0,4.309e-02,2.925e-02,6.350e-02,1.434e-02,9.578e-03,2.146e-02,9.029e-01,6.239e-03
AURKB,11390,spindle organization,GO:0007051,biological process,72.0,10.0,4.536e-02,2.758e-02,7.459e-02,2.404e-02,1.049e-02,5.510e-02,8.597e-01,1.790e-02
AURKB,11390,positive regulation of telomere maintenance via telomerase,GO:0032212,biological process,72.0,6.0,4.566e-02,2.665e-02,7.825e-02,2.479e-02,1.387e-02,4.433e-02,8.585e-01,1.340e-02
AURKB,11390,positive regulation of telomerase activity,GO:0051973,biological process,72.0,7.0,4.598e-02,2.679e-02,7.891e-02,3.021e-02,1.442e-02,6.333e-02,8.386e-01,1.741e-02
AURKB,11390,positive regulation of cytokinesis,GO:0032467,biological process,72.0,16.0,4.640e-02,2.653e-02,8.115e-02,3.576e-02,1.372e-02,9.323e-02,8.207e-01,2.379e-02
AURKB,11390,regulation of cytokinesis,GO:0032465,biological process,72.0,12.0,4.943e-02,3.026e-02,8.075e-02,3.484e-02,1.937e-02,6.267e-02,8.246e-01,1.458e-02
AURKB,11390,cellular response to UV,GO:0034644,biological process,72.0,12.0,5.078e-02,3.860e-02,6.681e-02,3.137e-02,1.738e-02,5.664e-02,8.357e-01,1.391e-02
AURKB,11390,positive regulation of telomere capping,GO:1904355,biological process,72.0,5.0,5.251e-02,4.098e-02,6.730e-02,3.720e-02,1.960e-02,7.062e-02,8.176e-01,1.588e-02
AURKB,11390,negative regulation of protein binding,GO:0032091,biological process,72.0,14.0,5.481e-02,3.704e-02,8.111e-02,3.339e-02,9.595e-03,1.162e-01,8.258e-01,2.970e-02
AURKB,11390,cleavage furrow formation,GO:0036089,biological process,72.0,4.0,6.701e-02,5.050e-02,8.892e-02,4.854e-02,1.777e-02,1.326e-01,7.873e-01,2.632e-02
AURKB,11390,protein localization to kinetochore,GO:0034501,biological process,72.0,8.0,7.620e-02,4.715e-02,1.231e-01,6.811e-02,3.379e-02,1.373e-01,7.483e-01,2.040e-02
AURKB,11390,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,72.0,54.0,9.528e-02,5.684e-02,1.597e-01,9.195e-02,5.115e-02,1.653e-01,7.100e-01,1.895e-02
AURKB,11390,negative regulation of B cell apoptotic process,GO:0002903,biological process,72.0,6.0,9.717e-02,4.093e-02,2.306e-01,9.488e-02,3.709e-02,2.427e-01,7.038e-01,3.027e-02
AURKB,11390,spindle pole centrosome,GO:0031616,cellular component,72.0,3.0,4.309e-02,2.925e-02,6.350e-02,6.898e-03,3.085e-03,1.542e-02,9.413e-01,9.033e-03
AURKB,11390,"condensed chromosome, centromeric region",GO:0000779,cellular component,72.0,4.0,4.309e-02,2.925e-02,6.350e-02,1.034e-02,5.577e-03,1.916e-02,9.215e-01,8.274e-03
AURKB,11390,"condensed nuclear chromosome, centromeric region",GO:0000780,cellular component,72.0,2.0,4.309e-02,2.925e-02,6.350e-02,1.063e-02,5.116e-03,2.209e-02,9.199e-01,9.082e-03
AURKB,11390,spindle microtubule,GO:0005876,cellular component,72.0,11.0,4.309e-02,2.925e-02,6.350e-02,1.741e-02,1.639e-02,1.849e-02,8.896e-01,1.121e-03
AURKB,11390,chromosome passenger complex,GO:0032133,cellular component,72.0,4.0,4.493e-02,2.744e-02,7.356e-02,2.084e-02,1.301e-02,3.338e-02,8.740e-01,1.027e-02
AURKB,11390,midbody,GO:0030496,cellular component,72.0,26.0,4.500e-02,2.736e-02,7.403e-02,1.613e-02,3.058e-03,8.508e-02,8.846e-01,2.630e-02
AURKB,11390,nucleus,GO:0005634,cellular component,72.0,151.0,4.566e-02,2.665e-02,7.825e-02,2.730e-02,9.952e-03,7.488e-02,8.469e-01,2.363e-02
AURKB,11390,nucleoplasm,GO:0005654,cellular component,72.0,74.0,4.598e-02,2.679e-02,7.891e-02,2.647e-02,7.181e-03,9.754e-02,8.470e-01,2.790e-02
AURKB,11390,spindle midzone,GO:0051233,cellular component,72.0,8.0,4.769e-02,2.500e-02,9.097e-02,3.064e-02,7.787e-03,1.206e-01,8.333e-01,3.324e-02
AURKB,11390,kinetochore,GO:0000776,cellular component,72.0,13.0,5.371e-02,4.225e-02,6.827e-02,4.382e-02,3.301e-02,5.818e-02,8.008e-01,7.553e-03
AURKB,11390,kinase binding,GO:0019900,molecular function,72.0,7.0,4.309e-02,2.925e-02,6.350e-02,5.456e-03,6.921e-04,4.301e-02,9.457e-01,2.444e-02
AURKB,11390,histone serine kinase activity,GO:0035174,molecular function,72.0,10.0,4.421e-02,3.265e-02,5.986e-02,1.683e-02,7.447e-03,3.803e-02,8.892e-01,1.564e-02
AURKB,11390,protein serine/threonine kinase activity,GO:0004674,molecular function,72.0,34.0,4.609e-02,3.043e-02,6.982e-02,2.145e-02,1.354e-02,3.400e-02,8.712e-01,9.404e-03
AURKB,11390,protein binding,GO:0005515,molecular function,72.0,332.0,4.628e-02,2.648e-02,8.089e-02,3.208e-02,1.132e-02,9.086e-02,8.310e-01,2.557e-02
TMEM107,28128,non-motile cilium assembly,GO:1905515,biological process,7.0,3.0,2.196e-02,3.936e-03,1.225e-01,6.633e-03,1.375e-03,3.200e-02,9.401e-01,1.880e-02
TMEM107,28128,protein localization to ciliary transition zone,GO:1904491,biological process,7.0,3.0,2.442e-02,3.053e-03,1.954e-01,1.015e-02,3.661e-04,2.816e-01,8.930e-01,5.681e-02
TMEM107,28128,cilium assembly,GO:0060271,biological process,7.0,12.0,3.407e-02,1.193e-02,9.730e-02,1.803e-02,1.162e-02,2.797e-02,8.862e-01,7.941e-03
TMEM107,28128,MKS complex,GO:0036038,cellular component,7.0,2.0,2.442e-02,3.053e-03,1.954e-01,1.275e-02,7.124e-04,2.283e-01,8.840e-01,5.561e-02
TMEM107,28128,ciliary transition zone,GO:0035869,cellular component,7.0,5.0,5.634e-02,2.700e-02,1.175e-01,4.989e-02,1.957e-02,1.272e-01,7.845e-01,2.636e-02
TMEM107,28128,protein binding,GO:0005515,molecular function,7.0,332.0,7.768e-02,5.004e-02,1.206e-01,7.110e-02,4.468e-02,1.131e-01,7.438e-01,1.418e-02
C10orf67,28716,,,,nan,nan,,,,,,,,
LBX2,15525,,,,nan,nan,,,,,,,,
DNHD1,26532,microtubule-based movement,GO:0007018,biological process,8.0,21.0,4.248e-02,1.802e-02,1.001e-01,2.817e-02,9.641e-03,8.230e-02,8.433e-01,2.477e-02
DNHD1,26532,extracellular exosome,GO:0070062,cellular component,8.0,33.0,4.557e-02,2.210e-02,9.397e-02,3.944e-02,1.715e-02,9.069e-02,8.108e-01,2.114e-02
DNHD1,26532,dynein complex,GO:0030286,cellular component,8.0,5.0,8.508e-02,2.482e-02,2.917e-01,8.160e-02,2.068e-02,3.220e-01,7.212e-01,4.107e-02
DNHD1,26532,dynein light intermediate chain binding,GO:0051959,molecular function,8.0,3.0,3.381e-02,1.152e-02,9.924e-02,9.490e-03,2.321e-03,3.880e-02,9.220e-01,1.880e-02
DNHD1,26532,dynein light chain binding,GO:0045503,molecular function,8.0,2.0,3.381e-02,1.152e-02,9.924e-02,1.631e-02,3.994e-03,6.658e-02,8.865e-01,2.666e-02
DNHD1,26532,dynein intermediate chain binding,GO:0045505,molecular function,8.0,2.0,3.381e-02,1.152e-02,9.924e-02,1.735e-02,5.126e-03,5.871e-02,8.838e-01,2.372e-02
DNHD1,26532,"ATP-dependent microtubule motor activity, minus-end-directed",GO:0008569,molecular function,8.0,2.0,3.574e-02,1.265e-02,1.010e-01,2.235e-02,8.292e-03,6.024e-02,8.642e-01,1.968e-02
TMEM86B,28448,ether lipid metabolic process,GO:0046485,biological process,8.0,4.0,1.822e-01,3.709e-02,8.948e-01,1.730e-01,3.234e-02,9.252e-01,5.957e-01,7.795e-02
TMEM86B,28448,membrane,GO:0016020,cellular component,8.0,53.0,1.450e-01,6.164e-02,3.413e-01,7.806e-02,4.169e-02,1.462e-01,7.314e-01,1.884e-02
TMEM86B,28448,cytoplasm,GO:0005737,cellular component,8.0,69.0,1.450e-01,6.164e-02,3.413e-01,9.025e-02,4.993e-02,1.631e-01,7.125e-01,1.952e-02
TMEM86B,28448,protein binding,GO:0005515,molecular function,8.0,332.0,1.450e-01,6.164e-02,3.413e-01,1.035e-01,5.174e-02,2.070e-01,6.933e-01,2.288e-02
TMEM86B,28448,alkenylglycerophosphocholine hydrolase activity,GO:0047408,molecular function,8.0,2.0,1.769e-01,3.967e-02,7.890e-01,1.567e-01,4.023e-02,6.104e-01,6.212e-01,5.837e-02
TMEM86B,28448,alkenylglycerophosphoethanolamine hydrolase activity,GO:0047409,molecular function,8.0,2.0,1.769e-01,3.967e-02,7.890e-01,1.595e-01,4.182e-02,6.081e-01,6.185e-01,5.766e-02
CCDC66,27709,microtubule bundle formation,GO:0001578,biological process,12.0,6.0,1.111e-01,4.360e-02,2.831e-01,4.812e-02,1.357e-02,1.706e-01,7.866e-01,3.339e-02
CCDC66,27709,cilium assembly,GO:0060271,biological process,12.0,12.0,1.215e-01,4.113e-02,3.588e-01,7.901e-02,1.403e-02,4.450e-01,7.216e-01,5.138e-02
CCDC66,27709,regulation of protein localization to cilium,GO:1903564,biological process,12.0,5.0,2.567e-01,6.671e-02,9.881e-01,2.362e-01,5.222e-02,1.068e+00,5.367e-01,8.288e-02
CCDC66,27709,centrosome,GO:0005813,cellular component,12.0,31.0,1.111e-01,4.360e-02,2.831e-01,3.299e-02,1.842e-02,5.906e-02,8.305e-01,1.397e-02
CCDC66,27709,microtubule,GO:0005874,cellular component,12.0,22.0,1.111e-01,4.360e-02,2.831e-01,3.849e-02,2.575e-02,5.755e-02,8.145e-01,1.014e-02
CCDC66,27709,ciliary basal body,GO:0036064,cellular component,12.0,12.0,1.111e-01,4.360e-02,2.831e-01,5.410e-02,2.039e-02,1.435e-01,7.747e-01,2.637e-02
CCDC66,27709,cilium,GO:0005929,cellular component,12.0,6.0,1.196e-01,4.141e-02,3.455e-01,6.221e-02,2.479e-02,1.561e-01,7.586e-01,2.705e-02
CCDC66,27709,centriolar satellite,GO:0034451,cellular component,12.0,4.0,1.661e-01,8.792e-02,3.136e-01,1.412e-01,6.009e-02,3.319e-01,6.467e-01,3.055e-02
CCDC66,27709,photoreceptor inner segment,GO:0001917,cellular component,12.0,2.0,1.684e-01,9.317e-02,3.045e-01,1.521e-01,7.388e-02,3.132e-01,6.358e-01,2.680e-02
CCDC66,27709,microtubule binding,GO:0008017,molecular function,12.0,22.0,1.111e-01,4.360e-02,2.831e-01,4.142e-02,3.622e-02,4.737e-02,8.072e-01,3.632e-03
CCDC66,27709,protein binding,GO:0005515,molecular function,12.0,332.0,1.849e-01,1.321e-01,2.588e-01,1.698e-01,1.316e-01,2.191e-01,6.202e-01,9.978e-03
FRAT2,16048,cytoplasm,GO:0005737,cellular component,3.0,69.0,6.057e-02,5.348e-02,6.859e-02,6.057e-02,5.348e-02,6.859e-02,7.640e-01,3.566e-03
ZNF678,28652,,,,nan,nan,,,,,,,,
ZBTB20,13503,nucleoplasm,GO:0005654,cellular component,5.0,74.0,3.143e-02,1.375e-02,7.188e-02,2.583e-02,1.001e-02,6.664e-02,8.525e-01,2.199e-02
ZBTB20,13503,nucleus,GO:0005634,cellular component,5.0,151.0,3.143e-02,1.375e-02,7.188e-02,2.656e-02,1.302e-02,5.417e-02,8.513e-01,1.658e-02
ZBTB20,13503,nuclear body,GO:0016604,cellular component,5.0,30.0,3.182e-02,1.374e-02,7.372e-02,2.656e-02,1.183e-02,5.963e-02,8.503e-01,1.789e-02
UBE2E2,12478,protein K11-linked ubiquitination,GO:0070979,biological process,16.0,3.0,2.445e-02,9.973e-03,5.995e-02,7.695e-03,1.957e-03,3.026e-02,9.344e-01,1.584e-02
UBE2E2,12478,protein K48-linked ubiquitination,GO:0070936,biological process,16.0,4.0,2.445e-02,9.973e-03,5.995e-02,8.719e-03,3.909e-03,1.944e-02,9.301e-01,1.007e-02
UBE2E2,12478,ISG15-protein conjugation,GO:0032020,biological process,16.0,2.0,2.445e-02,9.973e-03,5.995e-02,9.734e-03,3.964e-03,2.390e-02,9.237e-01,1.211e-02
UBE2E2,12478,protein K63-linked ubiquitination,GO:0070534,biological process,16.0,3.0,2.482e-02,9.935e-03,6.199e-02,1.451e-02,4.833e-03,4.358e-02,8.977e-01,1.772e-02
UBE2E2,12478,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,16.0,7.0,3.548e-02,7.611e-03,1.654e-01,2.812e-02,3.252e-03,2.432e-01,8.317e-01,4.346e-02
UBE2E2,12478,cellular response to DNA damage stimulus,GO:0006974,biological process,16.0,20.0,4.644e-02,2.759e-02,7.817e-02,3.910e-02,1.555e-02,9.828e-02,8.112e-01,2.288e-02
UBE2E2,12478,ubiquitin conjugating enzyme activity,GO:0061631,molecular function,16.0,5.0,2.558e-02,9.392e-03,6.969e-02,1.637e-02,4.659e-03,5.754e-02,8.874e-01,2.273e-02
UBE2E2,12478,ubiquitin-protein transferase activity,GO:0004842,molecular function,16.0,11.0,2.856e-02,1.938e-02,4.208e-02,1.425e-02,4.441e-03,4.575e-02,8.986e-01,1.811e-02
UBE2E2,12478,ISG15 transferase activity,GO:0042296,molecular function,16.0,4.0,3.197e-02,1.758e-02,5.811e-02,2.544e-02,1.162e-02,5.572e-02,8.553e-01,1.842e-02
UBE2E2,12478,protein binding,GO:0005515,molecular function,16.0,332.0,4.037e-02,1.757e-02,9.275e-02,2.844e-02,6.921e-03,1.168e-01,8.408e-01,3.513e-02
B4GALNT4,26315,,,,nan,nan,,,,,,,,
FBXL6,13603,,,,nan,nan,,,,,,,,
KPNA2,6395,NLS-bearing protein import into nucleus,GO:0006607,biological process,23.0,2.0,5.684e-02,1.755e-02,1.842e-01,5.920e-03,1.016e-03,3.451e-02,9.440e-01,1.953e-02
KPNA2,6395,entry of viral genome into host nucleus through nuclear pore complex via importin,GO:0075506,biological process,23.0,2.0,6.722e-02,1.602e-02,2.820e-01,1.174e-02,2.090e-03,6.593e-02,9.072e-01,2.436e-02
KPNA2,6395,positive regulation of viral life cycle,GO:1903902,biological process,23.0,10.0,9.378e-02,3.460e-02,2.542e-01,7.730e-02,3.071e-02,1.946e-01,7.312e-01,2.730e-02
KPNA2,6395,postsynapse to nucleus signaling pathway,GO:0099527,biological process,23.0,2.0,1.018e-01,3.242e-02,3.199e-01,8.939e-02,2.020e-02,3.956e-01,7.079e-01,4.556e-02
KPNA2,6395,cytosol,GO:0005829,cellular component,23.0,78.0,8.165e-02,3.727e-02,1.789e-01,5.136e-02,2.822e-02,9.348e-02,7.824e-01,1.670e-02
KPNA2,6395,nucleoplasm,GO:0005654,cellular component,23.0,74.0,8.236e-02,3.868e-02,1.754e-01,5.297e-02,4.748e-02,5.908e-02,7.794e-01,3.042e-03
KPNA2,6395,membrane,GO:0016020,cellular component,23.0,53.0,8.723e-02,3.359e-02,2.265e-01,6.485e-02,2.076e-02,2.026e-01,7.516e-01,3.505e-02
KPNA2,6395,glutamatergic synapse,GO:0098978,cellular component,23.0,4.0,9.134e-02,3.496e-02,2.387e-01,4.280e-02,8.460e-03,2.166e-01,7.966e-01,4.168e-02
KPNA2,6395,extrinsic component of postsynaptic specialization membrane,GO:0098892,cellular component,23.0,4.0,9.195e-02,3.470e-02,2.437e-01,6.307e-02,1.537e-02,2.589e-01,7.533e-01,3.968e-02
KPNA2,6395,RNA binding,GO:0003723,molecular function,23.0,63.0,8.165e-02,3.727e-02,1.789e-01,4.468e-02,3.485e-02,5.729e-02,7.988e-01,6.819e-03
KPNA2,6395,protein binding,GO:0005515,molecular function,23.0,332.0,8.165e-02,3.727e-02,1.789e-01,5.412e-02,2.564e-02,1.142e-01,7.758e-01,2.142e-02
KPNA2,6395,histone deacetylase binding,GO:0042826,molecular function,23.0,4.0,8.898e-02,3.588e-02,2.206e-01,5.965e-02,2.179e-02,1.633e-01,7.632e-01,2.787e-02
KPNA2,6395,nuclear localization sequence binding,GO:0008139,molecular function,23.0,3.0,9.195e-02,3.470e-02,2.437e-01,6.452e-02,1.544e-02,2.696e-01,7.503e-01,4.200e-02
NGRN,18077,positive regulation of mitochondrial translation,GO:0070131,biological process,6.0,6.0,8.606e-02,1.467e-02,5.049e-01,6.504e-02,7.142e-03,5.922e-01,7.389e-01,7.313e-02
NGRN,18077,mitochondrial membrane,GO:0031966,cellular component,6.0,4.0,7.110e-02,2.270e-02,2.227e-01,5.168e-02,1.480e-02,1.804e-01,7.784e-01,3.647e-02
NGRN,18077,nucleus,GO:0005634,cellular component,6.0,151.0,1.038e-01,6.336e-02,1.702e-01,8.923e-02,7.079e-02,1.125e-01,7.153e-01,7.486e-03
NGRN,18077,rRNA binding,GO:0019843,molecular function,6.0,10.0,6.975e-02,2.368e-02,2.054e-01,3.145e-02,1.276e-02,7.751e-02,8.337e-01,2.208e-02
NGRN,18077,RNA binding,GO:0003723,molecular function,6.0,63.0,7.528e-02,2.602e-02,2.178e-01,3.740e-02,1.560e-02,8.966e-02,8.161e-01,2.277e-02
SMTN,11126,actin cytoskeleton organization,GO:0030036,biological process,17.0,15.0,4.773e-02,9.853e-03,2.312e-01,3.540e-02,6.125e-03,2.046e-01,8.149e-01,4.003e-02
SMTN,11126,microtubule organizing center,GO:0005815,cellular component,17.0,16.0,4.671e-02,8.956e-03,2.436e-01,2.086e-02,2.091e-03,2.081e-01,8.566e-01,4.324e-02
SMTN,11126,filamentous actin,GO:0031941,cellular component,17.0,3.0,5.547e-02,8.399e-03,3.663e-01,5.547e-02,8.399e-03,3.663e-01,7.648e-01,5.068e-02
CDCA2,14623,positive regulation of protein dephosphorylation,GO:0035307,biological process,6.0,7.0,7.725e-02,3.740e-02,1.596e-01,6.132e-02,1.359e-02,2.765e-01,7.564e-01,4.117e-02
CDCA2,14623,chromosome,GO:0005694,cellular component,6.0,9.0,7.318e-02,3.716e-02,1.441e-01,3.593e-02,7.821e-03,1.650e-01,8.166e-01,4.069e-02
CDCA2,14623,nucleoplasm,GO:0005654,cellular component,6.0,74.0,8.098e-02,5.522e-02,1.188e-01,6.452e-02,3.547e-02,1.174e-01,7.552e-01,1.783e-02
CDCA2,14623,cytosol,GO:0005829,cellular component,6.0,78.0,8.154e-02,5.654e-02,1.176e-01,6.494e-02,5.327e-02,7.917e-02,7.556e-01,5.748e-03
PRR16,29654,,,,nan,nan,,,,,,,,
MAFF,6780,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,11.0,62.0,5.628e-02,2.747e-02,1.153e-01,3.365e-02,7.806e-03,1.451e-01,8.232e-01,3.417e-02
MAFF,6780,regulation of epidermal cell differentiation,GO:0045604,biological process,11.0,7.0,1.031e-01,7.844e-03,1.356e+00,7.000e-02,2.669e-03,1.836e+00,7.004e-01,1.211e-01
MAFF,6780,nucleus,GO:0005634,cellular component,11.0,151.0,7.332e-02,4.613e-02,1.165e-01,5.822e-02,3.141e-02,1.079e-01,7.678e-01,1.766e-02
MAFF,6780,mitochondrion,GO:0005739,cellular component,11.0,19.0,7.558e-02,5.366e-02,1.064e-01,6.123e-02,5.047e-02,7.428e-02,7.627e-01,5.564e-03
MAFF,6780,sequence-specific DNA binding,GO:0043565,molecular function,11.0,12.0,5.628e-02,2.747e-02,1.153e-01,1.987e-02,7.457e-03,5.294e-02,8.750e-01,1.966e-02
MAFF,6780,DNA-binding transcription factor activity,GO:0003700,molecular function,11.0,18.0,5.628e-02,2.747e-02,1.153e-01,1.962e-02,5.563e-03,6.922e-02,8.726e-01,2.241e-02
MAFF,6780,RNA polymerase II proximal promoter sequence-specific DNA binding,GO:0000978,molecular function,11.0,25.0,5.814e-02,3.162e-02,1.069e-01,3.142e-02,1.929e-02,5.117e-02,8.353e-01,1.180e-02
MAFF,6780,protein binding,GO:0005515,molecular function,11.0,332.0,8.157e-02,5.529e-02,1.203e-01,7.802e-02,4.853e-02,1.254e-01,7.321e-01,1.489e-02
BRF1,11551,"DNA-templated transcription, initiation",GO:0006352,biological process,10.0,7.0,6.794e-02,1.383e-02,3.338e-01,3.879e-02,4.138e-03,3.636e-01,7.997e-01,5.586e-02
BRF1,11551,RNA polymerase III preinitiation complex assembly,GO:0070898,biological process,10.0,2.0,1.160e-01,2.595e-02,5.188e-01,1.160e-01,2.595e-02,5.188e-01,6.702e-01,5.035e-02
BRF1,11551,transcription factor TFIIIB complex,GO:0000126,cellular component,10.0,4.0,6.285e-02,1.537e-02,2.570e-01,3.368e-02,4.971e-03,2.282e-01,8.178e-01,4.171e-02
BRF1,11551,nucleus,GO:0005634,cellular component,10.0,151.0,7.527e-02,3.337e-02,1.698e-01,4.640e-02,2.607e-02,8.261e-02,7.939e-01,1.547e-02
BRF1,11551,RNA polymerase III type 3 promoter sequence-specific DNA binding,GO:0001006,molecular function,10.0,3.0,6.285e-02,1.537e-02,2.570e-01,2.779e-02,2.332e-03,3.312e-01,8.283e-01,4.855e-02
BRF1,11551,transcription factor binding,GO:0008134,molecular function,10.0,19.0,6.330e-02,1.585e-02,2.528e-01,2.270e-02,8.686e-03,5.931e-02,8.644e-01,2.155e-02
BRF1,11551,protein binding,GO:0005515,molecular function,10.0,332.0,7.637e-02,3.262e-02,1.788e-01,6.160e-02,3.044e-02,1.247e-01,7.608e-01,1.989e-02
CDK10,1770,,,,nan,nan,,,,,,,,
DRG1,3029,positive regulation of microtubule polymerization,GO:0031116,biological process,21.0,7.0,9.608e-02,7.610e-02,1.213e-01,1.998e-02,1.025e-02,3.892e-02,8.764e-01,1.407e-02
DRG1,3029,regulation of mitotic spindle assembly,GO:1901673,biological process,21.0,8.0,9.608e-02,7.610e-02,1.213e-01,3.312e-02,1.433e-02,7.657e-02,8.291e-01,1.995e-02
DRG1,3029,cytoplasmic translation,GO:0002181,biological process,21.0,3.0,9.608e-02,7.610e-02,1.213e-01,4.278e-02,2.108e-02,8.684e-02,8.024e-01,1.898e-02
DRG1,3029,membrane,GO:0016020,cellular component,21.0,53.0,9.608e-02,7.610e-02,1.213e-01,4.277e-02,2.350e-02,7.782e-02,8.026e-01,1.548e-02
DRG1,3029,cytosol,GO:0005829,cellular component,21.0,78.0,9.627e-02,7.607e-02,1.218e-01,6.071e-02,4.863e-02,7.579e-02,7.635e-01,6.316e-03
DRG1,3029,cytoplasm,GO:0005737,cellular component,21.0,69.0,9.627e-02,7.607e-02,1.218e-01,6.597e-02,5.514e-02,7.892e-02,7.537e-01,5.227e-03
DRG1,3029,nucleus,GO:0005634,cellular component,21.0,151.0,9.723e-02,7.574e-02,1.248e-01,7.190e-02,6.468e-02,7.993e-02,7.431e-01,3.230e-03
DRG1,3029,polysome,GO:0005844,cellular component,21.0,2.0,1.072e-01,9.606e-02,1.196e-01,8.675e-02,5.261e-02,1.431e-01,7.181e-01,1.567e-02
DRG1,3029,nuclear body,GO:0016604,cellular component,21.0,30.0,1.093e-01,6.240e-02,1.913e-01,7.476e-02,3.122e-02,1.790e-01,7.357e-01,2.687e-02
DRG1,3029,identical protein binding,GO:0042802,molecular function,21.0,20.0,9.608e-02,7.610e-02,1.213e-01,3.520e-02,2.459e-02,5.039e-02,8.239e-01,8.869e-03
DRG1,3029,microtubule binding,GO:0008017,molecular function,21.0,22.0,9.608e-02,7.610e-02,1.213e-01,4.041e-02,1.832e-02,8.913e-02,8.084e-01,2.052e-02
DRG1,3029,protein binding,GO:0005515,molecular function,21.0,332.0,9.873e-02,7.339e-02,1.328e-01,7.784e-02,5.302e-02,1.143e-01,7.325e-01,1.189e-02
DRG1,3029,potassium ion binding,GO:0030955,molecular function,21.0,2.0,1.149e-01,6.120e-02,2.156e-01,9.550e-02,3.892e-02,2.343e-01,7.032e-01,2.933e-02
DRG1,3029,GTPase activity,GO:0003924,molecular function,21.0,7.0,1.319e-01,6.010e-02,2.893e-01,1.166e-01,4.943e-02,2.753e-01,6.753e-01,2.925e-02
DRG1,3029,GTP binding,GO:0005525,molecular function,21.0,7.0,1.733e-01,4.851e-02,6.194e-01,1.694e-01,4.395e-02,6.528e-01,6.106e-01,5.206e-02
AIDA,25761,,,,nan,nan,,,,,,,,
KIF18B,27102,mitotic cell cycle,GO:0000278,biological process,25.0,13.0,8.728e-02,7.272e-02,1.047e-01,3.996e-02,2.354e-02,6.783e-02,8.100e-01,1.320e-02
KIF18B,27102,microtubule depolymerization,GO:0007019,biological process,25.0,11.0,8.872e-02,6.995e-02,1.125e-01,4.266e-02,1.928e-02,9.438e-02,8.024e-01,2.141e-02
KIF18B,27102,mitotic sister chromatid segregation,GO:0000070,biological process,25.0,9.0,1.000e-01,7.400e-02,1.353e-01,6.793e-02,4.136e-02,1.116e-01,7.494e-01,1.437e-02
KIF18B,27102,regulation of cell division,GO:0051302,biological process,25.0,12.0,1.198e-01,8.434e-02,1.703e-01,8.370e-02,4.103e-02,1.708e-01,7.219e-01,2.179e-02
KIF18B,27102,microtubule-based movement,GO:0007018,biological process,25.0,21.0,1.230e-01,6.365e-02,2.377e-01,1.024e-01,3.076e-02,3.410e-01,6.915e-01,3.852e-02
KIF18B,27102,mitotic spindle midzone,GO:1990023,cellular component,25.0,4.0,8.728e-02,7.272e-02,1.047e-01,1.023e-02,4.891e-03,2.138e-02,9.222e-01,8.924e-03
KIF18B,27102,microtubule plus-end,GO:0035371,cellular component,25.0,6.0,8.728e-02,7.272e-02,1.047e-01,1.496e-02,1.172e-02,1.908e-02,9.004e-01,4.114e-03
KIF18B,27102,astral microtubule,GO:0000235,cellular component,25.0,5.0,8.728e-02,7.272e-02,1.047e-01,1.839e-02,1.215e-02,2.786e-02,8.844e-01,8.219e-03
KIF18B,27102,mitotic spindle astral microtubule,GO:0061673,cellular component,25.0,3.0,8.728e-02,7.272e-02,1.047e-01,2.070e-02,1.657e-02,2.585e-02,8.754e-01,4.750e-03
KIF18B,27102,microtubule,GO:0005874,cellular component,25.0,22.0,8.728e-02,7.272e-02,1.047e-01,3.023e-02,2.242e-02,4.074e-02,8.395e-01,7.126e-03
KIF18B,27102,kinesin complex,GO:0005871,cellular component,25.0,16.0,8.753e-02,7.223e-02,1.061e-01,4.495e-02,3.342e-02,6.046e-02,7.980e-01,8.133e-03
KIF18B,27102,microtubule end,GO:1990752,cellular component,25.0,6.0,9.237e-02,7.479e-02,1.141e-01,5.178e-02,2.792e-02,9.601e-02,7.814e-01,1.729e-02
KIF18B,27102,nuclear body,GO:0016604,cellular component,25.0,30.0,1.170e-01,6.720e-02,2.036e-01,8.361e-02,2.727e-02,2.563e-01,7.194e-01,3.689e-02
KIF18B,27102,cytosol,GO:0005829,cellular component,25.0,78.0,1.392e-01,1.002e-01,1.934e-01,1.232e-01,7.148e-02,2.123e-01,6.689e-01,1.895e-02
KIF18B,27102,nucleus,GO:0005634,cellular component,25.0,151.0,1.428e-01,1.112e-01,1.835e-01,1.286e-01,9.899e-02,1.669e-01,6.635e-01,9.412e-03
KIF18B,27102,cytoplasm,GO:0005737,cellular component,25.0,69.0,1.428e-01,1.112e-01,1.835e-01,1.313e-01,9.034e-02,1.909e-01,6.601e-01,1.344e-02
KIF18B,27102,microtubule motor activity,GO:0003777,molecular function,25.0,13.0,8.728e-02,7.272e-02,1.047e-01,2.629e-02,2.352e-02,2.938e-02,8.532e-01,2.663e-03
KIF18B,27102,microtubule binding,GO:0008017,molecular function,25.0,22.0,8.753e-02,7.223e-02,1.061e-01,3.401e-02,2.261e-02,5.116e-02,8.279e-01,9.909e-03
KIF18B,27102,motor activity,GO:0003774,molecular function,25.0,5.0,8.753e-02,7.223e-02,1.061e-01,3.517e-02,1.528e-02,8.094e-02,8.227e-01,2.023e-02
KIF18B,27102,"ATP-dependent microtubule motor activity, plus-end-directed",GO:0008574,molecular function,25.0,6.0,8.801e-02,7.129e-02,1.087e-01,4.490e-02,2.644e-02,7.627e-02,7.977e-01,1.433e-02
KIF18B,27102,kinesin binding,GO:0019894,molecular function,25.0,7.0,1.004e-01,6.571e-02,1.533e-01,7.109e-02,2.974e-02,1.699e-01,7.421e-01,2.652e-02
KIF18B,27102,ATPase activity,GO:0016887,molecular function,25.0,14.0,1.087e-01,8.259e-02,1.431e-01,8.025e-02,5.528e-02,1.165e-01,7.287e-01,1.174e-02
KIF18B,27102,protein binding,GO:0005515,molecular function,25.0,332.0,1.628e-01,1.574e-01,1.685e-01,1.617e-01,1.531e-01,1.708e-01,6.285e-01,2.112e-03
PTMA,9623,negative regulation of apoptotic process,GO:0043066,biological process,18.0,31.0,2.091e-02,9.682e-03,4.517e-02,1.852e-02,7.214e-03,4.755e-02,8.808e-01,1.834e-02
PTMA,9623,nucleus,GO:0005634,cellular component,18.0,151.0,1.781e-02,1.093e-02,2.903e-02,9.468e-03,4.151e-03,2.160e-02,9.260e-01,9.811e-03
PTMA,9623,cytosol,GO:0005829,cellular component,18.0,78.0,1.781e-02,1.093e-02,2.903e-02,9.363e-03,4.041e-03,2.169e-02,9.260e-01,1.098e-02
PTMA,9623,nucleoplasm,GO:0005654,cellular component,18.0,74.0,1.781e-02,1.093e-02,2.903e-02,1.177e-02,7.896e-03,1.754e-02,9.150e-01,5.265e-03
PTMA,9623,protein binding,GO:0005515,molecular function,18.0,332.0,1.879e-02,9.840e-03,3.587e-02,1.168e-02,3.947e-03,3.457e-02,9.115e-01,1.698e-02
PTMA,9623,activating transcription factor binding,GO:0033613,molecular function,18.0,3.0,2.018e-02,1.236e-02,3.295e-02,1.558e-02,6.883e-03,3.527e-02,8.947e-01,1.429e-02
ZNF286A,13501,,,,nan,nan,,,,,,,,
TMPPE,33865,,,,nan,nan,,,,,,,,
PRR19,33728,protein binding,GO:0005515,molecular function,2.0,332.0,6.249e-02,5.277e-02,7.400e-02,6.249e-02,5.277e-02,7.400e-02,7.602e-01,4.890e-03
HMX3,5019,,,,nan,nan,,,,,,,,
NOC2L,24517,cellular response to UV,GO:0034644,biological process,22.0,12.0,1.409e-01,1.192e-01,1.666e-01,6.679e-02,3.028e-02,1.473e-01,7.505e-01,2.309e-02
NOC2L,24517,negative regulation of intrinsic apoptotic signaling pathway,GO:2001243,biological process,22.0,11.0,1.430e-01,1.112e-01,1.838e-01,5.504e-02,5.595e-03,5.413e-01,7.607e-01,5.845e-02
NOC2L,24517,negative regulation of histone acetylation,GO:0035067,biological process,22.0,9.0,1.475e-01,1.089e-01,1.998e-01,1.049e-01,6.445e-02,1.706e-01,6.924e-01,1.631e-02
NOC2L,24517,chromatin assembly,GO:0031497,biological process,22.0,6.0,1.585e-01,9.151e-02,2.747e-01,7.953e-02,1.883e-02,3.358e-01,7.230e-01,4.744e-02
NOC2L,24517,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,22.0,54.0,1.593e-01,1.438e-01,1.764e-01,1.322e-01,8.866e-02,1.971e-01,6.589e-01,1.442e-02
NOC2L,24517,ribosomal large subunit biogenesis,GO:0042273,biological process,22.0,2.0,1.635e-01,9.549e-02,2.800e-01,1.057e-01,2.778e-02,4.025e-01,6.856e-01,4.348e-02
NOC2L,24517,negative regulation of B cell apoptotic process,GO:0002903,biological process,22.0,6.0,2.056e-01,1.326e-01,3.185e-01,1.928e-01,1.245e-01,2.985e-01,5.979e-01,1.805e-02
NOC2L,24517,nucleoplasm,GO:0005654,cellular component,22.0,74.0,1.393e-01,1.135e-01,1.711e-01,6.753e-02,4.841e-02,9.421e-02,7.505e-01,9.661e-03
NOC2L,24517,nucleus,GO:0005634,cellular component,22.0,151.0,1.393e-01,1.135e-01,1.711e-01,7.176e-02,5.501e-02,9.362e-02,7.431e-01,7.873e-03
NOC2L,24517,cytosol,GO:0005829,cellular component,22.0,78.0,1.393e-01,1.135e-01,1.711e-01,7.701e-02,5.693e-02,1.042e-01,7.341e-01,9.227e-03
NOC2L,24517,nucleolus,GO:0005730,cellular component,22.0,41.0,1.393e-01,1.135e-01,1.711e-01,8.129e-02,5.248e-02,1.259e-01,7.269e-01,1.346e-02
NOC2L,24517,Noc2p-Noc3p complex,GO:0030691,cellular component,22.0,2.0,1.950e-01,1.011e-01,3.762e-01,1.857e-01,8.648e-02,3.986e-01,6.020e-01,3.029e-02
NOC2L,24517,Noc1p-Noc2p complex,GO:0030690,cellular component,22.0,2.0,1.950e-01,1.011e-01,3.762e-01,1.867e-01,8.552e-02,4.076e-01,6.009e-01,3.088e-02
NOC2L,24517,histone binding,GO:0042393,molecular function,22.0,9.0,1.329e-01,1.126e-01,1.569e-01,2.364e-02,7.454e-03,7.496e-02,8.591e-01,2.470e-02
NOC2L,24517,nucleosome binding,GO:0031491,molecular function,22.0,6.0,1.329e-01,1.126e-01,1.569e-01,2.319e-02,4.877e-03,1.103e-01,8.566e-01,3.242e-02
NOC2L,24517,transcription corepressor activity,GO:0003714,molecular function,22.0,6.0,1.393e-01,1.135e-01,1.711e-01,2.339e-02,1.801e-02,3.038e-02,8.643e-01,5.962e-03
NOC2L,24517,repressing transcription factor binding,GO:0070491,molecular function,22.0,3.0,1.393e-01,1.135e-01,1.711e-01,6.135e-02,1.465e-02,2.568e-01,7.567e-01,4.007e-02
NOC2L,24517,protein binding,GO:0005515,molecular function,22.0,332.0,1.393e-01,1.135e-01,1.711e-01,7.969e-02,5.479e-02,1.159e-01,7.296e-01,1.148e-02
NOC2L,24517,RNA binding,GO:0003723,molecular function,22.0,63.0,1.427e-01,1.257e-01,1.619e-01,8.954e-02,5.468e-02,1.466e-01,7.139e-01,1.618e-02
NOC2L,24517,chromatin binding,GO:0003682,molecular function,22.0,17.0,1.430e-01,1.112e-01,1.838e-01,6.606e-02,2.919e-02,1.495e-01,7.517e-01,2.387e-02
FAM111B,24200,protein binding,GO:0005515,molecular function,2.0,332.0,4.789e-02,4.335e-02,5.291e-02,4.789e-02,4.335e-02,5.291e-02,7.909e-01,2.631e-03
H1F0,4714,nucleosome positioning,GO:0016584,biological process,27.0,3.0,5.854e-02,2.863e-02,1.197e-01,2.581e-02,9.172e-03,7.264e-02,8.517e-01,2.192e-02
H1F0,4714,chromosome condensation,GO:0030261,biological process,27.0,5.0,7.139e-02,3.541e-02,1.439e-01,3.318e-02,8.069e-03,1.365e-01,8.250e-01,3.496e-02
H1F0,4714,negative regulation of chromatin silencing,GO:0031936,biological process,27.0,13.0,7.332e-02,2.549e-02,2.109e-01,3.555e-02,2.136e-03,5.917e-01,7.991e-01,5.930e-02
H1F0,4714,chromatin silencing,GO:0006342,biological process,27.0,13.0,8.101e-02,2.365e-02,2.775e-01,4.355e-02,3.860e-03,4.913e-01,7.846e-01,5.666e-02
H1F0,4714,"regulation of transcription, DNA-templated",GO:0006355,biological process,27.0,36.0,8.108e-02,2.292e-02,2.869e-01,3.363e-02,1.883e-03,6.008e-01,8.033e-01,6.300e-02
H1F0,4714,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,27.0,54.0,9.769e-02,1.787e-02,5.342e-01,7.599e-02,7.627e-03,7.572e-01,7.193e-01,7.018e-02
H1F0,4714,positive regulation of transcription regulatory region DNA binding,GO:2000679,biological process,27.0,5.0,1.074e-01,3.813e-02,3.026e-01,1.019e-01,3.331e-02,3.118e-01,6.927e-01,3.569e-02
H1F0,4714,negative regulation of DNA recombination,GO:0045910,biological process,27.0,13.0,1.745e-01,2.598e-02,1.172e+00,1.486e-01,1.546e-02,1.429e+00,6.062e-01,1.023e-01
H1F0,4714,nuclear euchromatin,GO:0005719,cellular component,27.0,4.0,5.854e-02,2.863e-02,1.197e-01,1.095e-02,5.479e-03,2.188e-02,9.178e-01,9.739e-03
H1F0,4714,Golgi apparatus,GO:0005794,cellular component,27.0,15.0,5.854e-02,2.863e-02,1.197e-01,2.806e-02,1.708e-02,4.610e-02,8.464e-01,1.155e-02
H1F0,4714,nuclear chromatin,GO:0000790,cellular component,27.0,14.0,6.170e-02,3.551e-02,1.072e-01,1.924e-02,7.553e-03,4.903e-02,8.776e-01,1.732e-02
H1F0,4714,nuclear body,GO:0016604,cellular component,27.0,30.0,6.400e-02,2.427e-02,1.687e-01,3.956e-02,8.773e-03,1.784e-01,8.066e-01,3.952e-02
H1F0,4714,actin cytoskeleton,GO:0015629,cellular component,27.0,6.0,6.688e-02,3.328e-02,1.344e-01,3.371e-02,1.678e-02,6.774e-02,8.277e-01,1.698e-02
H1F0,4714,nucleus,GO:0005634,cellular component,27.0,151.0,6.732e-02,3.280e-02,1.382e-01,3.760e-02,1.590e-02,8.889e-02,8.158e-01,2.147e-02
H1F0,4714,transcriptional repressor complex,GO:0017053,cellular component,27.0,6.0,7.969e-02,2.052e-02,3.094e-01,3.932e-02,3.779e-03,4.091e-01,7.971e-01,6.502e-02
H1F0,4714,nucleosomal DNA binding,GO:0031492,molecular function,27.0,3.0,5.854e-02,2.863e-02,1.197e-01,1.450e-02,7.273e-03,2.890e-02,9.007e-01,1.096e-02
H1F0,4714,chromatin DNA binding,GO:0031490,molecular function,27.0,6.0,5.854e-02,2.863e-02,1.197e-01,1.695e-02,1.052e-02,2.731e-02,8.907e-01,8.499e-03
H1F0,4714,RNA binding,GO:0003723,molecular function,27.0,63.0,6.325e-02,2.627e-02,1.523e-01,1.855e-02,5.728e-04,6.008e-01,8.488e-01,5.568e-02
H1F0,4714,double-stranded DNA binding,GO:0003690,molecular function,27.0,13.0,6.862e-02,3.145e-02,1.497e-01,4.502e-02,1.636e-02,1.239e-01,7.954e-01,2.751e-02
H1F0,4714,protein binding,GO:0005515,molecular function,27.0,332.0,8.351e-02,4.935e-02,1.413e-01,6.025e-02,2.517e-02,1.442e-01,7.628e-01,2.437e-02
SP6,14530,,,,nan,nan,,,,,,,,
CD55,2665,"positive regulation of CD4-positive, alpha-beta T cell activation",GO:2000516,biological process,19.0,9.0,1.083e-01,6.232e-02,1.883e-01,4.269e-02,2.516e-02,7.244e-02,8.030e-01,1.345e-02
CD55,2665,negative regulation of complement activation,GO:0045916,biological process,19.0,9.0,1.141e-01,5.886e-02,2.212e-01,4.600e-02,1.001e-02,2.115e-01,7.899e-01,3.893e-02
CD55,2665,"positive regulation of CD4-positive, alpha-beta T cell proliferation",GO:2000563,biological process,19.0,4.0,1.141e-01,5.886e-02,2.212e-01,4.932e-02,1.288e-02,1.888e-01,7.833e-01,3.499e-02
CD55,2665,regulation of complement activation,GO:0030449,biological process,19.0,9.0,1.351e-01,9.998e-02,1.824e-01,7.246e-02,3.190e-02,1.646e-01,7.400e-01,2.452e-02
CD55,2665,regulation of lipopolysaccharide-mediated signaling pathway,GO:0031664,biological process,19.0,7.0,1.358e-01,1.094e-01,1.686e-01,7.753e-02,2.349e-02,2.559e-01,7.290e-01,3.731e-02
CD55,2665,"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,biological process,19.0,4.0,1.694e-01,4.379e-02,6.555e-01,1.118e-01,1.166e-02,1.073e+00,6.636e-01,7.581e-02
CD55,2665,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,19.0,8.0,2.118e-01,1.027e-01,4.369e-01,1.664e-01,8.452e-02,3.277e-01,6.213e-01,2.610e-02
CD55,2665,regulation of complement-dependent cytotoxicity,GO:1903659,biological process,19.0,4.0,2.257e-01,1.153e-01,4.419e-01,2.103e-01,9.378e-02,4.716e-01,5.787e-01,3.445e-02
CD55,2665,membrane raft,GO:0045121,cellular component,19.0,3.0,1.083e-01,6.232e-02,1.883e-01,2.990e-02,2.324e-02,3.846e-02,8.407e-01,5.942e-03
CD55,2665,plasma membrane,GO:0005886,cellular component,19.0,24.0,1.238e-01,1.121e-01,1.368e-01,3.382e-02,7.342e-03,1.558e-01,8.217e-01,3.467e-02
CD55,2665,extracellular exosome,GO:0070062,cellular component,19.0,33.0,1.304e-01,1.016e-01,1.675e-01,5.136e-02,1.360e-02,1.940e-01,7.787e-01,3.547e-02
CD55,2665,cell surface,GO:0009986,cellular component,19.0,5.0,1.733e-01,6.980e-02,4.302e-01,1.061e-01,1.931e-02,5.830e-01,6.794e-01,5.998e-02
CD55,2665,virus receptor activity,GO:0001618,molecular function,19.0,2.0,1.407e-01,4.028e-02,4.912e-01,5.018e-02,1.799e-03,1.400e+00,7.484e-01,9.529e-02
CD55,2665,protein binding,GO:0005515,molecular function,19.0,332.0,1.802e-01,7.599e-02,4.273e-01,1.298e-01,4.421e-02,3.810e-01,6.579e-01,3.752e-02
CD55,2665,lipid binding,GO:0008289,molecular function,19.0,15.0,2.078e-01,8.049e-02,5.362e-01,1.653e-01,4.772e-02,5.725e-01,6.170e-01,4.653e-02
CYSRT1,30529,extracellular exosome,GO:0070062,cellular component,10.0,33.0,4.863e-03,3.181e-03,7.434e-03,4.863e-03,3.181e-03,7.434e-03,9.571e-01,4.289e-03
HOXC6,5128,anterior/posterior pattern specification,GO:0009952,biological process,7.0,16.0,2.988e-01,1.752e-01,5.097e-01,2.988e-01,1.752e-01,5.097e-01,5.099e-01,2.966e-02
HOXC6,5128,nucleus,GO:0005634,cellular component,7.0,151.0,7.528e-02,5.694e-02,9.951e-02,4.570e-02,3.862e-02,5.409e-02,7.962e-01,4.615e-03
HOXC6,5128,nucleoplasm,GO:0005654,cellular component,7.0,74.0,7.528e-02,5.694e-02,9.951e-02,5.522e-02,3.958e-02,7.705e-02,7.744e-01,9.330e-03
HOXC6,5128,cytosol,GO:0005829,cellular component,7.0,78.0,7.528e-02,5.694e-02,9.951e-02,5.891e-02,4.229e-02,8.206e-02,7.671e-01,9.476e-03
HOXC6,5128,RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000980,molecular function,7.0,4.0,6.711e-02,5.939e-02,7.584e-02,2.258e-02,4.949e-03,1.030e-01,8.601e-01,3.445e-02
CHAMP1,20311,protein localization to kinetochore,GO:0034501,biological process,13.0,8.0,4.626e-02,3.546e-02,6.034e-02,1.135e-02,2.440e-03,5.279e-02,9.100e-01,2.338e-02
CHAMP1,20311,sister chromatid biorientation,GO:0031134,biological process,13.0,3.0,5.115e-02,4.307e-02,6.076e-02,2.589e-02,2.202e-02,3.043e-02,8.546e-01,3.875e-03
CHAMP1,20311,protein localization to microtubule,GO:0035372,biological process,13.0,5.0,5.139e-02,4.294e-02,6.150e-02,2.830e-02,7.168e-03,1.117e-01,8.404e-01,3.076e-02
CHAMP1,20311,attachment of mitotic spindle microtubules to kinetochore,GO:0051315,biological process,13.0,7.0,5.280e-02,4.149e-02,6.721e-02,3.272e-02,2.037e-02,5.255e-02,8.313e-01,1.169e-02
CHAMP1,20311,condensed chromosome kinetochore,GO:0000777,cellular component,13.0,6.0,4.626e-02,3.546e-02,6.034e-02,9.833e-03,6.311e-03,1.532e-02,9.250e-01,5.395e-03
CHAMP1,20311,condensed chromosome,GO:0000793,cellular component,13.0,6.0,4.773e-02,3.836e-02,5.939e-02,1.417e-02,5.565e-03,3.606e-02,9.010e-01,1.365e-02
CHAMP1,20311,spindle,GO:0005819,cellular component,13.0,15.0,5.028e-02,4.310e-02,5.866e-02,2.049e-02,1.088e-02,3.859e-02,8.745e-01,1.366e-02
CHAMP1,20311,Flemming body,GO:0090543,cellular component,13.0,4.0,6.571e-02,3.414e-02,1.265e-01,4.819e-02,2.394e-02,9.699e-02,7.893e-01,1.913e-02
CHAMP1,20311,nucleoplasm,GO:0005654,cellular component,13.0,74.0,8.108e-02,4.071e-02,1.615e-01,7.346e-02,4.319e-02,1.249e-01,7.394e-01,1.568e-02
CHAMP1,20311,nucleus,GO:0005634,cellular component,13.0,151.0,8.216e-02,4.029e-02,1.675e-01,7.126e-02,3.258e-02,1.559e-01,7.424e-01,2.272e-02
CHAMP1,20311,protein binding,GO:0005515,molecular function,13.0,332.0,8.679e-02,3.849e-02,1.957e-01,8.457e-02,3.437e-02,2.081e-01,7.196e-01,2.747e-02
PRC1,9341,regulation of cytokinesis,GO:0032465,biological process,17.0,12.0,7.083e-02,3.541e-02,1.417e-01,1.159e-02,6.774e-03,1.982e-02,9.154e-01,7.164e-03
PRC1,9341,positive regulation of cell population proliferation,GO:0008284,biological process,17.0,40.0,1.150e-01,4.497e-02,2.940e-01,1.150e-01,4.497e-02,2.940e-01,6.769e-01,3.123e-02
PRC1,9341,spindle,GO:0005819,cellular component,17.0,15.0,7.436e-02,4.013e-02,1.378e-01,2.146e-02,8.893e-03,5.179e-02,8.691e-01,1.785e-02
PRC1,9341,midbody,GO:0030496,cellular component,17.0,26.0,8.184e-02,4.169e-02,1.606e-01,3.864e-02,1.928e-02,7.744e-02,8.133e-01,1.788e-02
PRC1,9341,contractile ring,GO:0070938,cellular component,17.0,4.0,8.667e-02,4.719e-02,1.592e-01,5.651e-02,3.922e-02,8.142e-02,7.718e-01,1.037e-02
PRC1,9341,nucleus,GO:0005634,cellular component,17.0,151.0,8.667e-02,4.719e-02,1.592e-01,6.639e-02,3.625e-02,1.216e-01,7.518e-01,1.815e-02
PRC1,9341,protein kinase binding,GO:0019901,molecular function,17.0,32.0,7.795e-02,3.573e-02,1.701e-01,2.619e-02,7.542e-03,9.092e-02,8.486e-01,2.679e-02
PRC1,9341,kinesin binding,GO:0019894,molecular function,17.0,7.0,8.221e-02,3.872e-02,1.745e-01,4.680e-02,9.657e-03,2.268e-01,7.875e-01,4.038e-02
PRC1,9341,protein binding,GO:0005515,molecular function,17.0,332.0,8.912e-02,4.730e-02,1.679e-01,8.025e-02,4.408e-02,1.461e-01,7.279e-01,1.888e-02
MAGEE1,24934,,,,nan,nan,,,,,,,,
TGM2,11778,apoptotic cell clearance,GO:0043277,biological process,15.0,2.0,8.015e-02,3.110e-02,2.065e-01,1.425e-02,3.167e-03,6.411e-02,8.945e-01,2.770e-02
TGM2,11778,peptide cross-linking,GO:0018149,biological process,15.0,36.0,1.017e-01,2.012e-02,5.141e-01,4.404e-02,3.621e-03,5.357e-01,7.824e-01,7.371e-02
TGM2,11778,positive regulation of apoptotic process,GO:0043065,biological process,15.0,28.0,1.097e-01,2.514e-02,4.783e-01,7.519e-02,1.090e-02,5.189e-01,7.265e-01,5.515e-02
TGM2,11778,positive regulation of mitochondrial calcium ion concentration,GO:0051561,biological process,15.0,2.0,1.214e-01,2.112e-02,6.974e-01,7.427e-02,6.207e-03,8.885e-01,7.180e-01,7.919e-02
TGM2,11778,negative regulation of endoplasmic reticulum calcium ion concentration,GO:0032471,biological process,15.0,3.0,1.214e-01,2.112e-02,6.974e-01,9.664e-02,1.233e-02,7.572e-01,6.879e-01,7.035e-02
TGM2,11778,extracellular exosome,GO:0070062,cellular component,15.0,33.0,9.183e-02,2.884e-02,2.924e-01,4.370e-02,1.288e-02,1.483e-01,7.976e-01,3.350e-02
TGM2,11778,mitochondrion,GO:0005739,cellular component,15.0,19.0,9.183e-02,2.884e-02,2.924e-01,5.055e-02,2.022e-02,1.264e-01,7.831e-01,2.609e-02
TGM2,11778,intrinsic component of plasma membrane,GO:0031226,cellular component,15.0,9.0,9.425e-02,2.349e-02,3.782e-01,3.055e-02,3.084e-03,3.025e-01,8.237e-01,5.839e-02
TGM2,11778,focal adhesion,GO:0005925,cellular component,15.0,11.0,9.513e-02,2.842e-02,3.184e-01,5.463e-02,2.174e-02,1.373e-01,7.739e-01,2.521e-02
TGM2,11778,cytosol,GO:0005829,cellular component,15.0,78.0,1.072e-01,5.183e-02,2.219e-01,7.394e-02,2.504e-02,2.183e-01,7.356e-01,3.384e-02
TGM2,11778,collagen-containing extracellular matrix,GO:0062023,cellular component,15.0,13.0,1.080e-01,2.516e-02,4.635e-01,4.649e-02,4.302e-03,5.024e-01,7.781e-01,6.013e-02
TGM2,11778,protein binding,GO:0005515,molecular function,15.0,332.0,1.103e-01,5.463e-02,2.227e-01,7.096e-02,1.524e-02,3.305e-01,7.373e-01,4.626e-02
TGM2,11778,protein-glutamine gamma-glutamyltransferase activity,GO:0003810,molecular function,15.0,2.0,1.165e-01,2.255e-02,6.021e-01,6.930e-02,4.833e-03,9.937e-01,7.259e-01,7.485e-02
RBM20,27424,,,,nan,nan,,,,,,,,
PSMB8,9545,proteasomal ubiquitin-independent protein catabolic process,GO:0010499,biological process,20.0,3.0,5.602e-02,2.574e-02,1.219e-01,9.019e-03,2.789e-03,2.917e-02,9.275e-01,1.340e-02
PSMB8,9545,proteasomal protein catabolic process,GO:0010498,biological process,20.0,7.0,5.602e-02,2.574e-02,1.219e-01,1.831e-02,5.338e-03,6.280e-02,8.790e-01,2.086e-02
PSMB8,9545,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,20.0,17.0,5.748e-02,2.521e-02,1.311e-01,2.081e-02,3.579e-03,1.210e-01,8.638e-01,3.556e-02
PSMB8,9545,fat cell differentiation,GO:0045444,biological process,20.0,5.0,8.560e-02,4.417e-02,1.659e-01,4.775e-02,9.150e-03,2.492e-01,7.834e-01,4.781e-02
PSMB8,9545,regulation of endopeptidase activity,GO:0052548,biological process,20.0,8.0,1.026e-01,5.224e-02,2.013e-01,7.370e-02,1.477e-02,3.679e-01,7.321e-01,4.651e-02
PSMB8,9545,proteasome core complex,GO:0005839,cellular component,20.0,5.0,7.076e-02,6.957e-02,7.198e-02,1.982e-02,9.939e-03,3.953e-02,8.769e-01,1.486e-02
PSMB8,9545,proteasome complex,GO:0000502,cellular component,20.0,7.0,7.663e-02,6.597e-02,8.901e-02,4.513e-02,1.620e-02,1.257e-01,7.951e-01,2.651e-02
PSMB8,9545,extracellular exosome,GO:0070062,cellular component,20.0,33.0,7.905e-02,7.313e-02,8.544e-02,4.284e-02,3.604e-02,5.092e-02,8.036e-01,4.698e-03
PSMB8,9545,cytoplasm,GO:0005737,cellular component,20.0,69.0,8.766e-02,5.778e-02,1.330e-01,6.376e-02,3.952e-02,1.028e-01,7.572e-01,1.375e-02
PSMB8,9545,nucleus,GO:0005634,cellular component,20.0,151.0,8.766e-02,5.778e-02,1.330e-01,7.281e-02,3.875e-02,1.368e-01,7.401e-01,1.921e-02
PSMB8,9545,protein binding,GO:0005515,molecular function,20.0,332.0,8.766e-02,5.778e-02,1.330e-01,7.231e-02,4.518e-02,1.158e-01,7.417e-01,1.435e-02
PSMB8,9545,endopeptidase activity,GO:0004175,molecular function,20.0,10.0,9.819e-02,6.797e-02,1.419e-01,9.031e-02,7.210e-02,1.131e-01,7.135e-01,7.204e-03
FKBPL,13949,extracellular region,GO:0005576,cellular component,5.0,6.0,4.648e-02,1.197e-02,1.805e-01,4.648e-02,1.197e-02,1.805e-01,7.897e-01,3.658e-02
FKBPL,13949,protein binding,GO:0005515,molecular function,5.0,332.0,4.648e-02,1.197e-02,1.805e-01,3.494e-02,1.673e-02,7.299e-02,8.239e-01,1.794e-02
DCTN1,2711,microtubule anchoring at centrosome,GO:0034454,biological process,76.0,3.0,3.274e-02,1.951e-02,5.495e-02,5.498e-03,2.578e-03,1.173e-02,9.518e-01,7.884e-03
DCTN1,2711,neuron projection maintenance,GO:1990535,biological process,76.0,2.0,3.274e-02,1.951e-02,5.495e-02,9.246e-03,5.599e-03,1.527e-02,9.279e-01,5.797e-03
DCTN1,2711,positive regulation of microtubule nucleation,GO:0090063,biological process,76.0,4.0,3.324e-02,2.040e-02,5.416e-02,1.007e-02,5.079e-03,1.997e-02,9.231e-01,8.418e-03
DCTN1,2711,regulation of mitotic spindle organization,GO:0060236,biological process,76.0,9.0,3.466e-02,1.704e-02,7.050e-02,1.220e-02,1.508e-03,9.867e-02,8.982e-01,3.746e-02
DCTN1,2711,centriole-centriole cohesion,GO:0010457,biological process,76.0,4.0,3.511e-02,1.975e-02,6.242e-02,1.649e-02,6.729e-03,4.039e-02,8.900e-01,1.717e-02
DCTN1,2711,positive regulation of microtubule polymerization,GO:0031116,biological process,76.0,7.0,3.536e-02,2.026e-02,6.172e-02,1.455e-02,1.052e-02,2.012e-02,9.022e-01,5.334e-03
DCTN1,2711,non-motile cilium assembly,GO:1905515,biological process,76.0,3.0,3.537e-02,2.007e-02,6.234e-02,1.861e-02,1.207e-02,2.871e-02,8.834e-01,8.084e-03
DCTN1,2711,establishment of mitotic spindle orientation,GO:0000132,biological process,76.0,4.0,3.651e-02,2.416e-02,5.517e-02,1.080e-02,1.963e-03,5.940e-02,9.107e-01,2.668e-02
DCTN1,2711,neuromuscular junction development,GO:0007528,biological process,76.0,4.0,4.189e-02,2.543e-02,6.901e-02,1.982e-02,4.103e-03,9.575e-02,8.697e-01,3.020e-02
DCTN1,2711,nuclear envelope disassembly,GO:0051081,biological process,76.0,6.0,4.820e-02,3.218e-02,7.220e-02,3.839e-02,2.402e-02,6.134e-02,8.147e-01,1.198e-02
DCTN1,2711,positive regulation of neuromuscular junction development,GO:1904398,biological process,76.0,5.0,4.890e-02,2.200e-02,1.087e-01,3.412e-02,1.103e-02,1.055e-01,8.246e-01,2.913e-02
DCTN1,2711,neuromuscular process,GO:0050905,biological process,76.0,5.0,5.319e-02,1.774e-02,1.595e-01,4.195e-02,9.582e-03,1.836e-01,8.005e-01,3.972e-02
DCTN1,2711,motor behavior,GO:0061744,biological process,76.0,3.0,5.840e-02,1.875e-02,1.819e-01,3.641e-02,5.086e-03,2.607e-01,8.104e-01,5.249e-02
DCTN1,2711,neuron cellular homeostasis,GO:0070050,biological process,76.0,5.0,5.873e-02,1.938e-02,1.780e-01,4.680e-02,1.088e-02,2.013e-01,7.883e-01,3.842e-02
DCTN1,2711,"retrograde transport, endosome to Golgi",GO:0042147,biological process,76.0,8.0,5.944e-02,2.595e-02,1.361e-01,3.948e-02,7.156e-03,2.179e-01,8.047e-01,4.380e-02
DCTN1,2711,ventral spinal cord development,GO:0021517,biological process,76.0,2.0,7.019e-02,3.369e-02,1.463e-01,6.144e-02,2.280e-02,1.655e-01,7.595e-01,2.904e-02
DCTN1,2711,cell cortex,GO:0005938,cellular component,76.0,5.0,3.274e-02,1.951e-02,5.495e-02,5.056e-03,2.395e-03,1.067e-02,9.552e-01,7.551e-03
DCTN1,2711,centrosome,GO:0005813,cellular component,76.0,31.0,3.274e-02,1.951e-02,5.495e-02,5.661e-03,1.585e-03,2.021e-02,9.490e-01,1.354e-02
DCTN1,2711,centriolar subdistal appendage,GO:0120103,cellular component,76.0,4.0,3.274e-02,1.951e-02,5.495e-02,6.430e-03,2.461e-03,1.680e-02,9.444e-01,1.063e-02
DCTN1,2711,microtubule associated complex,GO:0005875,cellular component,76.0,9.0,3.377e-02,2.129e-02,5.356e-02,1.150e-02,5.131e-03,2.578e-02,9.150e-01,1.145e-02
DCTN1,2711,spindle,GO:0005819,cellular component,76.0,15.0,3.388e-02,1.799e-02,6.382e-02,1.107e-02,1.770e-03,6.922e-02,9.086e-01,2.832e-02
DCTN1,2711,microtubule,GO:0005874,cellular component,76.0,22.0,3.397e-02,1.813e-02,6.365e-02,1.346e-02,3.588e-03,5.049e-02,9.004e-01,2.311e-02
DCTN1,2711,centriole,GO:0005814,cellular component,76.0,5.0,3.415e-02,1.837e-02,6.349e-02,1.337e-02,2.995e-03,5.972e-02,8.988e-01,2.686e-02
DCTN1,2711,microtubule plus-end,GO:0035371,cellular component,76.0,6.0,3.439e-02,1.879e-02,6.295e-02,1.500e-02,3.936e-03,5.714e-02,8.931e-01,2.342e-02
DCTN1,2711,spindle pole,GO:0000922,cellular component,76.0,15.0,3.484e-02,1.910e-02,6.358e-02,1.371e-02,2.243e-03,8.383e-02,8.959e-01,2.589e-02
DCTN1,2711,neuronal cell body,GO:0043025,cellular component,76.0,3.0,3.495e-02,1.962e-02,6.224e-02,1.368e-02,5.114e-03,3.661e-02,9.031e-01,1.406e-02
DCTN1,2711,cell cortex region,GO:0099738,cellular component,76.0,17.0,3.595e-02,2.106e-02,6.137e-02,2.275e-02,1.001e-02,5.171e-02,8.650e-01,1.832e-02
DCTN1,2711,neuron projection,GO:0043005,cellular component,76.0,21.0,3.633e-02,2.177e-02,6.061e-02,2.222e-02,1.560e-02,3.164e-02,8.690e-01,7.602e-03
DCTN1,2711,kinetochore,GO:0000776,cellular component,76.0,13.0,3.634e-02,2.175e-02,6.074e-02,2.250e-02,1.093e-02,4.631e-02,8.665e-01,1.591e-02
DCTN1,2711,membrane,GO:0016020,cellular component,76.0,53.0,4.239e-02,1.542e-02,1.166e-01,2.615e-02,3.526e-03,1.939e-01,8.409e-01,4.356e-02
DCTN1,2711,nuclear envelope,GO:0005635,cellular component,76.0,4.0,4.350e-02,1.635e-02,1.157e-01,2.955e-02,5.237e-03,1.667e-01,8.328e-01,4.008e-02
DCTN1,2711,intermediate filament cytoskeleton,GO:0045111,cellular component,76.0,8.0,4.447e-02,1.512e-02,1.308e-01,2.347e-02,1.426e-03,3.864e-01,8.391e-01,5.326e-02
DCTN1,2711,cytoplasm,GO:0005737,cellular component,76.0,69.0,4.582e-02,2.099e-02,1.000e-01,3.744e-02,1.391e-02,1.008e-01,8.158e-01,2.455e-02
DCTN1,2711,cytosol,GO:0005829,cellular component,76.0,78.0,4.709e-02,2.041e-02,1.086e-01,3.904e-02,1.313e-02,1.161e-01,8.106e-01,2.731e-02
DCTN1,2711,retromer complex,GO:0030904,cellular component,76.0,2.0,6.109e-02,1.924e-02,1.939e-01,5.297e-02,1.319e-02,2.127e-01,7.742e-01,4.088e-02
DCTN1,2711,tubulin binding,GO:0015631,molecular function,76.0,6.0,3.324e-02,2.040e-02,5.416e-02,9.607e-03,5.984e-03,1.543e-02,9.259e-01,6.026e-03
DCTN1,2711,microtubule binding,GO:0008017,molecular function,76.0,22.0,3.429e-02,1.848e-02,6.361e-02,1.196e-02,2.718e-03,5.259e-02,9.079e-01,2.156e-02
DCTN1,2711,protein kinase binding,GO:0019901,molecular function,76.0,32.0,3.902e-02,2.238e-02,6.804e-02,2.421e-02,8.020e-03,7.309e-02,8.568e-01,2.264e-02
DCTN1,2711,protein binding,GO:0005515,molecular function,76.0,332.0,5.765e-02,3.730e-02,8.912e-02,5.051e-02,2.818e-02,9.056e-02,7.843e-01,1.596e-02
HAUS3,28719,spindle assembly,GO:0051225,biological process,16.0,7.0,4.505e-02,2.511e-02,8.083e-02,1.265e-02,4.404e-03,3.635e-02,9.078e-01,1.430e-02
HAUS3,28719,centrosome cycle,GO:0007098,biological process,16.0,4.0,4.715e-02,2.820e-02,7.885e-02,2.949e-02,2.070e-02,4.201e-02,8.418e-01,8.360e-03
HAUS3,28719,centrosome,GO:0005813,cellular component,16.0,31.0,4.505e-02,2.511e-02,8.083e-02,1.516e-02,9.633e-03,2.386e-02,8.987e-01,7.752e-03
HAUS3,28719,HAUS complex,GO:0070652,cellular component,16.0,2.0,4.505e-02,2.511e-02,8.083e-02,1.442e-02,4.923e-03,4.222e-02,8.987e-01,1.635e-02
HAUS3,28719,mitotic spindle,GO:0072686,cellular component,16.0,17.0,4.505e-02,2.511e-02,8.083e-02,1.823e-02,9.939e-03,3.343e-02,8.845e-01,1.101e-02
HAUS3,28719,microtubule cytoskeleton,GO:0015630,cellular component,16.0,17.0,4.667e-02,2.697e-02,8.074e-02,2.625e-02,1.153e-02,5.979e-02,8.519e-01,1.843e-02
HAUS3,28719,mitochondrion,GO:0005739,cellular component,16.0,19.0,4.846e-02,3.169e-02,7.412e-02,3.809e-02,2.957e-02,4.907e-02,8.161e-01,6.227e-03
HAUS3,28719,intercellular bridge,GO:0045171,cellular component,16.0,25.0,4.898e-02,2.656e-02,9.032e-02,3.843e-02,1.728e-02,8.550e-02,8.134e-01,1.997e-02
HAUS3,28719,nucleoplasm,GO:0005654,cellular component,16.0,74.0,5.391e-02,2.585e-02,1.124e-01,5.198e-02,2.442e-02,1.106e-01,7.804e-01,2.096e-02
HAUS3,28719,protein binding,GO:0005515,molecular function,16.0,332.0,5.391e-02,2.585e-02,1.124e-01,5.252e-02,2.478e-02,1.113e-01,7.793e-01,2.120e-02
PPME1,30178,protein demethylation,GO:0006482,biological process,11.0,5.0,4.619e-02,3.722e-02,5.733e-02,2.666e-02,2.032e-02,3.498e-02,8.514e-01,6.434e-03
PPME1,30178,protein phosphatase 2A binding,GO:0051721,molecular function,11.0,2.0,2.011e-02,8.107e-03,4.990e-02,3.352e-03,1.351e-03,8.317e-03,9.698e-01,7.628e-03
PPME1,30178,protein phosphatase binding,GO:0019903,molecular function,11.0,7.0,3.208e-02,1.936e-02,5.316e-02,1.308e-02,4.086e-03,4.190e-02,9.037e-01,1.979e-02
PPME1,30178,cadherin binding,GO:0045296,molecular function,11.0,9.0,4.619e-02,3.722e-02,5.733e-02,3.147e-02,2.545e-02,3.892e-02,8.355e-01,4.903e-03
PPME1,30178,protein binding,GO:0005515,molecular function,11.0,332.0,5.001e-02,4.142e-02,6.039e-02,4.610e-02,3.237e-02,6.565e-02,7.951e-01,9.491e-03
PPME1,30178,protein C-terminal methylesterase activity,GO:0051722,molecular function,11.0,2.0,5.119e-02,4.025e-02,6.510e-02,4.817e-02,3.084e-02,7.524e-02,7.900e-01,1.207e-02
CCDC7,26533,,,,nan,nan,,,,,,,,
KLLN,37212,,,,nan,nan,,,,,,,,
TMA7,26932,,,,nan,nan,,,,,,,,
PPP1R3E,14943,,,,nan,nan,,,,,,,,
GET4,21690,tail-anchored membrane protein insertion into ER membrane,GO:0071816,biological process,13.0,2.0,6.108e-02,3.060e-02,1.219e-01,1.108e-02,5.576e-03,2.201e-02,9.179e-01,8.640e-03
GET4,21690,protein insertion into ER membrane,GO:0045048,biological process,13.0,7.0,8.851e-02,5.186e-02,1.510e-01,2.880e-02,1.283e-02,6.463e-02,8.429e-01,1.856e-02
GET4,21690,maintenance of unfolded protein involved in ERAD pathway,GO:1904378,biological process,13.0,2.0,1.188e-01,5.373e-02,2.629e-01,1.115e-01,4.527e-02,2.748e-01,6.813e-01,3.238e-02
GET4,21690,cytoplasmic sequestering of protein,GO:0051220,biological process,13.0,4.0,1.553e-01,7.440e-02,3.241e-01,1.457e-01,7.433e-02,2.857e-01,6.429e-01,2.490e-02
GET4,21690,cytosol,GO:0005829,cellular component,13.0,78.0,1.061e-01,4.745e-02,2.373e-01,6.519e-02,2.967e-02,1.432e-01,7.533e-01,2.361e-02
GET4,21690,cytoplasm,GO:0005737,cellular component,13.0,69.0,1.061e-01,4.745e-02,2.373e-01,6.971e-02,3.933e-02,1.236e-01,7.458e-01,1.738e-02
GET4,21690,nucleoplasm,GO:0005654,cellular component,13.0,74.0,1.061e-01,4.745e-02,2.373e-01,7.209e-02,4.868e-02,1.068e-01,7.423e-01,1.201e-02
GET4,21690,nucleolus,GO:0005730,cellular component,13.0,41.0,1.070e-01,4.653e-02,2.461e-01,5.612e-02,1.258e-02,2.503e-01,7.665e-01,4.347e-02
GET4,21690,BAT3 complex,GO:0071818,cellular component,13.0,2.0,1.095e-01,4.403e-02,2.726e-01,8.390e-02,2.370e-02,2.970e-01,7.178e-01,4.134e-02
GET4,21690,chaperone binding,GO:0051087,molecular function,13.0,3.0,5.759e-02,2.631e-02,1.261e-01,6.597e-03,1.590e-03,2.737e-02,9.416e-01,1.618e-02
GET4,21690,protein binding,GO:0005515,molecular function,13.0,332.0,1.061e-01,4.745e-02,2.373e-01,7.401e-02,3.861e-02,1.419e-01,7.380e-01,2.030e-02
ARHGAP8,677,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,6.0,4.0,7.255e-02,3.026e-02,1.740e-01,5.328e-02,1.394e-02,2.036e-01,7.741e-01,3.950e-02
ARHGAP8,677,GTPase activator activity,GO:0005096,molecular function,6.0,6.0,7.255e-02,3.026e-02,1.740e-01,5.864e-02,1.341e-02,2.565e-01,7.619e-01,4.194e-02
ARHGAP8,677,protein binding,GO:0005515,molecular function,6.0,332.0,8.269e-02,4.341e-02,1.575e-01,6.252e-02,4.619e-02,8.464e-02,7.600e-01,8.889e-03
MICAL3,24694,cytoskeleton organization,GO:0007010,biological process,12.0,15.0,5.840e-02,2.877e-02,1.186e-01,2.109e-02,1.365e-02,3.259e-02,8.729e-01,8.991e-03
MICAL3,24694,actin filament depolymerization,GO:0030042,biological process,12.0,4.0,5.840e-02,2.877e-02,1.186e-01,3.528e-02,2.664e-02,4.671e-02,8.239e-01,6.912e-03
MICAL3,24694,plasma membrane,GO:0005886,cellular component,12.0,24.0,5.840e-02,2.877e-02,1.186e-01,3.204e-02,1.282e-02,8.005e-02,8.318e-01,2.256e-02
MICAL3,24694,cytosol,GO:0005829,cellular component,12.0,78.0,6.278e-02,2.882e-02,1.367e-01,5.408e-02,2.438e-02,1.199e-01,7.758e-01,2.196e-02
MICAL3,24694,nucleoplasm,GO:0005654,cellular component,12.0,74.0,6.278e-02,2.882e-02,1.367e-01,5.552e-02,1.778e-02,1.734e-01,7.707e-01,3.051e-02
MICAL3,24694,nucleus,GO:0005634,cellular component,12.0,151.0,6.278e-02,2.882e-02,1.367e-01,6.231e-02,2.901e-02,1.338e-01,7.592e-01,2.159e-02
MICAL3,24694,actin binding,GO:0003779,molecular function,12.0,7.0,5.840e-02,2.877e-02,1.186e-01,3.265e-02,2.034e-02,5.239e-02,8.318e-01,1.127e-02
GLI4,4320,,,,nan,nan,,,,,,,,
PCDHGB1,8708,,,,nan,nan,,,,,,,,
CHMP1B,24287,viral budding via host ESCRT complex,GO:0039702,biological process,27.0,2.0,7.618e-02,4.963e-02,1.170e-01,2.014e-02,1.367e-02,2.968e-02,8.772e-01,8.254e-03
CHMP1B,24287,nucleus organization,GO:0006997,biological process,27.0,16.0,7.618e-02,4.963e-02,1.170e-01,2.173e-02,1.105e-02,4.272e-02,8.693e-01,1.342e-02
CHMP1B,24287,establishment of protein localization,GO:0045184,biological process,27.0,9.0,7.618e-02,4.963e-02,1.170e-01,2.717e-02,9.135e-03,8.078e-02,8.466e-01,2.359e-02
CHMP1B,24287,mitotic metaphase plate congression,GO:0007080,biological process,27.0,9.0,7.726e-02,5.130e-02,1.164e-01,2.969e-02,1.004e-02,8.783e-02,8.384e-01,2.464e-02
CHMP1B,24287,endosome transport via multivesicular body sorting pathway,GO:0032509,biological process,27.0,5.0,7.761e-02,4.748e-02,1.269e-01,1.825e-02,3.140e-03,1.061e-01,8.743e-01,3.738e-02
CHMP1B,24287,late endosome to vacuole transport,GO:0045324,biological process,27.0,6.0,7.763e-02,4.744e-02,1.270e-01,3.892e-02,1.388e-02,1.091e-01,8.111e-01,2.737e-02
CHMP1B,24287,midbody abscission,GO:0061952,biological process,27.0,6.0,8.256e-02,5.757e-02,1.184e-01,4.247e-02,1.898e-02,9.504e-02,8.027e-01,2.147e-02
CHMP1B,24287,regulation of mitotic spindle assembly,GO:1901673,biological process,27.0,8.0,8.413e-02,5.562e-02,1.272e-01,5.490e-02,2.065e-02,1.459e-01,7.730e-01,2.628e-02
CHMP1B,24287,protein transport,GO:0015031,biological process,27.0,23.0,8.681e-02,6.273e-02,1.201e-01,6.121e-02,5.164e-02,7.255e-02,7.626e-01,4.798e-03
CHMP1B,24287,regulation of centrosome duplication,GO:0010824,biological process,27.0,7.0,9.870e-02,5.200e-02,1.874e-01,7.839e-02,2.638e-02,2.330e-01,7.286e-01,3.273e-02
CHMP1B,24287,cell division,GO:0051301,biological process,27.0,20.0,1.063e-01,5.412e-02,2.087e-01,9.704e-02,4.145e-02,2.272e-01,7.014e-01,2.885e-02
CHMP1B,24287,multivesicular body,GO:0005771,cellular component,27.0,2.0,7.618e-02,4.963e-02,1.170e-01,2.317e-02,8.149e-03,6.588e-02,8.611e-01,2.116e-02
CHMP1B,24287,extracellular exosome,GO:0070062,cellular component,27.0,33.0,7.763e-02,4.744e-02,1.270e-01,3.496e-02,1.249e-02,9.785e-02,8.224e-01,2.614e-02
CHMP1B,24287,endosome membrane,GO:0010008,cellular component,27.0,10.0,7.870e-02,4.911e-02,1.261e-01,4.217e-02,2.627e-02,6.768e-02,8.047e-01,1.256e-02
CHMP1B,24287,midbody,GO:0030496,cellular component,27.0,26.0,8.918e-02,4.333e-02,1.835e-01,6.104e-02,2.076e-02,1.795e-01,7.597e-01,3.257e-02
CHMP1B,24287,membrane coat,GO:0030117,cellular component,27.0,4.0,8.997e-02,6.562e-02,1.233e-01,5.503e-02,1.846e-02,1.640e-01,7.721e-01,3.038e-02
CHMP1B,24287,nucleus,GO:0005634,cellular component,27.0,151.0,1.012e-01,6.078e-02,1.686e-01,8.583e-02,4.215e-02,1.748e-01,7.187e-01,2.264e-02
CHMP1B,24287,ESCRT III complex,GO:0000815,cellular component,27.0,3.0,1.029e-01,7.472e-02,1.418e-01,7.050e-02,2.019e-02,2.462e-01,7.410e-01,3.689e-02
CHMP1B,24287,identical protein binding,GO:0042802,molecular function,27.0,20.0,7.618e-02,4.963e-02,1.170e-01,3.312e-02,2.643e-02,4.152e-02,8.303e-01,5.313e-03
CHMP1B,24287,protein domain specific binding,GO:0019904,molecular function,27.0,82.0,8.964e-02,4.593e-02,1.750e-01,6.117e-02,2.128e-02,1.759e-01,7.599e-01,3.006e-02
CHMP1B,24287,protein binding,GO:0005515,molecular function,27.0,332.0,1.016e-01,5.603e-02,1.842e-01,8.519e-02,3.116e-02,2.329e-01,7.179e-01,3.141e-02
C17orf100,34494,,,,nan,nan,,,,,,,,
CEP95,25141,centrosome,GO:0005813,cellular component,4.0,31.0,3.509e-02,2.242e-02,5.493e-02,1.264e-02,9.885e-03,1.617e-02,9.112e-01,3.774e-03
CEP95,25141,spindle pole,GO:0000922,cellular component,4.0,15.0,4.555e-02,1.876e-02,1.106e-01,3.037e-02,1.250e-02,7.375e-02,8.374e-01,2.081e-02
CEP95,25141,protein binding,GO:0005515,molecular function,4.0,332.0,7.539e-02,6.856e-02,8.290e-02,7.539e-02,6.856e-02,8.290e-02,7.371e-01,2.855e-03
SPON1,11252,cell adhesion,GO:0007155,biological process,6.0,11.0,1.762e-01,1.250e-01,2.482e-01,1.740e-01,1.216e-01,2.489e-01,6.157e-01,1.461e-02
SPON1,11252,collagen-containing extracellular matrix,GO:0062023,cellular component,6.0,13.0,1.239e-01,6.935e-02,2.213e-01,2.683e-02,1.313e-02,5.483e-02,8.500e-01,1.587e-02
SPON1,11252,extracellular matrix,GO:0031012,cellular component,6.0,10.0,1.514e-01,1.297e-01,1.768e-01,1.026e-01,7.992e-02,1.317e-01,6.960e-01,8.323e-03
SPON1,11252,extracellular space,GO:0005615,cellular component,6.0,6.0,1.514e-01,1.297e-01,1.768e-01,1.114e-01,5.651e-02,2.198e-01,6.829e-01,2.396e-02
SPON1,11252,protein binding,GO:0005515,molecular function,6.0,332.0,1.480e-01,1.379e-01,1.588e-01,9.398e-02,4.466e-02,1.977e-01,7.063e-01,2.349e-02
PSMB3,9540,proteasomal ubiquitin-independent protein catabolic process,GO:0010499,biological process,20.0,3.0,3.635e-02,1.677e-02,7.881e-02,6.417e-03,2.867e-03,1.436e-02,9.449e-01,8.363e-03
PSMB3,9540,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,20.0,17.0,3.635e-02,1.677e-02,7.881e-02,1.496e-02,3.127e-03,7.159e-02,8.914e-01,2.737e-02
PSMB3,9540,proteasomal protein catabolic process,GO:0010498,biological process,20.0,7.0,3.648e-02,1.671e-02,7.963e-02,1.502e-02,3.610e-03,6.247e-02,8.927e-01,2.188e-02
PSMB3,9540,proteasome complex,GO:0000502,cellular component,20.0,7.0,4.720e-02,4.162e-02,5.352e-02,3.014e-02,1.416e-02,6.415e-02,8.387e-01,1.785e-02
PSMB3,9540,proteasome core complex,GO:0005839,cellular component,20.0,5.0,4.819e-02,3.951e-02,5.878e-02,1.707e-02,6.341e-03,4.596e-02,8.866e-01,1.887e-02
PSMB3,9540,extracellular exosome,GO:0070062,cellular component,20.0,33.0,4.836e-02,3.971e-02,5.889e-02,2.806e-02,1.946e-02,4.044e-02,8.465e-01,8.578e-03
PSMB3,9540,cytoplasm,GO:0005737,cellular component,20.0,69.0,5.681e-02,2.733e-02,1.181e-01,4.268e-02,2.022e-02,9.010e-02,8.024e-01,2.000e-02
PSMB3,9540,nucleus,GO:0005634,cellular component,20.0,151.0,5.681e-02,2.733e-02,1.181e-01,4.989e-02,2.022e-02,1.231e-01,7.848e-01,2.564e-02
PSMB3,9540,protein binding,GO:0005515,molecular function,20.0,332.0,5.681e-02,2.733e-02,1.181e-01,4.819e-02,2.205e-02,1.053e-01,7.891e-01,2.189e-02
PSMB3,9540,endopeptidase activity,GO:0004175,molecular function,20.0,10.0,6.641e-02,3.895e-02,1.132e-01,6.641e-02,3.895e-02,1.132e-01,7.521e-01,1.567e-02
